
<html lang="en"     class="pb-page"  data-request-id="39979697-2c2d-4c75-a5af-dba2392b5637"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-21;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b00802;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle" /></meta><meta name="dc.Creator" content="Richard L.  Mackman" /></meta><meta name="dc.Creator" content="Victoria A.  Steadman" /></meta><meta name="dc.Creator" content="David K.  Dean" /></meta><meta name="dc.Creator" content="Petr  Jansa" /></meta><meta name="dc.Creator" content="Karine G.  Poullennec" /></meta><meta name="dc.Creator" content="Todd  Appleby" /></meta><meta name="dc.Creator" content="Carol  Austin" /></meta><meta name="dc.Creator" content="Caroline A.  Blakemore" /></meta><meta name="dc.Creator" content="Ruby  Cai" /></meta><meta name="dc.Creator" content="Carina  Cannizzaro" /></meta><meta name="dc.Creator" content="Gregory  Chin" /></meta><meta name="dc.Creator" content="Jean-Yves C.  Chiva" /></meta><meta name="dc.Creator" content="Neil A.  Dunbar" /></meta><meta name="dc.Creator" content="Hans  Fliri" /></meta><meta name="dc.Creator" content="Adrian J.  Highton" /></meta><meta name="dc.Creator" content="Hon  Hui" /></meta><meta name="dc.Creator" content="Mingzhe  Ji" /></meta><meta name="dc.Creator" content="Haolun  Jin" /></meta><meta name="dc.Creator" content="Kapil  Karki" /></meta><meta name="dc.Creator" content="Andrew J.  Keats" /></meta><meta name="dc.Creator" content="Linos  Lazarides" /></meta><meta name="dc.Creator" content="Yu-Jen  Lee" /></meta><meta name="dc.Creator" content="Albert  Liclican" /></meta><meta name="dc.Creator" content="Michael  Mish" /></meta><meta name="dc.Creator" content="Bernard  Murray" /></meta><meta name="dc.Creator" content="Simon B.  Pettit" /></meta><meta name="dc.Creator" content="Peter  Pyun" /></meta><meta name="dc.Creator" content="Michael  Sangi" /></meta><meta name="dc.Creator" content="Rex  Santos" /></meta><meta name="dc.Creator" content="Jonathan  Sanvoisin" /></meta><meta name="dc.Creator" content="Uli  Schmitz" /></meta><meta name="dc.Creator" content="Adam  Schrier" /></meta><meta name="dc.Creator" content="Dustin  Siegel" /></meta><meta name="dc.Creator" content="David  Sperandio" /></meta><meta name="dc.Creator" content="George  Stepan" /></meta><meta name="dc.Creator" content="Yang  Tian" /></meta><meta name="dc.Creator" content="Gregory M.  Watt" /></meta><meta name="dc.Creator" content="Hai  Yang" /></meta><meta name="dc.Creator" content="Brian E.  Schultz" /></meta><meta name="dc.Description" content="Cyclophilins are a family of peptidyl-prolyl isomerases that are implicated in a wide range of diseases including hepatitis C. Our aim was to discover through total synthesis an orally bioavailable..." /></meta><meta name="Description" content="Cyclophilins are a family of peptidyl-prolyl isomerases that are implicated in a wide range of diseases including hepatitis C. Our aim was to discover through total synthesis an orally bioavailable..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 3, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00802" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00802" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00802" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00802" /></link>
        
    
    

<title>Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00802" /></meta><meta property="og:title" content="Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0013.jpeg" /></meta><meta property="og:description" content="Cyclophilins are a family of peptidyl-prolyl isomerases that are implicated in a wide range of diseases including hepatitis C. Our aim was to discover through total synthesis an orally bioavailable, non-immunosuppressive cyclophilin (Cyp) inhibitor with potent anti-hepatitis C virus (HCV) activity that could serve as part of an all oral antiviral combination therapy. An initial lead 2 derived from the sanglifehrin A macrocycle was optimized using structure based design to produce a potent and orally bioavailable inhibitor 3. The macrocycle ring size was reduced by one atom, and an internal hydrogen bond drove improved permeability and drug-like properties. 3 demonstrates potent Cyp inhibition (Kd = 5 nM), potent anti-HCV 2a activity (EC50 = 98 nM), and high oral bioavailability in rat (100%) and dog (55%). The synthetic accessibility and properties of 3 support its potential as an anti-HCV agent and for interrogating the role of Cyp inhibition in a variety of diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00802"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00802">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00802&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00802&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00802&amp;href=/doi/10.1021/acs.jmedchem.8b00802" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9473-9499</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01555" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Featured Article</span><a href="/doi/10.1021/acs.jmedchem.8b00736" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Richard L. Mackman</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard L. Mackman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#46142f252e273422680b27252d2b272806212f2a2327226825292b"><span class="__cf_email__" data-cfemail="52003b313a3320367c1f3331393f333c12353b3e3733367c313d3f">[emailÂ protected]</span></a>. Phone: 650 522 5258.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+L.++Mackman">Richard L. Mackman</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8861-7205" title="Orcid link">http://orcid.org/0000-0001-8861-7205</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Victoria A. Steadman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Victoria A. Steadman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Victoria+A.++Steadman">Victoria A. Steadman</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1583-0202" title="Orcid link">http://orcid.org/0000-0003-1583-0202</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">David K. Dean</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David K. Dean</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+K.++Dean">David K. Dean</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Petr Jansa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Petr Jansa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Petr++Jansa">Petr Jansa</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Karine G. Poullennec</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karine G. Poullennec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karine+G.++Poullennec">Karine G. Poullennec</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Todd Appleby</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Todd Appleby</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Todd++Appleby">Todd Appleby</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Carol Austin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carol Austin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carol++Austin">Carol Austin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Caroline A. Blakemore</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Caroline A. Blakemore</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Caroline+A.++Blakemore">Caroline A. Blakemore</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ruby Cai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruby Cai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruby++Cai">Ruby Cai</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Carina Cannizzaro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carina Cannizzaro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carina++Cannizzaro">Carina Cannizzaro</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Gregory Chin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory Chin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory++Chin">Gregory Chin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jean-Yves C. Chiva</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-Yves C. Chiva</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Yves+C.++Chiva">Jean-Yves C. Chiva</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Neil A. Dunbar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Neil A. Dunbar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Neil+A.++Dunbar">Neil A. Dunbar</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hans Fliri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hans Fliri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cypralis Ltd., Babraham Research Campus, Cambridge CB22 3AT, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hans++Fliri">Hans Fliri</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Adrian J. Highton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adrian J. Highton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adrian+J.++Highton">Adrian J. Highton</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hon Hui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hon Hui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hon++Hui">Hon Hui</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Mingzhe Ji</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mingzhe Ji</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mingzhe++Ji">Mingzhe Ji</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Haolun Jin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haolun Jin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haolun++Jin">Haolun Jin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Kapil Karki</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kapil Karki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kapil++Karki">Kapil Karki</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Andrew J. Keats</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew J. Keats</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Keats">Andrew J. Keats</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Linos Lazarides</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Linos Lazarides</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Linos++Lazarides">Linos Lazarides</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Yu-Jen Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu-Jen Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu-Jen++Lee">Yu-Jen Lee</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Albert Liclican</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Albert Liclican</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Albert++Liclican">Albert Liclican</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Michael Mish</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Mish</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Mish">Michael Mish</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Bernard Murray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bernard Murray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bernard++Murray">Bernard Murray</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Simon B. Pettit</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simon B. Pettit</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simon+B.++Pettit">Simon B. Pettit</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Peter Pyun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Pyun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Pyun">Peter Pyun</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Michael Sangi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Sangi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Sangi">Michael Sangi</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Rex Santos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rex Santos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rex++Santos">Rex Santos</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jonathan Sanvoisin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan Sanvoisin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Sanvoisin">Jonathan Sanvoisin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Uli Schmitz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Uli Schmitz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Uli++Schmitz">Uli Schmitz</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Adam Schrier</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adam Schrier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Schrier">Adam Schrier</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Dustin Siegel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dustin Siegel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dustin++Siegel">Dustin Siegel</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">David Sperandio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Sperandio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Sperandio">David Sperandio</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">George Stepan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">George Stepan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=George++Stepan">George Stepan</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Yang Tian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yang Tian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Tian">Yang Tian</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Gregory M. Watt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory M. Watt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+M.++Watt">Gregory M. Watt</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hai Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hai Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hai++Yang">Hai Yang</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Brian E. Schultz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian E. Schultz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+E.++Schultz">Brian E. Schultz</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9757-2547" title="Orcid link">http://orcid.org/0000-0001-9757-2547</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00802&amp;href=/doi/10.1021%2Facs.jmedchem.8b00802" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9473â9499</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 3, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 May 2018</li><li><span class="item_label"><b>Published</b> online</span>3 August 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00802" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00802</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9473%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRichard%2BL.%2BMackman%252C%2BVictoria%2BA.%2BSteadman%252C%2BDavid%2BK.%2BDean%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D21%26contentID%3Dacs.jmedchem.8b00802%26title%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BOrally%2BBioavailable%2BCyclophilin%2BInhibitor%2BDerived%2Bfrom%2Bthe%2BSanglifehrin%2BMacrocycle%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9499%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00802"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3479</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">34</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00802" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;L. Mackman&quot;},{&quot;first_name&quot;:&quot;Victoria&quot;,&quot;last_name&quot;:&quot;A. Steadman&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;K. Dean&quot;},{&quot;first_name&quot;:&quot;Petr&quot;,&quot;last_name&quot;:&quot;Jansa&quot;},{&quot;first_name&quot;:&quot;Karine&quot;,&quot;last_name&quot;:&quot;G. Poullennec&quot;},{&quot;first_name&quot;:&quot;Todd&quot;,&quot;last_name&quot;:&quot;Appleby&quot;},{&quot;first_name&quot;:&quot;Carol&quot;,&quot;last_name&quot;:&quot;Austin&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;A. Blakemore&quot;},{&quot;first_name&quot;:&quot;Ruby&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;Carina&quot;,&quot;last_name&quot;:&quot;Cannizzaro&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;Chin&quot;},{&quot;first_name&quot;:&quot;Jean-Yves&quot;,&quot;last_name&quot;:&quot;C. Chiva&quot;},{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;A. Dunbar&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;Fliri&quot;},{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;J. Highton&quot;},{&quot;first_name&quot;:&quot;Hon&quot;,&quot;last_name&quot;:&quot;Hui&quot;},{&quot;first_name&quot;:&quot;Mingzhe&quot;,&quot;last_name&quot;:&quot;Ji&quot;},{&quot;first_name&quot;:&quot;Haolun&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Kapil&quot;,&quot;last_name&quot;:&quot;Karki&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Keats&quot;},{&quot;first_name&quot;:&quot;Linos&quot;,&quot;last_name&quot;:&quot;Lazarides&quot;},{&quot;first_name&quot;:&quot;Yu-Jen&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;Liclican&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Mish&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;Murray&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;B. Pettit&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Pyun&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Sangi&quot;},{&quot;first_name&quot;:&quot;Rex&quot;,&quot;last_name&quot;:&quot;Santos&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Sanvoisin&quot;},{&quot;first_name&quot;:&quot;Uli&quot;,&quot;last_name&quot;:&quot;Schmitz&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Schrier&quot;},{&quot;first_name&quot;:&quot;Dustin&quot;,&quot;last_name&quot;:&quot;Siegel&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Sperandio&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;Stepan&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Tian&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;M. Watt&quot;},{&quot;first_name&quot;:&quot;Hai&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;E. Schultz&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9473-9499&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00802&quot;},&quot;abstract&quot;:&quot;Cyclophilins are a family of peptidyl-prolyl isomerases that are implicated in a wide range of diseases including hepatitis C. Our aim was to discover through total synthesis an orally bioavailable, non-immunosuppressive cyclophilin (Cyp) inhibitor with potent anti-hepatitis C virus (HCV) activity that could serve as part of an all oral antiviral combination therapy. An initial lead 2 derived from the sanglifehrin A macrocycle was optimized using structure based design to produce a potent and orally bioavailable inhibitor 3. The macrocycle ring size was reduced by one atom, and an internal hydrogen bond drove improved permeability and drug-like properties. 3 demonstrates potent Cyp inhibition (Kd = 5 nM), potent anti-HCV 2a activity (EC50 = 98 nM), and high oral bioavailability in rat (100%) and dog (55%). The synthetic accessibility and properties of 3 support its potential as an anti-HCV agent and for interrogating the role of Cyp inhibition in a variety of diseases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00802&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00802" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00802&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00802" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00802&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00802" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00802&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00802&amp;href=/doi/10.1021/acs.jmedchem.8b00802" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00802" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00802" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00802%26sid%3Dliteratum%253Aachs%26pmid%3D30074795%26genre%3Darticle%26aulast%3DMackman%26date%3D2018%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BOrally%2BBioavailable%2BCyclophilin%2BInhibitor%2BDerived%2Bfrom%2Bthe%2BSanglifehrin%2BMacrocycle%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D21%26spage%3D9473%26epage%3D9499%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a>,</li><li><a href="/action/doSearch?ConceptID=290795" title="Quinolines">Quinolines</a>,</li><li><a href="/action/doSearch?ConceptID=291163" title="Macrocycles">Macrocycles</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/jmcmar.2018.61.issue-21/20181108/jmcmar.2018.61.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cyclophilins are a family of peptidyl-prolyl isomerases that are implicated in a wide range of diseases including hepatitis C. Our aim was to discover through total synthesis an orally bioavailable, non-immunosuppressive cyclophilin (Cyp) inhibitor with potent anti-hepatitis C virus (HCV) activity that could serve as part of an all oral antiviral combination therapy. An initial lead <b>2</b> derived from the sanglifehrin A macrocycle was optimized using structure based design to produce a potent and orally bioavailable inhibitor <b>3</b>. The macrocycle ring size was reduced by one atom, and an internal hydrogen bond drove improved permeability and drug-like properties. <b>3</b> demonstrates potent Cyp inhibition (<i>K</i><sub>d</sub> = 5 nM), potent anti-HCV 2a activity (EC<sub>50</sub> = 98 nM), and high oral bioavailability in rat (100%) and dog (55%). The synthetic accessibility and properties of <b>3</b> support its potential as an anti-HCV agent and for interrogating the role of Cyp inhibition in a variety of diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cyclophilins are a family of peptidyl-prolyl isomerases that are involved in a variety of biological processes.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> They are known to be mediators of the immunosuppressive effects of cyclosporin A (CsA), which acts by simultaneously binding to calcineurin and the cyclophilin (Cyp) isomerase active site.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> The modified CsA analogue, NIM-811, is an inhibitor of Cyp isomerase activity but does not bind calcineurin, making it a valuable tool for studying the non-immunosuppressive biology of Cyp isomerases.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> These studies have implicated Cypâs in a variety of diseases ranging from asthma to viral replication.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7â10)</a> Indeed, several non-immunosuppressive cyclosporin analogues discovered after NIM-811, e.g., alisporivir and SCY-635, have been investigated in clinical trials as potential therapies for hepatitis C virus (HCV) infection.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Alisporivir, the furthest advanced, demonstrated an antiviral effect in HCV-infected patients, but was halted following toxicity observations when dosed in combination with ribavirin and pegylated interferon.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The HCV NS5a protein was identified as the binding target of intracellular Cyp A, one member of the family of human cyclophilins, and although the exact mechanism of viral inhibition remains to be elucidated, it is presumed that interference of the Cyp A and HCV NS5a protein interaction prevents viral replication.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14â18)</a> Cyp inhibitors have also been demonstrated to reduce hepatitis B virus (HBV) infection through interaction with the hepatocyte sodium taurocholate cotransporting polypeptide (NTCP) surface receptor that is required for entry of HBV particles into hepatocytes.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a></div><div class="NLM_p">Despite the broad therapeutic potential of Cyp inhibition, progress in the field has been hampered by the fact that potent Cyp inhibitors are derived from structurally complex natural products such as CsA and sanglifehrins.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25 ref26">(21â26)</a> While semisynthesis strategies have been successfully utilized to improve upon these natural products, this approach fundamentally limits the structureâactivity relationship (SAR) investigations necessary for improving oral pharmacokinetic (PK) properties. Synthetic small molecule inhibitors have been identified from screening campaigns, but, to the best of our knowledge, no highly potent, small molecule with oral properties has been reported to date.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a></div><div class="NLM_p">Our interest in Cyp inhibition stemmed from the potential to administer an oral Cyp A inhibitor in combination with other oral anti-HCV agents as part of a pan genotype, all oral, anti-HCV regimen. It was anticipated that inhibition of a host enzyme such as Cyp A would confer a high barrier to resistance and broad, pan-genotypic activity. We therefore initiated an effort to discover an orally bioavailable, small molecule Cyp A inhibitor that would have a low propensity for drugâdrug interactions. Our first report<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> detailed efforts based on the sanglifehrin A macrocycle, following encouraging reports of anti-HCV activity of a sanglifehrin derived semisynthetic analogue AAE931.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This work culminated in the identification of leads <b>1</b> and <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) that had potent Cyp inhibition and modest ant-HCV activity but poor pharmacokinetics. Here we describe the structure-guided optimization of these leads into a potent and orally bioavailable Cyp A inhibitor <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). A pivotal part of our strategy was to maintain a tractable convergent synthesis that employed readily accessible building blocks. The key advances from <b>2</b> to <b>3</b> are described in three phases, beginning with the isoquinoline replacement of the styrene in <b>2</b> and a reduction in macrocycle ring size to a 21-membered ring. These modifications improved binding affinity and anti-HCV replicon potency in addition to reducing human plasma protein binding. In the second phase, the C1 lactone and C13 lactam groups were switched along with changing from isoquinoline to quinoline, which introduced an intramolecular hydrogen bond. This resulted in significantly improved membrane permeability leading to high oral absorption. The final phase included modification of the C14 substituents to a spiro-1,3-dioxane that lowered log D, reduced oxidative metabolism, and also reduced pregnane X receptor (PXR) activation, which was a liability with respect to drugâdrug interactions. Compound <b>3</b> has high binding affinity, a tractable synthesis, and high oral bioavailability in rat and dog. While <b>3</b> is a potential oral development candidate for anti-HCV combination regimens, it also has utility in interrogating the role of Cyp inhibition in a variety of other preclinical disease models.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Simplified sanglifehrin macrocycles that bind to Cyp A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A time-resolved fluorescence resonance energy transfer (TR-FRET) biochemical assay assessed binding affinity of the compounds toward Cyp A.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The HCV replicon genotype 2a assay in huh-7 cells served as a cell-based functional assay (EC<sub>50</sub>) of Cyp inhibition. The free fraction (% free) in human plasma was determined using equilibrium dialysis between human plasma and buffer. The ratio of cell culture media (CCM) % free and human plasma % free was used to calculate the human plasma-adjusted (pa) EC<sub>50</sub>. For example, <b>2</b> is 59% free in CCM/buffer and 12% free in human plasma/buffer resulting in a 4.9-fold human plasma/CCM shift and a calculated paEC<sub>50</sub> â 1.6 Î¼M. Exposures of <b>2</b> exceeding 1.6 Î¼M would therefore be required to maintain Cyp inhibition above 50%, so significant improvements in the paEC<sub>50</sub> potency of <b>2</b> were desirable. Oral absorption potential was assessed in vitro using log D and Caco-2 assays, while clearance was optimized using predictions from in vitro microsomal stability assays. In vivo correlations to the in vitro PK properties were determined in rat, dog, and cynomolgus monkey following intravenous and oral dosing.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profile of Isoquinoline Analogues <b>4â9</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpdÂ #</th><th class="colsep0 rowsep0" align="center">TR-FRET Cyp A <i>K</i><sub>d</sub> (nM)</th><th class="colsep0 rowsep0" align="center">HCV 2a EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">MT4 CC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">%Â free CCM/HP</th><th class="colsep0 rowsep0" align="center">plasma stab. <i>t</i><sub>1/2</sub>Â h/d/r (min)</th><th class="colsep0 rowsep0" align="center">MS pred. CL h/d (L/h/kg)</th><th class="colsep0 rowsep0" align="center">Caco-2 AB/BA (10<sup>â6</sup>Â cmÂ s<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center">logÂ D pH 7.4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SfA<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CsA<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">773</td><td class="colsep0 rowsep0" align="left">5608</td><td class="colsep0 rowsep0" align="left">14/0.5</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.77/â</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">282</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">333</td><td class="colsep0 rowsep0" align="left">29751</td><td class="colsep0 rowsep0" align="left">59/12</td><td class="colsep0 rowsep0" align="left">S<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a>/600/5</td><td class="colsep0 rowsep0" align="left">1.1/1.3</td><td class="colsep0 rowsep0" align="left">12/31</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">6490</td><td class="colsep0 rowsep0" align="left">79/14</td><td class="colsep0 rowsep0" align="left">750/1047/5</td><td class="colsep0 rowsep0" align="left">1.0/0.6</td><td class="colsep0 rowsep0" align="left">4.4/37</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">284</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">88/12</td><td class="colsep0 rowsep0" align="left">S<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a>/ S<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a>/8</td><td class="colsep0 rowsep0" align="left">0.52/0.30</td><td class="colsep0 rowsep0" align="left">0.33/25</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">604</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">894</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">36853</td><td class="colsep0 rowsep0" align="left">75/32</td><td class="colsep0 rowsep0" align="left">559/417/8</td><td class="colsep0 rowsep0" align="left"><0.17/<0.17</td><td class="colsep0 rowsep0" align="left">0.32/13</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">470</td><td class="colsep0 rowsep0" align="left">2777</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data shown from at least two experiments; TR-FRET, time-resolved fluorescence resonance energy transfer probe displacement assay using cyclophilin A (Cyp A); hepatitis C 2a replicon in huh-7 cells, effective concentration for 50% reduction (EC<sub>50</sub>) in replication; MT4 human leukemia T cell, effective concentration for 50% reduction in cell viability (CC<sub>50</sub>); % free in cell culture media/buffer dialysis (CCM) and % free in human plasma/buffer dialysis (HP); half-life in plasma from human (h), dog (d) and rat (r); microsome (MS) predicted clearance (CL); apical to basolateral (AB) and basolateral to apical (BA) permeability in Caco-2 cells.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">SfA, sanglifehrin A.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">CsA, cyclosporin A.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">S, stable or >1500 min.</p></div></div></div><div class="NLM_p">In the discovery of <b>2</b>, the binding mode of the macrocycle to Cyp A was elucidated wherein the styrene group forms a Ï-stacking interaction with arginine 55 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> This new interaction enabled the <i>m</i>-tyrosine to be replaced by alanine, thereby reducing molecular weight and hydrogen bond donor count without a loss in potency. Given the importance of the arginine 55 Ï-stacking interaction, our initial efforts to optimize <b>2</b> explored a variety of aromatic replacements of styrene, including biphenyl, phenol, and bicyclic heteroaryls.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31â33)</a> This culminated in the identification of isoquinolines <b>4</b>â<b>9</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Overlay of sanglifehrin A (white) with lead <b>2</b> (yellow) illustrating that the piperazic acid-alanine/<i>m</i>-tyrosine-valine backbone atoms are positioned in a similar pose. The sanglifehrin A <i>m</i>-tyrosine group forms a hydrogen bond with histidine 126, and the diene is perpendicular to arginine 55, while the styrene in <b>2</b> invokes a Ï-stacking interaction with arginine 55 and the <i>m</i>-tyrosine is replaced with alanine. (B) Overlay of <b>2</b> (yellow) and the 21-membered ring macrocycle <b>8</b> (cyan) reflecting the differences upon changing the Ï-stacking group and the macrocycle ring size. In the smaller macrocycle <b>8</b>, the isoquinoline aryl ring is positioned over arginine 55 forming the Ï-stacking interaction, and the C13 to C16 carbon atoms in the spacer region are situated further away from the protein surface relative to C13 to C17 of <b>2</b>. A similar distance from arginine 55 is maintained for the Ï-stacking interactions of both <b>2</b> and <b>8</b>. (C) Overlay of isoquinoline <b>8</b> (cyan) and the corresponding quinoline <b>19</b> (purple) illustrating a close overlap of the macrocycle; the most significant difference is the orientation of the <i>trans</i> double bond. (D) Overlay of quinoline <b>19</b> (purple) and its C14 <i>gem</i>-dimethyl analogue <b>20</b> (orange) illustrating the positioning of the C13âC16 atoms closer to the protein surface and the C14 <i>pro-R</i> methyl group forming a lipophilic interaction with threonine 73. (E) Overlay of C1 lactone/C13 lactam <b>20</b> (orange), with C1 lactam/C13 lactone <b>34</b> (pink), illustrating that the respective switch of the C1 and C13 groups leads to a similar binding mode. (F) Overlay of C14 <i>spiro</i>-1,3-dioxane <b>3</b> (green) with C14 <i>gem</i>-dimethyl <b>34</b> (pink) illustrating a similar binding mode of the macrocycle and positioning of the C14 substituents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analogues <b>4</b>â<b>9</b> were synthesized using  methods similar to those reported earlier, employing ring closing metathesis (RCM) in the key macrocyclization step (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The valine terminus of tripeptide <b>10</b> was <i>N</i>-BOC deprotected and the amine coupled with unsaturated acid precursors (e.g., <b>14</b>). The trichloroethyl (TCE) ester was then hydrolyzed and the acid was re-esterified with isoquinoline <b>17</b> to generate the required RCM precursors <b>12a</b>â<b>e</b>. The acid <b>14</b> was prepared in three steps from Oppolzerâs sultam <b>13</b>, using methods similar to those described previously for <b>2</b>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The chiral (<i>R</i>)-hydroxyalkyl isoquinoline, <b>17</b>, was prepared in a Stille coupling, acid hydrolysis, and Noyori reduction sequence, that generated <b>16</b> stereoselectively, followed by a final Stille vinylation. The RCM was conducted using Hoveyda-Grubbs second generation catalyst at a concentration of 3 mM to provide <b>4</b>â<b>7</b> in unoptimized yields ranging from 31 to 63%. The yield was reduced to 23% for the 21-membered ring analogue <b>8</b>. In example <b>8</b>, the RCM substrate <b>12e</b> containing the trisubstituted pent-3-enoic acid was found to be superior to but-3-enoic acid (not shown), which cyclized under similar conditions but provided a mixture of <i>cis</i> and <i>trans</i> double bond isomers in <10% combined yield. Hydrogenation of the unsaturated bond in <b>8</b> using Pd/C afforded the reduced analogue <b>9</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Macrocycles <b>4</b>-<b>9</b> via RCM<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSOTf, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C; (b) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, <b>14 (</b>93% over two steps), pent-4-enoic acid (62% over two steps), hex-5-enoic acid (82% over two steps), hept-6-enoic acid (75% over two steps); (c) Zn, NH<sub>4</sub>OAc, H<sub>2</sub>O, THF, 86â96%; (d) EDC, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, <b>17</b>, 42â89%; (e) Hoveyda-Grubbs II, PhMe, reflux, 3 mmol (2 mmol for <b>12d</b>), 23â63%; (f) EDC, HOBT, CH<sub>3</sub>CN, (<i>E</i>)-pent-3-enoic acid, 88% over two steps from <b>10</b>; (g) LiOH, THF, H<sub>2</sub>O, 95â97%; (h) 10% Pd/C, THF, EtOAc, H<sub>2</sub>, 48%; (i) TMSOTf, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, crotonaldehyde, 1 M TiCl<sub>4</sub> in CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C, 89%; (j) proton sponge, Me<sub>3</sub>OBF<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, quant.; (k) 2 M LiOH, THF, 60 Â°C, 59%; (l) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, tri-<i>n</i>-butyl(1-ethoxyvinyl)tin, PhMe, 50 Â°C, quant.; (m) 2 M HCl, 1,4-dioxane, 89%; (n) dichloro(<i>p</i>-cymene) ruthenium(II) dimer, (1<i>R</i>, 2<i>R</i>)-(â)-<i>N</i>-<i>p</i>-tosyl-1,2-diphenylethylenediamine, THF, H<sub>2</sub>O, HCO<sub>2</sub>Na, 40 Â°C, 92%; (o) tri-<i>n</i>-butyl(vinyl)tin, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1,4-dioxane, 150 Â°C, 50%.</p></p></figure><div class="NLM_p">The binding affinity, replicon activity, and in vitro PK properties for isoquinolines <b>4</b>â<b>9</b> are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Compound <b>4</b> exhibited a â¼5-fold improvement in HCV replicon 2a potency versus <b>2</b> and established the superiority of the isoquinoline series over styrene. Removal of the C14 and C15 substituents, compound <b>5</b>, maintained binding affinity but exhibited weaker replicon 2a potency, implying a role for the substitutions in this region for generating optimal cell based activity. Compound <b>5</b> is also more polar, demonstrating a lower log D and poorer Caco-2 permeability in the apical to basolateral direction. This property was not altogether surprising since we had observed in our earlier report the structural feature in which the C15 methoxy oxygen in <b>4</b> can form an intramolecular hydrogen bond with the C13 NH, thereby reducing its overall polarity.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Despite the weaker antiviral potency of <b>5</b>, it provided a good basis for the rapid exploration of the relationship between macrocycle ring size and Cyp A binding affinity, a relationship that had not been previously reported for the sanglifehrin based inhibitors. Increasing ring size to 23- and 24-membered rings, analogues <b>6</b> and <b>7</b>, respectively, reduced binding affinity relative to <b>5</b>, but in contrast, the smaller 21-membered ring, <b>8</b>, improved binding affinity to below that of CsA. Moreover, the smaller ring had a lower log D and reduced human plasma protein binding (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, column 5, 32% vs 12%). Indeed, <b>8</b> had the lowest calculated paEC<sub>50</sub> = 258 nM of the isoquinoline series and was a 6-fold improvement over <b>2</b>. Compounds <b>4</b>â<b>9</b> showed >100-fold selectivity in the replicon EC<sub>50</sub> relative to the MT4 cell line CC<sub>50</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, column 4), a cell line sensitive to the potential cytotoxic effects of compounds. Interestingly, the smaller macrocycle <b>8</b> also displayed a significantly improved microsomal predicted clearance (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, column 7), presumably due to its lower log D or, alternatively, the shorter more compact C14âC17 spacer region contributing fewer metabolic soft spots relative to <b>5</b>. Saturated analogue <b>9</b> was significantly weaker in binding affinity suggesting that the conformational rigidity of the macrocycle was a critical feature of potent binding.</div><div class="NLM_p">The X-ray structure of isoquinoline <b>8</b> complexed to Cyp A was solved and compared to styrene <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The tripeptide backbone that forms the key hydrogen bond interactions with the Cyp protein remains in a comparable pose to that of <b>2</b>. As expected, the isoquinoline heterocycle is positioned over arginine 55 resulting in a Ï-stacking interaction. The most notable difference was the positioning of the C13âC16 atoms between the isoquinoline and the C13 NH, where the removal of one methylene resulted in these atoms moving away from the protein surface. Armed with the structural information on <b>8</b> and its promising profile, efforts were focused on further evaluation of this novel 21-membered macrocycle.</div><div class="NLM_p">Oral dosing of <b>8</b> in dog and cynomolgus monkey revealed low oral bioavailability, likely due to its low log D and poor Caco-2 permeability. This was confirmed in an oral study in portal vein-cannulated dogs that established only 8% of a 5 mg/kg oral dose was being absorbed (data not shown). We sought to improve the permeability and oral properties of <b>8</b> through continued SAR exploration of the isoquinoline heterocycle and modifications to the C13âC16 region where modeling suggested that the C14 methylene would likely tolerate substitution. The immediate goal was to raise log D and improve permeability. Naphthyl and quinoline analogues, <b>18</b> and <b>19</b>, respectively, were targeted, along with the C14 <i>gem</i>-dimethyl analogues <b>20</b> and <b>21</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The <i>gem</i>-dimethyl groups avoided the need for introducing chirality into this region, and it was thought they would not only raise log D but also improve permeability by shielding the polarity of the nearby C13 lactam group. We also explored the impact of switching the C1 lactone and C13 lactam groups in the context of the quinoline and isoquinoline heterocycles, analogues <b>34</b> and <b>35</b>, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In the case of quinoline <b>34</b>, this could potentially improve permeability through the introduction of an intramolecular hydrogen bond between the quinoline nitrogen and C1 lactam NH.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Profile of Naphthyl <b>18</b>, Quinolines <b>19</b>, <b>20, 34</b> and Isoquinolines <b>21</b> and <b>35</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0011.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpdÂ #</th><th class="colsep0 rowsep0" align="center" char=".">TR-FRET Cyp A <i>K</i><sub>d</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">HCV 2a EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">MT4 CC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">%Â free CCM/HP</th><th class="colsep0 rowsep0" align="center">plasma stab. <i>t</i><sub>1/2</sub>Â h/d/r (min)</th><th class="colsep0 rowsep0" align="center">MS pred. CLÂ h/d (L/h/kg)</th><th class="colsep0 rowsep0" align="center">Caco-2 AB/BA (10<sup>â6</sup>Â cmÂ s<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">logÂ D pH 7.4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="left">36853</td><td class="colsep0 rowsep0" align="left">75/32</td><td class="colsep0 rowsep0" align="left">559/417/8</td><td class="colsep0 rowsep0" align="left"><0.17/<0.17</td><td class="colsep0 rowsep0" align="center">0.32/13</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">400</td><td class="colsep0 rowsep0" align="left">18859</td><td class="colsep0 rowsep0" align="left">32/5</td><td class="colsep0 rowsep0" align="left">S/S/â</td><td class="colsep0 rowsep0" align="left">0.46/0.49</td><td class="colsep0 rowsep0" align="center">6.2/38</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">154</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">49/40</td><td class="colsep0 rowsep0" align="left">532/S/â</td><td class="colsep0 rowsep0" align="left"><0.17/0.19</td><td class="colsep0 rowsep0" align="center">1.2/3.5</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="left">>30000</td><td class="colsep0 rowsep0" align="left">84/19</td><td class="colsep0 rowsep0" align="left">1023/S/15</td><td class="colsep0 rowsep0" align="left">0.18/0.18</td><td class="colsep0 rowsep0" align="center">2.0/21</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="left">>30000</td><td class="colsep0 rowsep0" align="left">51/18</td><td class="colsep0 rowsep0" align="left">S/S/â</td><td class="colsep0 rowsep0" align="left">0.24/<0.17</td><td class="colsep0 rowsep0" align="center">2.3/34</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="left">>30000</td><td class="colsep0 rowsep0" align="left">62/9.6</td><td class="colsep0 rowsep0" align="left">S/S/412</td><td class="colsep0 rowsep0" align="left">0.68/0.24</td><td class="colsep0 rowsep0" align="center">17/47</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="left">26947</td><td class="colsep0 rowsep0" align="left">85/23</td><td class="colsep0 rowsep0" align="left">S/729/564</td><td class="colsep0 rowsep0" align="left">0.32/0.17</td><td class="colsep0 rowsep0" align="center">0.1/7.9</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data shown from at least two experiments. See <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> footnote for other details.</p></div></div></div><div class="NLM_p">Macrolactamization and macrolactonization approaches to the macrocycles were developed as alternative methods to the RCM.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> This strategy permitted the isoquinoline and related heterocycles to be cross coupled with the different C13âC16 unsaturated acids (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), prior to coupling with the tripeptide and final macrocyclization described in <a class="ref internalNav" href="#sch3" aria-label="Schemes 3">Schemes 3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Dibromo intermediate <b>22</b> was converted to a monoketone, stereoselectively reduced to the (<i>R</i>)-hydroxyalkyl intermediate <b>23</b> using a Noyori reduction, and then coupled with but-3-enoic acid in a Heck reaction to provide <b>24</b>. The 2-chloroquinoline <b>25</b> was converted to the 2-iodo analogue in situ to promote a more efficient Stille coupling with tri-<i>n</i>-butyl(1-ethoxyvinyl)tin, and then the product was subsequently hydrolyzed to the monoketone. Noyori reduction of the ketone generated the (<i>R</i>)-hydroxyalkyl intermediate <b>26</b>, which was then coupled with the respective unsaturated ester/acid in a Heck reaction to provide <b>27</b> and <b>28</b> respectively. The <i>gem</i> dimethyl isoquinoline precursor <b>29</b> was formed in a Suzuki cross coupling between 2-chloroisoquinoline <b>16</b> and the <i>gem</i>-dimethyl boronate ester <b>31</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> followed by ester hydrolysis. The macrolactonization at C1 (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, path a) began with <i>N</i>-BOC removal in tripeptide <b>10</b> followed by HATU mediated coupling of the acid precursors <b>24</b>, <b>28</b>, or <b>29</b> to afford the intermediates <b>32a</b>â<b>c</b>. The TCE ester, and hydroxyl protecting group present in <b>32b</b>, were then removed to reveal the <i>seco</i>-acid intermediates, which were cyclized by slow addition over 6â10 h to 2-methyl-6-nitrobenzoic acid anhydride (Shiina conditions<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a>) at a maximal concentration of 3 mmol. The C14 <i>gem</i>-dimethyl analogues <b>20</b> and <b>21</b> were isolated in â¼50% yield without optimization, and the C14 unsubstituted naphthyl analogue <b>18</b> in 18% yield. The alternative macrolactamization at C13 (path b) began with deprotection of the TCE ester in tripeptide <b>10</b> followed by EDC mediated coupling with <b>27</b> to afford <b>33</b>. Treatment with acid removed the <i>N</i>-BOC and <i>tert</i>-butyl esters to reveal the <i>seco</i>-acid intermediate that macrocyclized to <b>19</b> in 10% yield at 10 mM using HATU. The C1 lactam analogues, quinoline <b>34</b> and isoquinoline <b>35</b>, required the amine precursors described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The (<i>R</i>)-aminoalkyl heterocycles <b>39</b> and <b>42</b> were prepared from the ketones <b>36</b> and <b>40</b>, generated in the synthesis of the (<i>R</i>)-hydroxyalkyl heterocycles <b>16</b> and <b>26,</b> respectively. The ketones were converted using Ellmanâs chiral auxiliary to <b>37</b> and <b>41</b>.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Sulfinamide <b>37</b> was hydrolyzed and <i>N</i>-BOC protected prior to Suzuki coupling with the boronate ester <b>31</b>, a step that proceeded in a comparable yield to its (<i>R</i>)-hydroxyl alkyl counterpart <b>16</b> shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Hydrolysis of the ester then afforded the desired acid <b>39</b> with the amine <i>N</i>-BOC protected to avoid interference in the subsequent ester formation with tripeptide <b>44</b>. Quinoline sulfinamide <b>41</b> was coupled to the boronate ester <b>31</b> in a Suzuki reaction followed by hydrolysis of the sulfinamide to the amine <b>42</b>. The Suzuki coupling proceeded in 86% yield, which was superior to the Heck procedure used on the corresponding (<i>R</i>)-hydroxyalkyl precursor <b>26</b> described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The methyl ester in <b>42</b> was deemed necessary to avoid any competition of this acid in the subsequent amide bond forming reaction with the piperazic acid. The tripeptide <b>44</b> was prepared in two steps from the TCE protected piperazic ester <b>43</b><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> starting with <i>N</i>-BOC deprotection and then EDC coupling with the hydroxy substituted butanoic acid. Quinoline <b>34</b> was prepared from <b>44</b> by removal of the TCE ester and coupling to amine <b>42</b> to generate <b>45</b>. Methyl ester hydrolysis and macrolactonization at C13 proceeded in 45% yield to provide <b>34</b>. Isoquinoline <b>35</b> was prepared in a reverse sequence beginning with ester formation on tripeptide <b>44</b> to form <b>46</b>, followed by TCE and <i>N</i>-BOC deprotection, and finally C1 macrolactamization. The unoptimized yield of <b>35</b> was only 3% over the final three steps and therefore inferior to the C13 Shiina macrolactonization procedure for compound <b>34</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Precursors <b>24</b> and <b>27</b>â<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, Me(CO)N(OMe)Me, THF, â78 Â°C, 75%; (b) dichloro(<i>p</i>-cymene) ruthenium(II) dimer, H<sub>2</sub>O, (1<i>R</i>, 2<i>R</i>)-(â)-<i>N</i>-<i>p</i>-tosyl-1,2-diphenylethylenediamine, THF, HCO<sub>2</sub>Na, 40 Â°C, 69% (<b>23</b>), 98% (<b>26</b>); (c) Pd(OAc)<sub>2</sub>, P(<i>o</i>-PhMe)<sub>3</sub>, Et<sub>3</sub>N, CH<sub>3</sub>CN, 100â120 Â°C, but-3-enoic acid (81%); 2,2-dimethylbut-3-enoic acid (61%); (d) AcCl, NaI, CH<sub>3</sub>CN, 80 Â°C; (e) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, tri-<i>n</i>-butyl(1-ethoxyvinyl)tin, 1,4-dioxane, 100 Â°C, 66% over two steps from <b>25</b>; (f) Pd(P<sup><i>t</i></sup>Bu<sub>3</sub>)<sub>2</sub>, (C<sub>6</sub>H<sub>11</sub>)<sub>2</sub>NMe, CH<sub>3</sub>CN, but-3-enoic acid <i>tert</i>-butyl ester, reflux, 95%; (g) Ac<sub>2</sub>O, Et<sub>3</sub>N, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 99%; (h) PdCl<sub>2</sub>[PCy<sub>2</sub>(<i>p</i>-NMe<sub>2</sub>Ph)]<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, cyclopentylmethyl ether, H<sub>2</sub>O, 90 Â°C, <b>31</b>, 85%; (i) LiOH, THF, MeOH, H<sub>2</sub>O, quant.; (j) bis(cyclopentadienyl)zirconium chloride hydride, pinacolborane, CH<sub>2</sub>Cl<sub>2</sub>, 57%.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>18</b>â<b>21</b> via C1 Macrolactonization or C13 Macrolactamization<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSOTf, CH<sub>2</sub>Cl<sub>2</sub>, <i>i</i>-Pr<sub>2</sub>NEt, 0 Â°C; (b) HATU, <i>i</i>-Pr<sub>2</sub>NEt, DMF, <b>24</b> (65% over two steps); <b>28</b> (62% over two steps); <b>29</b> (71% over two steps); (c) LiOH, THF, MeOH, H<sub>2</sub>O; (d) 2-methyl-6-nitrobenzoic anhydride, 4-DMAP, 1,2-dichloroethane, 50 Â°C, 3 mmol, 22% (two steps from <b>32a</b>); 51% (two steps from <b>32b</b>); 52% (two steps from <b>32c</b>); (e) Zn, NH<sub>4</sub>OAc, H<sub>2</sub>O, quant.; (f) EDC, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, <b>27</b>, 44% over two steps from <b>10</b>; (g) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, 0 Â°C-rt, 10 mmol, 10% over two steps from <b>33</b>.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>34</b> and <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (<i>R</i>)-(+)-2-methylpropanesulfinamide, Ti(OEt)<sub>4</sub>, THF, 60â65 Â°C, 86% (from <b>36</b>); 22% (from <b>40</b>); (b) dichloro(<i>p</i>-cymene) ruthenium(II) dimer, (1<i>S</i>,2<i>R</i>)-(â)-<i>cis</i>-1-amino-2-indanol, 4 Ã mol. sieves, 2-propanol, KO<sup><i>t</i></sup>Bu, 40 Â°C, 96% (<b>37</b>); 64% (<b>41</b>); (c) 4 M HCl, 1,4-dioxane, quant.; (d) Boc<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 79% over two steps; (e) PdCl<sub>2</sub>[PCy<sub>2</sub>(<i>p</i>-NMe<sub>2</sub>Ph)]<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, cyclopentylmethyl ether, H<sub>2</sub>O, 80 Â°C, <b>31</b>, 86% (from <b>41</b>); (f) 0.1 M NaOH, THF, 40 Â°C, 76% (over two steps from <b>38)</b>; (g) TMSOTf, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C; (h) EDC, HOBT, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, (<i>S</i>)-2-hydroxy-3-methylbutanoic acid, 0 Â°C, 73% over two steps; (i) LiOH, THF, H<sub>2</sub>O, quant.; (j) HATU, <i>i</i>-Pr<sub>2</sub>NEt, 4 Ã mol. sieves, CH<sub>3</sub>CN, <b>42</b>, 28% over two steps; (k) 2-methyl-6-nitrobenzoic anhydride, 4-DMAP, 1,2-dichloroethane, 4 Ã mol. sieves, 50 Â°C, 3 mmol, acid added over 5 h, 45%; (l) 2-methyl-6-nitrobenzoic anhydride, <i>i</i>-Pr<sub>2</sub>NEt, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, <b>39</b>, 97%; (m) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 2.5 mmol, 3% (over three steps from <b>46</b>).</p></p></figure><div class="NLM_p">Naphthyl <b>18</b> and quinoline <b>19</b> were both more lipophilic than isoquinoline <b>8</b>, leading to improved Caco-2 permeability (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, column 8). The increased lipophilicity of <b>19</b> is thought to be driven by the placement of the heterocyclic nitrogen directed toward the âinteriorâ of the macrocycle that minimizes its impact on overall polarity. Consistent with this hypothesis, the two quinoline regioisomers of <b>19</b> in which the quinoline nitrogen is situated on the âexteriorâ of the macrocycle showed reduced lipophilicty by at least 0.8 log D units relative to <b>19</b> (data not shown). The addition of the C14 <i>gem</i>-dimethyl groups, quinoline <b>20</b> and isoquinoline <b>21</b>, further improved permeability relative to the respective C14 unsubstituted counterparts. Moreover, the methyl groups also drove a 2â3 fold improved binding affinity and HCV replicon potency. Unfortunately, oral bioavailability in dog when dosed as a solution was <10% for <b>20</b> and only marginally improved for <b>21</b>. Investigation of the physicochemical properties of <b>20</b> and <b>21</b> was instructive and revealed that both compounds were poorly soluble as amorphous solids, with an aqueous solubility limit <6 Î¼g/mL at pH 7.2, and also highly crystalline with melting points of 277 Â°C, and 310 Â°C, respectively. This led to the conclusion that oral bioavailability was likely limited due to high crystallinity and moderate to low permeability, potentially leading to precipitation of compound in the intestine. In an attempt to reduce crystallinity, extensive modifications were explored to destabilize crystal packing forces and also increase polarity, including alternative side chains to alanine or valine, or modifications to the C14 <i>gem</i>-dimethyl groups. These changes were unsuccessful since the addition of polar groups, thereby increasing the number of hydrogen bond donor/acceptors, resulted in a significant loss of permeability. The solution to this dilemma was to first elevate the permeability of the macrocycle to a more significant extent by altering the environment of one of the three NH hydrogen bond donors in the core of the macrocycle, and then address solubility with polar groups. Replacement of the piperazic acid NH or the alanine NH was not feasible due to their critical role in binding, thus leaving the remaining valine NH as the most logical choice for manipulation. Simple methyl substitution of the nitrogen was found to reduce potency (compound not shown). The breakthrough compound was <b>34</b>, in which the C13 lactam and C1 lactone groups of quinoline <b>20</b> are switched with each other (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The significant improvement in apical to basolateral permeability was not unexpected because of the potential for an internal hydrogen bond to form between the C1 lactam NH and the quinoline nitrogen.<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39â41)</a> The presence of the internal hydrogen bond for <b>34</b> in lipophilic environments is evidenced by two factors, first the 0.5 unit increase in log D relative to <b>20</b>, and second the stark contrast in permeability properties relative to isoquinoline <b>35</b>. Isoquinoline <b>35</b> has no potential for an internal hydrogen bond and relative to <b>34</b> has a > 1 unit lower log D, very poor apical to basolateral permeability, and high efflux (ratio of BA/AB = 79 fold, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). It is also worth noting that the measured log D for compound <b>20</b> was reliably predicted by calculated methods, but <b>34</b> was underpredicted by 0.6 units. This highlights the importance of employing measured log D data during the SAR optimization process, especially for constrained molecules where dynamic hydrogen bonds can impact lipophilicity. NMR experiments conducted on <b>3</b>, an optimized C1 lactam described in the next phase of optimization, provided evidence for the presence of an intramolecular hydrogen bond in lipophilic environments (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf" class="ext-link">Supporting Information</a>). Given that permeability was successfully addressed in <b>34</b>, we compared its solubility properties with <b>35</b>, expecting that its higher log D would make it less soluble. However, the aqueous dissolution limit of <b>34</b> and <b>35</b> from amorphous solids demonstrated a surprisingly favorable solubility limit of 55 Î¼g/mL for <b>34</b> compared to 6 Î¼g/mL for <b>35</b> in aqueous media. This rare finding was presumed to be due to the flexibility of the macrocycle or âchameleonic effectâ that allowed it to readily adopt alternate conformations in more polar environments. The âchameleonicâ behavior of macrocyclic compounds adapting to different environments through making or breaking of intramolecular hydrogen bonds has been noted as drug delivery tactic for compounds in chemical space beyond the rule of 5.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> Gratifyingly, <b>34</b> dosed as an oral solution in rat and dog demonstrated excellent absorption properties leading to high oral bioavailability (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Moreover, the predicted clearance from in vitro hepatocyte incubations nicely correlated with the in vivo measured clearance. An additional attractive feature of <b>34</b> is the esterase labile lactone group is now adjacent to the C14 <i>gem</i>-dimethyl groups and therefore more hindered than it was at the C1 position in <b>20</b>. Thus, the plasma stability of <b>34</b> relative to <b>20</b> also increased, especially in rat, which has high plasma esterase activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, column 6).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> This is an important feature because it eliminates or reduces a key metabolic pathway in rodents, allowing these compounds to be deployed in rodent disease models.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. PK Parameters of <b>3</b> and <b>34</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">In vivo blood PK</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpdÂ #</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">IV/oral dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">plasma stab. (min)</th><th class="colsep0 rowsep0" align="center" char=".">MS pred. CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Hep pred. CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub>Â (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>%</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">1/5</td><td class="colsep0 rowsep0" align="left">412</td><td class="colsep0 rowsep0" align="char" char=".">1.40</td><td class="colsep0 rowsep0" align="char" char=".">0.68</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">dog<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1/5</td><td class="colsep0 rowsep0" align="left">>1500</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">>1500</td><td class="colsep0 rowsep0" align="char" char=".">0.68</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">10/10</td><td class="colsep0 rowsep0" align="left">>1500</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char=".">1.35</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">1/5</td><td class="colsep0 rowsep0" align="left">>1500</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">>1500</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Dosed in solution, formulation and dosing details are in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf" class="ext-link">Supporting Information</a>; Hep, hepatocytes; CL, clearance; <i>V</i><sub>ss</sub>, steady state volume of distribution; <i>t</i><sub>1/2</sub>, terminal half-life.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Dogs used in this study were bile duct-cannulated in the IV arm and portal vein-cannulated in the oral arm.</p></div></div></div><div class="NLM_p">X-ray structures of quinolines <b>19</b>, <b>20</b>, and <b>34</b> complexed to Cyp A were generated to probe differences in the binding mode relative to <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>CâE). The most noticeable difference in the structure of quinoline <b>19</b> relative to isoquinoline <b>8</b> (panel C) was the orientation of the <i>trans</i> double bond in the C14âC16 region. The small change in the position of the quinoline ring over the R55 residue likely drives the alternative orientation of the <i>trans</i> double bond. A 3-fold improvement in binding affinity was observed with the introduction of the C14 <i>gem</i> dimethyl groups in analogue <b>20</b> compared to <b>19</b>. The overlay of <b>19</b> and <b>20</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D) revealed that the macrocycle <b>20</b> sits closer to the protein surface, similar to that observed for <b>2</b>, and the C14 <i>pro R</i> methyl forms a favorable lipophilic interaction with threonine 73. The structure of compound <b>20</b> also illustrates that the C1 lactone oxygen and the C13 lactam NH are not involved in direct interactions with the protein, supporting the hypothesis that these groups are potentially interchangeable without potency differences, as was found in <b>34</b> and <b>35</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The overlay of <b>34</b> in Cyp A with <b>20</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E) confirms that both compounds have a similar binding mode. An interesting observation in the structure of <b>34</b> is that the intramolecular hydrogen bond between the C1 NH and the quinoline nitrogen is not present when binding to Cyp A. This is consistent with the macrocycle adopting a low energy conformation without the intramolecular hydrogen bond in polar environments such as the Cyp active site, and its improved aqueous solubility.</div><div class="NLM_p">The breakthrough in oral bioavailability prompted efforts to address the remaining liabilities of <b>34</b>, which included moderate to high metabolic clearance (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, column 6) and significant PXR activation potential (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, column 8).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Activation of PXR raised our concerns for potential drugâdrug interactions, especially important when considering combination regimens with other drugs. The strategy employed in this final phase was to revisit replacements of the C14 <i>gem</i>-dimethyl groups with the goal of introducing polar groups to lower log D and reduce oxidative metabolism and PXR activation. The structure of <b>34</b> established that the C14 <i>gem</i>-dimethyl groups remained in the same pose as compound <b>20</b> and were therefore suitable branch points for these modifications that would not alter binding potency (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E). The introduction of polar groups was still expected to erode permeability, but given the high intrinsic permeability of <b>34</b> we reasoned that the permeability would remain in a satisfactory range, and likely benefits would be gained in solubility. To keep the overall synthesis succinct, an emphasis was placed on C14 substituents that were readily accessed as illustrated by targets <b>3</b> and <b>47</b>â<b>54</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Profile of Quinoline Macrocycles <b>3</b>, <b>47â51</b>, and <b>53â54</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0012.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpdÂ #</th><th class="colsep0 rowsep0" align="center" char=".">TR-FRET Cyp A <i>K</i><sub>d</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">HCV 2a EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">MT4 CC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">%Â free CCM/HP</th><th class="colsep0 rowsep0" align="center">MS pred. CL h/d (L/h/kg)</th><th class="colsep0 rowsep0" align="center">Caco-2 AB/BA (10<sup>â6</sup>Â cmÂ s<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center">PXR %Â act. 1.5/15 Î¼M<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">logÂ D pH 7.4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="left">>40000</td><td class="colsep0 rowsep0" align="left">62/9.6</td><td class="colsep0 rowsep0" align="left">0.69/0.24</td><td class="colsep0 rowsep0" align="left">17/47</td><td class="colsep0 rowsep0" align="left">23/88</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="left">>40000</td><td class="colsep0 rowsep0" align="left">100/41</td><td class="colsep0 rowsep0" align="left">0.42/0.80</td><td class="colsep0 rowsep0" align="left">1.5/13</td><td class="colsep0 rowsep0" align="left">10/45</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="left">>40000</td><td class="colsep0 rowsep0" align="left">100/40</td><td class="colsep0 rowsep0" align="left">0.41/0.34</td><td class="colsep0 rowsep0" align="left">0.61/9.2</td><td class="colsep0 rowsep0" align="left">8/47</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="left">>40000</td><td class="colsep0 rowsep0" align="left">97/28</td><td class="colsep0 rowsep0" align="left">0.45/0.59</td><td class="colsep0 rowsep0" align="left">0.90/7.1</td><td class="colsep0 rowsep0" align="left">7/22</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="left">37000</td><td class="colsep0 rowsep0" align="left">68/11</td><td class="colsep0 rowsep0" align="left">0.68/0.67</td><td class="colsep0 rowsep0" align="left">13/33</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="left">>40000</td><td class="colsep0 rowsep0" align="left">100/28</td><td class="colsep0 rowsep0" align="left">0.79/0.52</td><td class="colsep0 rowsep0" align="left">3.2/19</td><td class="colsep0 rowsep0" align="left">15/88</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">355</td><td class="colsep0 rowsep0" align="left">>40000</td><td class="colsep0 rowsep0" align="left">100/51</td><td class="colsep0 rowsep0" align="left">0.24/<0.17</td><td class="colsep0 rowsep0" align="left">0.48/12</td><td class="colsep0 rowsep0" align="left">9/13</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="left">>40000</td><td class="colsep0 rowsep0" align="left">100/52</td><td class="colsep0 rowsep0" align="left">0.72/0.77</td><td class="colsep0 rowsep0" align="left">0.72/10</td><td class="colsep0 rowsep0" align="left">9/31</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">320</td><td class="colsep0 rowsep0" align="left">>40000</td><td class="colsep0 rowsep0" align="left">88/66</td><td class="colsep0 rowsep0" align="left">0.21/0.31</td><td class="colsep0 rowsep0" align="left">0.08/0.59</td><td class="colsep0 rowsep0" align="left">8/8</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Data shown from at least <i>n</i> = 2 experiments. See <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> footnote for other details.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Pregnane X receptor (PXR) fractional activation over vehicle control at 1.5 Î¼M and 15 Î¼M relative to rifampicin.</p></div></div></div><div class="NLM_p">Compounds <b>47</b>â<b>50</b> were prepared via macrolactamization at C1 (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>) according to the same method described for <b>35</b>. The quinoline prescursors <b>56a</b>â<b>c</b> were generated by Heck coupling of bromide <b>55</b> with spiro substituted substituted but-3-enoic acids/esters <b>58</b>, <b>59</b>, and <b>61</b> in 59â89% yield. The ketone <b>58</b> was converted to the methoxy spiro acid <b>59</b> by borohydride reduction, followed by methylation of the major <i>trans</i> product, and hydrolysis. The pyran ester <b>61</b> was prepared by alkylation of <b>60</b> with vinyl bromide. The ketone group in precursor <b>56a</b> was also reduced to its <i>cis</i>/<i>trans</i> hydroxy mixture, the ester then hydrolyzed to the acid, followed by <i>O</i>-silyl protection of the hydroxyl to provide intermediate <b>57</b>. Following a similar procedure to that described for <b>35</b>, the quinoline precursors <b>56b</b>â<b>c</b> and <b>57</b> were coupled with tripeptide <b>44</b> to generate intermediates <b>62aâc</b>, deprotected to generate the <i>seco</i> acids, and then subjected to macrolactamization at C1 to form <b>47</b>â<b>50</b>. Similar to <b>35,</b> the yields for <b>47</b>â<b>49</b> were <10% over the final sequence from <b>62a</b>â<b>c</b> but a significantly improved yield of 45% was achieved for <b>50</b> by the addition of catalytic DMAP. Despite the improved yield for <b>50</b> a two-step route using the key bromide intermediate <b>63</b> and macrolactonization at C13 was used to generate compounds <b>3</b> and <b>51</b>â<b>54</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). The spiro acid <b>65</b> was generated from thiopyran <b>63</b>, while ethyl acetoactete <b>66</b> served as the starting material to both the unsubstituted and substituted 1,3-dioxane acids <b>68a</b> and <b>68b</b>, respectively. The 1,4-dioxepane <b>69</b> was transformed via the nitroalkene <b>70</b> to the desired acid <b>71</b>. The formation of the <i>seco</i> acids for C13 macrolactonization began with the coupling of the quinoline bromide <b>72</b>, generated in the synthesis of <b>55</b>, onto the tripeptide <b>44</b>, followed by Heck coupling of the spiro but-3-enoic acid <b>65</b>, <b>68a/b</b> or <b>71</b>. Without purification, the <i>seco</i>-acid products were then subjected to macrolactonization using the Shiina conditions at concentrations of â¼3 mmol to provide <b>3</b> and <b>51</b>â<b>53</b>. Overall the yields for the two-step sequence were modest ranging from 7 to 30%, the highest for compound <b>3</b>. The synthesis of <b>3</b> was therefore achieved in a convergent four-step synthesis from tripeptide <b>44</b> with an unoptimized yield of 17%. Compound <b>52</b> also served as the precursor to <b>54</b> that was realized upon treatment of <b>52</b> with acid.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>47</b>â<b>50</b> via C1 Macrolactamization<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CH<sub>2</sub>Cl<sub>2</sub>, 4 M HCl, 1,4-dioxane; (b) Boc<sub>2</sub>O, Et<sub>3</sub>N, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 70% over two steps; (c) Pd(OAc)<sub>2</sub>, P(<i>o</i>-PhMe)<sub>3</sub>, Et<sub>3</sub>N, 1,4-dioxane, 100 Â°C, <b>58 (</b>65%), <b>59</b> (89%), <b>61</b> (59%); (d) K-selectride, THF, â60 Â°C, 81%; (e) LiOH, THF, MeOH, H<sub>2</sub>O, 50 Â°C; (f) TBSCl, imidazole, DMF, 35 Â°C; (g) K<sub>2</sub>CO<sub>3</sub>, THF, MeOH, 85% over three steps. (h) NaBH<sub>4</sub>, MeOH, 0 Â°C, 16%; (i) proton sponge, Me<sub>3</sub>OBF<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 49%; (j) LiOH, THF, MeOH, H<sub>2</sub>O, quant.; (k) LDA, [(<sup><i>t</i></sup>Bu<sub>3</sub>P)PdBr]<sub>2</sub>, PhMe, vinyl bromide, 0 Â°C, 45%; (l) 2-methyl-6-nitrobenzoic anhydride, <i>i</i>-Pr<sub>2</sub>NEt, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 39% (<b>62a</b>); 62% (<b>62b</b>); 85% (<b>62c</b> over two steps from <b>56c)</b>; (m) 1 M KOH, THF, MeOH, H<sub>2</sub>O, 50 Â°C; (n) K<sub>2</sub>CO<sub>3</sub>, THF, MeOH, H<sub>2</sub>O, 0â30 Â°C; (o) 4 M HCl, 1,4-dioxane; (p) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 1 mmol, 8% over three steps (<b>47</b>), 2% over three steps (<b>48</b>), 20% over three steps (<b>49</b>), 45% with cat. 4-DMAP over three steps (<b>50</b>); (q) LiOH, THF, H<sub>2</sub>O, quant.; (r) KOH, THF, H<sub>2</sub>O, rt.</p></p></figure><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>3</b> and <b>51</b>â<b>54</b> via C13 Macrolactonization<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CHO, THF, â78 Â°C, 87%; (b) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 60%; (c) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, then DBU, 70% over two steps; (d) LiOH, THF, MeOH, H<sub>2</sub>O, 95â100%; (e) 40% CH<sub>2</sub>O, Et<sub>3</sub>N, THF, 1,4-dioxane, 40 Â°C; (f) 40% CH<sub>2</sub>O, conc. HCl, 50 Â°C, 14% over two steps; (g) NaBH<sub>4</sub>, EtOH, 0 Â°C, 84%; (h) <i>p</i>-TsCl, pyridine, 0 Â°C, 76%; (i) DBU, 140 Â°C, 33%; (j) 2,2-dimethoxypropane, acetone, <i>p</i>-TsOH, 31% over two steps from <b>66</b>; (k) <i>n</i>-BuLi, <i>i</i>-Pr<sub>2</sub>NEt, THF, PhNTf<sub>2</sub>, â78 Â°C; (l) <i>n</i>-Bu<sub>3</sub>N, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, HCO<sub>2</sub>H, DMF, 60 Â°C, 50% over two steps; (m) LiOH, THF, MeOH, H<sub>2</sub>O, 90%; (n) CH<sub>3</sub>NO<sub>2</sub>, 2,8,9-triisopropyl-2,5,8,9-tetraaza-1-phosphabicyclo[3,3,3]undecane, MgSO<sub>4</sub>, 40 Â°C, 58%; (o) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C, 77%; (p) potassium vinyltrifluoroborate, 2,2â²-bis(diphenylphosphino)-1,1â²-binaphthalene, PhMe, H<sub>2</sub>O, bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate, reflux, 26%; (q) NaNO<sub>2</sub>, DMF, AcOH, 40 Â°C, 51%; (r) Zn, NH<sub>4</sub>OAc, THF, H<sub>2</sub>O; (s) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, 55% over two steps; (t) Pd(dba)<sub>2</sub>, P(<i>o</i>-PhMe)<sub>3</sub>, Et<sub>3</sub>N, 1,4-dioxane, 50â100 Â°C; (u) 2-methyl-6-nitrobenzoic anhydride, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 4 Ã mol. sieves, 2â5 mmol, acid added over 3â4 h, 7% over two steps (<b>51</b>), 20% over two steps (<b>52</b>), 30% over two steps (<b>3</b>), 8% over two steps (<b>53</b>); (v) 1 M HCl, MeOH, 75%.</p></p></figure><div class="NLM_p">The potency, metabolic, and PXR activation properties of the C14 modified analogues are compared to <b>34</b> in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. In general, binding affinity was comparable or up to 2-fold more potent than <b>34</b> for most analogues, and HCV replicon was generally EC<sub>50</sub> < 100 nM. As anticipated from prior modeling, the X-ray complex of <b>3</b> with Cyp A confirmed that the overall binding mode was approximately the same as the <i>gem</i>-dimethyl analogue <b>34</b>, with the 1,3-dioxane ring positioned in the same geometry as the methyl groups (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>F). All the compounds demonstrated low protein binding shifts relative to <b>34</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, column 5), with compound <b>3</b> demonstrating a calculated paEC<sub>50</sub> = 240 nM. The predicted microsomal clearance, permeability, and PXR activation potential trended in line with the lipophilicity of the compounds. Compounds <b>49</b> and <b>50</b> with the higher log D values had the best permeability properties, but also high metabolic clearance and PXR activation potential comparable to <b>34</b>. In contrast, the compounds with log D â 2.0, e.g., <b>3</b>, <b>47â48</b> and <b>52</b>, <b>53</b>, sacrificed some apical to basolateral permeability but tended to be more metabolically stable and have lower PXR activation. Diol <b>54</b> bearing two hydrogen bond donors relative to <b>34</b> had the lowest log D, and not surprisingly, the poorest permeability. Compound <b>3</b> demonstrated the best overall profile and was subsequently selected for in vivo studies.</div><div class="NLM_p">To support in vivo studies, several grams of <b>3</b> were synthesized using the procedure described in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. As indicated earlier, a key component during the SAR optimization toward <b>3</b> was to minimize structural complexity and focus on synthetically accessible building blocks that could be readily converged together. The end result is that <b>3</b> can be prepared in a short four-step sequence that brings together three key building blocks, <b>44</b>, <b>72</b>, and <b>68a</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The three key building blocks in turn can be generated in relatively short sequences from commercially available materials. The efficiency of the route also enables future SAR explorations on the sanglifehrin macrocycle beyond the scope presented here. For example, elaborating the methyl side chain of <b>72</b> would allow the inclusion of some of the structural features found in AAE931 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Taken together, 18 synthetic steps are required for the preparation of <b>3</b>, and the flexibility afforded by total synthesis over semisynthetic methods enables more rapid exploration of sanglifehrin based Cyp A inhibitors.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Macrocycle 3 synthesis schematic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Prior to extensive in vivo studies, a hERG patch clamp assessment at physiological temperature was conducted on <b>3</b> and showed an IC<sub>50</sub> > 100 Î¼M, indicating minimal risk for QT prolongation in vivo. Intravenous dosing of <b>3</b> in rat and dog demonstrated low in vivo clearance rates, 2â3-fold better than predicted from the in vitro hepatocyte assays (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This favorable trend, combined with the good in vitro hepatocyte and in vivo clearance correlation established for <b>34</b>, suggests that the human hepatocyte clearance prediction of 0.3 L/h/kg for compound <b>3</b> is likely a conservative prediction of human in vivo clearance. Additional in vitro and in vivo data in more species would be necessary to derive a more robust human clearance prediction for <b>3</b>. Following a 5 mg/kg oral dose in dog, the blood concentrations of <b>3</b> at 24 h exceeded 1 Î¼M, >4-fold above the paEC<sub>50</sub> of 240 nM. Oral bioavailability was 100% in rat and 55% in dog, demonstrating good intestinal permeability properties. The superior plasma-adjusted anti-HCV potency and optimal PK properties of <b>3</b> resulted in its selection as an oral candidate for in vivo efficacy studies in a variety of disease models. Moreover, the low projected clearance in humans together with the oral bioavailability data across multiple species supports the potential of <b>3</b> to also be used in the clinical setting as an oral inhibitor of Cyps.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Cyp inhibition by oral small molecules holds significant promise for the interrogation of Cyps and their role in disease. The current report extends our previous findings on sanglifehrin based macrocyclic inhibitors resulting in the identification of the potent and orally bioavailable Cyp inhibitor <b>3</b>. Compound <b>3</b> has Cyp A <i>K</i><sub>d</sub> = 5 nM, a high plasma free fraction leading to a calculated paEC<sub>50</sub> = 240 nM, excellent oral bioavailability above 50% in two preclinical species, and minimal PXR activation potential. Critical advances during the structure driven optimization process were reducing the macrocycle size and combining a quinoline heterocycle with a C1 lactam and C13 lactone switch that dramatically improved permeability through formation of an intramolecular hydrogen bond. Late stage elaboration of the C14 substituent to a spirocyclic1,3-dioxane lowered log D, reduced PXR activation, and improved metabolic stability resulting in the identification of <b>3</b> as the best oral inhibitor. Importantly, <b>3</b> can be derived from three readily available precursors following a short four-step sequence. Synthesis developments have since been introduced beyond this report to generate <b>3</b> on a 100â1000 g scale to enable its use in a variety of preclinical disease models. These advances and results from the models will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45680" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45680" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All research compounds were synthesized at Gilead Sciences Inc. (Foster City, CA, USA) or Selcia Ltd. (Ongar, UK). Commercially available solvents and reagents were used as received without further purification. Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 300, 400, or 500 MHz NMR or a Varian Mercury Plus 400 MHz NMR. Chemical shifts are reported in ppm (Î´) using the residual solvent line as internal standard (CDCl<sub>3</sub>: Î´ 7.26, CD<sub>3</sub>OD: Î´ 3.31, CD<sub>3</sub>CN: Î´ 1.94 DMSO-<i>d</i><sub>6</sub>: Î´ 2.50). Splitting patterns are designated as s, singlet; d, doublet; t, triplet; q, quartet; p, pentet; m, multiplet; br, broad; ABq, AB quartet; <i>app</i>, apparent. Compound <b>3</b><sup>13</sup>C NMR assignment can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf" class="ext-link">Supporting Information</a>. All isolated characterized final compounds for assay were determined to have a purity of >95% at 254 nM by HPLC (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf" class="ext-link">Supporting Information</a>). High resolution mass spectrometry (HRMS) and low resolution (unit mass) liquid chromatography/mass spectrometry (LC/MS) details are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf" class="ext-link">Supporting Information</a>. Retention times are denoted as <i>T</i><sub>r</sub>. Preparative normal phase silica gel chromatography was carried out manually or using a Teledyne ISCO CombiFlash Companion instrument with silica gel cartridges.. All in vivo studies were performed in accordance with local IACUC guidelines.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (2<i>R</i>,3<i>S</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7-dimethylspiro[11-oxa-3,8-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphanene-13,5â²-[1,3]dioxan]-14-ene-4,6,9,12-tetraone (<b>3</b>)</h3><div class="NLM_p last"><b>73</b> (398.4 mg, 0.745 mmol), <b>68a</b> (117.9 mg, 0.745 mmol), tri(<i>o</i>-tolyl)phosphine (45.3 mg, 0.149 mmol), and Et<sub>3</sub>N (0.32 mL, 2.235 mmol) were mixed in 1,4-dioxane (15 mL) and degassed with N<sub>2</sub> for 5 min. The mixture was heated to 50 Â°C and treated with tris(dibenzylideneacetone)dipalladium(0) (68.2 mg, 0.074 mmol). The mixture was stirred at 100 Â°C for 40 min, cooled to rt, and filtered through a pad of Celite, and the Celite pad was rinsed with EtOAc. The mixture was concentrated <i>in vacuo</i> to afford the <i>seco</i>-acid that was used without further purification. LC/MS Method A (<i>m</i>/<i>z</i>) 612.2 [M + H], <i>T</i><sub>r</sub> = 1.70 min. A solution of the <i>seco</i>-acid (0.745 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (18 mL) was added via syringe pump over 3 h to a solution of 2-methyl-6-nitrobenzoic anhydride (385.0 mg, 1.12 mmol), 4-DMAP (273.0 mg, 2.24 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (230 mL) containing 4 Ã molecular sieves. The reaction mixture was stirred at rt for 40 min, filtered, and partially concentrated <i>in vacuo</i>. The organic layer was washed with pH 4 citrate buffer (100 mL), a saturated solution of sodium bicarbonate (100 mL), and filtered. The mixture was concentrated <i>in vacuo</i>, and the residue was subjected to silica gel chromatography eluting with isohexanes/acetone (1:0 to 1:1) to provide the title compound (134 mg, 30%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.26 (d, <i>J</i> = 8.5 Hz, 1H, ArâH4), 7.85 (d, <i>J</i> = 8.5 Hz, 1H, ArâH5), 7.74 (s, 1H, ArâH8), 7.69 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H, ArâH6), 7.48 (d, <i>J</i> = 8.5 Hz, 1H, ArâH3), 6.63 (d, <i>J</i> = 16.6 Hz, 1H, ArâCHâC), 6.15 (d, <i>J</i> = 16.6 Hz, 1H, ArâCâCH), 5.82 (q, <i>J</i> = 7.2 Hz, 1H, Câ(O)âC<i>H</i>NHCO), 5.36 (d, <i>J</i> = 9.2 Hz, 1H, Câ(O)âCHâO), 5.09â5.06 (m, 1H, ArâCHN), 4.99 (d, <i>J</i> = 6.1 Hz, 1H, OCH<sub>2a</sub>O), 4.81 (d, <i>J</i> = 6.1 Hz, 1H, OCH<sub>2b</sub>O), 4.68 (dd, <i>J</i> = 11.3, 2.3 Hz, 1H, CH<sub>2a</sub>O), 4.51 (dd, <i>J</i> = 11.2, 2.3 Hz, 1H, CH<sub>2a</sub>O), 4.47â4.39 (m, 1H, C<i>H</i><sub>2a</sub>N-NH), 3.88 (dd, <i>J</i> = 28.4, 11.3 Hz, 2H, CH<sub>2b</sub>O x 2), 3.69â3.58 (m, 1H, C<i>H</i>NH-N), 2.71 (td, <i>J</i> = 12.9, 3.2 Hz, 1H, C<i>H</i><sub>2b</sub>N-NH), 2.33â2.11 (m, 2H, C<i>H</i><sub>2a</sub>CHNH and C<i>H</i>CHâO), 2.01â1.88 (m, 1H, C<i>H</i><sub>2a</sub>CH<sub>2</sub>N), 1.74â1.48 (m, 8H, C<i>H</i><sub>3</sub>CHNH x 2, C<i>H</i><sub>2b</sub>CH<sub>2</sub>N, C<i>H</i><sub>2b</sub>CHNH), 1.11 (d, <i>J</i> = 6.8 Hz, 3H, C<i>H</i><sub>3</sub>CHCH<sub>3</sub>), 1.06 (d, <i>J</i> = 6.6 Hz, 3H, C<i>H</i><sub>3</sub>CHCH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) Î´ 173.65, 171.29, 170.05, 169.60, 160.35, 146.74, 137.90, 136.57, 133.44, 128.74, 127.64, 126.94, 126.02, 122.75, 119.10, 93.46, 78.10, 70.99, 70.42, 60.73, 50.83, 49.68, 46.26, 41.35, 30.30, 25.68, 23.12, 20.64, 17.35, 17.11, 16.34. LC/MS Method A (<i>m</i>/<i>z</i>) 594.1 [M + H], <i>T</i><sub>r</sub> = 2.60 min. HRMS C<sub>31</sub>H<sub>39</sub>N<sub>5</sub>O<sub>7</sub> calculated 593.2849, found 593.2866.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,13<i>R</i>,14<i>R</i>,<i>E</i>)-10-Isopropyl-14-methoxy-2,7,13-trimethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-3-oxa-8,11-diaza-1(6,3)-isoquinolina-5(3,1)-pyridazinacyclohexadecaphan-15-ene-4,6,9,12-tetraone (<b>4</b>)</h3><div class="NLM_p last"><b>12a</b> (54 mg, 0.087 mmol) was subjected to the procedure for <b>5</b> at 3 mmol to afford the title compound (18 mg, 36%) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>CN) Î´ 9.20 (s, 1H), 8.15 (<i>br</i> s, 1H), 8.02 (d, <i>J</i> = 8.5 Hz, 1H), 8.00 (<i>br</i> s, 1H), 7.52 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H), 7.33 (d, <i>J</i> = 9.2 Hz, 1H), 7.20 (dd, <i>J</i> = 16.3, 8.5 Hz, 1H), 6.96 (d, <i>J</i> = 8.3 Hz, 1H), 6.90 (d, <i>J</i> = 16.3 Hz, 1H), 6.11 (q, <i>J</i> = 6.5 Hz, 1H), 5.80â5.69 (m, 1H), 4.41 (<i>br</i> d, 1H), 4.33â4.26 (m, 2H), 3.99 (dd, <i>J</i> = 8.2, 2.9 Hz, 1H), 3.73â3.64 (m, 1H), 3.41 (s, 3H), 2.75â2.65 (m, 1H), 2.55â2.47 (m, 1H), 2.15â1.65 (m, 5H), 1.61 (d, <i>J</i> = 6.7 Hz, 3H), 1.47 (d, <i>J</i> = 7.1 Hz, 3H), 1.35 (d, <i>J</i> = 7.4 Hz, 3H), 1.02 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 580 [M + H], <i>T</i><sub>r</sub> = 4.36 min.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7-dimethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-3-oxa-8,11-diaza-1(6,3)-isoquinolina-5(3,1)-pyridazinacyclohexadecaphan-15-ene-4,6,9,12-tetraone (<b>5</b>)</h3><div class="NLM_p last">A solution of <b>12b</b> (180 mg, 0.32 mmol) in toluene (100 mL) was stirred at rt under N<sub>2</sub>. Hoveyda-Grubbs second generation catalyst (20 mg, 0.032 mmol) was added, and the mixture was heated at reflux under N<sub>2</sub> for 2 h. Additional Hoveyda-Grubbs second generation catalyst (10 mg, 0.016 mmol) was added, and the reaction mixture was heated at reflux for 1 h. The reaction mixture was cooled to rt and filtered. The majority of the filtrate was concentrated <i>in vacuo</i>, silica gel was added, and the mixture was further concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with EtOAc/acetone (1:0 to 5:1). The residue was triturated with Et<sub>2</sub>O and EtOAc, and the resulting solid was collected and dried to afford the title compound (66 mg, 39%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.13 (s, 1H), 7.89 (d, <i>J</i> = 8.7 Hz, 1H), 7.76 (s, 1H), 7.67 (s, 1H), 7.35 (d, <i>J</i> = 8.7 Hz, 1H), 6.80â6.65 (m, 2H), 6.42 (d, <i>J</i> = 8.5 Hz, 1H), 6.31 (d, <i>J</i> = 9.6 Hz, 1H), 6.09 (q, <i>J</i> = 6.6 Hz, 1H), 5.65â5.55 (m, 1H), 4.55 (<i>br</i> d, 1H), 4.44â4.38 (m, 1H), 3.64â3.60 (m, 2H), 2.90â1.75 (m, 10H), 1.67 (d, <i>J</i> = 6.5 Hz, 3H), 1.54 (d, <i>J</i> = 7.1 Hz, 3H), 1.00 (d, <i>J</i> = 6.5 Hz, 3H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 536 [M + H], <i>T</i><sub>r</sub> = 1.33 min. HRMS C<sub>29</sub>H<sub>37</sub>N<sub>5</sub>O<sub>5</sub> calculated 535.2795, found 535.2806.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7-dimethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-3-oxa-8,11-diaza-1(6,3)-isoquinolina-5(3,1)-pyridazinacycloheptadecaphan-16-ene-4,6,9,12-tetraone (<b>6</b>)</h3><div class="NLM_p last"><b>12c</b> (209 mg, 0.362 mmol) was subjected to the procedure for <b>5</b> at a concentration of 3 mmol to afford the title compound (125 mg, 63%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 9.00 (s, 1H), 7.91 (d, <i>J</i> = 8.4 Hz, 1H), 7.77 (s, 1H), 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 7.23 (s, 1H), 6.64 (m, 1H), 6.29 (d, <i>J</i> = 15.4 Hz, 1H), 5.97 (q, <i>J</i> = 5.9 Hz, 1H), 5.53 (q, <i>J</i> = 7.0 Hz, 1H), 4.37â4.18 (m, 2H), 3.65 (d, <i>J</i> = 9.8 Hz, 1H), 2.65 (t, <i>J</i> = 12.3 Hz, 1H), 2.36â2.18 (m, 4H), 1.98 (m, 1H), 1.94â1.73 (m, 3H), 1.71â1.57 (m, 3H), 1.55 (d, <i>J</i> = 5.6 Hz, 6H), 0.83 (d, <i>J</i> = 6.6 Hz, 3H), 0.78 (d, <i>J</i> = 6.6 Hz, 3H). LC/MS Method C (<i>m</i>/<i>z</i>) 550.2 [M + H], <i>T</i><sub>r</sub> = 2.55 min. HRMS C<sub>30</sub>H<sub>39</sub>N<sub>5</sub>O<sub>5</sub> calculated 549.2951, found 549.2972.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7-dimethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-3-oxa-8,11-diaza-1(6,3)-isoquinolina-5(3,1)-pyridazinacyclooctadecaphan-17-ene-4,6,9,12-tetraone (<b>7</b>)</h3><div class="NLM_p last"><b>12d</b> (255 mg, 0.431 mmol) was subjected to the procedure for <b>5</b> at a concentration of 2 mmol to afford the title compound (76 mg, 31%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 9.01 (s, 1H), 7.93 (d, <i>J</i> = 8.5 Hz, 1H), 7.69 (s, 1H), 7.57 (s, 1H), 7.43 (d, <i>J</i> = 8.5 Hz, 1H), 6.55 (m, 1H), 5.95 (m, 1H), 5.43 (m, 1H), 5.23 (m, 3H), 4.32 (m, 1H), 4.20 (m, 1H), 3.67 (m, 1H), 2.69 (m, 1H), 2.30 (m, 2H), 2.13 (m, 2H), 1.96 (m, 3H), 1.83 (m, 1H), 1.64 (m, 3H), 1.56 (d, <i>J</i> = 6.7 Hz, 3H), 1.44 (d, <i>J</i> = 7.4 Hz, 3H), 0.92â0.72 (m, 6H). LC/MS Method C (<i>m</i>/<i>z</i>) 564.4 [M + H], <i>T</i><sub>r</sub> = 2.60 min. HRMS C<sub>31</sub>H<sub>41</sub>N<sub>5</sub>O<sub>5</sub> calculated 563.3108, found 563.3121.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7-dimethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-3-oxa-8,11-diaza-1(6,3)-isoquinolina-5(3,1)-pyridazinacyclopentadecaphan-14-ene-4,6,9,12-tetraone (<b>8</b>)</h3><div class="NLM_p last"><b>12e</b> (1.13 g, 2 mmol) was subjected to the general RCM method for <b>5</b> to afford the title compound (245 mg, 23%) containing â¼10% <i>cis</i> isomer. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.13 (s, 1H), 7.92 (d, <i>J</i> = 8.3 Hz, 1H), 7.72 (s, 1H), 7.55 (s, 1H), 7.39 (d, <i>J</i> = 8.3 Hz, 1H), 6.72 (d, <i>J</i> = 16.3 Hz, 1H), 6.53â6.38 (m, 3H), 6.04 (q, <i>J</i> = 6.7 Hz, 1H), 5.76â5.65 (m, 1H), 4.57â4.53 (m, 1H), 4.29â4.23 (m, 1H), 3.77â3.63 (m, 2H), 3.40â3.20 (m, 2H), 2.70â1.75 (m, 6H), 1.71 (d, <i>J</i> = 6.9 Hz, 3H), 1.53 (d, <i>J</i> = 6.9 Hz, 3H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.97 (d, <i>J</i> = 6.9 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 522.0 [M + H], <i>T</i><sub>r</sub> = 1.40 min. HRMS C<sub>28</sub>H<sub>35</sub>N<sub>5</sub>O<sub>5</sub> calculated 521.2638, found 521.2651.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>)-10-Isopropyl-2,7-dimethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-3-oxa-8,11-diaza-1(6,3)-isoquinolina-5(3,1)-pyridazinacyclopentadecaphane-4,6,9,12-tetraone (<b>9</b>)</h3><div class="NLM_p last">A mixture of <b>8</b> (16 mg, 0.03 mmol) in EtOAc (5 mL) and THF (2 mL) was treated with 10% palladium on carbon (15 mg), and the mixture was stirred under H<sub>2</sub> for 3 h. The reaction mixture was degassed and filtered through filter aid, and the filter pad was washed with EtOAc. The filtrate was concentrated <i>in vacuo</i>, and the residue was triturated with Et<sub>2</sub>O (2 Ã 2 mL). The solid was dried to afford the title compound (7.6 mg, 48%) as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.17 (s, 1H), 7.93 (d, <i>J</i> = 8.3 Hz, 1H), 7.80 (s, 1H), 7.36 (d, <i>J</i> = 8.3 Hz, 1H), 7.34 (s, 1H), 6.33 (d, <i>J</i> = 7.8 Hz, 1H), 6.11â6.05 (m, 2H), 5.92â5.83 (m, 1H), 4.49â4.44 (m, 1H), 4.37â4.32 (m, 1H), 3.90 (d, <i>J</i> = 11.8 Hz, 1H), 3.75â3.68 (m, 1H), 3.10â2.70 (m, 3H), 2.40â1.60 (m, 9H), 1.68 (d, <i>J</i> = 6.5 Hz, 3H), 1.50 (d, <i>J</i> = 7.1 Hz, 3H), 0.95 (d, <i>J</i> = 6.5 Hz, 3H), 0.90 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 524.3 [M + H], <i>T</i><sub>r</sub> = 0.59 min. HRMS C<sub>28</sub>H<sub>37</sub>N<sub>5</sub>O<sub>5</sub> calculated 523.2795, found 523.2810.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(((2<i>R</i>,3<i>R</i>)-3-Methoxy-2-methylpent-4-enoyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>11a</b>)</h3><div class="NLM_p last">A solution of <b>10</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (2.17 g, 4.09 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was cooled to 0 Â°C, treated with TMSOTf (1.2 mL, 6.81 mmol), and stirred for 30 min. <i>N,N</i>-Diisopropylethylamine (2.4 mL, 13.63 mmol) was then added, and the mixture was concentrated <i>in vacuo</i>. The residue was treated with CH<sub>3</sub>CN (50 mL), <b>14</b> (539.0 mg, 3.407 mmol), and <i>N,N-</i>diisopropylethylamine (2.4 mL, 13.63 mmol). The reaction mixture was cooled to 0 Â°C and 2-(1<i>H</i>-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate methanaminium (1.814 g, 4.770 mmol) was added. The mixture was stirred at rt for 16 h, quenched with 1 M HCl (100 mL), and extracted with EtOAc (2 Ã 100 mL). The organic extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo.</i> The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (1:0 to 1:4) to afford the title compound (2.19 g, 93%) as a light yellow solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 6.76 (d, <i>J</i> = 7.3 Hz, 1H), 5.72 (dq, <i>J</i> = 15.1, 6.7 Hz, 1H), 5.57 (d, <i>J</i> = 8.5 Hz, 1H), 5.38â5.19 (m, 2H), 4.96 (d, <i>J</i> = 11.8 Hz, 1H), 4.72 (d, <i>J</i> = 11.8 Hz, 1H), 4.44â4.30 (m, 2H), 3.85 (d, <i>J</i> = 11.2 Hz, 1H), 3.70 (td, <i>J</i> = 10.3, 3.4 Hz, 1H), 3.56 (<i>app</i> t, <i>J</i> = 8.5 Hz, 1H), 3.24 (s, 3H), 2.95â2.84 (m, 1H), 2.34 (<i>app</i> p, <i>J</i> = 7.6 Hz, 1H), 2.25â2.09 (m, 2H), 2.00â1.86 (m, 1H), 1.82â1.62 (m, 2H), 1.76 (d, <i>J</i> = 6.4 Hz, 3H), 1.32 (d, <i>J</i> = 6.9 Hz, 3H), 1.08 (d, <i>J</i> = 7.1 Hz, 3H), 0.96 (d, <i>J</i> = 6.9 Hz, 3H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A1 (<i>m</i>/<i>z</i>) 571.1 [M + H], <i>T</i><sub>r</sub> = 5.00 min.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(Pent-4-enoyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>11b</b>)</h3><div class="NLM_p last"><b>10</b> (1.06 g, 2 mmol) was combined with pent-4-enoic acid (220 mg, 2.2 mmol) as described for the preparation of <b>11a</b>. The crude <b>11b</b> was subjected to silica gel chromatography eluting with a gradient of isohexanes/EtOAc (3:1 to 1:3) to afford the title compound (634 mg, 62%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 6.66 (d, <i>J</i> = 7.6 Hz, 1H), 6.18 (d, <i>J</i> = 8.7 Hz, 1H), 5.92â5.78 (m, 1H), 5.36â5.26 (m, 1H), 5.10 (dd, <i>J</i> = 17.2, 1.6 Hz, 1H), 5.06 (dd, <i>J</i> = 10.3, 1.6 Hz, 1H), 4.97 (d, <i>J</i> = 12.0 Hz, 1H), 4.71 (d, <i>J</i> = 12.0 Hz, 1H), 4.48â4.30 (m, 2H), 3.88â3.66 (m, 3H), 3.00â2.88 (m, 1H), 2.50â1.60 (m, 8H), 1.32 (d, <i>J</i> = 6.7 Hz, 3H), 0.95 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 513/515 [M + H], <i>T</i><sub>r</sub> = 4.20 min.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(hex-5-enoyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>11c</b>)</h3><div class="NLM_p last"><b>10</b> (1.06 g, 2 mmol) was combined with hex-5-enoic acid (251 mg, 2.2 mmol) as described for the preparation of <b>11a</b>. The crude <b>11c</b> was subjected to silica gel chromatography eluting with 0 to 40% EtOAc/MeOH (4:1 mixture) in isohexanes to afford the title compound (864 mg, 82%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.84 (d, <i>J</i> = 8.6 Hz, 1H), 7.81 (d, <i>J</i> = 7.1 Hz, 1H), 5.72 (ddt, <i>J</i> = 17.0, 10.2, 6.7 Hz, 1H), 5.28 (m, 1H), 4.97â4.84 (m, 2H), 4.91 (d, <i>J</i> = 12.1 Hz, 1H), 4.71 (d, <i>J</i> = 12.1 Hz, 1H), 4.14â4.07 (m, 1H), 3.75â3.22 (m, 3H), 2.22â2.15 (m, 2H), 1.98 (m, 4H), 1.78 (m, 2H), 1.66â1.56 (m, 3H), 1.20 (d, <i>J</i> = 7.0 Hz, 3H), 0.87 (d, <i>J</i> = 6.6 Hz, 3H), 0.84 (d, <i>J</i> = 6.6 Hz, 3H). LC/MS Method C (<i>m</i>/<i>z</i>) 527.4/529.2 [M + H], <i>T</i><sub>r</sub> = 3.56 min.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(Hept-6-enoyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>11d</b>)</h3><div class="NLM_p last"><b>10</b> (1.06 g, 2 mmol) was combined with hept-6-enoic acid (220 mg, 2.2 mmol) as described for the preparation of <b>11a</b>. The crude <b>11d</b> was subjected to silica gel chromatography eluting with isohexanes/(EtOAc/MeOH 4:1 mixture) (1:0 to 5:2) to afford the title compound (817 mg, 75%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.05â7.87 (m, 1H), 5.80 (td, <i>J</i> = 17.0, 6.8 Hz, 1H), 5.36 (m, 1H), 5.01 (d, <i>J</i> = 12.1 Hz, 1H), 5.03â4.89 (m, 2H), 4.81 (d, <i>J</i> = 12.1 Hz, 1H), 4.20 (m, 1H), 3.79â3.38 (m, 3H), 2.27 (m, 2H), 2.07 (m, 4H), 1.87 (m, 2H), 1.74â1.66 (m, 1H), 1.62 (m, 2H), 1.48â1.37 (m, 2H), 1.29 (d, <i>J</i> = 6.9 Hz, 3H), 0.96 (d, <i>J</i> = 6.3 Hz, 3H), 0.93 (d, <i>J</i> = 6.9 Hz, 3H). LC/MS Method C (<i>m</i>/<i>z</i>) 541.3/543.3 [M + H], <i>T</i><sub>r</sub> = 3.75 min.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(((<i>E</i>)-Pent-3-enoyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>11e</b>)</h3><div class="NLM_p last">Compound <b>10</b> (10.6 g, 20 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (300 mL) was stirred at 0 Â°C under N<sub>2</sub> and treated dropwise with TMSOTf (6.66 g, 5.4 mL, 30 mmol). The reaction mixture was stirred at 0 Â°C for 1 h and then treated with cold saturated sodium hydrogen carbonate solution (200 mL). The mixture was stirred at 0 Â°C for 15 min, the organic layer separated, washed with saturated sodium hydrogen carbonate solution (100 mL), brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue in CH<sub>3</sub>CN (240 mL) was stirred at 0 Â°C under N<sub>2</sub> and treated with (<i>E</i>)-pent-3-enoic acid (2.20 g, 2.2 mL, 22 mmol), 1-hydroxybenzotriazole hydrate (3.82 g, 20 mmol, wetted with not less than 20 wt % water), and <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>â²-ethylcarbodiimide hydrochloride (5.38 g, 28 mmol). The mixture was stirred at 0 Â°C for 15 min, then at rt for 20 h, and then concentrated <i>in vacuo</i>. The residue was partitioned between EtOAc (100 mL) and water (100 mL), and the organic layer was separated. The aqueous layer was washed with EtOAc (100 mL), and the combined organic extracts washed with water (100 mL), brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (3:1 to 0:1) to afford the title compound (9.0 g, 88%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 6.69 (d, <i>J</i> = 7.6 Hz, 1H), 6.28 (d, <i>J</i> = 8.7 Hz, 1H), 5.73â5.51 (m, 2H), 5.36â5.27 (m, 1H), 4.96 (d, <i>J</i> = 11.8 Hz, 1H), 4.72 (d, <i>J</i> = 11.8 Hz, 1H), 4.40â4.27 (m, 2H), 3.88 (d, <i>J</i> = 11.2 Hz, 1H), 3.74â3.67 (m, 1H), 2.99 (d, <i>J</i> = 6.7 Hz, 2H), 2.95â2.88 (m, 1H), 2.75â1.75 (m, 5H), 1.74 (d, <i>J</i> = 5.4 Hz, 3H), 1.32 (d, <i>J</i> = 6.6 Hz, 3H), 0.93 (<i>app</i> t, <i>J</i> = 6.6 Hz, 6H). LC/MS Method A (<i>m</i>/<i>z</i>) 513.1/515.1 [M + H], <i>T</i><sub>r</sub> = 2.59 min.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>R</i>)-1-(3-Vinylisoquinolin-6-yl)ethyl (<i>S</i>)-1-(((2<i>R</i>,3<i>R</i>)-3-Methoxy-2-methylpent-4-enoyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>12a</b>)</h3><div class="NLM_p last"><b>11a</b> (763.4 mg, 1.34 mmol) in THF (25 mL) was treated with zinc powder (1.92 g, 29.4 mmol) and a solution of ammonium acetate (1.54 g, 20 mmol) in water (5 mL). The mixture was stirred for 16 h, filtered through Celite, and then treated with 2 M HCl. The mixture was extracted with EtOAc (2 Ã 50 mL), and the combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was azeotroped with toluene to afford (<i>S</i>)-1-(((2<i>R</i>,3<i>R</i>)-3-methoxy-2-methylpent-4-enoyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylic acid (566 mg, 96%) as a light orange solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.74 (d, <i>J</i> = 9.1 Hz, 1H), 7.56 (d, <i>J</i> = 7.6 Hz, 1H), 5.67 (dq, <i>J</i> = 15.4, 6.0 Hz, 1H), 5.25â5.09 (m, 2H), 5.04 (d, <i>J</i> = 10.5 Hz, 1H), 4.16 (dd, <i>J</i> = 8.7, 6.2 Hz, 1H), 4.00â3.90 (m, 1H), 3.06 (s, 3H), 3.00â2.86 (m, 1H), 2.10â1.97 (m, 1H), 1.95â1.85 (m, 1H), 1.71 (d, <i>J</i> = 6.5 Hz, 4H), 1.61â1.46 (m, 2H), 1.14 (d, <i>J</i> = 6.9 Hz, 3H), 0.89â0.79 (m, 9H). (<i>S</i>)-1-(((2<i>R</i>,3<i>R</i>)-3-methoxy-2-methylpent-4-enoyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylic acid (180 mg, 0.40 mmol) and <b>17</b> (111 mg, 0.56 mmol) were added to CH<sub>2</sub>Cl<sub>2</sub> (10 mL). The mixture was stirred at rt under N<sub>2</sub> and treated with <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>â²-ethylcarbodiimide hydrochloride (108 mg, 0.56 mmol) and 4-DMAP (25 mg, 0.2 mmol). The mixture was stirred for 20 h, diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated sodium hydrogen carbonate solution, water, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in <i>vacuo</i>. The residue was subjected to silica gel chromatography using a gradient of isohexanes/EtOAc (1:1 to 0:1) to afford the title compound (103 mg, 42%) as a clear viscous oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.23 (s, 1H), 7.99 (d, <i>J</i> = 8.5 Hz, 1H), 7.76 (<i>br</i> s, 1H), 7.63 (<i>br</i> s, 1H), 7.54 (dd, <i>J</i> = 8.5, 1.3 Hz, 1H), 6.97 (dd, <i>J</i> = 17.2, 10.7 Hz, 1H), 6.71 (d, <i>J</i> = 7.6 Hz, 1H), 6.51 (d, <i>J</i> = 8.7 Hz, 1H), 6.41 (d, <i>J</i> = 17.2 Hz, 1H), 6.11 (q, <i>J</i> = 6.7 Hz, 1H), 5.72â5.65 (m, 1H), 5.52 (d, <i>J</i> = 10.7 Hz, 1H), 5.34â5.20 (m, 2H), 4.43 (<i>br</i> d, 1H), 4.33 (dd, <i>J</i> = 8.7, 5.6 Hz, 1H), 3.85â3.52 (m, 3H), 3.24 (s, 3H), 2.85â2.75 (m, 2H), 2.40â1.75 (m, 5H), 1.75 (d, <i>J</i> = 6.2 Hz, 3H), 1.67 (d, <i>J</i> = 6.5 Hz, 3H), 1.31 (d, <i>J</i> = 6.7 Hz, 3H), 1.07 (d, <i>J</i> = 6.9 Hz, 3H), 0.95 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (d, <i>J</i> = 6.9 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 622 [M + H], <i>T</i><sub>r</sub> = 5.15 min.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>R</i>)-1-(3-Vinylisoquinolin-6-yl)ethyl (<i>S</i>)-1-(Pent-4-enoyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>12b</b>)</h3><div class="NLM_p last"><b>11b</b> (616 mg, 1.2 mmol) was converted to <b>12b</b> according to the procedure reported for compound <b>12a</b> to afford the title compound (180 mg, 58%) as a foam. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.23 (s, 1H), 8.00 (d, <i>J</i> = 8.5 Hz, 1H), 7.76 (<i>br</i> s, 1H), 7.62 (<i>br</i> s, 1H), 7.54 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H), 6.97 (dd, <i>J</i> = 17.2, 10.7 Hz, 1H), 6.63 (d, <i>J</i> = 7.6 Hz, 1H), 6.41 (dd, <i>J</i> = 17.2, 1.6 Hz, 1H), 6.15â6.08 (m, 2H), 5.90â5.78 (m, 1H), 5.53 (dd, <i>J</i> = 10.7, 1.4 Hz, 1H), 5.35â5.23 (m, 1H), 5.09 (dd, <i>J</i> = 17.2, 1.6 Hz, 1H), 5.02 (dd, <i>J</i> = 10.2, 1.6 Hz, 1H), 4.42 (<i>br</i> d, 1H), 4.31 (dd, <i>J</i> = 8.7, 6.0 Hz, 1H), 3.82â3.76 (m, 1H), 3.62â3.55 (m, 1H), 2.83â2.77 (m, 1H), 2.50â1.90 (m, 9H), 1.67 (d, <i>J</i> = 6.5 Hz, 3H), 1.31 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 564 [M + H], <i>T</i><sub>r</sub> = 2.04 min.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>R</i>)-1-(3-Vinylisoquinolin-6-yl)ethyl (<i>S</i>)-1-(Hex-5-enoyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>12c</b>)</h3><div class="NLM_p last">A solution of <b>11c</b> (830 mg, 1.57 mmol) in THF (40 mL) was treated with water (10 mL) and lithium hydroxide hydrate (57 mg, 2.38 mmol). The mixture was stirred for 2 h and then filtered through a 5 cm layer of DOWEX D50 Ã 8 resin in H<sup>+</sup> cycle (resin first washed with water). The resin was washed with additional water (50 mL), the filtrates collected, concentrated <i>in vacuo</i>, azeotroped with toluene (2 Ã 10 mL), and dried <i>in vacuo</i> to afford (<i>S</i>)-1-(hex-5-enoyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylic acid (590 mg, 95%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.84 (s, 2H), 5.72 (m, 1H), 5.24 (m, 1H), 4.93 (d, <i>J</i> = 16.9 Hz, 1H), 4.87 (d, <i>J</i> = 10.4 Hz, 1H), 4.10 (m, 1H), 3.98 (m, 1H), 3.43 (m, 1H), 2.96 (m, 1H), 2.19 (m, 2H), 1.98 (m, 4H), 1.74 (s, 1H), 1.67â1.56 (m, 4H), 1.20 (d, <i>J</i> = 5.9 Hz, 3H), 0.91â0.81 (m, 6H). LC/MS Method C (<i>m</i>/<i>z</i>) 397.3 [M + H], <i>T</i><sub>r</sub> = 2.43 min. The ester formation was performed as described for compound <b>12a</b> using (<i>S</i>)-1-(hex-5-enoyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylic acid (238 mg, 0.6 mmol) and <b>17</b> (120 mg, 0.6 mmol) to afford the title compound (307 mg, 89%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 9.17 (s, 1H), 8.07 (d, <i>J</i> = 7.7 Hz, 1H), 7.92 (s, 1H), 7.86 (s, 1H), 7.81 (s, 1H), 7.63 (d, <i>J</i> = 7.8 Hz, 1H), 7.15â6.87 (m, 1H), 6.31 (d, <i>J</i> = 17.9 Hz, 1H), 6.09 (m, 1H), 5.78 (m, 1H), 5.50 (d, <i>J</i> = 10.6 Hz, 1H), 5.36 (m, 1H), 5.00 (d, <i>J</i> = 17.3 Hz, 1H), 4.94 (d, <i>J</i> = 10.1 Hz, 1H), 4.18 (m, 1H), 3.89 (m, 1H), 3.72 (m, 1H), 2.25 (m, 2H), 2.05 (m, 4H), 1.81 (m, 3H), 1.66 (m, 6H), 1.31 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (m, 6H). LC/MS Method C (<i>m</i>/<i>z</i>) 578.3 [M + H], <i>T</i><sub>r</sub> = 3.23 min.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>R</i>)-1-(3-Vinylisoquinolin-6-yl)ethyl (<i>S</i>)-1-(Hept-6-enoyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>12d</b>)</h3><div class="NLM_p last"><b>11d</b> (790 mg, 1.46 mmol) was converted to <b>12d</b> according to the procedure reported for compound <b>12c</b> to afford the title compound (316 mg, 79%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 9.06 (s, 1H), 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.76 (s, 1H), 7.71 (s, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 6.87 (dd, <i>J</i> = 17.4, 10.9 Hz, 1H), 6.21 (d, <i>J</i> = 17.5 Hz, 1H), 5.99 (q, <i>J</i> = 6.3 Hz, 1H), 5.67 (m, 1H), 5.40 (d, <i>J</i> = 10.8 Hz, 1H), 5.26 (m, 1H), 4.87 (d, <i>J</i> = 17.1 Hz, 1H), 4.80 (d, <i>J</i> = 9.6 Hz, 1H), 4.08 (d, <i>J</i> = 7.0 Hz, 1H), 3.80 (s, 1H), 3.61 (m, 1H), 2.15 (m, 2H), 1.94 (m, 4H), 1.78â1.66 (m, 2H), 1.63â1.44 (m, 3H), 1.53 (d, <i>J</i> = 6.6 Hz, 3H), 1.29 (m, 3H), 1.21 (d, <i>J</i> = 6.9 Hz, 3H), 0.81 (m, 6H). LC/MS Method C (<i>m</i>/<i>z</i>) 592.2 [M + H], <i>T</i><sub>r</sub> = 3.41 min.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>R</i>)-1-(3-Vinylisoquinolin-6-yl)ethyl (<i>S</i>)-1-(((<i>E</i>)-Pent-3-enoyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>12e</b>)</h3><div class="NLM_p last"><b>11e</b> (9.0 g, 17.5 mmol) was converted to <b>12e</b> according to the procedure reported for compound <b>12a</b> to afford the title compound (3.91 g, 51%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.23 (s, 1H), 8.00 (d, <i>J</i> = 8.5 Hz, 1H), 7.76 (<i>br</i> s, 1H), 7.62 (s, 1H), 7.53 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H), 6.98 (dd, <i>J</i> = 17.4, 10.7 Hz, 1H), 6.64 (d, <i>J</i> = 7.4 Hz, 1H), 6.41 (dd, <i>J</i> = 17.2, 1.3 Hz, 1H), 6.22 (d, <i>J</i> = 8.5 Hz, 1H), 6.11 (q, <i>J</i> = 6.7 Hz, 1H), 5.71â5.57 (m, 2H), 5.53 (dd, <i>J</i> = 10.7, 1.3 Hz, 1H), 5.33â5.26 (m, 1H), 4.46â4.40 (m, 1H), 4.28 (dd, <i>J</i> = 8.7, 6.0 Hz, 1H), 3.79 (d, <i>J</i> = 11.6 Hz, 1H), 3.62â3.55 (m, 1H), 2.98 (d, <i>J</i> = 6.7 Hz, 2H), 2.85â2.78 (m, 1H), 2.16â1.86 (m, 5H), 1.74 (dd, <i>J</i> = 6.0, 0.9 Hz, 3H), 1.67 (d, <i>J</i> = 6.7 Hz, 3H), 1.31 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (<i>app</i> t, <i>J</i> = 6.6 Hz, 6H). LC/MS Method A (<i>m</i>/<i>z</i>) 564.3 [M + H], <i>T</i><sub>r</sub> = 2.06 min.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (2<i>R</i>,3<i>R</i>,<i>E</i>)-3-Methoxy-2-methylhex-4-enoic Acid (<b>14</b>)</h3><div class="NLM_p last">A solution of <b>13</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (6.0 g, 22.1 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (24 mL) was treated with TMSOTf (5.0 mL, 22.1 mmol), followed by Et<sub>3</sub>N (3.54 mL, 25.4 mmol). The reaction mixture was stirred under N<sub>2</sub> at rt for 15 h. The dark solution was concentrated <i>in vacuo</i>, and the residue was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (22 mL). The mixture was treated dropwise with a solution of crotonaldehyde (3.66 mL, 44.2 mmol) and 1 M titanium tetrachloride in CH<sub>2</sub>Cl<sub>2</sub> (44.2 mL, 44.2 mmol), at â78 Â°C under N<sub>2</sub>. The reaction mixture was stirred at â78 Â°C for 1 h, treated with ammonium chloride solution (30 mL), and then allowed to warm to rt. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 25 mL), and the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (4:1) to afford (2<i>R</i>,3<i>R</i>,<i>E</i>)-1-((3a<i>R</i>,6<i>S</i>,7a<i>S</i>)-8,8-dimethyl-2,2-dioxidotetrahydro-3<i>H</i>-3a,6-methanobenzo[<i>c</i>]isothiazol-1(4<i>H</i>)-yl)-3-hydroxy-2-methylhex-4-en-1-one (6.7 g, 89%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 5.82â5.67 (m, 1H), 5.57â5.46 (m, 1H), 3.94â3.87 (m, 1H), 3.58â3.42 (m, 2H), 3.29â3.18 (m, 1H), 2.47 (d, <i>J</i> = 8.5 Hz, 1H), 2.17â2.04 (m, 3H), 2.00â1.84 (m, 3H), 1.69 (d, <i>J</i> = 6.5 Hz, 3H), 1.46â1.32 (m, 2H), 1.24â1.17 (m, 6H), 0.98 (s, 3H). LC/MS Method A1 (<i>m</i>/<i>z</i>) 364.08 [M + Na], <i>T</i><sub>r</sub> = 3.47 min. A solution of (2<i>R</i>,3<i>R</i>,<i>E</i>)-1-((3a<i>R</i>,6<i>S</i>,7a<i>S</i>)-8,8-dimethyl-2,2-dioxidotetrahydro-3<i>H</i>-3a,6-methanobenzo[<i>c</i>]isothiazol-1(4<i>H</i>)-yl)-3-hydroxy-2-methylhex-4-en-1-one (4.15 g, 12.1 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (80 mL) was treated with 1,8-bis(dimethylamino)naphthalene (7.78 g, 36.3 mmol) followed by trimethyloxonium tetrafluoroborate (3.6 g, 24.2 mmol). The reaction mixture was stirred at rt for 3 h, treated with MeOH (3 mL), stirred for another 5 min, and then 2 M HCl (200 mL) and EtOAc (250 mL) were added. The mixture was filtered, the organic layer separated, and the aqueous layer extracted with EtOAc (2 Ã 100 mL). The combined organic extracts were washed with brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to afford (2<i>R</i>,3<i>R</i>,<i>E</i>)-1-((3a<i>R</i>,6<i>S</i>,7a<i>S</i>)-8,8-dimethyl-2,2-dioxidotetrahydro-3<i>H</i>-3a,6-methanobenzo[<i>c</i>]isothiazol-1(4<i>H</i>)-yl)-3-methoxy-2-methylhex-4-en-1-one (4.80 g, 100%) as a pale brown solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 5.79â5.65 (m, 1H), 5.34â5.22 (m, 1H), 3.90 (t, <i>J</i> = 6.2 Hz, 1H), 3.66 (t, <i>J</i> = 9.0 Hz, 1H), 3.56â3.38 (m, 2H), 3.32â3.19 (m, 1H), 3.17 (s, 3H), 2.10â2.05 (m, 3H), 2.00â1.85 (m, 3H), 1.74 (dd, <i>J</i> = 6.5, 1.6 Hz, 2H), 1.45â1.31 (m, 2H), 1.24â1.18 (m, 3H), 1.05 (d, <i>J</i> = 6.9 Hz, 3H), 0.98 (s, 3H). LC/MS Method A1 (<i>m</i>/<i>z</i>) 378.14 [M + Na], <i>T</i><sub>r</sub> = 3.76 min. A 2 M solution of lithium hydroxide (50 mL, 100 mmol) was added to a stirred solution of (2<i>R</i>,3<i>R</i>,<i>E</i>)-1-((3a<i>R</i>,6<i>S</i>,7a<i>S</i>)-8,8-dimethyl-2,2-dioxidotetrahydro-3<i>H</i>-3a,6-methanobenzo[<i>c</i>]isothiazol-1(4<i>H</i>)-yl)-3-methoxy-2-methylhex-4-en-1-one (4.80 g, 12.1 mmol) in THF (130 mL). The reaction mixture was heated at 60 Â°C for 15 h. The reaction mixture was cooled to rt, partially concentrated <i>in vacuo</i>, and treated with 2 M HCl (150 mL). The mixture was extracted with EtOAc (3 Ã 50 mL), and the combined extracts dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/Et<sub>2</sub>O (1:1) to afford the title compound (1.132 g, 59%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 11.15 (<i>br</i> s, 1H), 5.82â5.67 (m, 1H), 5.30â5.18 (m, 1H), 3.65 (t, <i>J</i> = 8.8 Hz, 1H), 3.26 (s, 3H), 2.63â2.51 (m, 1H), 1.77 (dd, <i>J</i> = 6.5, 1.6 Hz, 3H), 1.10 (d, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>R</i>)-1-(3-Chloroisoquinolin-6-yl)ethan-1-ol (<b>16</b>)</h3><div class="NLM_p last">A solution of <b>15</b> (972 mg, 4 mmol) and tri-<i>n</i>-butyl(1-ethoxyvinyl)tin (2.5 g, 2.5 mL, 7 mmol) in toluene (12 mL) was degassed with N<sub>2</sub> for 30 min. Bis(triphenylphosphine)palladium(II) dichloride (280 mg, 0.4 mmol) was added, and the reaction mixture was heated at 50 Â°C for 18 h. The reaction mixture was cooled to rt and concentrated <i>in vacuo</i>, and the residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (19:1 to 10:1) to afford 3-chloro-6-(1-ethoxyvinyl)isoquinoline (964 mg, â¼ 100%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.94 (s, 1H), 8.04 (s, 1H), 7.97â7.85 (m, 2H), 7.76 (s, 1H), 4.90 (d, <i>J</i> = 2.8 Hz, 1H), 4.45 (d, <i>J</i> = 2.8 Hz, 1H), 4.01 (q, <i>J</i> = 7.0 Hz, 2H), 1.51 (t, <i>J</i> = 7.0 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 234/236 [M + H], <i>T</i><sub>r</sub> = 5.40 min. A solution of 3-chloro-6-(1-ethoxyvinyl)isoquinoline (934 mg, 4 mmol) in 1,4-dioxane (10 mL) and 2 M HCl (5 mL) was stirred at rt for 30 min. The mixture was concentrated <i>in vacuo</i>, and the residue was partitioned between EtOAc (30 mL) and water (30 mL). The organic layer was separated, and the aqueous phase was extracted with EtOAc (30 mL). The organic extracts were combined, washed with water, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of isohexanes/EtOAc (9:1 to 4:1) to afford 1-(3-chloroisoquinolin-6-yl)ethan-1-one (732 mg, 89%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.17 (s, 1H), 8.37 (br s, H), 8.15 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 8.05 (d, <i>J</i> = 8.5 Hz, 1H), 7.88 (s, 1H), 2.77 (s, 3H). LC/MS Method A1 (<i>m</i>/<i>z</i>) 206/208 [M + H], <i>T</i><sub>r</sub> = 4.40 min. Dichloro(<i>p</i>-cymene)ruthenium(II) dimer (3 mg, 0.005 mmol) and (1<i>R</i>,2<i>R</i>)-(â)-<i>N</i>-<i>p</i>-tosyl-1,2-diphenylethylenediamine (4.4 mg, 0.012 mmol) were suspended in N<sub>2</sub> degassed water (2 mL), and the mixture was then further degassed with N<sub>2</sub> for 15 min. The mixture was stirred at 70 Â°C under N<sub>2</sub> for 90 min. The yellow solution was cooled to rt and 1-(3-chloroisoquinolin-6-yl)ethan-1-one (206 mg, 1 mmol), sodium formate (340 mg, 5 mmol), and degassed THF (1 mL) were added. The reaction mixture was degassed with N<sub>2</sub> for 5 min and then vigorously stirred at 40 Â°C for 2.5 h. The reaction mixture was cooled to rt and EtOAc (30 mL) was added. The organic layer was separated, washed with water, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of isohexanes/EtOAc (4:1 to 2:1) to afford the title compound (193 mg, 92%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.04 (s, 1H), 7.96 (d, <i>J</i> = 8.6 Hz, 1H), 7.77 (br s, 1H), 7.72 (s, 1H), 7.63 (dd, <i>J</i> = 8.6, 1.6 Hz, 1H), 5.16â5.08 (m, 1H), 2.14 (d, <i>J</i> = 3.1 Hz, 1H), 1.60 (d, <i>J</i> = 5.9 Hz, 3H). LC/MS Method A1 (<i>m</i>/<i>z</i>) 208/210 [M + H], <i>T</i><sub>r</sub> = 4.25 min.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>R</i>)-1-(3-Vinylisoquinolin-6-yl)ethan-1-ol (<b>17</b>)</h3><div class="NLM_p last">1,4-Dioxane (5 mL) was degassed with N<sub>2</sub>, and <b>16</b> (208 mg, 1 mmol), tri-<i>n</i>-butyl(vinyl)tin (951 mg, 0.9 mL, 3 mmol), and bis(triphenylphosphine)palladium(II) dichloride (70 mg, 0.1 mmol) were added. The reaction mixture was heated at 150 Â°C in a microwave reactor for 1 h. Additional tri-<i>n</i>-butyl(vinyl)tin (0.3 mL, 1 mmol) and bis(triphenylphosphine)palladium(II) dichloride (70 mg, 0.1 mmol) were added, and the reaction mixture was heated at 150 Â°C in a microwave reactor for 1 h. The mixture was cooled to rt and filtered, and the filter pad washed with EtOAc. The filtrate was concentrated <i>in vacuo</i>, and the residue was subjected to silica gel chromatography eluting with a gradient of isohexanes/EtOAc (4:1 to 2:1) followed by a second silica gel chromatography eluting with isohexanes/EtOAc (3:1) to afford the title compound (100 mg, 50%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.19 (s, 1H), 7.94 (d, <i>J</i> = 8.5 Hz, 1H), 7.78 (br s, 1H), 7.58 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H), 7.57 (s, 1H), 6.95 (dd, <i>J</i> = 17.2, 10.7 Hz, 1H), 6.40 (dd, <i>J</i> = 17.2, 1.6 Hz, 1H), 5.52 (dd, <i>J</i> = 10.6, 1.6 Hz, 1H), 5.10 (q, <i>J</i> = 6.5 Hz, 1H), 2.11 (br s, 1H), 1.60 (d, <i>J</i> = 6.5 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 200 [M + H], <i>T</i><sub>r</sub> = 1.50 min.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (1<sup>3</sup><i>S</i>,4<i>R</i>,11<i>S</i>,14<i>S</i>,<i>E</i>)-11-Isopropyl-4,14-dimethyl-1<sup>1</sup>,1<sup>2</sup>,1<sup>3</sup>,1<sup>4</sup>,1<sup>5</sup>,1<sup>6</sup>-hexahydro-3-oxa-10,13-diaza-1(3,1)-pyridazina-5(2,7)-naphthalenacyclopentadecaphan-6-ene-2,9,12,15-tetraone (<b>18</b>)</h3><div class="NLM_p last"><b>32a</b> (55 mg, 0.08 mmol) was dissolved in a mixture of THF (2 mL), MeOH (1 mL), and water (1 mL). The solution was treated with lithium hydroxide hydrate (4 mg, 0.16 mmol), and the mixture was stirred at rt for 1 h. CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and water (10 mL) were added to the reaction mixture followed by 1 M HCl until pH â 2. The organic layer was separated, and the aqueous layer was back extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 10 mL). The combined organic extracts were concentrated <i>in vacuo</i> to afford the <i>seco</i>-acid 2,2,2-trichloroethyl (<i>S</i>)-1-(((<i>E</i>)-4-(7-((<i>R</i>)-1-hydroxyethyl)naphthalen-2-yl)but-3-enoyl)-<i>L</i>-valyl-<i>L</i>-alanyl)hexahydropyridazine-3-carboxylate (37 mg, 84%) as a white solid. LC/MS Method C (<i>m</i>/<i>z</i>) 537.2 [M â H]. 2-Methyl-6-nitrobenzoic anhydride (19 mg, 0.056 mmol) and 4-DMAP (23 mg, 0.185 mmol) were dissolved in 1,2-dichloroethane (18 mL), and the solution was heated at 50 Â°C. The <i>seco</i>-acid (20 mg, 0.037 mmol) in <i>N,N</i>-dimethylformamide (1 mL) was added over 10 h by syringe pump, washing the syringe pump with additional <i>N,N</i>-dimethylformamide (1 mL). The reaction mixture was stirred at 50 Â°C for an additional 2 h and concentrated <i>in vacuo</i>, and the residue was subjected to preparative HPLC (0 to 100% CH<sub>3</sub>CN/water) to afford the title compound (4 mg, 22%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.84â7.74 (m, 3H), 7.56 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.47â7.43 (m, 1H), 7.35 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 6.52 (d, <i>J</i> = 16.3 Hz, 1H), 6.31 (ddd, <i>J</i> = 16.2, 6.1, 4.8 Hz, 1H), 6.05 (q, <i>J</i> = 6.6 Hz, 1H), 5.58 (q, <i>J</i> = 7.2 Hz, 1H), 4.48â4.38 (m, 1H), 4.31 (d, <i>J</i> = 10.0 Hz, 1H), 3.80 (dd, <i>J</i> = 11.3, 2.8 Hz, 1H), 3.37 (dd, <i>J</i> = 6.2, 1.7 Hz, 1H), 2.99 (ddd, <i>J</i> = 15.1, 4.7, 2.0 Hz, 1H), 2.76 (td, <i>J</i> = 12.8, 3.2 Hz, 1H), 2.05â1.70 (m, 5H), 1.69 (d, <i>J</i> = 1.7 Hz, 3H), 1.67 (d, <i>J</i> = 2.3 Hz, 3H), 1.03 (dd, <i>J</i> = 13.8, 6.7 Hz, 6H). LC/MS Method C (<i>m</i>/<i>z</i>) 521.1 [M â H], <i>T</i><sub>r</sub> = 3.18 min. HRMS C<sub>29</sub>H<sub>36</sub>N<sub>4</sub>O<sub>5</sub> calculated 520.2686, found 520.2694.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (5<sup>3</sup>S,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7-dimethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-3-oxa-8,11-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphan-14-ene-4,6,9,12-tetraone (<b>19</b>)</h3><div class="NLM_p last">A solution of <b>33</b> (342 mg, 0.492 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.5 mL) was cooled to 0 Â°C and treated with TMSOTf (0.18 mL, 0.96 mmol). The mixture was stirred at 0 Â°C for 2.75 h, and additional TMSOTf (0.073 mL, 0.45 mmol) was then added. The mixture was stirred for another 80 min, treated with <i>N,N-</i>diisopropylethylamine (0.6 mL, 3.44 mmol), and stirred an additional 10 min. The mixture was concentrated <i>in vacuo</i> to afford the <i>seco</i>-acid (<i>E</i>)-4-(2-((<i>R</i>)-1-(((<i>S</i>)-1-(<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carbonyl)oxy)ethyl)quinolin-7-yl)but-3-enoic acid (266 mg, 0.45 mmol). The <i>seco</i>-acid was dissolved in CH<sub>3</sub>CN (50 mL) at 0 Â°C under N<sub>2</sub> and treated with <i>N,N-</i>diisopropylethylamine (0.343 mL, 1.971 mmol) and 2-(1<i>H</i>-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate methanaminium (262 mg, 0.70 mmol). The mixture was stirred at 0 Â°C and allowed to warm to rt over 16 h. The mixture was treated with 2 M HCl (20 mL), and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (9:1) (2 Ã 100 mL). The combined organic extracts were washed with saturated sodium hydrogen carbonate solution (2 Ã 200 mL), brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to give a crude residue. The residue was subjected to silica gel chromatography eluting with gradient of EtOAc/acetone (97:3 to 94:6) to afford a solid, which was then triturated with Et<sub>2</sub>O to afford the title compound (25.4 mg, 10%) as a pale yellow solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 8.21 (d, <i>J =</i> 8.5 Hz, 1H), 7.81 (d, <i>J =</i> 8.7 Hz, 1H), 7.75 (dd, <i>J =</i> 8.7, 1.3 Hz, 1H), 7.65 (s, 1H), 7.40 (d, <i>J =</i> 8.5 Hz, 1H), 6.55 (dt, <i>J =</i> 16.7, 4.7 Hz, 1H), 6.41 (d, <i>J =</i> 16.7 Hz, 1H), 5.94 (q, <i>J =</i> 6.9 Hz, 1H), 5.72 (q, <i>J =</i> 7.1 Hz, 1H), 4.43 (<i>br</i> d, <i>J =</i> 11.2 Hz, 1H), 4.23 (d, <i>J =</i> 10.5 Hz, 1H), 3.88â3.79 (m, 1H), 3.40â3.35 (m, 1H), 3.07â2.97 (m, 1H), 2.75 (dd, <i>J =</i> 12.9, 2.9 Hz, 1H), 2.08â1.85 (m, 4H), 1.74 (d, <i>J =</i> 6.9 Hz, 3H), 1.72â1.66 (m, 1H), 1.64 (d, <i>J =</i> 7.1 Hz, 3H), 1.01 (d, <i>J =</i> 6.7 Hz, 3H), 0.99 (d, <i>J =</i> 6.48 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 522.2 [M + H], <i>T</i><sub>r</sub> = 1.90 min. HRMS C<sub>28</sub>H<sub>38</sub>N<sub>5</sub>O<sub>5</sub> calculated 520.2638, found 521.2649.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7,13,13-tetramethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-3-oxa-8,11-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphan-14-ene-4,6,9,12-tetraone (<b>20</b>)</h3><div class="NLM_p last"><b>32b</b> (1.11 g, 1.50 mmol) was hydrolyzed to the <i>seco</i>-acid according to the method for <b>18</b> except using 4 equiv of LiOH. The <i>seco</i>-acid was cyclized according to the method for <b>18</b> with addition by syringe pump over 6 h reaching a concentration of 3 mmol. The crude residue was subjected to silica gel chromatography eluting with isohexanes, then isohexanes/acetone (4:1), then isohexanes/acetone (7:3), and finally isohexanes/acetone (3:2). The product was treated with brine (200 mL) and then extracted with EtOAc (2 Ã 100 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to a second silica gel chromatography eluting with isohexanes/acetone (95:5), then isohexanes/acetone (93:7), then isohexanes/acetone (88:12) (3 L), and finally, isohexanes/acetone (82:16). Two purest fractions were combined, concentrated <i>in vacuo</i>, and triturated twice with Et<sub>2</sub>O to afford the title compound â¼241 mg. The less pure fractions were subjected to preparative reverse phase HPLC, and the isolated product combined to afford the title compound (422 mg, 51%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.18 (d, <i>J</i> = 8.5 Hz, 1H), 7.81â7.71 (m, 2H), 7.61 (s, 1H), 7.38 (d, <i>J</i> = 8.5 Hz, 1H), 7.26 (d, <i>J</i> = 9.6 Hz, 1H), 6.46 (d, <i>J</i> = 16.5 Hz, 1H), 6.25 (d, <i>J</i> = 16.5 Hz, 1H), 5.89 (q, <i>J</i> = 6.8 Hz, 1H), 5.72 (qd, <i>J</i> = 7.2, 4.8 Hz, 1H), 4.37 (d, <i>J</i> = 12.1 Hz, 1H), 4.29 (t, <i>J</i> = 10.0 Hz, 1H), 3.83â3.73 (m, 1H), 2.72 (td, <i>J</i> = 12.6, 3.5 Hz, 1H), 1.97 (m, 2H), 1.88 (m, 1H), 1.71 (d, <i>J</i> = 6.9 Hz, 3H), 1.67 (m, 2H), 1.59 (d, <i>J</i> = 7.2 Hz, 3H), 1.48 (s, 3H), 1.34 (s, 3H), 0.94 (t, <i>J</i> = 6.3 Hz, 6H). LC/MS Method A (<i>m</i>/<i>z</i>) 550.1 [M + H], <i>T</i><sub>r</sub> = 2.24 min. HRMS C<sub>30</sub>H<sub>39</sub>N<sub>5</sub>O<sub>5</sub> calculated 549.2951, found 549.2968.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7,13,13-tetramethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-3-oxa-8,11-diaza-1(6,3)-isoquinolina-5(3,1)-pyridazinacyclopentadecaphan-14-ene-4,6,9,12-tetraone (<b>21</b>)</h3><div class="NLM_p last"><b>32c</b> (1.50 g, 2.15 mmol) was hydrolyzed to the <i>seco</i>-acid according to the method for <b>18</b> except using 4 equiv of LiOH. The <i>seco</i>-acid was cyclized according to the method for <b>18</b> with addition by syringe pump over 6 h reaching a concentration of 3 mmol. The residue was subjected to silica gel chromatography eluting with 35 to 65% acetone in isohexanes to afford the title compound (445 mg). The impure fractions were subjected to recrystallization from acetone/isohexanes to afford additional material and a combined yield of title compound (619 mg, 52%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 9.13 (s, 1H), 8.04 (d, <i>J</i> = 8.5 Hz, 1H), 7.89 (s, 1H), 7.55 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H), 7.53 (s, 1H), 6.73â6.34 (m, 2H), 6.03 (q, <i>J</i> = 6.6 Hz, 1H), 5.63 (q, <i>J</i> = 7.2 Hz, 1H), 4.67 (d, <i>J</i> = 12.2 Hz, 1H), 4.47â4.21 (m, 2H), 3.81â3.73 (m, 1H), 2.76â2.64 (m, 1H), 2.08â1.81 (m, 3H), 1.80â1.58 (m, 8H), 1.51 (s, 3H), 1.35 (s, 3H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method B1 (<i>m</i>/<i>z</i>) 550.2 [M + H], <i>T</i><sub>r</sub> = 2.74 min. HRMS C<sub>30</sub>H<sub>39</sub>N<sub>5</sub>O<sub>5</sub> calculated 549.2951, found 549.2964.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>R</i>)-1-(7-Bromonaphthalen-2-yl)ethan-1-ol (<b>23</b>)</h3><div class="NLM_p last">2,7-Dibromonaphthalene <b>22</b> (1 g, 3.50 mmol) in anhydrous THF (18 mL), at â78 Â°C under N<sub>2</sub>, was treated dropwise with a solution of <i>n</i>-butyllithium (2.5 M in hexanes, 1.5 mL, 3.67 mmol). The mixture was stirred at â78 Â°C for 20 min, and then <i>N</i>-methoxy-<i>N</i>-methylacetamide (409 Î¼L, 3.85 mmol) was added. The mixture was stirred for 15 min, warmed to rt, and stirred an additional 30 min. The reaction was quenched with 2 M HCl and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 50 mL). The combined organic extracts were dried through a hydrophobic frit and concentrated <i>in vacuo</i>. The residue was subjected to silica flash chromatography eluting with isohexanes/EtOAc (7:1) to afford 1-(7-bromonaphthalen-2-yl)ethan-1-one (650 mg, 75%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.38 (s, 1H), 8.15 (s, 1H), 8.06 (dd, <i>J</i> = 8.7, 1.6 Hz, 1H), 7.89 (d, <i>J</i> = 8.7 Hz, 1H), 7.78 (d, <i>J</i> = 8.7 Hz, 1H), 7.69 (dd, <i>J</i> = 8.7, 1.8 Hz, 1H), 2.74 (s, 3H). Dichloro (<i>p</i>-cymene) ruthenium(II) dimer (8 mg, 0.013 mmol) in water (5 mL) was treated with (1<i>R</i>, 2<i>R</i>)-(â)-<i>N</i>-<i>p</i>-tosyl-1, 2-diphenylethylenediamine (11.5 mg, 0.031 mmol). The mixture was degassed for 15 min and then heated at 70 Â°C for 1.5 h. The reaction was cooled and treated with a solution of 1-(7-bromonaphthalen-2-yl)ethan-1-one (650 mg, 2.61 mmol) in degassed anhydrous THF (2 mL) followed by sodium formate (874 mg, 13.1 mmol). The mixture was heated at 40 Â°C for 3 h, cooled to rt, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 50 mL). The combined organic extracts were dried through a hydrophobic frit and concentrated <i>in vacuo</i>. The product was subjected to silica flash chromatography eluting with isohexanes/EtOAc (4:1) to afford the title compound (450 mg, 69%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.01 (d, <i>J</i> = 1.8 Hz, 1H), 7.83 (d, <i>J</i> = 8.5 Hz, 1H), 7.77â7.68 (m, 2H), 7.59â7.51 (m, 2H), 5.09 (qd, <i>J</i> = 6.5 Hz, 3.6 Hz, 1H), 1.90 (d, <i>J</i> = 3.6 Hz, 1H), 1.60 (d, <i>J</i> = 6.5 Hz, 3H).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>R</i>,<i>E</i>)-4-(7-(1-Hydroxyethyl)naphthalen-2-yl)but-3-enoic Acid (<b>24</b>)</h3><div class="NLM_p last"><b>23</b> (42 mg, 0.17 mmol) was dissolved in CH<sub>3</sub>CN (2 mL) and treated with but-3-enoic acid (35 mg, 0.41 mmol), palladium(II) acetate (4 mg, 0.017 mmol), tri-(<i>o</i>-tolyl)phosphine (10 mg, 0.034 mmol), and Et<sub>3</sub>N (0.12 mL). The mixture was heated at 120 Â°C in the microwave reactor for 15 min. The reaction mixture was then filtered and concentrated <i>in vacuo</i>, and the residue was subjected to silica gel chromatography eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:3) to afford the title compound (35 mg, 81%) as a yellow solid. LC/MS Method C (<i>m</i>/<i>z</i>) 255.2 [M â H], <i>T</i><sub>r</sub> = 1.80 min.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>R</i>)-1-(7-Bromoquinolin-2-yl)ethan-1-ol (<b>26</b>)</h3><div class="NLM_p">A slurry of <b>25</b> (8.10 g, 33.4 mmol) and sodium iodide (50.0 g, 334 mmol) in CH<sub>3</sub>CN (27 mL) was treated with acetyl chloride (3.56 mL, 50.0 mmol). The flask was sealed and heated at 80 Â°C for 3 h. The cooled mixture was treated sequentially with 10% w/w aqueous potassium carbonate solution (80 mL), 5% w/w aqueous sodium sulfite solution (80 mL) and saturated aqueous sodium thiosulfate solution (80 mL). The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 250 mL), and the combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to provide crude 7-bromo-2-iodoquinoline. The crude 7-bromo-2-iodoquinoline was treated with tri-<i>n</i>-butyl(1-ethoxyvinyl)tin (13.6 mL, 40.1 mmol), 1,4-dioxane (67 mL), and bis(triphenylphosphine)palladium(II) dichloride (2.37 g, 3.34 mmol), and the reaction mixture was heated at 100 Â°C for 5 h. The mixture was treated with 2 M HCl (67 mL), stirred for 1 h, and the solids were removed and washed with EtOAc. The filtrate was concentrated <i>in vacuo</i> to remove organics, and then the aqueous solution was extracted with EtOAc (3 Ã 250 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of 0 to 6% EtOAc in isohexanes, and first doping the silica gel with 10% w/w potassium carbonate, to afford 1-(7-bromoquinolin-2-yl)ethan-1-one <b>40</b> (5.5 g, 66%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.42 (s, 1H), 8.21 (ABq, ÎÎ´<sub>AB</sub> = 0.11, <i>J</i><sub>AB</sub> = 8.5 Hz, 2H), 7.80â7.72 (m, 2H), 2.86 (s, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 250.1/252.1 [M + H], <i>T</i><sub>r</sub> = 2.90 min.</div><div class="NLM_p last">Dichloro (<i>p</i>-cymene) ruthenium(II) dimer (61 mg, 0.100 mmol) and (1<i>R</i>,2<i>R</i>)-(â)-<i>N</i>-<i>p</i>-tosyl-1,2-diphenylethylenediamine (88 mg, 0.012 mmol) were suspended in degassed water (40 mL), and the mixture was degassed with N<sub>2</sub> for 5 min. The mixture was stirred at 70 Â°C for 90 min. The turbid orange mixture was allowed to cool to rt, and then 1-(7-bromoquinolin-2-yl)ethan-1-one (5.00 g, 20 mmol) in degassed THF (40 mL) was added followed by sodium formate (6.8 g, 100 mmol). The reaction mixture was degassed with N<sub>2</sub> for 5 min and then vigorously stirred at 40 Â°C for 4 h. The mixture was diluted with EtOAc (100 mL) and water (100 mL), and the organic layer was separated, washed with water (100 mL), brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of 0â30% EtOAc in isohexanes to afford the title compound (4.96 g, 98%) as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.28 (d, <i>J =</i> 1.6 Hz, 1H), 8.15 (d, <i>J =</i> 8.5 Hz, 1H), 7.71 (d, <i>J =</i> 8.7 Hz, 1H), 7.64 (dd, <i>J =</i> 8.7, 1.6 Hz, 1H), 7.40 (d, <i>J =</i> 8.5 Hz, 1H), 5.07â5.04 (m, 1H), 4.85 (d, <i>J =</i> 4.5 Hz, 1H), 1.59 (d, <i>J =</i> 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 252.1/254.1 [M + H], <i>T</i><sub>r</sub> = 1.74 min.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>tert</i>-Butyl (<i>R</i>,<i>E</i>)-4-(7-(1-hydroxyethyl)naphthalen-2-yl)but-3-enoate (<b>27</b>)</h3><div class="NLM_p last">A solution of <b>26</b> (295 mg, 1.17 mmol) in anhydrous CH<sub>3</sub>CN (12 mL) was treated with but-3-enoic acid <i>tert</i>-butyl ester (0.44 mL, 2.75 mmol), bis(tri<i>tert</i>-butylphosphine)palladium(0) (25 mg, 0.049 mmol), and <i>N,N</i>-dicyclohexylmethylamine (0.39 mL, 1.83 mmol). The mixture was heated at reflux for 2 h and concentrated <i>in vacuo</i>, and the residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (95:5) to afford the title compound (348 mg, 95%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.11 (d, <i>J =</i> 8.5 Hz, 1H), 7.97 (<i>app</i> s, 1H), 7.77 (d, <i>J =</i> 8.5 Hz, 1H), 7.67 (dd, <i>J =</i> 8.5, 1.6 Hz, 1H), 7.31 (d, <i>J =</i> 8.5 Hz, 1H), 6.69 (d, <i>J =</i> 16.1 Hz, 1H), 6.60â6.47 (m, 1H), 5.10â4.96 (m, 2H), 3.26 (dd, <i>J =</i> 1.1, 6.9 Hz, 2H), 1.59 (d, <i>J =</i> 6.3 Hz, 3H), 1.51 (s, 9H). LC/MS Method A (<i>m</i>/<i>z</i>) 314.2 [M + H], <i>T</i><sub>r</sub> = 1.91 min.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>R</i>,<i>E</i>)-4-(2-(1-Acetoxyethyl)quinolin-7-yl)-2,2-dimethylbut-3-enoic Acid (<b>28</b>)</h3><div class="NLM_p last">A solution of <b>26</b> (1.00 g, 3.97 mmol) and Et<sub>3</sub>N (1.65 mL, 11.9 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> at 0 Â°C was treated with acetic anhydride (0.75 mL, 7.93 mmol) and 4-(dimethylamino)pyridine (24 mg, 0.197 mmol). The reaction mixture was allowed to warm to rt and stirred for 1.5 h. Water (100 mL) was added, the organic layer was separated, and the aqueous layer was back extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 100 mL). The combined organic extracts were washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes followed by isohexanes/EtOAc (95:5) and finally isohexanes/EtOAc (9:1) to afford (<i>R</i>)-1-(7-bromoquinolin-2-yl)ethyl acetate (1.16 g, 99%) as a colorless oil. The oil was dissolved in anhydrous CH<sub>3</sub>CN (20 mL) and treated with palladium(II) acetate (89 mg, 0.395 mmol), 2,2-dimethyl-but-3-enoic acid (496 mg, 4.35 mmol), tri(<i>o</i>-tolyl)phosphine (241 mg, 0.790 mmol), and Et<sub>3</sub>N (1.09 mL, 7.90 mmol). The mixture was heated in the microwave at 100 Â°C for 20 min and then concentrated <i>in vacuo</i>. Water (200 mL) was added and the mixture was extracted with EtOAc (2 Ã 50 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (95:5) followed by isohexanes/EtOAc (9:1) and finally isohexanes/EtOAc (3:1) to afford the title compound (792 mg, 61%) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 8.31 (d, <i>J =</i> 8.5 Hz, 1H), 7.94 (s, 1H), 7.88 (d, <i>J =</i> 8.5 Hz, 1H), 7.77 (dd, <i>J =</i> 8.5, 1.3 Hz, 1H), 7.54 (d, <i>J</i> = 8.5 Hz, 1H), 6.74 (ABq, ÎÎ´<sub>AB</sub> = 0.02, <i>J</i><sub>AB</sub> = 16.5 Hz, 2H), 5.98 (q, <i>J =</i> 6.8 Hz, 1H), 2.16 (s, 3H), 1.65 (d, <i>J =</i> 6.8 Hz, 3H), 1.47 (s, 6H). LC/MS Method A (<i>m</i>/<i>z</i>) 328.1 [M + H], <i>T</i><sub>r</sub> = 2.11 min.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>R</i>,<i>E</i>)-4-(6-(1-Hydroxyethyl)isoquinolin-3-yl)-2,2-dimethylbut-3-enoic Acid (<b>29</b>)</h3><div class="NLM_p last"><b>16</b> (880 mg, 4.23 mmol), <b>31</b> (1.24 g, 4.88 mmol), bis[(dicyclohexyl)(4-dimethylaminophenyl)phosphine]palladium(II) chloride (173 mg, 0.21 mmol), and potassium phosphate tribasic (2.64 g, 12.4 mmol) were dissolved in cyclopentyl methyl ether (11.9 mL) and water (5.1 mL). The biphasic mixture was vigorously stirred at 90 Â°C for 3.5 h then cooled to rt and diluted with EtOAc (50 mL) and water (40 mL). The organic phase was separated, and the aqueous phase was extracted with EtOAc (2 Ã 50 mL). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with 25â60% EtOAc in <i>iso-</i>hexanes to afford methyl (<i>R</i>,<i>E</i>)-4-(6-(1-hydroxyethyl)isoquinolin-3-yl)-2,2-dimethylbut-3-enoate (1.07 g, 85%) as a yellow oil. A solution of the methyl (<i>R</i>,<i>E</i>)-4-(6-(1-hydroxyethyl)isoquinolin-3-yl)-2,2-dimethylbut-3-enoate (1.05 g, 3.51 mmol) in THF (8 mL), MeOH (4 mL), and water (4 mL) was treated with lithium hydroxide hydrate (297 mg, 7.08 mmol). The mixture was stirred for 6 h and then quenched with 1 M HCl (7.2 mL, 7.2 mmol). The mixture was concentrated and then azeotroped with anhydrous MeOH (50 mL) followed by toluene (50 mL) to afford the title compound (1.3 g, 100%) as a yellow solid that was used without further purification. LC/MS Method A (<i>m</i>/<i>z</i>) 286.1 [M + H], <i>T</i><sub>r</sub> = 1.97 min.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Methyl (<i>E</i>)-2,2-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-enoate (<b>31</b>)</h3><div class="NLM_p last">Bis(cyclopentadienyl)zirconium chloride hydride (290 mg, 1.1 mmol) was cooled in an ice water bath under argon. A solution of <b>30</b> (1.4 g, 11.1 mmol) and pinacolborane (2.4 mL, 16.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added by cannula, washing the cannula and flask with an additional portion of CH<sub>2</sub>Cl<sub>2</sub> (2 mL). The mixture was removed from the cold bath and stirred for 72 h at rt. The mixture was then diluted with EtOAc (50 mL), quenched with dropwise water (5 mL), and then further diluted with water (50 mL). The organic phase was separated, and the aqueous phase was extracted with EtOAc (30 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with 5â15% EtOAc in hexanes to afford the title compound (1.6 g, 57%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 6.73 (d, <i>J</i> = 18.5 Hz, 1H), 5.50 (d, <i>J</i> = 18.5 Hz, 1H), 3.67 (s, 3H), 1.31 (s, 6H), 1.27 (s, 12H). LC/MS Method B1 (<i>m</i>/<i>z</i>) 255.2 [M + H], <i>T</i><sub>r</sub> = 4.03 min.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(((<i>E</i>)-4-(7-((<i>R</i>)-1-Hydroxyethyl)naphthalen-2-yl)but-3-enoyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>32a</b>)</h3><div class="NLM_p last"><b>10</b> (95 mg, 0.18 mmol) was deprotected as described in the synthesis of <b>32b</b> and then combined with <b>24</b> (40 mg, 0.08 mmol) as described in the synthesis of <b>32b</b>. The crude residue was subjected to silica gel chromatography eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:10) to afford the title compound (68 mg, 65%) as a yellow solid. 1H NMR (400 MHz, CD3OD) Î´ 7.88â7.75 (m, 4H), 7.56 (dd, J = 8.8, 1.6 Hz, 1H), 7.43 (d, J = 8.8 Hz, 1H), 6.71 (d, J = 16.4 Hz, 1H), 6.51â6.42 (m, 1H), 5.38 (q, J = 7.6 Hz, 1H), 4.98â4.93 (m, 2H), 4.78 (d, J = 12.8 Hz, 1H), 4.25 (d, J = 10.4 Hz, 1H), 3.78â3.75 (m, 2H), 3.24 (d, J = 10.2 Hz, 2H), 2.10â2.02 (m, 2H), 1.84â1.81 (m, 2H), 1.65â1.62 (m, 1H), 1.52 (d, J = 7.2 Hz, 3H), 1.30â1.24 (m, 3H), 0.98â0.92 (m, 6H). LC/MS Method C (<i>m</i>/<i>z</i>) 668.9 [M + H], <i>T</i><sub>r</sub> = 2.17 min.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(((<i>E</i>)-4-(2-((<i>R</i>)-1-Acetoxyethyl)quinolin-7-yl)-2,2-dimethylbut-3-enoyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>32b</b>)</h3><div class="NLM_p last">A solution of <b>10</b> (1.29 g, 2.42 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL) was cooled in an iceâwater bath under N<sub>2</sub>. TMSOTf (0.715 mL, 4.84 mmol) was added dropwise, and the mixture stirred for 1 h. <i>N,N</i>-Diisopropylethylamine (1.69 mL, 9.68 mmol) was added, and the reaction mixture was concentrated <i>in vacuo</i> to afford (<i>S</i>)-1-[(<i>S</i>)-2-((<i>S</i>)-2-amino-3-methyl-butyrylamino)-propionyl]-hexahydro-pyridazine-3-carboxylic acid 2,2,2-trichloro-ethyl ester as a white solid. A solution of <b>28</b> (792 mg, 2.42 mmol) in <i>N,N</i>-dimethylformamide (10 mL) at 0 Â°C was treated with <i>N,N</i>-diisopropylethylamine (2.11 mL, 12.1 mmol) and 2-(1<i>H</i>-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate methanaminium (1.01 g, 2.66 mmol). The mixture was stirred at rt for 15 min and then cooled to 0 Â°C. (<i>S</i>)-1-[(<i>S</i>)-2-((<i>S</i>)-2-amino-3-methyl-butyrylamino)-propionyl]-hexahydro-pyridazine-3-carboxylic acid 2,2,2-trichloro-ethyl ester dissolved in <i>N,N</i>-dimethylformamide (10.7 mL) was added, and the stirred reaction mixture was then allowed to warm to rt. The mixture was stirred for 1 h and then diluted with EtOAc (100 mL) and water (100 mL). The organic phase was separated, and the aqueous phase was extracted with EtOAc (100 mL). The combined organic extracts were washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/acetone (95:5) followed by isohexanes/acetone (9:1), followed by isohexanes/acetone (85:15), and finally, isohexanes/acetone (3:1) to afford the title compound (1.11 g, 62%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 8.21 (d, <i>J =</i> 8.5 Hz, 1H), 7.81 (d, <i>J =</i> 8.7 Hz, 1H), 7.75 (dd, <i>J =</i> 1.3, 8.7 Hz, 1H), 7.65 (s, 1H), 7.40 (d, <i>J =</i> 8.5 Hz, 1H), 6.55 (dt, <i>J =</i> 4.7, 16.7 Hz, 1H), 6.41 (d, <i>J =</i> 16.7 Hz, 1H), 5.94 (q, <i>J =</i> 6.9 Hz, 1H), 5.72 (q, <i>J =</i> 7.1 Hz, 1H), 4.43 (<i>br</i> d, <i>J =</i> 11.2 Hz, 1H), 4.23 (d, <i>J =</i> 10.5 Hz, 1H), 3.88â3.79 (m, 1H), 3.40â3.35 (m, 1H), 3.07â2.97 (m, 1H), 2.75 (dd, <i>J =</i> 2.9, 12.9 Hz, 1H), 2.08â1.85 (m, 4H), 1.74 (d, <i>J =</i> 6.9 Hz, 3H), 1.72â1.66 (m, 1H), 1.64 (d, <i>J =</i> 7.1 Hz, 3H), 1.01 (d, <i>J =</i> 6.7 Hz, 3H), 0.99 (d, <i>J =</i> 6.48 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 522.2 [M + H], <i>T</i><sub>r</sub> = 1.90 min.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(((<i>E</i>)-4-(6-((<i>R</i>)-1-Hydroxyethyl)isoquinolin-3-yl)-2,2-dimethylbut-3-enoyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>32c</b>)</h3><div class="NLM_p last"><b>29</b> (1.05 g, 2.84 mmol) and <b>10</b> (1.61 g, 3.03 mmol) were combined as described in <b>32b</b>. The crude residue was subjected to silica gel chromatography eluting with 35â60% acetone in <i>iso-</i>hexanes to afford the title compound (1.51 g, 71% over two steps from <b>10</b>) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) 9.14 (s, 1H), 7.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.74 (s, 1H), 7.61â7.48 (m, 2H), 7.07 (d, <i>J</i> = 15.9 Hz, 1H), 6.77 (d, <i>J</i> = 15.9 Hz, 1H), 6.66 (d, <i>J</i> = 7.7 Hz, 1H), 6.39 (d, <i>J</i> = 8.4 Hz, 1H), 5.27 (m, 1H), 5.07 (q, <i>J</i> = 6.4 Hz, 1H), 4.91 (d, <i>J</i> = 11.9 Hz, 1H), 4.67 (d, <i>J</i> = 11.9 Hz, 1H), 4.31 (d, <i>J</i> = 12.2 Hz, 1H), 4.25 (dd, <i>J</i> = 8.4, 6.1 Hz, 1H), 3.84 (d, <i>J</i> = 11.2 Hz, 1H), 3.70â3.62 (m, 1H), 2.88â2.80 (m, 1H), 2.20â2.04 (m, 3H), 1.97â1.84 (m, 1H), 1.77â1.62 (m, 2H), 1.57 (d, <i>J</i> = 6.5 Hz, 3H), 1.48 (<i>br</i> s, 6H), 1.28 (d, <i>J</i> = 6.8 Hz, 3H), 0.91 (d, <i>J</i> = 6.8 Hz, 3H), 0.85 (d, <i>J</i> = 7.5 Hz, 3H). LC/MS Method B1 (<i>m</i>/<i>z</i>) 697.8 [M + H], <i>T</i><sub>r</sub> = 3.08 min.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>R</i>)-1-(7-((<i>E</i>)-4-(<i>tert</i>-Butoxy)-4-oxobut-1-en-1-yl)quinolin-2-yl)ethyl (<i>S</i>)-1-((<i>tert</i>-Butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>33</b>)</h3><div class="NLM_p last">A solution of compound <b>10</b> (804 mg, 1.51 mmol) in THF (38 mL) was treated with zinc powder (2.18 g, 33.3 mmol) followed by a solution of ammonium acetate (1.75 g, 22.7 mmol) in water (9.4 mL). The reaction mixture was stirred at room temperature for 72 h. The reaction mixture was filtered through a Hyflo-supercel, washing with EtOAc and saturated aqueous potassium hydrogen sulfate. The mixture was treated with 1 M HCl (3 mL), and the layers were separated. The aqueous layer was extracted with EtOAc (2 Ã 100 mL). The organic layers were combined, washed with brine, filtered, and concentrated to give a colorless gum. The residue was azeotroped with <i>in vacuo</i> toluene (3 Ã 200 mL) to afford (<i>S</i>)-1-[(<i>S</i>)-2-((<i>S</i>)-2-<i>tert</i>-butoxycarbonylamino-3-methyl-butyrylamino)-propionyl]-hexahydro-pyridazine-3-carboxylic acid (605 mg, quantitative) as a white solid. LC/MS Method A (<i>m</i>/<i>z</i>) 401.2 [M + H], <i>T</i><sub>r</sub> = 1.78 min. Compound <b>27</b> (363 mg, 1.16 mmol) and (<i>S</i>)-1-[(<i>S</i>)-2-((<i>S</i>)-2-<i>tert</i>-butoxycarbonylamino-3-methyl-butyrylamino)-propionyl]-hexahydro-pyridazine-3-carboxylic acid (505 mg, 1.26 mmol) were dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and treated with <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>â²-ethylcarbodiimide hydrochloride (311 mg, 1.62 mmol) and 4-DMAP (142 mg, 1.16 mmol). The mixture was stirred at rt for 16 h and then treated with saturated aqueous ammonium chloride solution (100 mL). The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 50 mL), and the organic extracts were washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (4:1) followed by isohexanes/EtOAc (7:3), then isohexanes/EtOAc (3:2) to afford the title compound (357 mg, 44%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.17 (d, <i>J =</i> 8.5 Hz, 1H), 7.97 (s, 1H), 7.77 (d, <i>J =</i> 8.7 Hz, 1H), 7.67 (dd, <i>J =</i> 1.6, 8.5 Hz, 1H), 7.40 (d, <i>J =</i> 8.5 Hz, 1H), 6.77â6.63 (m, 2H), 6.59â6.46 (m, 1H), 6.13 (q, <i>J =</i> 6.7 Hz, 1H), 5.35â5.23 (m, 1H), 5.12 (<i>br</i> d, <i>J =</i> 8.3 Hz, 1H), 4.46 (<i>br</i> d, <i>J =</i> 12.9 Hz, 1H), 4.01â3.91 (m, 1H), 3.83 (d, <i>J =</i> 11.6 Hz, 1H), 3.68â3.57 (m,1H), 3.26 (d, <i>J =</i> 6.9 Hz, 2H), 2.72 (m, 1H), 2.23â2.02 (m, 3H), 1.99â1.86 (m, 1H), 1.73 (d, <i>J =</i> 6.9 Hz, 3H), 1.70â1.65 (m, 1H), 1.51 (s, 9H), 1.46 (s, 9H), 1.33 (d, <i>J =</i> 6.9 Hz, 3H), 1.00â0.86 (m, 6H). LC/MS Method A (<i>m</i>/<i>z</i>) 696.4 [M + H], <i>T</i><sub>r</sub> = 3.29 min.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7,13,13-tetramethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-11-oxa-3,8-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphan-14-ene-4,6,9,12-tetraone (<b>34</b>)</h3><div class="NLM_p last"><b>45</b> (117 mg, 0.201 mmol) was hydrolyzed according to the method for <b>18</b> over 20 h followed by preparative HPLC eluting with a gradient of 20 to 100% CH<sub>3</sub>CN in water to afford the <i>seco</i>-acid (60 mg, 53%). LC/MS Method A (<i>m</i>/<i>z</i>) 568.3 [M + H], <i>T</i><sub>r</sub> = 1.60 min. A slurry of 2-methyl-6-nitrobenzoic anhydride (177 mg, 0.500 mmol), 4-DMAP (92 mg, 0.750 mmol), and powdered 4 Ã molecular sieves (1 g) in 1,2-dichloroethane (33 mL) was stirred under N<sub>2</sub> at 50 Â°C. The <i>seco</i>-acid (57 mg, 0.100 mmol) was dissolved in <i>N,N</i>-dimethylformamide (5 mL), and the solution was added to the slurry over 5 h via syringe pump. The acid containing flask was washed with further <i>N,N</i>-dimethylformamide (1 mL), and the washings were transferred to the reaction vessel over 30 min. The reaction mixture was stirred at 50 Â°C for 1 h and then concentrated <i>in vacuo</i>. The residue was subjected to preparative HPLC eluting with a gradient of 5â100% CH<sub>3</sub>CN in water to afford the title compound (24.5 mg, 45%) as a white solid.<sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 1H), 7.75 (s, 1H), 7.58 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.41 (d, <i>J</i> = 8.5 Hz, 1H), 6.51 (d, <i>J</i> = 16.3 Hz, 1H), 6.33 (d, <i>J</i> = 16.3 Hz, 1H), 5.77 (q, <i>J</i> = 7.2 Hz, 1H), 5.20 (d, <i>J</i> = 9.0 Hz, 1H), 5.09â5.01 (m, 1H), 4.40 (d, <i>J</i> = 12.1 Hz, 1H), 3.65â3.51 (m, 1H), 2.67 (td, <i>J</i> = 12.9, 3.2 Hz, 1H), 2.25 (d, <i>J</i> = 13.7 Hz, 1H), 2.20â2.06 (m, 1H), 1.92 (d, <i>J</i> = 13.6 Hz, 1H), 1.66 (dt, <i>J</i> = 12.9, 4.0 Hz, 1H), 1.57 (dd, <i>J</i> = 18.2, 7.0 Hz, 5H), 1.50 (s, 3H), 1.39 (s, 3H), 1.25 (d, <i>J</i> = 9.9 Hz, 1H), 1.23â1.11 (m, 1H), 1.03 (d, <i>J</i> = 6.8 Hz, 2H), 0.97 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 550.2 [M + H], <i>T</i><sub>r</sub> = 2.05 min. HRMS C<sub>30</sub>H<sub>39</sub>N<sub>5</sub>O<sub>5</sub> calculated 549.2951, found 549.2962.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7,13,13-tetramethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-11-oxa-3,8-diaza-1(6,3)-isoquinolina-5(3,1)-pyridazinacyclopentadecaphan-14-ene-4,6,9,12-tetraone (<b>35</b>)</h3><div class="NLM_p last"><b>46</b> (390 mg, 0.48 mmol) in THF (20 mL) was treated with a solution of lithium hydroxide (13 mg, 0.53 mmol) in water (10 mL), and the mixture was stirred at rt for 2 h. 1 M HCl was added (0.55 mL) and the reaction mixture was concentrated <i>in vacuo</i>. The residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and water (50 mL), and the organic layer was separated, concentrated <i>in vacuo</i>, and dried under high vacuum. The residue was treated with 4 M HCl in 1,4-dioxane (10 mL, 40 mmol) and stirred at rt for 4 h. The mixture was concentrated <i>in vacuo</i>, and then dissolved in <i>N,N</i>-dimethylformamide (5 mL). The mixture was added into an argon purged flask containing 2-(1<i>H</i>-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate methanaminium (276 mg, 0.73 mmol), <i>N,N</i>-diisopropylethylamine (312 mg, 2.42 mmol), and CH<sub>2</sub>Cl<sub>2</sub> (200 mL). The reaction mixture was repurged with argon and then stirred at rt for 2 h. The mixture was washed with water (100 mL), brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with 0â40% EtOAc/MeOH (4/1) in isohexanes to afford the title compound (4 mg, 3%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) Î´ 9.12 (s, 1H), 7.94 (d, <i>J</i> = 8.3 Hz, 1H), 7.60 (s, 1H), 7.44 (d, <i>J</i> = 9.0 Hz, 2H), 7.28 (dd, <i>J</i> = 18.5, 6.4 Hz, 2H), 7.03 (d, <i>J</i> = 15.9 Hz, 1H), 6.81 (d, <i>J</i> = 15.9 Hz, 1H), 5.65 (d, <i>J</i> = 3.5 Hz, 1H), 4.95 (dq, <i>J</i> = 13.2, 6.8 Hz, 2H), 4.29 (d, <i>J</i> = 11.7 Hz, 1H), 3.24 (s, 1H), 2.92 (d, <i>J</i> = 12.9 Hz, 1H), 2.42â2.23 (m, 1H), 1.70 (d, <i>J</i> = 16.1 Hz, 2H), 1.59 (s, 3H), 1.52 (d, <i>J</i> = 6.1 Hz, 2H), 1.49â1.39 (m, 9H), 1.01 (d, <i>J</i> = 7.0 Hz, 3H), 0.91 (d, <i>J</i> = 6.8 Hz, 3H). LC/MS Method C (<i>m</i>/<i>z</i>) 550.4 [M + H], <i>T</i><sub>r</sub> = 1.81 min. HRMS C<sub>30</sub>H<sub>39</sub>N<sub>5</sub>O<sub>5</sub> calculated 549.2951, found 549.2963.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>R</i>)-<i>N</i>-((<i>R</i>)-1-(3-Chloroisoquinolin-6-yl)ethyl)-2-methylpropane-2-sulfinamide (<b>37</b>)</h3><div class="NLM_p last">A solution of 1-(3-chloroisoquinolin-6-yl)ethan-1-one (see compound <b>16</b>) (1.72 g, 8.3 mmol) in THF (40 mL) was stirred under N<sub>2</sub>. Titanium(IV) ethoxide (3.8 g, 3.45 mL, 16.6 mmol, tech. grade) was added followed by (<i>R</i>)-(+)-2-methylpropanesulfinimide (1.11 g, 9.2 mmol), and the reaction mixture was stirred at 60 Â°C under N<sub>2</sub> for 18 h. Additional (<i>R</i>)-(+)-2-methylpropanesulfinimide (190 mg, 1.67 mmol) was added, and the reaction mixture was stirred at 65 Â°C for a further 2 h. The reaction mixture was cooled to room temperature, treated with EtOAc and brine, and the suspension was filtered through Celite, washing the filter pad with EtOAc. The EtOAc layer was separated, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of isohexanes/EtOAc 7:3 to 3:7 to afford the intermediate sulfinimide (2.2 g, 86%) as a yellow solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.13 (s, 1H), 8.19 (s, 1H), 8.16 (d, <i>J</i> = 8.8 Hz, 1H), 8.02 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 2.92 (s, 3H), 1.39 (s, 9H). LC/MS Method B (<i>m</i>/<i>z</i>) 309.1/311.1 [M + H], <i>T</i><sub>r</sub> = 2.31 min. A mixture of (1<i>S</i>, 2<i>R</i>)-(â)-<i>cis</i>-1-amino-2-indanol (60 mg, 0.4 mmol), dichloro (<i>p</i>-cymene) ruthenium(II) dimer (122 mg, 0.2 mmol), and powdered 4 Ã molecular sieves (2 g) was suspended in anhydrous 2-propanol (9 mL) and stirred under N<sub>2</sub>. The suspension was heated at 90 Â°C for 20 min, cooled to 40 Â°C, and treated with a solution of (<i>R</i>)-2-methylpropane-2-sulfinic acid [1-(3-chloro-isoquinolin-6-yl)-eth-(<i>E</i>)-ylidene]-amide (1.23 g, 4 mmol) in 2-propanol (28 mL) followed by a solution of potassium <i>tert</i>-butoxide (122 mg, 1.1 mmol) in 2-propanol (10 mL). The reaction mixture was stirred at 40 Â°C for 2 h and then allowed to cool. The mixture was poured directly onto a silica gel cartridge and eluted with EtOAc to afford the title compound (1.19 g, 96%) as a brown gum. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.07 (s, 1H), 7.79 (d, <i>J</i> = 8.5 Hz, 1H), 7.74 (<i>br</i> s, 2H), 7.63 (dd, <i>J</i> = 8.5, 1.3 Hz, 1H), 4.71â4.79 (m, 1H), 3.53 (d, <i>J</i> = 3.4 Hz, 1H), 1.63 (<i>app</i> t, <i>J</i> = 6.7 Hz, 3H), 1.28 (s, 9H). LC/MS Method B (<i>m</i>/<i>z</i>) 311.0/313.0 [M + H], <i>T</i><sub>r</sub> = 2.19 min.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>tert</i>-Butyl (<i>R</i>)-(1-(3-chloroisoquinolin-6-yl)ethyl)carbamate (<b>38</b>)</h3><div class="NLM_p last">A solution of <b>37</b> (932 mg, 3 mmol) in MeOH (9 mL) was stirred at rt under N<sub>2</sub>. 4 M HCl in 1,4-dioxane (3 mL, 12 mmol) was added, and the reaction mixture stirred at rt for 30 min. The mixture was concentrated <i>in vacuo</i>, and the residue was triturated with Et<sub>2</sub>O to form an orange solid that was collected, washed with Et<sub>2</sub>O, and dried to afford (<i>R</i>)-1-(3-chloroisoquinolin-6-yl)ethan-1-amine hydrochloride salt (777 mg, quant). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.25 (s, 1H), 8.80â8.65 (br, 3H), 8.26 (d, <i>J</i> = 8.5, 1H), 8.05 (br, 1H), 8.04 (br, 1H), 7.90 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 4.67â4.58 (m, 1H), 1.61 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method C (<i>m</i>/<i>z</i>) 207/209 [M + H], <i>T</i><sub>r</sub> = 0.72 min. A mixture of the hydrochloride salt (730 mg, 3 mmol) and Et<sub>3</sub>N (909 mg, 1.25 mL, 9 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL), was stirred at rt until a solution formed. A solution of di-<i>tert</i>-butyl dicarbonate (981 mg, 4.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was then added, and the reaction mixture was stirred at rt for 20 h. The mixture was washed with water (30 mL), brine (30 mL), dried, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with 10â30% EtOAc in isohexanes to afford the title compound (714 mg, 79% over two steps) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.05 (s, 1H), 7.96 (d, <i>J</i> = 8.5, 1H), 7.71 (br, 1H), 7.67 (br, 1H), 7.57 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 5.00â4.90 (br, 2H), 1.53 (d, <i>J</i> = 6.5 Hz, 3H), 1.44 (s, 9H). LC/MS Method C (<i>m</i>/<i>z</i>) 307/309 [M + H], <i>T</i><sub>r</sub> = 2.67 min.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>R</i>,<i>E</i>)-4-(6-(1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)isoquinolin-3-yl)-2,2-dimethylbut-3-enoic Acid (<b>39</b>)</h3><div class="NLM_p last"><b>38</b> (200 mg, 0.65 mmol) was subjected to the same coupling procedure with <b>31</b> as described for compound <b>29</b>. The crude product was dissolved in THF (9.5 mL, 0.1 M) and then treated with 0.1 M NaOH (9.5 mL, 1.03 mmol) followed by heating the mixture at 40 Â°C for 3 h. The mixture was cooled to rt, treated with 1 M HCl (3.6 mL) until pH â 4, and then concentrated <i>in vacuo</i> to afford the crude acid (191 mg, 76% over two steps from <b>38</b>) as a yellow solid that was used without further purification. LC/MS Method C (<i>m</i>/<i>z</i>) 385.1 [M + H].</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>R</i>)-<i>N</i>-((<i>R</i>)-1-(7-Bromoquinolin-2-yl)ethyl)-2-methylpropane-2-sulfinamide (<b>41</b>)</h3><div class="NLM_p last">A solution of 1-(7-bromoquinolin-2-yl)ethan-1-one <b>40</b> (1.42 g, 5.68 mmol, see preparation of <b>26</b>) in THF (28 mL) was treated with titanium(IV) ethoxide (2.6 g, 2.35 mL, 11.4 mmol) followed by (<i>R</i>)-(+)-2-methylpropanesulfinimide (825 mg, 6.82 mmol). The reaction mixture was stirred at 60 Â°C for 6 h. Brine was added followed by EtOAc (25 mL), and the suspension was filtered through Celite, washing the filter pad with EtOAc. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of isohexanes/EtOAc (9:1 to 3:1) to afford the intermediate sulfinimide (448 mg, 22%) as an orange solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.37 (s, 1H), 8.24 (d, <i>J</i> = 8.6 Hz, 1H), 8.16 (d, <i>J</i> = 8.6 Hz, 1H), 7.71 (m, 2H), 2.99 (s, 3H), 1.38 (s, 9H). LC/MS Method A (<i>m</i>/<i>z</i>) 352.9/354.9 [M + H], <i>T</i><sub>r</sub> = 3.14 min. A mixture of (1<i>S</i>, 2<i>R</i>)-(â)-<i>cis</i>-1-amino-2-indanol (19 mg, 0.13 mmol), [Ru(<i>p</i>-cymene)Cl<sub>2</sub>]<sub>2</sub> (39 mg, 0.064 mmol) and powdered 4 Ã molecular sieves (0.7 g) was suspended in anhydrous 2-propanol (3 mL) and stirred under N<sub>2</sub>. The suspension was heated at 90 Â°C for 30 min. The reaction mixture was cooled to 40 Â°C, and a solution of the intermediate sulfinimide (448 mg, 1.27 mmol) in 2-propanol (9 mL) was added followed by a solution of potassium <i>tert</i>-butoxide (36 mg, 0.32 mmol) in 2-propanol (3 mL). The reaction mixture was stirred for 2 h at 40 Â°C and then allowed to cool before filtration through a silica gel plug eluting with EtOAc. The eluant was concentrated <i>in vacuo</i>, and the residue was subjected to silica gel chromatography eluting with a gradient of i<i>so</i>-hexanes/EtOAc (1:1 to 0:1) to afford the title compound (287 mg, 64%) as a brown gum. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.25 (s, 1H), 8.12 (d, <i>J</i> = 8.7 Hz, 1H), 7.68 (d, <i>J</i> = 8.7 Hz, 1H), 7.62 (dd, <i>J</i> = 8.5, 1.2 Hz, 1H), 7.42 (d, <i>J</i> = 8.5 Hz, 1H), 5.42 (<i>br</i> d, <i>J</i> = 4.2 Hz, 1H), 4.80 (m, 1H), 1.60 (d, <i>J</i> = 6.7 Hz, 3H), 1.33 (s, 9H). LC/MS Method A (<i>m</i>/<i>z</i>) 354.9/356.8 [M + H], <i>T</i><sub>r</sub> = 2.49 min.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Methyl (<i>R</i>,<i>E</i>)-4-(2-(1-Aminoethyl)quinolin-7-yl)-2,2-dimethylbut-3-enoate (<b>42</b>)</h3><div class="NLM_p last"><b>41</b> (207 mg, 0.583 mmol), <b>31</b> (170 mg, 0.670 mmol), bis[(dicyclohexyl)(4-dimethylaminophenyl)phosphine] palladium(II) chloride (24 mg, 0.029 mmol), and potassium phosphate tribasic (371 mg, 1.75 mmol) were suspended in cyclopentylmethyl ether (3 mL) and water (1.5 mL). The mixture was stirred and heated at 80 Â°C under N<sub>2</sub> for 5 h. The reaction mixture was allowed to cool and diluted with EtOAc (20 mL) and water (20 mL). The aqueous layer was separated and washed with further EtOAc (20 mL), and the combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of EtOAc in isohexanes (1:1 to 3:1) to afford methyl (<i>E</i>)-4-(2-((<i>R</i>)-1-(((<i>R</i>)-<i>tert</i>-butylsulfinyl)amino)ethyl)quinolin-7-yl)-2,2-dimethylbut-3-enoate as a yellow oil (201 mg, 86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.08 (d, <i>J</i> = 8.5 Hz, 1H), 7.93 (s, 1H), 7.73 (d, <i>J</i> = 8.5 Hz, 1H), 7.62 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.35 (d, <i>J</i> = 8.5 Hz, 1H), 6.63 (s, 2H), 5.48 (d, <i>J</i> = 4.0 Hz, 1H), 4.85â4.74 (m, 1H), 3.74 (s, 3H), 1.59 (d, <i>J</i> = 6.7 Hz, 3H), 1.48 (s, 6H), 1.33 (s, 9H). LC/MS Method A (<i>m</i>/<i>z</i>) 403.2 [M + H], <i>T</i><sub>r</sub> = 2.56 min. Methyl (<i>E</i>)-4-(2-((<i>R</i>)-1-(((<i>R</i>)-<i>tert</i>-butylsulfinyl)amino)ethyl)quinolin-7-yl)-2,2-dimethylbut-3-enoate (193 mg, 0.48 mmol) in MeOH (20 mL) was treated with 4 M HCl in 1,4-dioxane (10 mL). The mixture was stirred at rt for 2 h, concentrated <i>in vacuo</i>, and azeatroped with toluene (3 Ã 15 mL) to afford the title compound (166 mg, quant.) as a yellow solid that was used without purification. LC/MS Method A (<i>m</i>/<i>z</i>) 299.1 [M + H], <i>T</i><sub>r</sub> = 1.35 min.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(((<i>S</i>)-2-hydroxy-3-methylbutanoyl)-<i>L</i>-alanyl)hexahydropyridazine-3-carboxylate (<b>44</b>)</h3><div class="NLM_p last">2,2,2-Trichloroethyl (<i>S</i>)-1-((<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate <b>43</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (1.5 g, 3.5 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was cooled to 0 Â°C and treated with TMSOTf (941 Î¼L, 5.2 mmol). The reaction mixture was stirred at 0 Â°C for 1 h, <i>N,N</i>-diisopropylethylamine (2.2 mL, 13.9 mmol) was added, and the mixture was then concentrated <i>in vacuo</i> to afford crude 2,2,2-trichloroethyl (<i>S</i>)-1-(<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate. The residue was dissolved in anhydrous CH<sub>3</sub>CN (20 mL), cooled to 0 Â°C and treated with (<i>S</i>)-2-hydroxy-3-methylbutanoic acid (413 mg, 3.5 mmol), hydroxybenzotriazole monohydrate (796 mg, 5.2 mmol), 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide (1.02 g, 5.2 mmol), and <i>N,N</i>-diisopropylethylamine (1.7 mL, 10.4 mmol). The reaction mixture was stirred at 0 Â°C for 90 min, warmed to rt, and then stirred another 72 h. The mixture was concentrated <i>in vacuo</i>, and the residue was treated with EtOAc (30 mL) washed with saturated ammonium chloride (50 mL) and brine (50 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexane/acetone (2:1) to afford the title compound (1.1 g, 73% over two steps) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 7.09 (d, <i>J</i> = 7.1 Hz, 1H), 5.46â5.34 (m, 1H), 4.97 (d, <i>J</i> = 12.0 Hz, 1H), 4.73 (d, <i>J</i> = 12 Hz, 1H), 4.00â3.95 (m, 1H), 4.43â4.31 (m, 1H), 3.86 (d, <i>J</i> = 11.2 Hz, 1H), 3.78â3.67 (m, 1H), 3.02â2.85 (m, 1H), 2.67 (d, <i>J</i> = 5.6 Hz, 1H), 2.26â2.08 (m, 2H), 2.02â1.90 (m, 1H), 1.84â1.66 (m, 2H), 1.36 (d, <i>J</i> = 6.7 Hz, 3H), 1.05 (d, <i>J</i> = 6.9 Hz, 3H), 0.89 (d, <i>J</i> = 6.9 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 434.63 [M + H], <i>T</i><sub>r</sub> = 2.26 min.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Methyl (<i>E</i>)-4-(2-((<i>R</i>)-1-((<i>S</i>)-1-(((<i>S</i>)-2-Hydroxy-3-methylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxamido)ethyl)quinolin-7-yl)-2,2-dimethylbut-3-enoate (<b>45</b>)</h3><div class="NLM_p last"><b>44</b> (502 mg, 1.16 mmol) was suspended in THF (15 mL) and water (3 mL) and treated with lithium hydroxide monohydrate (69 mg, 1.65 mmol). The reaction mixture was stirred for 45 min, and then 2 M HCl (0.75 mL) was added. The reaction mixture was stirred for 5 min and concentrated <i>in vacuo</i> to afford the crude (<i>S</i>)-1-(((<i>S</i>)-2-hydroxy-3-methylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylic acid (350 mg, quant.) that was used without further purification. <b>42</b> (166 mg, 0.48 mmol), (<i>S</i>)-1-[(<i>S</i>)-2-((<i>S</i>)-2-hydroxy-3-methyl-butyrylamino)-propionyl]-hexahydro-pyridazine-3-carboxylic acid (190 mg, 0.48 mmol), <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N,N,N</i>â²<i>,N</i>â²-tetramethyluronium hexafluorophosphate (256 mg, 0.67 mmol), and powdered 4 Ã molecular sieves were suspended in CH<sub>3</sub>CN (9.6 mL) under N<sub>2</sub>. The mixture was treated with <i>N</i>,<i>N</i>-diisopropylethylamine (186 mg, 250 Î¼L, 1.44 mmol) and stirred for 20 h. The mixture was filtered through a phase separator, and the filtrate was concentrated <i>in vacuo</i>. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and washed with saturated sodium bicarbonate solution (30 mL), water (30 mL), saturated aq. ammonium chloride (30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of EtOAc in isohexanes (1:1 to 1:0) to afford the title compound as a yellow gum (77 mg, 28% over two steps from <b>44</b>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.18â8.07 (m, 3H), 7.74 (d, <i>J</i> = 8.5 Hz, 1H), 7.67 (dd, <i>J</i> = 8.7, 1.3 Hz, 1H), 7.25 (m, 1H), 6.76 (d, J = 16.3 Hz, 1H), 6.64 (m, 1H), 5.42 (m, 1H), 5.24 (m, 1H), 4.55 (<i>br</i> d, <i>J</i> = 13.2 Hz, 1H), 3.97 (<i>br</i> s, 1H), 3.80 (d, <i>J</i> = 11.8 Hz, 1H), 3.73 (s, 3H), 3.46 (m, 1H), 2.87 (<i>br</i> s, 1H), 2.70 (m, 1H), 2.27 (m, 1H), 2.11 (m, 1H), 1.71â1.58 (m, 3H), 1.57 (d, <i>J</i> = 6.7 Hz, 3H), 1.48 (s, 6H), 1.42 (d, <i>J</i> = 6.9 Hz, 3H), 1.00 (d, <i>J</i> = 6.9 Hz, 3H), 0.87 (d, <i>J</i> = 6.9 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 582.2 [M + H], <i>T</i><sub>r</sub> = 1.91 min.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(((<i>S</i>)-2-(((<i>E</i>)-4-(6-((<i>R</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)isoquinolin-3-yl)-2,2-dimethylbut-3-enoyl)oxy)-3-methylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>46</b>)</h3><div class="NLM_p last">2-Methyl-6-nitrobenzoic anhydride (344 mg, 1 mmol), 4-DMAP (128 mg, 1.05 mmol), and <b>39</b> (191 mg, 0.50 mmol) were stirred in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (20 mL). The mixture was treated with <i>N,N</i>-diisopropylethylamine (0.26 mL, 1.50 mmol) and then stirred at rt for 10 min. <b>44</b> (331 mg, 0.75 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise, and the mixture was stirred at rt for 12 h. The mixture was washed with water (20 mL) and brine (10 mL). The aqueous phase was back extracted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL), and the combined organic extracts were washed with brine (20 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with 0â40% EtOAc/MeOH (4:1 mixture) in isohexanes to afford the title compound (391 mg, 97%) as a white solid. LC/MS Method C (<i>m</i>/<i>z</i>) 798.1 [M + H], <i>T</i><sub>r</sub> = 2.82 min.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (2â²<i>R</i>,3â²<i>S</i>,7â²<i>S</i>,10â²<i>S</i>,<i>E</i>)-4-Hydroxy-10â²-isopropyl-2â²,7â²-dimethylspiro[cyclohexane-1,13â²-11-oxa-3,8-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphanen]-14â²-ene-4â²,6â²,9â²,12â²-tetraone (<b>47</b> Major and <b>48</b> Minor)</h3><div class="NLM_p">A mixture of <b>62a</b> (90 mg, 0.093 mmol) in THF (1 mL), MeOH (1 mL), and water (1 mL) was treated with K<sub>2</sub>CO<sub>3</sub> (89 mg, 0.644 mmol), and the mixture was stirred at 0 Â°C for 2.5 h. The mixture was stored for 64 h in a freezer, stirred at rt for 3 h, and then at 30 Â°C for 1.5 h. The mixture was diluted with brine and extracted with EtOAc (2 Ã 50 mL). The aqueous fractions were back extracted with EtOAc (50 mL), and the combined organic extracts dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was dissolved in 4 M HCl in 1,4-dioxane (3 mL) and stirred at rt for 45 min. The mixture was concentrated and dried <i>in vacuo</i> for 2 h to obtain the crude <i>seco</i>-acid. The crude <i>seco</i>-acid (0.093 mmol) was treated with 5 equiv of HATU and 8 equiv of <i>N,N</i>-diisopropylethylamine according to the procedure for compound <b>35</b> in CH<sub>2</sub>Cl<sub>2</sub> (100 mL). The mixture was concentrated <i>in vacuo</i>, and the residue was diluted with EtOAc (50 mL). The solution was washed with 5% LiCl solution (2 Ã 50 mL), 0.1 M HCl (50 mL), and water (50 mL). The aqueous fractions were back extracted with EtOAc (50 mL), and the combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to preparative HPLC using a 21.2 Ã 250 mm 10 Î¼m C18 Phenomenex Gemini semipreparative column and CH<sub>3</sub>CN/water (containing 0.1% TFA modifier) as mobile phase at a flow rate of 20 mL/min with a 50 min gradient consisting of 0â5 min: 20% CH<sub>3</sub>CN; 5â48 min: 20% CH<sub>3</sub>CN to 80% CH<sub>3</sub>CN; 48â50 min: 80% CH<sub>3</sub>CN to obtain the product fractions. Each combined product fraction was concentrated <i>in vacuo</i> to remove CH<sub>3</sub>CN, neutralized with NaHCO<sub>3</sub> solution, diluted with water, and then extracted with EtOAc (2 Ã 50 mL). The organic extracts were then concentrated to afford the title compound (major isomer <b>47</b>, 4.6 mg, 8%; and minor isomer <b>48</b>, 1.1 mg, 2%). Compound <b>47</b>: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.23 (d, <i>J</i> = 8.5 Hz, 1H), 7.82 (d, <i>J</i> = 8.4 Hz, 1H), 7.77 (d, <i>J</i> = 1.5 Hz, 1H), 7.62 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H), 7.43 (d, <i>J</i> = 8.5 Hz, 1H), 6.61 (d, <i>J</i> = 16.4 Hz, 1H), 6.29 (d, <i>J</i> = 16.4 Hz, 1H), 5.79 (q, <i>J</i> = 7.2 Hz, 1H), 5.23 (d, <i>J</i> = 8.6 Hz, 1H), 5.06 (q, <i>J</i> = 6.6 Hz, 1H), 4.41 (dd, <i>J</i> = 13.2, 4.3 Hz, 1H), 3.88 (s, 1H), 3.57 (dd, <i>J</i> = 11.8, 2.9 Hz, 1H), 2.68 (td, <i>J</i> = 13.0, 3.3 Hz, 1H), 2.25 (d, <i>J</i> = 12.5 Hz, 1H), 2.16 (d, <i>J</i> = 12.8 Hz, 3H), 2.00â1.88 (m, 3H), 1.84â1.63 (m, 5H), 1.60 (d, <i>J</i> = 7.3 Hz, 3H), 1.57 (d, <i>J</i> = 6.7 Hz, 3H), 1.61â1.47 (m, 1H), 1.28 (s, 1H), 1.05 (d, <i>J</i> = 6.8 Hz, 3H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method B (<i>m</i>/<i>z</i>) 606.3 [M + H], <i>T</i><sub>r</sub> = 2.03 min. HRMS C<sub>33</sub>H<sub>43</sub>N<sub>5</sub>O<sub>6</sub> calculated 605.3213, found 605.3227.</div><div class="NLM_p last">Compound <b>48</b>: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.22 (d, <i>J</i> = 8.5 Hz, 1H), 7.81 (d, <i>J</i> = 8.5 Hz, 1H), 7.76 (s, 1H), 7.59 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.42 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (d, <i>J</i> = 16.4 Hz, 1H), 6.24 (d, <i>J</i> = 16.4 Hz, 1H), 5.85â5.74 (m, 1H), 5.28 (d, <i>J</i> = 8.6 Hz, 1H), 5.06 (dd, <i>J</i> = 7.2, 4.8 Hz, 1H), 4.46â4.36 (m, 1H), 3.68â3.61 (m, 1H), 3.57 (dd, <i>J</i> = 11.7, 3.0 Hz, 1H), 2.68 (td, <i>J</i> = 13.0, 3.3 Hz, 1H), 2.57 (dd, <i>J</i> = 14.1, 3.0 Hz, 1H), 2.33 (dd, <i>J</i> = 13.0, 3.3 Hz, 1H), 2.24 (d, <i>J</i> = 13.7 Hz, 1H), 2.18 (dt, <i>J</i> = 8.1, 6.4 Hz, 1H), 2.00â1.86 (m, 3H), 1.76â1.62 (m, 2H), 1.61 (d, <i>J</i> = 7.3 Hz, 3H), 1.57 (d, <i>J</i> = 6.8 Hz, 3H), 1.55â1.26 (m, 5H), 1.07 (d, <i>J</i> = 6.8 Hz, 3H), 1.04 d, <i>J</i> = 6.6 Hz, 3H). LC/MS Method B (<i>m</i>/<i>z</i>) 606.3 [M + H], <i>T</i><sub>r</sub> = 2.02 min. HRMS C<sub>33</sub>H<sub>43</sub>N<sub>5</sub>O<sub>6</sub> calculated 605.3213, found 605.3226.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (1<i>r</i>,2â²<i>R</i>,3â²<i>S</i>,4<i>S</i>,7â²<i>S</i>,10â²<i>S</i>,<i>E</i>)-10â²-Isopropyl-4-methoxy-2â²,7â²-dimethylspiro[cyclohexane-1,13â²-11-oxa-3,8-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphanen]-14â²-ene-4â²,6â²,9â²,12â²-tetraone (<b>49</b>)</h3><div class="NLM_p last"><b>62b</b> (0.32 mmol) was cyclized according to the procedure for the preparation of <b>35</b> from <b>46</b> in CH<sub>2</sub>Cl<sub>2</sub> (400 mL) and then subjected to HPLC purification (21.2 Ã 250 mm 10 Î¼m C18 Phenomenex Gemini semipreparative column eluting with CH<sub>3</sub>CN/water (containing 0.1% TFA modifier) at a flow rate of 20 mL/min; 50 min gradient consisting of 0â5 min, 20% CH<sub>3</sub>CN; 5â48 min, 20% to 80% CH<sub>3</sub>CN gradient, 48â50 min, 80% CH<sub>3</sub>CN) to afford <b>49</b> (40 mg, 20%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.25 (d, <i>J</i> = 8.5 Hz, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 1H), 7.79 (s, 1H), 7.63 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.45 (d, <i>J</i> = 8.5 Hz, 1H), 6.59 (d, <i>J</i> = 16.4 Hz, 1H), 6.29 (d, <i>J</i> = 16.4 Hz, 1H), 5.82 (q, <i>J</i> = 7.2 Hz, 1H), 5.27 (d, <i>J</i> = 8.6 Hz, 1H), 5.09 (q, <i>J</i> = 6.7 Hz, 1H), 4.44 (dd, <i>J</i> = 13.3, 3.6 Hz, 1H), 3.68 (s, 1H), 3.60 (dd, <i>J</i> = 11.7, 2.8 Hz, 1H), 3.48 (s, 1H), 3.37 (s, 3H), 2.70 (td, <i>J</i> = 12.9, 3.1 Hz, 1H), 2.32â2.11 (m, 3H), 2.11â1.83 (m, 6H), 1.71 (dd, <i>J</i> = 15.4, 11.1 Hz, 2H), 1.65â1.49 (m, 8H), 1.06 (dd, <i>J</i> = 19.3, 6.7 Hz, 6H). LC/MS Method B (<i>m</i>/<i>z</i>) 620.6 [M + H]. HRMS C<sub>34</sub>H<sub>45</sub>N<sub>5</sub>O<sub>6</sub> calculated 619.3370, found 619.3383.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (2â²<i>R</i>,3â²<i>S</i>,7â²<i>S</i>,10â²<i>S</i>,<i>E</i>)-10â²-Isopropyl-2â²,7â²-dimethyl-2,3,5,6-tetrahydrospiro[pyran-4,13â²-11-oxa-3,8-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphanen]-14â²-ene-4â²,6â²,9â²,12â²-tetraone (<b>50</b>)</h3><div class="NLM_p last">A solution of <b>62c</b> (0.70 g, 0.83 mmol) in THF (10 mL) was treated with 1 N KOH in water (0.83 mL). The reaction mixture was vigorously stirred at rt for 20 min and then acidified by adding 1 M HCl in water (0.83 mL). The mixture was concentrated <i>in vacuo</i>, and the residue was dissolved in 4 M HCl in 1,4-dioxane (2 mL). The mixture was stirred for 1 h, concentrated <i>in vacuo</i>, and azeotroped with toluene (3 Ã 5 mL) to afford the crude <i>seco</i>-acid. The <i>seco</i>-acid (0.83 mmol) was cyclized with HATU according to the procedure for compound <b>35</b> in CH<sub>2</sub>Cl<sub>2</sub> (800 mL) except including a catalytic amount of 4-DMAP. The mixture was concentrated and the residue subjected to preparative HPLC to obtain the title product (0.22 g, 45%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.23 (d, <i>J</i> = 8.5 Hz, 1H), 7.83 (d, <i>J</i> = 8.5 Hz, 1H), 7.78 (s, 1H), 7.63 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.43 (d, <i>J</i> = 8.5 Hz, 1H), 6.60 (d, <i>J</i> = 16.3 Hz, 1H), 6.29 (d, <i>J</i> = 16.3 Hz, 1H), 5.80 (q, <i>J</i> = 7.2 Hz, 1H), 5.29 (d, <i>J</i> = 8.6 Hz, 1H), 5.08 (d, <i>J</i> = 5.3 Hz, 1H), 5.05 (d, <i>J</i> = 6.7 Hz, 1H), 4.41 (dd, <i>J</i> = 13.1, 3.4 Hz, 1H), 3.93 (tt, <i>J</i> = 11.9, 3.7 Hz, 2H), 3.65 (s, 2H), 3.63â3.45 (m, 3H), 2.68 (td, <i>J</i> = 12.9, 3.3 Hz, 1H), 2.40 (d, <i>J</i> = 13.7 Hz, 1H), 2.32â2.10 (m, 3H), 2.00â1.89 (m, 2H), 1.85 (ddd, <i>J</i> = 13.8, 10.8, 4.3 Hz, 1H), 1.67 (dt, <i>J</i> = 13.0, 4.2 Hz, 1H), 1.60 (d, <i>J</i> = 7.2 Hz, 3H), 1.57 (d, <i>J</i> = 6.7 Hz, 3H), 1.07 (d, <i>J</i> = 6.8 Hz, 3H), 1.01 (d, <i>J</i> = 6.6 Hz, 3H). LC/MS Method B (<i>m</i>/<i>z</i>) 592.3 [M + H], <i>T</i><sub>r</sub> = 2.15 min. HRMS C<sub>32</sub>H<sub>41</sub>N<sub>5</sub>O<sub>6</sub> calculated 591.3057, found 591.3069.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (2â²<i>R</i>,3â²<i>S</i>,7â²<i>S</i>,10â²<i>S</i>,<i>E</i>)-10â²-Isopropyl-2â²,7â²-dimethyl-2,3,5,6-tetrahydrospiro[thiopyran-4,13â²-11-oxa-3,8-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphanen]-14â²-ene-4â²,6â²,9â²,12â²-tetraone 1,1-Dioxide (<b>51</b>)</h3><div class="NLM_p last"><b>73</b> (187 mg, 0.35 mmol) and <b>65</b> (79 mg, 0.38 mmol) were combined using the same method as <b>3</b>, except heating at 80 Â°C for 30 min to form the <i>seco</i>-acid. LC/MS Method A (<i>m</i>/<i>z</i>) 658.2 [M + H], <i>T</i><sub>r</sub> = 1.57 min. The <i>seco</i>-acid was cyclized in the same manner as <b>3</b> except by dropwise addition over 4 h, followed by stirring of the mixture for 4 h. The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc/MeOH (1:1:0 to 0:1:0 to 0:9:1) followed by reverse phase preparative HPLC eluting with a gradient of CH<sub>3</sub>CN (containing 0.1% trifluoroacetic acid)/water (containing 0.1% trifluoroacetic acid) from 9:1 to 1:1. The resultant product was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and saturated sodium hydrogen carbonate solution (20 mL), separated, and the organic layer washed with brine (30 mL). The organic solution was filtered through a hydrophobic frit and then concentrated <i>in vacuo</i> to afford the title compound (14 mg, 7% over two steps) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 8.28 (d, <i>J</i> = 8.5 Hz, 1H), 7.87 (d, <i>J</i> = 8.5 Hz, 1H), 7.85 (<i>br</i> s, 1H), 7.68 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H), 7.47 (d, <i>J</i> = 8.5 Hz, 1H), 6.73 (d, <i>J</i> = 16.3 Hz, 1H), 6.36 (d, <i>J</i> = 16.3 Hz, 1H), 5.85 (q, <i>J</i> = 7.1 Hz, 1H), 5.33 (d, <i>J</i> = 8.3 Hz, 1H), 5.09 (q, <i>J</i> = 6.7 Hz, 1H), 4.46â4.40 (m, 1H), 3.65â3.55 (m, 1H), 2.25â2.17 (m, 11H), 1.97â1.92 (m, 1H), 1.71â1.63 (m, 2H), 1.62 (d, <i>J</i> = 7.1 Hz, 3H), 1.59 (d, <i>J</i> = 6.7 Hz, 3H), 1.09 (d, <i>J</i> = 6.7 Hz, 3H), 1.05 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 640.2 [M + H], <i>T</i><sub>r</sub> = 2.09 min. HRMS C<sub>32</sub>H<sub>41</sub>N<sub>5</sub>O<sub>7</sub>S calculated 639.2727, found 639.2739.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (2<i>R</i>,3<i>S</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,2â²,2â²,7-tetramethylspiro[11-oxa-3,8-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphanene-13,5â²-[1,3]dioxan]-14-ene-4,6,9,12-tetraone (<b>52</b>)</h3><div class="NLM_p last"><b>73</b> (228 mg, 0.426 mmol) and <b>68b</b> (79 mg, 0.426 mmol) were combined using the same method as <b>3</b>, except heating at 60 Â°C for 1 h to form the <i>seco</i>-acid. The <i>seco</i>-acid was cyclized in the same manner as <b>3</b> except by dropwise addition over 4 h. The crude product was subjected to reverse phase preparative HPLC eluting with water/CH<sub>3</sub>CN 3:2 to afford the title compound (53 mg, 20% over two steps) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 8.24 (d, <i>J</i> = 8.5 Hz, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 1H), 7.74â7.66 (m, 2H), 7.46 (d, <i>J</i> = 8.7 Hz, 1H), 6.64 (d, <i>J</i> = 16.7 Hz, 1H), 6.17 (d, <i>J</i> = 16.7 Hz, 1H), 5.87â5.75 (m, 1H), 5.38 (d, <i>J</i> = 9.1 Hz, 1H), 5.12â5.01 (m, 1H), 4.51â4.39 (m, 2H), 4.37â4.29 (m, 1H), 4.16â4.03 (m, 2H), 3.64â3.56 (m, 1H), 2.80â2.65 (m, 1H), 2.29â2.14 (m, 2H), 2.00â1.90 (m, 1H), 1.64 (d, <i>J</i> = 7.4 Hz, 3H), 1.60 (d, <i>J</i> = 6.7 Hz, 3H), 1.77â1.58 (m, 2H), 1.55 (s, 3H), 1.35 (s, 3H), 1.11 (d, <i>J</i> = 6.7 Hz, 3H), 1.06 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 622.3 [M + H], <i>T</i><sub>r</sub> = 2.38 min. HRMS C<sub>33</sub>H<sub>43</sub>N<sub>5</sub>O<sub>7</sub> calculated 621.3162, found 621.3176.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (2<i>R</i>,3<i>S</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-10-Isopropyl-2,7-dimethylspiro[11-oxa-3,8-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphanene-13,6â²-[1,4]dioxepan]-14-ene-4,6,9,12-tetraone (<b>53</b>)</h3><div class="NLM_p last"><b>73</b> (68 mg, 0.128 mmol) and <b>71</b> (79 mg, 0.426 mmol) were combined using the same method as <b>3</b>, except heating at reflux for 40 min to form the <i>seco</i>-acid. LC/MS Method A (<i>m</i>/<i>z</i>) 626.2 [M + H], <i>T</i><sub>r</sub> = 1.67 min. The <i>seco</i>-acid was cyclized in the same manner as <b>3</b> except by dropwise addition over 2.5 h. The crude residue was subjected to reverse phase preparative HPLC eluting with a gradient of CH<sub>3</sub>CN/water containing 0.1% formic acid (1:9 to 7:3). The isolated residue was then triturated with Et<sub>2</sub>O, and collected to provide the title compound (6.5 mg, 8% over two steps) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 8.25 (d, <i>J</i> = 8.5 Hz, 1H), 8.19 (<i>br</i> s, 1H), 7.85 (d, <i>J</i> = 8.9 Hz, 1H), 7.73â7.68 (m, 2H), 7.46 (d, <i>J</i> = 8.5 Hz, 1H), 6.49 (d, <i>J</i> = 16.5 Hz, 1H), 6.30 (d, <i>J</i> = 16.5 Hz, 1H), 5.86â5.76 (m, 1H), 5.35 (d, <i>J</i> = 9.2 Hz, 1H), 5.07 (q, <i>J</i> = 6.7 Hz, 1H), 4.53 (d, <i>J</i> = 12.7 Hz, 1H), 4.46â4.38 (m, 1H), 4.38 (d, <i>J</i> = 12.7 Hz, 1H), 4.13 (d, <i>J</i> = 12.5 Hz, 1H), 3.91â3.76 (m, 5H), 3.65â3.57 (m, 1H), 2.75â2.63 (m, 1H), 2.28â2.10 (m, 2H), 2.00â1.90 (m, 1H), 1.66 (d, <i>J</i> = 7.4 Hz, 3H), 1.60 (d, <i>J</i> = 6.7 Hz, 3H), 1.73â1.53 (m, 2H), 1.08 (d, <i>J</i> = 6.7 Hz, 3H), 1.04 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 608.2 [M + H], <i>T</i><sub>r</sub> = 2.12 min. HRMS C<sub>32</sub>H<sub>41</sub>N<sub>5</sub>O<sub>7</sub> calculated 607.3006, found 607.3014.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (5<sup>3</sup><i>S</i>,2<i>R</i>,7<i>S</i>,10<i>S</i>,<i>E</i>)-13,13-Bis(hydroxymethyl)-10-isopropyl-2,7-dimethyl-5<sup>1</sup>,5<sup>2</sup>,5<sup>3</sup>,5<sup>4</sup>,5<sup>5</sup>,5<sup>6</sup>-hexahydro-11-oxa-3,8-diaza-1(2,7)-quinolina-5(3,1)-pyridazinacyclopentadecaphan-14-ene-4,6,9,12-tetraone (<b>54</b>)</h3><div class="NLM_p last">A solution of compound <b>52</b> (20 mg, 0.032 mmol) in MeOH (1 mL) was treated with 1 M HCl (3 mL) and then stirred for 1 h at rt. The mixture was neutralized by addition of saturated sodium bicarbonate solution followed by NaCl to saturate the solution. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>, the organic extracts filtered through a hydrophobic frit, and then concentrated <i>in vacuo</i> to afford the title compound (14 mg, 75%) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 8.24 (d, <i>J</i> = 8.5 Hz, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 1H), 7.74â7.65 (m, 2H), 7.45 (d, <i>J</i> = 8.5 Hz, 1H), 6.63 (d, <i>J</i> = 16.7 Hz, 1H), 6.31 (d, <i>J</i> = 16.7 Hz, 1H), 5.81 (q, <i>J</i> = 7.3 Hz, 1H), 5.32 (d, <i>J</i> = 9.1 Hz, 1H), 5.06 (q, <i>J</i> = 6.7 Hz, 1H), 4.46â4.37 (m, 1H), 4.16â3.93 (m, 4H), 3.64â3.56 (m, 1H), 2.77â2.64 (m, 1H), 2.28â2.08 (m, 2H), 1.96â1.84 (m, 1H), 1.65 (d, <i>J</i> = 7.4 Hz, 3H), 1.60 (d, <i>J</i> = 6.9 Hz, 3H), 1.77â1.49 (m, 2H), 1.04 (d, <i>J</i> = 6.7 Hz, 3H), 1.01 (d, <i>J</i> = 6.7 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 582.5 [M + H], <i>T</i><sub>r</sub> = 1.60 min. HRMS C<sub>30</sub>H<sub>39</sub>N<sub>5</sub>O<sub>7</sub> calculated 581.2849, found 581.2858.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>tert</i>-Butyl (<i>R</i>)-(1-(7-Bromoquinolin-2-yl)ethyl)carbamate (<b>55</b>)</h3><div class="NLM_p last"><b>41</b> (533 mg, 1.5 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (23 mL) and 4 M HCl in 1,4-dioxane (7.5 mL). The mixture was stirred for 2 h and then concentrated <i>in vacuo</i>. The residue was passed though an SCX cation exchange cartridge eluting with MeOH and then methanolic ammonia to afford the crude (<i>R</i>)-1-(7-bromoquinolin-2-yl)ethan-1-amine <b>72</b>. A solution of <b>72</b> (3.5 g, 12.2 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> at 0 Â°C under an atmosphere of N<sub>2</sub> was treated with Et<sub>3</sub>N (5.1 mL, 36.5 mmol), 4-DMAP (297 mg, 2.4 mmol), and di-<i>tert</i>-butyl dicarbonate (4.0 g, 18.3 mmol). The reaction mixture was stirred at rt for 2 h. The reaction mixture was cooled to 0 Â°C and quenched with 1 M HCl. The organic layer was separated, washed with brine, dried through a hydrophobic frit, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc 6:1 to afford the title compound (3 g, 70%) as a yellow solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.29 (s, 1H), 8.11 (d, <i>J</i> = 8.5 Hz, 1H), 7.69 (d, <i>J</i> = 8.7 Hz, 1H), 7.62 (dd, <i>J</i> = 8.7, 1.8 Hz, 1H), 7.38 (d, <i>J</i> = 8.5 Hz, 1H), 6.20â6.01 (m, 1H), 5.10â4.93 (m, 1H), 1.55 (d, <i>J</i> = 6.9 Hz, 3H), 1.49 (s, 9H). LC/MS Method A (<i>m</i>/<i>z</i>) 353.0 [M + H], <i>T</i><sub>r</sub> = 3.02 min.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Ethyl (<i>R</i>,<i>E</i>)-1-(2-(2-(1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)-4-oxocyclohexane-1-carboxylate (<b>56a</b>)</h3><div class="NLM_p last">A mixture of <b>55</b> (556 mg, 1.58 mmol), <b>58</b> (559 mg, 2.85 mmol, obtained from Small Molecules, Inc., Hoboken, USA), Pd(OAc)<sub>2</sub> (70 mg, 0.31 mmol), and (<i>o</i>-Tol)<sub>3</sub>P (100 mg, 0.33 mmol) in 1,4-dioxane (5 mL) was treated with Et<sub>3</sub>N (0.72 mL, 5.17 mmol), and the mixture was heated at 100 Â°C for 30 min in a microwave reactor. The mixture was concentrated and diluted with water (50 mL) and EtOAc (50 mL). The mixture was filtered through Celite pad, and the organic layer was separated. The aqueous fraction was extracted with EtOAc (50 mL), and the combined organic fractions were washed with water (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with hexanes/EtOAc to obtain the title product (479 mg, 65%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.07 (d, <i>J</i> = 8.3 Hz, 1H), 8.01 (s, 1H), 7.75 (d, <i>J</i> = 8.5 Hz, 1H), 7.58 (d, <i>J</i> = 8.3 Hz, 1H), 7.31 (d, <i>J</i> = 8.5 Hz, 1H), 6.74 (d, <i>J</i> = 16.1 Hz, 1H), 6.47 (d, <i>J</i> = 16.3 Hz, 1H), 6.16 (s, 1H), 4.27 (q, <i>J</i> = 7.1 Hz, 2H), 2.76â2.56 (m, 2H), 2.57â2.38 (m, 4H), 2.18â2.00 (m, 2H), 1.47 (s, 9H), 1.32 (t, <i>J</i> = 7.1 Hz, 3H). LC/MS Method B (<i>m</i>/<i>z</i>) 467.0 [M + H], <i>T</i><sub>r</sub> = 2.33 min.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Methyl (1<i>r</i>,4<i>R</i>)-1-((<i>E</i>)-2-(2-((<i>R</i>)-1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)-4-methoxycyclohexane-1-carboxylate (<b>56b</b>)</h3><div class="NLM_p last"><b>59</b> (223 mg, 1.05 mmol) and <b>55</b> (369 mg, 1.05 mmol) were combined as described in the preparation of <b>56a</b> to afford the title compound (424 mg, 89%). LC/MS Method B (<i>m</i>/<i>z</i>) 455.1 [M + H].</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (<i>R</i>,<i>E</i>)-4-(2-(2-(1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)tetrahydro-2<i>H</i>-pyran-4-carboxylic acid (<b>56c</b>)</h3><div class="NLM_p last"><b>61</b> (0.726 g, 4.27 mmol) and <b>55</b> (1.5 g, 4.27 mmol) were combined as described in the preparation of <b>56a</b> to afford the title compound (1.1 g, 59%). LC/MS Method B (<i>m</i>/<i>z</i>) 441.2 [M + H], <i>T</i><sub>r</sub> = 2.21 min.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1-((<i>E</i>)-2-(2-((<i>R</i>)-1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)-4-((<i>tert</i>-butyldimethylsilyl)oxy)cyclohexane-1-carboxylic Acid (<b>57</b>)</h3><div class="NLM_p last">A solution of <b>56a</b> (237 mg, 0.51 mmol) in THF (5 mL) was stirred at â60 Â°C and treated with 1 M K-selectride in THF (0.61 mL). The reaction mixture was slowly warmed to 0 Â°C over 30 min, diluted with EtOAc (50 mL), and washed with water (2 Ã 50 mL). The aqueous fractions were back extracted with EtOAc (50 mL), and the combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with hexanes/EtOAc to provide ethyl 1-((<i>E</i>)-2-(2-((<i>R</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)-4-hydroxycyclohexane-1-carboxylate (192 mg, 81%) as a â¼4:1 isomer mixture. LC/MS Method B (<i>m</i>/<i>z</i>) 469.0 [M + H], <i>T</i><sub>r</sub> = 2.20 min. A mixture of ethyl 1-((<i>E</i>)-2-(2-((<i>R</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)-4-hydroxycyclohexane-1-carboxylate (192 mg, 0.41 mmol) and LiOH (87.7 mg, 2.09 mmol) in THF (2 mL), MeOH (2 mL), and water (2 mL) was stirred at 50 Â°C for 3 h. The mixture was concentrated to â¼1/3 volume, diluted with water (20 mL), neutralized with 1 M HCl (2.2 mL), and then extracted with EtOAc (2 Ã 50 mL). The combined organic extracts were washed with water (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to provide crude 1-((<i>E</i>)-2-(2-((<i>R</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)-4-hydroxycyclohexane-1-carboxylic acid. A solution of the crude 1-((<i>E</i>)-2-(2-((<i>R</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)-4-hydroxycyclohexane-1-carboxylic acid, imidazole (115 mg, 1.69 mmol), and TBSCl (79 mg, 0.52 mmol) in DMF was stirred at 35 Â°C bath for 1.5 h. The mixture was treated with additional imidazole (102 mg, 1.50 mmol), and TBSCl (77 mg, 0.51 mmol) and stirred at 35 Â°C for 17 h. The mixture was concentrated to 1/3 volume <i>in vacuo</i> and then diluted with EtOAc (50 mL). The solution was washed with 5% LiCl solution (2 Ã 50 mL). The aqueous fractions were back extracted with EtOAc (50 mL), and the combined organic fractions dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was was dissolved in THF (2 mL), MeOH (2 mL), and water (2 mL), and stirred with K<sub>2</sub>CO<sub>3</sub> (226 mg, 1.64 mmol) at rt for 30 min. The solution was concentrated to â¼1/2 volume, diluted with water (20 mL), and acidified with 1 M HCl (â¼3.5 mL). The solution was extracted with EtOAc (2 Ã 50 mL). The extracts were washed with water (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with hexanes/EtOAc to afford the title compound (193 mg, 85%) as an apparent â¼4:1 isomer mixture. LC/MS Method B (<i>m</i>/<i>z</i>) 555.1 [M + H], <i>T</i><sub>r</sub> = 2.60 min.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (1<i>r</i>,4<i>r</i>)-4-Methoxy-1-vinylcyclohexane-1-carboxylic Acid (<b>59</b>)</h3><div class="NLM_p last"><b>58</b> (3.0 g, 15.29 mmol) in MeOH (80 mL) was treated dropwise with NaBH<sub>4</sub> (697 mg, 18.35 mmol) in MeOH (80 mL) at 0 Â°C. The mixture was stirred at 0 Â°C for 10 min, and then at rt for 48 h before quenching with saturated NH<sub>4</sub>Cl solution. The mixture was extracted with EtOAc (100 mL), washed with brine (50 mL) dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with 30% EtOAC in isohexanes to isolate methyl (1<i>r</i>,4<i>r</i>)-4-hydroxy-1-vinylcyclohexane-1-carboxylate (425 mg, 16%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 5.84â5.71 (m, 1H), 5.23â5.11 (m, 2H), 4.11 (q, <i>J</i> = 7.5 Hz, 2H), 3.79 (tq, <i>J</i> = 6.8, 3.6 Hz, 1H), 1.90 (ddd, <i>J</i> = 11.7, 8.2, 4.2 Hz, 4H), 1.71 (ddt, <i>J</i> = 11.9, 7.8, 3.7 Hz, 2H), 1.61â1.50 (m, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). Combined <i>cis</i> and <i>cis</i>/<i>trans</i> mixtures (1.3 g, 43%) were also obtained. The methyl (1<i>r</i>,4<i>r</i>)-4-hydroxy-1-vinylcyclohexane-1-carboxylate (425 mg, 2.13 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and treated with CH<sub>3</sub>OBF<sub>4</sub> (1.66 g, 10.7 mmol) and 1,8-bis(dimethylamino)naphthalene (2.3 g, 10.7 mmol). The mixture was stirred at rt for 24 h and then filtered through Celite. The filtrate was washed with saturated NaHCO<sub>3</sub> (30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with EtOAC/hexane to afford methyl (1<i>r</i>,4<i>r</i>)-4-methoxy-1-vinylcyclohexane-1-carboxylate (223 mg, 49%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 5.87â5.68 (m, 1H), 5.20â4.99 (m, 2H), 4.23â3.95 (m, 2H), 3.36â3.19 (m, 4H), 1.87 (pd, <i>J</i> = 13.5, 5.6 Hz, 4H), 1.75â1.54 (m, 4H), 1.29â1.14 (m, 3H). Methyl (1<i>r</i>,4<i>r</i>)-4-methoxy-1-vinylcyclohexane-1-carboxylate (223 mg, 1.05 mmol) and 1 M aq. LiOH (2 mL) in THF (4 mL) and MeOH (0.5 mL) was stirred at room temperature for 1 h. The reaction mixture was acidified with 1 M HCl, and extracted with EtOAc (10 mL) followed by 20% iPrOH in CHCl<sub>3</sub> (10 mL), twice. The extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford the title compound (202 mg, quant.). LCMS Method B (<i>m</i>/<i>z</i>) 185.11 [M + H].</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Methyl 4-vinyltetrahydro-2<i>H</i>-pyran-4-carboxylate (<b>61</b>)</h3><div class="NLM_p last">Methyl tetrahydro-2<i>H</i>-pyran-4-carboxylate <b>60</b> was reacted according to the method of Bercot, E. A. et al.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> to afford the title compound <b>61</b> (1.6 g, 45%).</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 2,2,2-Trichloroethyl (3<i>S</i>)-1-(((2<i>S</i>)-2-((1-((<i>E</i>)-2-(2-((<i>R</i>)-1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)-4-((<i>tert</i>-butyldimethylsilyl)oxy)cyclohexane-1-carbonyl)oxy)-3-methylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>62a</b>)</h3><div class="NLM_p last">A mixture of <b>57</b> (131 mg, 0.236 mmol), <b>44</b> (125 mg, 0.289 mmol), 2-methyl-6-nitrobenzoic anhydride (98 mg, 0.285 mmol), and 4-DMAP (72 mg, 0.589 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3 mL), and the mixture was stirred for 3 min. <i>N,N</i>-Diisopropylethylamine (0.1 mL, 0.574 mmol) was added, and the resulting mixture was stirred at rt for 17 h. The mixture was diluted with EtOAc (50 mL) and washed with water (2 Ã 50 mL). The aqueous fractions were back extracted with EtOAc (50 mL), and the combined organic fractions dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with hexanes/EtOAc to obtain the title compound (90 mg, 39%) as a â¼4:1 mixture. LC/MS Method B (<i>m</i>/<i>z</i>) 968.2 [M + H], <i>T</i><sub>r</sub> = 3.04 min.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(((<i>S</i>)-2-(((1<i>r</i>,4<i>S</i>)-1-((<i>E</i>)-2-(2-((<i>R</i>)-1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)-4-methoxycyclohexane-1-carbonyl)oxy)-3-methylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>62b</b>)</h3><div class="NLM_p last"><b>56b</b> (243 mg, 0.53 mmol) and <b>44</b> were combined following the same procedure as the preparation of <b>62</b>a to afford the title compound (287 mg, 62%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.03 (d, <i>J</i> = 8.4 Hz, 1H), 7.96 (s, 1H), 7.74â7.54 (m, 2H), 7.26 (d, <i>J</i> = 11.4 Hz, 2H), 7.00 (d, <i>J</i> = 7.6 Hz, 1H), 6.76 (d, <i>J</i> = 16.3 Hz, 1H), 6.42 (d, <i>J</i> = 16.2 Hz, 1H), 6.17 (s, 1H), 5.25â5.14 (m, 1H), 5.08 (d, <i>J</i> = 3.7 Hz, 1H), 4.94 (d, <i>J</i> = 9.2 Hz, 1H), 4.89 (d, <i>J</i> = 12.0 Hz, 1H), 4.66 (d, <i>J</i> = 11.9 Hz, 1H), 4.23 (d, <i>J</i> = 13.6 Hz, 1H), 4.09 (q, <i>J</i> = 7.1 Hz, 2H), 3.66 (m, 2H), 3.34 (d, <i>J</i> = 8.9 Hz, 1H), 2.77 (s, 1H), 2.30 (td, <i>J</i> = 7.0, 3.9 Hz, 1H), 2.14 (d, <i>J</i> = 18.3 Hz, 5H), 2.02 (s, 3H), 1.89â1.56 (m, 7H), 1.50 (d, <i>J</i> = 6.8 Hz, 3H), 1.44 (s, 9H), 1.28â1.15 (m, 6H), 0.91 (d, J = 6.9 Hz, 6H). LC/MS Method B (<i>m</i>/<i>z</i>) 870.3 [M + H].</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2,2,2-Trichloroethyl (<i>S</i>)-1-(((<i>S</i>)-2-((4-((<i>E</i>)-2-(2-((<i>R</i>)-1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)tetrahydro-2<i>H</i>-pyran-4-carbonyl)oxy)-3-methylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxylate (<b>62c</b>)</h3><div class="NLM_p last">A solution of <b>56c</b> (1.0 g, 2.27 mmol) in THF (10 mL) and MeOH (5 mL) was treated with 1 N KOH in water (11.4 mL). The reaction mixture was stirred at 50 Â°C for 2 h and then acidified by adding 1 M HCl in water (11.4 mL). The mixture was extracted with EtOAc (2 Ã 100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to afford (<i>R</i>,<i>E</i>)-4-(2-(2-(1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)tetrahydro-2<i>H</i>-pyran-4-carboxylic acid that was used without further purification. The (<i>R</i>,<i>E</i>)-4-(2-(2-(1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)quinolin-7-yl)vinyl)tetrahydro-2<i>H</i>-pyran-4-carboxylic acid (0.328 g, 0.77 mmol), <b>44</b> (0.398, 0.92 mmol), 4-DMAP (0.225 g, 1.85 mmol), <i>N,N</i>-diisopropylethylamine (0.239 g, 1.85 mmol), and 2-methyl-6-nitrobenzoic anhydride (0.632 g, 1.84 mmol) were dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL). The reaction mixture was stirred at rt for 16 h and then concentrated <i>in vacuo</i>. The residue was diluted with EtOAc (100 mL), washed with saturated NH<sub>4</sub>Cl (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of isohexanes/EtOAc (1:0 to 0:1) to afford the title compound (0.55 g, 85%). LC/MS Method B (<i>m</i>/<i>z</i>) 841.2 [M + H], <i>T</i><sub>r</sub> = 2.56 min.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Methyl 4-(1-hydroxyethyl)tetrahydro-2<i>H</i>-thiopyran-4-carboxylate 1,1-Dioxide (<b>64</b>)</h3><div class="NLM_p last">A solution of <i>N,N-</i>diisopropylamine (1.51 g, 2.1 mL, 15 mmol) in anhydrous THF (10 mL) was stirred at â78 Â°C under N<sub>2</sub>. <i>n</i>-Butyl lithium (6 mL, 15 mmol, 2.5 M solution in hexane) was added dropwise, and the reaction mixture stirred at â78 Â°C for 30 min. A solution of <b>63</b> (1.60 g, 10 mmol) in THF (4 mL) was added, and the reaction mixture was stirred at â78 Â°C for 20 min. Acetaldehyde (1.32 g, 1.7 mL, 30 mmol) was then added in one portion, the cooling bath was removed, and the mixture was stirred at rt for 1 h. The reaction mixture was cooled to 0 Â°C, and ice-cold 2 M HCl was added to adjust to pH 2. Sodium chloride was added to saturate the aqueous phase, and the mixture was extracted with Et<sub>2</sub>O (3 Ã 50 mL). The organic extracts were combined and washed with brine (100 mL), filtered through a hydrophobic frit, and then concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with pentane/Et<sub>2</sub>O (3:1 to 1:3) to afford methyl 4-(1-hydroxyethyl)tetrahydro-2<i>H</i>-thiopyran-4-carboxylate (1.77 g, 87%) as a yellow oil. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 4.85 (d, <i>J</i> = 5.8 Hz, 1H), 3.63 (s, 3H), 3.58â3.50 (m, 1H), 2.57â2.43 (m, 4H), 2.28â2.12 (m, 2H), 1.73â1.46 (m, 2H), 0.96 (d, <i>J</i> = 6.5 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 227.1 [M + Na], <i>T</i><sub>r</sub> = 1.53 min. A solution of methyl 4-(1-hydroxyethyl)tetrahydro-2<i>H</i>-thiopyran-4-carboxylate (408 mg, 2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was stirred at 0 Â°C and treated with <i>meta</i>-chloroperbenzoic acid (70% pure containing 20% water and 10% <i>meta</i>-chlorobenzoic acid, 830 mg, 4.8 mmol). The mixture was stirred at 0 Â°C for 3 h, and then additional <i>meta</i>-chloroperbenzoic acid (830 mg, 4.8 mmol) was added. The mixture was stirred at 0 Â°C for 3 h, and then sodium thiosulfate solution and saturated sodium hydrogen carbonate solution were added. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 50 mL), and the combined organic extracts were washed with brine (50 mL), filtered through a hydrophobic frit, and then concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of isohexanes/EtOAc (1:1 to 0:1) to afford the title compound (281 mg, 60%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 5.12 (d, <i>J</i> = 5.8 Hz, 1H), 3.71â3.64 (m, 4H), 3.11â2.92 (m, 4H), 2.30â1.90 (m, 4H), 0.99 (d, <i>J</i> = 6.5 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 237.1 [M + H], <i>T</i><sub>r</sub> = 0.76 min.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 4-Vinyltetrahydro-2<i>H</i>-thiopyran-4-carboxylic Acid 1,1-Dioxide (<b>65</b>)</h3><div class="NLM_p last">A solution of <b>64</b> (281 mg, 1.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was stirred at 0 Â°C under N<sub>2</sub>. Pyridine (284 mg, 0.3 mL, 3.6 mmol) was added followed by dropwise addition of trifluoromethanesulfonic anhydride (677 mg, 0.4 mL, 2.4 mmol). The reaction mixture was stirred at 0 Â°C for 30 min, and then saturated sodium hydrogen carbonate solution was added. The organic layer was separated, washed with brine (10 mL), filtered through a hydrophobic frit, and then concentrated <i>in vacuo</i> to a volume of â¼5 mL. 1,8-Diazabicycloundec-7-ene (0.6 mL, 3.6 mmol) was added, and the reaction mixture was stirred at rt for 45 min. The reaction mixture was cooled to 0 Â°C and adjusted to pH 2 with ice-cold 2 M HCl. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 30 mL), and the combined organic extracts were washed with water (30 mL), brine (30 mL), filtered through a hydrophobic frit, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (4:1 to 1:1) to afford methyl 4-vinyltetrahydro-2<i>H</i>-thiopyran-4-carboxylate 1,1-dioxide (182 mg, 70% over two steps) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 5.82 (dd, <i>J</i> = 17.6, 10.7 Hz, 1H), 5.31 (d, <i>J</i> = 10.7 Hz, 1H), 5.23 (d, <i>J</i> = 17.6 Hz, 1H), 3.13â3.05 (m, 4H), 3.79 (s, 3H), 2.66â2.59 (m, 2H), 2.34â2.25 (m, 2H). LC/MS Method A (<i>m</i>/<i>z</i>) 219.1 [M + H], <i>T</i><sub>r</sub> = 1.33 min. The methyl 4-vinyltetrahydro-2<i>H</i>-thiopyran-4-carboxylate 1,1-dioxide (174 mg, 0.8 mmol) in THF (4 mL) and MeOH (0.5 mL) was stirred at rt under N<sub>2</sub> and treated with a solution of lithium hydroxide monohydrate (134 mg, 3.2 mmol) in water (1 mL). The reaction mixture was stirred at rt for 1 h, cooled to 0 Â°C, and adjusted to pH 2 with 2 M HCl. Sodium chloride was added, and the mixture was extracted with EtOAc (2 Ã 50 mL). The combined organic extracts were washed with brine (50 mL), filtered through a hydrophobic frit, and then concentrated <i>in vacuo</i> to afford the title compound (163 mg, 100%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.1â12.9 (<i>br</i> s, 1H), 5.87 (dd, <i>J</i> = 17.6, 10.7 Hz, 1H), 5.25 (d, <i>J</i> = 10.7 Hz, 1H), 5.23 (d, <i>J</i> = 17.6 Hz, 1H), 3.13â2.96 (m, 4H), 2.42â2.33 (m, 2H), 2.12â2.03 (m, 2H). LC/MS Method A (<i>m</i>/<i>z</i>) 227.1 [M + Na], <i>T</i><sub>r</sub> = 0.96 min.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 5-Vinyl-1,3-dioxane-5-carboxylic Acid (<b>67a</b>)</h3><div class="NLM_p last">A mixture of <b>66</b> (150 g, 1.2 mol) in formaldehyde (210 mL, 2.8 mol, 40% aq.) and 1,4-dioxane (550 mL) was treated dropwise with Et<sub>3</sub>N (1.0 M in THF, 57 mL, 0.06 mol) at 0 Â°C. The mixture was heated to 35â40 Â°C, stirred for 1 h and then diluted with water (400 mL). The solution was extracted with toluene (3 Ã 600 mL), and the aqueous phase was concentrated <i>in vacuo</i> at 35 Â°C to â¼1/4 of the initial volume. The aqueous solution was extracted with EtOAc (3 Ã 900 mL), and the organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i> to afford ethyl 2,2-bis(hydroxymethyl)-3-oxobutanoate (75 g, 0.39 mol). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 4.86 (t, <i>J</i> = 5.3 Hz, 2H), 4.09 (q, <i>J</i> = 7.1 Hz, 2H), 3.87 (d, <i>J</i> = 5.3 Hz, 4H), 2.07 (s, 3H), 1.16 (t, <i>J</i> = 7.1 Hz, 3H). Ethyl 2,2-bis(hydroxymethyl)-3-oxobutanoate (75 g, 0.39 mol) was mixed with 40% formaldehyde (360 mL) in concentrated HCl (360 mL) and then heated at 50 Â°C for 17 h. The mixture was cooled to rt and extracted with EtOAc (2 Ã 200 mL), and the combined organic extracts were washed with water (300 mL), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with petroleum ether/EtOAc (15:1 to 9:1) to afford the title compound <b>67a</b> (33 g, 14% over two steps) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 4.82 (d, <i>J</i> = 6.0 Hz, 1H), 4.77 (d, <i>J</i> = 6.0 Hz, 1H), 4.35 (d, <i>J</i> = 12.0 Hz, 2H), 4.25â4.19 (m, 4H), 2.31 (s, 3H), 1.25 (m, 3H).</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Ethyl 5-Acetyl-2,2-dimethyl-1,3-dioxane-5-carboxylate (<b>67b</b>)</h3><div class="NLM_p last">Ethyl 2,2-bis(hydroxymethyl)-3-oxobutanoate (for preparation see <b>67a</b>) (7.6 g, 40 mmol), acetone (30 mL, 400 mmol), 2,2-dimethoxypropane (41.6 g, 50 mL, 400 mmol), and 4-toluenesulfonic acid hydrate (152 mg, 0.8 mmol) were mixed together and stirred at rt for 18 h. The mixture was concentrated <i>in vacuo</i> to a volume of â¼20 mL and treated with saturated sodium hydrogen carbonate solution (50 mL). The mixture was extracted with EtOAc (3 Ã 70 mL), and the combined organic extracts were washed with water (100 mL), brine (100 mL), filtered through a hydrophobic frit, and then concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (9:1 to 4:1) to afford the title compound (8.5 g, 31% over two steps) as a clear oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 4.30 (ABq, ÎÎ´<sub>AB</sub> = 0.04, <i>J</i><sub>AB</sub> = 11.9 Hz, 4H), 4.23 (q, <i>J</i> = 7.1 Hz, 2H), 2.33 (s, 3H), 1.40 (s, 3H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 5-Vinyl-1,3-dioxane-5-carboxylic Acid (<b>68a</b>)</h3><div class="NLM_p last"><b>67a</b> (22.3 g, 0.11 mol) was dissolved in EtOH (100 mL) and treated portionwise with sodium borohydride (2.08 g, 0.055 mol) at 0 Â°C. The mixture was stirred at 0 Â°C for 1 h and then treated with acetone. The solution was extracted with EtOAc (3 Ã 600 mL), and the combined organic extracts were concentrated <i>in vacuo</i> to afford ethyl 5-(1-hydroxyethyl)-1,3-dioxane-5-carboxylate (18.9 g, 84%) as a colorless oil. A mixture of ethyl 5-(1-hydroxyethyl)-1,3-dioxane-5-carboxylate (16.8 g, 83 mmol) in anhydrous pyridine (40 mL) at 0 Â°C was treated with 4-toluenesulfonyl chloride (19.1 g, 99 mmol). The mixture was stirred at rt for 16 h, and then water (40 mL) was added. The mixture was extracted with EtOAc (2 Ã 400 mL), and the extracts were washed with brine (3 Ã 200 mL) and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with petroleum ether/EtOAc (25:1 to 5:1) to provide ethyl 5-(1-(tosyloxy)ethyl)-1,3-dioxane-5-carboxylate (22.7 g, 76%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.79 (d, <i>J</i> = 8.8 Hz, 2H), 7.34 (d, <i>J</i> = 8.0 Hz, 2H), 5.03â4.98 (m, 1H), 4.20â4.17 (m, 2H), 4.08 (d, <i>J</i> = 12.0 Hz, 1H), 4.02 (d, <i>J</i> = 11.6 Hz, 1H), 3.87 (d, <i>J</i> = 11.6 Hz, 1H), 3.80 (d, <i>J</i> = 11.6 Hz, 1H), 2.45 (s, 3H), 1.34 (d, <i>J</i> = 6.8 Hz, 3H), 1.26 (m, 3H). Ethyl 5-(1-(tosyloxy)ethyl)-1,3-dioxane-5-carboxylate (20.7 g, 58 mmol) in DBU (25 mL) was heated at 140 Â°C for 3 h and then cooled to rt. The mixture was poured into Et<sub>2</sub>O (300 mL), washed with brine (3 Ã 100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with petroleum ether/Et<sub>2</sub>O (30:1 to 20:1) to provide an oil which was then distilled <i>in vacuo</i> (45 to 49 Â°C/0.3 mbar) to afford ethyl 5-vinyl-1,3-dioxane-5-carboxylate (3.6 g, 33%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 5.65 (m, 1H), 5.27 (m, 1H), 5.24 (m, 1H), 4.95 (d, <i>J</i> = 6.0 Hz, 1H), 4.71 (d, <i>J</i> = 8.0 Hz, 1H), 4.44 (t, <i>J</i> = 11.2 Hz, 2H), 4.25 (t, <i>J</i> = 7.2 Hz, 2H), 3.70 (d, <i>J</i> = 11.6 Hz, 2H), 1.29 (t, <i>J</i> = 11.0 Hz, 3H). Ethyl 5-vinyl-1,3-dioxane-5-carboxylate (397.7 mg, 2.136 mmol) in THF/MeOH/water (15 mL, 2:2:1) was treated with lithium hydroxide monohydrate (269 mg, 6.408 mmol). The mixture was stirred at rt for 1.5 h, concentrated <i>in vacuo</i>, cooled to 0 Â°C, and quenched with 1 M HCl. The aqueous layer was saturated with sodium chloride and then extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 100 mL). The combined organic extracts were filtered through a phase separator and concentrated <i>in vacuo</i> to provide the title compound (320.3 mg, 95%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 5.69 (dd, <i>J</i> = 17.6, 10.9 Hz, 1H), 5.27â5.39 (m, 2H), 5.02 (d, <i>J</i> = 6.0 Hz, 1H), 4.73 (d, <i>J</i> = 6.2 Hz, 1H), 4.50 (d, <i>J</i> = 11.4 Hz, 2H), 3.72 (d, <i>J</i> = 11.6 Hz, 2H).</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 2,2-Dimethyl-5-vinyl-1,3-dioxane-5-carboxylic Acid (<b>68b</b>)</h3><div class="NLM_p last"><i>N,N</i>-Diisopropylamine (1.51 g, 2.1 mL, 15 mmol) in anhydrous THF (30 mL) was stirred and cooled to â78 Â°C under N<sub>2</sub>. <i>n</i>-Butyl lithium (2.5 M in hexanes, 5.6 mL, 14 mmol) was added dropwise, and the mixture was stirred at â78 Â°C for 30 min. <b>67b</b> (2.3 g, 10 mmol) in THF (5 mL) was added to the reaction mixture, and the mixture was stirred at â78 Â°C for 15 min. <i>N</i>-Phenyl-(bis-trifluoromethanesulfonamide) (3.93 g, 11 mmol) in THF (30 mL) was added, and the mixture was stirred at â78 Â°C for 15 min. The mixture was allowed to warm to rt and stirred for 30 min. The mixture was concentrated <i>in vacuo</i>, and Et<sub>2</sub>O (50 mL) was added. The mixture was cooled to 5 Â°C and washed with cold 1 M sodium hydroxide solution (3 Ã 30 mL) and brine (30 mL). The organic layer was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo.</i> The residue in <i>N,N</i>-dimethylformamide (20 mL) was treated with tri-<i>n</i>-butylamine (5.55 g, 7 mL, 30 mmol) and stirred at rt under N<sub>2</sub>. Bis(triphenylphosphine) palladium(II) dichloride (350 mg, 0.5 mmol) and formic acid (920 mg, 0.77 mL, 20 mmol) were added, and the reaction mixture was heated at 60 Â°C for 90 min. The reaction mixture was cooled to room temperature and EtOAc (100 mL) and water (100 mL) were added. The organic layer was separated, washed with water (5 Ã 30 mL), brine (50 mL), filtered through a hydrophobic frit, and then concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with isohexanes/EtOAc (9:1) followed by silica gel chromatography eluting with isohexanes/EtOAc (19:1 to 9:1) to afford ethyl 2,2-dimethyl-5-vinyl-1,3-dioxane-5-carboxylate (1.07 g, 50%) as a clear oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 5.24 (dd, <i>J</i> = 17.4, 10.9 Hz, 1H), 5.28 (d, <i>J</i> = 10.9 Hz, 1H), 5.24 (d, <i>J</i> = 17.4 Hz, 1H), 4.26 (q, <i>J</i> = 7.1 Hz, 2H), 4.10 (ABq, ÎÎ´<sub>AB</sub> = 0.44, <i>J</i><sub>AB</sub> = 11.9 Hz, 4H), 1.46 (s, 3H), 1.41 (s, 3H), 1.31 (t, <i>J</i> = 7.1 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 237.0 [M + Na], <i>T</i><sub>r</sub> = 2.14 min. A solution of 2,2-dimethyl-5-vinyl-[1,3]dioxane-5-carboxylic acid ethyl ester (150 mg, 0.7 mmol) in THF (3 mL) was stirred at 5 Â°C under N<sub>2</sub>. A solution of lithium hydroxide monohydrate (59 mg, 1.4 mmol) in water (1 mL) was added, and the reaction mixture was stirred at 5 Â°C for 30 min and then at room temperature for 5 h. MeOH (0.5 mL) was added to give a clear solution, and the reaction mixture was stirred at room temperature for 22 h. The mixture was concentrated <i>in vacuo</i>. Water (2 mL) was added to the residue, and the solution was acidified to pH 2 with 2 M HCl. Brine was added and the mixture was extracted with EtOAc. The organic extracts were combined and washed with brine. The organic extract was separated, washed with water (Ã5), and brine. The organic solution was filtered through a hydrophobic frit, and the filtrate was concentrated <i>in vacuo</i> to afford the title compound (117 mg, 90%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 5.76 (dd, <i>J</i> = 17.8, 10.7 Hz, 1H), 5.35 (d, <i>J</i> = 10.7 Hz, 1H), 5.30 (d, <i>J</i> = 17.8 Hz, 1H), 4.32 (d, <i>J</i> = 12.0 Hz, 2H), 3.91 (d, <i>J</i> = 12.0 Hz, 2H), 1.49 (s, 3H), 1.44 (s, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 185.1 [M â H], <i>T</i><sub>r</sub> = 1.26 min.</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 6-(Nitromethylene)-1,4-dioxepane (<b>70</b>)</h3><div class="NLM_p last">MgSO<sub>4</sub> (2.05 g, 17.0 mmol) in nitromethane (4 mL) was vigorously stirred under N<sub>2</sub> and treated with a solution of <b>69</b><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (899 mg, 7.74 mmol) in nitromethane (2 mL). The mixture was stirred at rt for 5 min, and a solution of 2,8,9-triisopropyl-2,5,8,9-tetraaza-1-phosphabicyclo[3,3,3]undecane (231 mg, 250 Î¼L, 0.77 mmol) in nitromethane (2 mL) was then added. The mixture was heated at 40 Â°C for 19 h, cooled, and directly subjected to silica gel chromatography eluting with pentane/Et<sub>2</sub>O (1:1 to 1:3) to afford 6-(nitromethyl)-1,4-dioxepan-6-ol (798 mg, 58%) as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 4.58 (s, 2H), 3.85 (s, 4H), 3.93â3.77 (m, 4H), 3.27 (s, 1H). 6-(Nitromethyl)-1,4-dioxepan-6-ol (0.74 g, 4.18 mmol) and Et<sub>3</sub>N (1.86 g, 2.56 mL, 18.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL), under N<sub>2</sub>, were cooled to â78 Â°C. Methanesulfonyl chloride (1.43 g, 970 Î¼L, 12.5 mmol) was added dropwise, and the mixture was stirred for 30 min. The mixture was quenched with saturated ammonium chloride solution, and the organic layer was separated. The aqueous layer was back extracted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL). The combined organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with pentane/Et<sub>2</sub>O (3:1 to 1:1) to afford the title compound (512 mg, 77%) as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 7.02 (t, <i>J</i> = 2.5 Hz, 1H), 5.04 (d, <i>J</i> = 2.5 Hz, 2H), 4.36 (d, <i>J</i> = 0.5 Hz, 2H), 3.90â3.81 (m, 4H). LC/MS Method A (<i>m</i>/<i>z</i>) 182.1 [M + Na], <i>T</i><sub>r</sub> = 1.04 min.</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 6-Vinyl-1,4-dioxepane-6-carboxylic Acid (<b>71</b>)</h3><div class="NLM_p last">Toluene (13 mL) and water (3.25 mL) were deoxygenated by bubbling N<sub>2</sub> through for 20 min and then treated with <b>70</b> (512 mg, 3.22 mmol), 2,2â²-bis(diphenylphosphino)-1,1â²-binaphthalene (218 mg, 0.35 mmol), and potassium vinyltrifluoroborate (1.73 g, 12.9 mmol). The mixture was deoxygenated with N<sub>2</sub> for 5 min and then treated with bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate (131 mg, 0.32 mmol). The reaction mixture was stirred and heated at reflux under N<sub>2</sub> for 4.5 h. The mixture was partitioned between Et<sub>2</sub>O (30 mL) and water (30 mL). The aqueous layer was separated and extracted with Et<sub>2</sub>O (2 Ã 30 mL), and the combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was subjected to silica gel chromatography eluting with a gradient of isohexanes/Et<sub>2</sub>O (3:1 to 13:7) to afford 6-(nitromethyl)-6-vinyl-1,4-dioxepane (155 mg, 26%) as a pale brown oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 5.79 (dd, <i>J</i> = 17.8, 11.2 Hz, 1H), 5.30 (d, <i>J</i> = 11.2 Hz, 1H), 5.22 (d, <i>J</i> = 17.9 Hz, 1H), 4.64 (s, 2H), 3.93â3.77 (m, 8H). LC/MS Method A (<i>m</i>/<i>z</i>) 210.1 [M + Na], <i>T</i><sub>r</sub> = 1.51 min. 6-(Nitromethyl)-6-vinyl-1,4-dioxepane (214 mg, 1.14 mmol) in <i>N,N</i>-dimethylformamide (5 mL) under N<sub>2</sub> was treated with acetic acid (684 mg, 652 Î¼L, 11.4 mmol) and sodium nitrite (237 mg, 3.43 mmol). The mixture was heated at 40 Â°C for 23 h, cooled, and adjusted to pH 1 with 2 M HCl. The aqueous layer was extracted with Et<sub>2</sub>O (3 Ã 20 mL), and the combined organic extracts were washed with water (20 mL), dried over MgSO<sub>4</sub>, filtered, concentrated <i>in vacuo</i>. The residue was azeotroped with toluene to afford a yellow gum. The original aqueous layer was saturated with NaCl and extracted with Et<sub>2</sub>O (3 Ã 20 mL), and the combined organic extracts were washed with water, dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was azeoptroped with toluene and then combined with the first extract to afford the title compound (101 mg, 51%).<sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 5.79 (dd, <i>J</i> = 17.4, 10.9 Hz, 1H), 5.27 (d, <i>J</i> = 10.9 Hz, 1H), 5.26 (d, <i>J</i> = 17.8 Hz, 1H), 4.35 (d, <i>J</i> = 12.7 Hz, 2H), 3.88 (d, <i>J</i> = 12.5 Hz, 2H), 3.93â3.76 (m, 4H). LC/MS Method A (<i>m</i>/<i>z</i>) 195.2 [M + Na], <i>T</i><sub>r</sub> = 0.96 min.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (<i>R</i>)-1-(7-Bromo-quinolin-2-yl)-ethylamine Hydrochloride (<b>72</b>)</h3><div class="NLM_p last">Prepared as described in the synthesis of <b>55</b>.</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (<i>S</i>)-<i>N</i>-((<i>R</i>)-1-(7-Bromoquinolin-2-yl)ethyl)-1-(((<i>S</i>)-2-hydroxy-3-methylbutanoyl)-<span class="smallcaps smallerCapital">l</span>-alanyl)hexahydropyridazine-3-carboxamide (<b>73</b>)</h3><div class="NLM_p last"><b>44</b> (400 mg, 0.92 mmol) in THF (20 mL) was treated with zinc dust (1.3 g, 20.3 mmol) and ammonium acetate (1.1 g, 13.9 mmol) in water (7 mL). The mixture was stirred at rt for 16 h, the zinc residues were filtered off, and the volatiles were removed <i>in vacuo</i>. The residue was partitioned between EtOAc and saturated potassium hydrogen sulfate solution, the aqueous layer was extracted twice with EtOAc (50 mL), and the combined organic extracts were concentrated <i>in vacuo</i>. The residual acetic acid was azeotroped off with toluene (3 Ã 10 mL) to afford crude (<i>S</i>)-1-[(<i>S</i>)-2-((<i>S</i>)-2-hydroxy-3-methyl-butyrylamino)-propionyl]-hexahydro-pyridazine-3-carboxylic acid (280 mg, 99%). (<i>S</i>)-1-[(<i>S</i>)-2-((<i>S</i>)-2-Hydroxy-3-methyl-butyrylamino)-propionyl]-hexahydro-pyridazine-3-carboxylic acid (140 mg, 0.46 mmol) was combined with <b>72</b> (194 mg, 0.60 mmol) and <i>N,N-</i>diisopropylethylamine (0.400 mL, 2.3 mmol) in anhydrous CH<sub>3</sub>CN (10 mL). The mixture was then treated with 2-(1<i>H</i>-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate methanaminium (227 mg, 0.60 mmol) and stirred at rt for 3 h. The mixure was concentrated <i>in vacuo</i>, the residue dissolved in EtOAc and subsequently washed with saturated ammonium chloride solution and sodium bicarbonate solution. The organic layer was concentrated <i>in vacuo</i>, and the residue was subjected to silica gel chromatography eluting with isohexanes/acetone (1:0 to 1:1) to afford the title compound (136 mg, 55%) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 8.33 (d, <i>J</i> = 8.7 Hz, 1H), 8.26 (d, <i>J</i> = 1.6 Hz, 1H), 7.85 (d, <i>J</i> = 8.7 Hz, 1H), 7.69 (dd, <i>J</i> = 8.7, 1.8 Hz, 1H), 7.57 (d, <i>J</i> = 8.7 Hz, 1H), 5.40â5.31 (m, 1H), 5.28â5.18 (m, 1H), 4.34â4.24 (m, 1H), 3.81 (d, <i>J</i> = 3.4 Hz, 1H), 3.62â3.55 (m, 1H), 3.00â2.87 (m, 1H), 2.12â2.02 (m, 2H), 1.96â1.87 (m, 1H), 1.75â1.65 (m, 3H), 1.60 (d, <i>J</i> = 6.9 Hz, 3H), 1.38 (d, <i>J</i> = 6.9 Hz, 3H), 0.98 (d, <i>J</i> = 6.9 Hz, 3H), 0.83 (d, <i>J</i> = 6.9 Hz, 3H). LC/MS Method A (<i>m</i>/<i>z</i>) 534.1/536.1 [M + H], <i>T</i><sub>r</sub> = 2.27 min.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Cyclophilin A TR-FRET Competitive Binding Assay</h3><div class="NLM_p last">Cyclopilin A protein isolation and binding assay procedures were described previously.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> For sanglifehrin A data reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, a modified version of the previously described assay was used as described in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Cell Based HCV Replicon Genotype 2a, MT4 Cell Viability Assays, in Vitro and in Vivo Pharmacokinetic Assessments and Crystallography Methods</h3><div class="NLM_p last">See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf" class="ext-link">Supporting Information</a>. All in vivo studies were performed in accordance with local IACUC guidelines.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00802" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00802" class="ext-link">10.1021/acs.jmedchem.8b00802</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HCV replicon assay methods in huh-7 cells, MT4 viability and TR-FRET assay method for sanglifehrin A; organic compound liquid chromatography mass spectrometry methods; pharmacokinetic in vitro and in vivo methods; X-ray crystallography; <sup>1</sup>H NMR spectra for assayed compounds, carbon assignment for compound <b>3</b>, intramolecular hydrogen bond NMR data, and HPLC spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for <b>3</b>â<b>9</b>, <b>18</b>â<b>21</b>, <b>34</b>â<b>35</b>, <b>47</b>â<b>51</b>, and <b>53</b>â<b>54</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf">jm8b00802_si_001.pdf (5.71 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_002.csv">jm8b00802_si_002.csv (3.87 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Cocrystal structures of Cyp A and <b>3</b>, <b>8</b>, <b>19</b>, <b>20</b>, <b>34</b>. Authors will release the atomic coordinates upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00802" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard L. Mackman</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8861-7205" title="Orcid link">http://orcid.org/0000-0001-8861-7205</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5f0d363c373e2d3b71123e3c34323e311f3836333a3e3b713c3032"><span class="__cf_email__" data-cfemail="15477c767d7467713b5874767e78747b55727c797074713b767a78">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victoria A. Steadman</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1583-0202" title="Orcid link">http://orcid.org/0000-0003-1583-0202</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David K. Dean</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Petr Jansa</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karine G. Poullennec</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span>;Â 
    <span>Present Address:
                        (K.G.P.) UCB, Avenue de lâIndustrie, 1420 Braine-lâAlleud, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Todd Appleby</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carol Austin</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline A. Blakemore</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span>;Â 
    <span>Present Address:
                        (C.A.B.) Pfizer, 280 Shennecossett Rd, Groton, CT 06340, USA</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruby Cai</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carina Cannizzaro</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory Chin</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Yves C. Chiva</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil A. Dunbar</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans Fliri</span> - <span class="hlFld-Affiliation affiliation">Cypralis Ltd., Babraham Research Campus, Cambridge CB22 3AT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian J. Highton</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hon Hui</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingzhe Ji</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haolun Jin</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kapil Karki</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Keats</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linos Lazarides</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu-Jen Lee</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert Liclican</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Mish</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard Murray</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon B. Pettit</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Pyun</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Sangi</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rex Santos</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Sanvoisin</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Uli Schmitz</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Schrier</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dustin Siegel</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Sperandio</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George Stepan</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Tian</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory M. Watt</span> - <span class="hlFld-Affiliation affiliation">Selcia Ltd., Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5
0GS, United Kingdom</span>;Â 
    <span>Present Address:
                        (G.M.W.) Carbosynth, 8 and 9 Old Station Business Park, Compton, Berkshire, RG20 6NE, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai Yang</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian E. Schultz</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9757-2547" title="Orcid link">http://orcid.org/0000-0001-9757-2547</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The authors are current or former employees of Selcia, Ltd., Cypralis, Ltd., or Gilead Sciences, and may own company stock.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e12743-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We express our thanks to the following individuals: Kathy Brendza and Loredana Serafini for HRMS analysis, Ke-Yu Wang and Ian Marshall (Selcia) for NMR assistance. This work was funded by Gilead Sciences Inc. and Selcia Ltd.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Cyp</td><td class="NLM_def"><p class="first last">cyclophilin</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">pa</td><td class="NLM_def"><p class="first last">plasma-adjusted</p></td></tr><tr><td class="NLM_term">CsA</td><td class="NLM_def"><p class="first last">cyclosporin A</p></td></tr><tr><td class="NLM_term">HBV</td><td class="NLM_def"><p class="first last">hepatitis B virus</p></td></tr><tr><td class="NLM_term">NTCP</td><td class="NLM_def"><p class="first last">sodium taurocholate cotransporting polypeptide</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationships</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">effective concentration for 50% inhibition</p></td></tr><tr><td class="NLM_term">PXR</td><td class="NLM_def"><p class="first last">pregnane X receptor</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">CCM</td><td class="NLM_def"><p class="first last">cell culture media</p></td></tr><tr><td class="NLM_term">RCM</td><td class="NLM_def"><p class="first last">ring closing metathesis</p></td></tr><tr><td class="NLM_term">BOC</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">TCE</td><td class="NLM_def"><p class="first last">trichloroethyl</p></td></tr><tr><td class="NLM_term">CC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration for 50% cell viability loss</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(<i>N</i>,<i>N</i>-dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">potassium channel of the human <i>ether-Ã -go-go</i> related gene</p></td></tr><tr><td class="NLM_term">IACUC</td><td class="NLM_def"><p class="first last">International Animal Care and Use Committee</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last">Tris(2-carboxyethyl)phosphine</p></td></tr><tr><td class="NLM_term">SfA</td><td class="NLM_def"><p class="first last">sanglifehrin A</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Catalysis of protein folding by prolyl isomerase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">268</span>â <span class="NLM_lpage">270</span>, <span class="refDoi">Â DOI: 10.1038/329268a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1038%2F329268a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=268-270&author=K.+Langauthor=F.+X.+Schmidauthor=G.+Fischer&title=Catalysis+of+protein+folding+by+prolyl+isomerase&doi=10.1038%2F329268a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F329268a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F329268a0%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DK.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DCatalysis%2520of%2520protein%2520folding%2520by%2520prolyl%2520isomerase%26jtitle%3DNature%26date%3D1987%26volume%3D329%26spage%3D268%26epage%3D270%26doi%3D10.1038%2F329268a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann-Liebold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefhaber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">476</span>â <span class="NLM_lpage">478</span>, <span class="refDoi">Â DOI: 10.1038/337476a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1038%2F337476a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=2492638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADyaL1MXhs1yrtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1989&pages=476-478&author=G.+Fischerauthor=B.+Wittmann-Lieboldauthor=K.+Langauthor=T.+Kiefhaberauthor=F.+X.+Schmid&title=Cyclophilin+and+peptidyl-prolyl+cis-trans+isomerase+are+probably+identical+proteins&doi=10.1038%2F337476a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins</span></div><div class="casAuthors">Fischer, Gunter; Wittmann-Liebold, Brigitte; Lang, Kurt; Kiefhaber, Thomas; Schmid, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6206</span>),
    <span class="NLM_cas:pages">476-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The N-terminal sequence of peptidyl-prolyl cis-trans isomerase (PPIase), together with further chem. and enzymic properties are reported.  The results indicate that this enzyme is probably identical to cyclophilin, a recently discovered mammalian protein which binds tightly to cyclosporin A (CsA).  Cyclophilin is thought to be linked to the immunosuppressive action of CsA.  The 1st 38 amino acid residues of porcine PPIase and of bovine cyclophilin are identical and the 2 proteins both have a relative mol. mass of â¼17,000.  The catalysis of prolyl isomerization in oligopeptides and of protein folding by PPIase are strongly inhibited in the presence of low levels of CsA.  The activities of both PPIase and cyclophilin depend on a single SH group.  At present it is unknown whether the inhibition of prolyl isomerase activity is related to the immunosuppressive action of CsA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw-oWHYr-dkrVg90H21EOLACvtfcHk0liWeIjpeugEwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhs1yrtL4%253D&md5=91b3b3b13b28c21b61a63d7e65a95636</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F337476a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F337476a0%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DWittmann-Liebold%26aufirst%3DB.%26aulast%3DLang%26aufirst%3DK.%26aulast%3DKiefhaber%26aufirst%3DT.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26atitle%3DCyclophilin%2520and%2520peptidyl-prolyl%2520cis-trans%2520isomerase%2520are%2520probably%2520identical%2520proteins%26jtitle%3DNature%26date%3D1989%26volume%3D337%26spage%3D476%26epage%3D478%26doi%3D10.1038%2F337476a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handschumacher, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drugge, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speicher, D. W.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin: a specific cytosolic binding protein for cyclosporin A</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">544</span>â <span class="NLM_lpage">547</span>, <span class="refDoi">Â DOI: 10.1126/science.6238408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1126%2Fscience.6238408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=6238408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADyaL2MXktFOmtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=544-547&author=R.+E.+Handschumacherauthor=M.+W.+Hardingauthor=J.+Riceauthor=R.+J.+Druggeauthor=D.+W.+Speicher&title=Cyclophilin%3A+a+specific+cytosolic+binding+protein+for+cyclosporin+A&doi=10.1126%2Fscience.6238408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin:  a specific cytosolic binding protein for cyclosporin A</span></div><div class="casAuthors">Handschumacher, Robert E.; Harding, Matthew W.; Rice, Jeffrey; Drugge, Rhett J.; Speicher, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4674</span>),
    <span class="NLM_cas:pages">544-7</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Cyclophilin (I), a specific cytosolic binding protein responsible for the concn. of the immunosuppressant, cyclosporin A (II), by lymphoid cells, was purified to homogeneity from bovine thymocytes.  Cation-exchange HPLC resolved a major and minor I species that bound II with a dissocn. const. of â¼2 Ã 10-7 M and specific activities of 77 and 67 Î¼g/mg protein, resp.  Both I species had an apparent mol. wt. of 15,000, a pI of 9.6, and nearly identical amino acid compns.  A portion of the N-terminal amino acid sequence of the major species was detd.  The II-binding activity of I was SH group-dependent, unstable at 56Â° and at pH 4 or 9.5, and sensitive to trypsin but not to chymotrypsin degrdn.  I specifically bound a series of II analogs in proportion to their activity in a mixed lymphocyte reaction.  The isolation of I from the cytosol of thymocytes suggested that the immunosuppressive activity of II is mediated by an intracellular mechanism, rather than by a membrane-assocd. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX8f6D1eP5SLVg90H21EOLACvtfcHk0liWeIjpeugEwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktFOmtg%253D%253D&md5=a8c71d98008b8b2190bab4c091af4092</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.6238408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6238408%26sid%3Dliteratum%253Aachs%26aulast%3DHandschumacher%26aufirst%3DR.%2BE.%26aulast%3DHarding%26aufirst%3DM.%2BW.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DDrugge%26aufirst%3DR.%2BJ.%26aulast%3DSpeicher%26aufirst%3DD.%2BW.%26atitle%3DCyclophilin%253A%2520a%2520specific%2520cytosolic%2520binding%2520protein%2520for%2520cyclosporin%2520A%26jtitle%3DScience%26date%3D1984%26volume%3D226%26spage%3D544%26epage%3D547%26doi%3D10.1126%2Fscience.6238408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">807</span>â <span class="NLM_lpage">815</span>, <span class="refDoi">Â DOI: 10.1016/0092-8674(91)90124-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2F0092-8674%2891%2990124-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1715244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1991&pages=807-815&author=J.+Liuauthor=J.+D.+Farmerauthor=W.+S.+Laneauthor=J.+Friedmanauthor=I.+Weissmanauthor=S.+L.+Schreiber&title=Calcineurin+is+a+common+target+of+cyclophilin-cyclosporin+A+and+FKBP-FK506+complexes&doi=10.1016%2F0092-8674%2891%2990124-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</span></div><div class="casAuthors">Liu, Jun; Farmer, Jesse D., Jr.; Lane, Willam S.; Friedman, Jeff; Weissman, Irving; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Although the immediate receptors (immunophilins) of the immunosuppressants cyclosporin A (CsA) and FK506 are distinct, their similar mechanisms of inhibition of cell signaling suggest that their assocd. immunophilin complexes interact with a common target.  The authors report that the complexes cyclophilin-CsA and FKBP-FK506 (but not cyclophilin, FKBP, FKBP-rapamycin, or FKBP-506BD) competitively bind to and inhibit the Ca2+- and calmodulin-dependent phosphatase calcineurin, although the binding and inhibition of calcineurin do not require calmodulin.  These results suggest that calcineurin is involved in a common step assocd. with T cell receptor and IgE receptor signaling pathways and that cyclophilin and FKBP mediate the actions of CsA and FK506, resp., by forming drug-dependent complexes with and altering the activity of calcineurin-calmodulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfN8mg-hNhLVg90H21EOLACvtfcHk0lizlPl0xaecDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D&md5=00c4883ea86e6b2c554f8f72ed717ac9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2891%2990124-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252891%252990124-H%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFarmer%26aufirst%3DJ.%2BD.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DWeissman%26aufirst%3DI.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DCalcineurin%2520is%2520a%2520common%2520target%2520of%2520cyclophilin-cyclosporin%2520A%2520and%2520FKBP-FK506%2520complexes%26jtitle%3DCell%26date%3D1991%26volume%3D66%26spage%3D807%26epage%3D815%26doi%3D10.1016%2F0092-8674%2891%2990124-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatsch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerschmid, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaksche, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peichl, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1763</span>â <span class="NLM_lpage">1772</span>, <span class="refDoi">Â DOI: 10.1128/AAC.38.8.1763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1128%2FAAC.38.8.1763" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1994&pages=1763-1772&author=B.+Rosenwirthauthor=A.+Billichauthor=R.+Datemaauthor=P.+Donatschauthor=F.+Hammerschmidauthor=R.+Harrisonauthor=P.+Hiestandauthor=H.+Jakscheauthor=P.+Mayerauthor=P.+Peichl&title=Inhibition+of+human+immunodeficiency+virus+type+1+replication+by+SDZ+NIM+811%2C+a+nonimmunosuppressive+cyclosporine+analog&doi=10.1128%2FAAC.38.8.1763"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FAAC.38.8.1763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.38.8.1763%26sid%3Dliteratum%253Aachs%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DDatema%26aufirst%3DR.%26aulast%3DDonatsch%26aufirst%3DP.%26aulast%3DHammerschmid%26aufirst%3DF.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DJaksche%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DP.%26aulast%3DPeichl%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520by%2520SDZ%2520NIM%2520811%252C%2520a%2520nonimmunosuppressive%2520cyclosporine%2520analog%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1994%26volume%3D38%26spage%3D1763%26epage%3D1772%26doi%3D10.1128%2FAAC.38.8.1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loosli, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawen, A.</span></span> <span> </span><span class="NLM_article-title">[MeIle<sup>4</sup>]Cyclosporin, a novel natural cyclosporin with anti-HIV activity: structural elucidation, biosynthesis and biological properties</span>. <i>Antiviral Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">331</span>â <span class="NLM_lpage">339</span>, <span class="refDoi">Â DOI: 10.1177/095632029400500507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1177%2F095632029400500507" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=331-339&author=R.+Traberauthor=H.+Kobelauthor=H.-R.+Loosliauthor=H.+Sennauthor=B.+Rosenwirthauthor=A.+Lawen&title=%5BMeIle4%5DCyclosporin%2C+a+novel+natural+cyclosporin+with+anti-HIV+activity%3A+structural+elucidation%2C+biosynthesis+and+biological+properties&doi=10.1177%2F095632029400500507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1177%2F095632029400500507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F095632029400500507%26sid%3Dliteratum%253Aachs%26aulast%3DTraber%26aufirst%3DR.%26aulast%3DKobel%26aufirst%3DH.%26aulast%3DLoosli%26aufirst%3DH.-R.%26aulast%3DSenn%26aufirst%3DH.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DLawen%26aufirst%3DA.%26atitle%3D%255BMeIle4%255DCyclosporin%252C%2520a%2520novel%2520natural%2520cyclosporin%2520with%2520anti-HIV%2520activity%253A%2520structural%2520elucidation%252C%2520biosynthesis%2520and%2520biological%2520properties%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D1994%26volume%3D5%26spage%3D331%26epage%3D339%26doi%3D10.1177%2F095632029400500507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nigro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capogrossi, M. C.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin A: a key player for human disease</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e888</span>, <span class="refDoi">Â DOI: 10.1038/cddis.2013.410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1038%2Fcddis.2013.410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=24176846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCqsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e888&author=P.+Nigroauthor=G.+Pompilioauthor=M.+C.+Capogrossi&title=Cyclophilin+A%3A+a+key+player+for+human+disease&doi=10.1038%2Fcddis.2013.410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin A: a key player for human disease</span></div><div class="casAuthors">Nigro, P.; Pompilio, G.; Capogrossi, M. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">e888</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cyclophilin A (CyPA) is a ubiquitously distributed protein belonging to the immunophilin family.  CyPA has peptidyl prolyl cis-trans isomerase (PPIase) activity, which regulates protein folding and trafficking.  Although CyPA was initially believed to function primarily as an intracellular protein, recent studies have revealed that it can be secreted by cells in response to inflammatory stimuli.  Current research in animal models and humans has provided compelling evidences supporting the crit. function of CyPA in several human diseases.  This review discusses recently available data about CyPA in cardiovascular diseases, viral infections, neurodegeneration, cancer, rheumatoid arthritis, sepsis, asthma, periodontitis and aging.  It is believed that further elucidations of the role of CyPA will provide a better understanding of the mol. mechanisms underlying these diseases and will help develop novel pharmacol. therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2VfguTlVXYLVg90H21EOLACvtfcHk0lizlPl0xaecDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCqsrbI&md5=8e09a9495fc807f0ca5832735cdd12d1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.410%26sid%3Dliteratum%253Aachs%26aulast%3DNigro%26aufirst%3DP.%26aulast%3DPompilio%26aufirst%3DG.%26aulast%3DCapogrossi%26aufirst%3DM.%2BC.%26atitle%3DCyclophilin%2520A%253A%2520a%2520key%2520player%2520for%2520human%2520disease%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De888%26doi%3D10.1038%2Fcddis.2013.410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naoumov, N. V.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin inhibition as potential therapy for liver diseases</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1166</span>â <span class="NLM_lpage">1174</span>, <span class="refDoi">Â DOI: 10.1016/j.jhep.2014.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.jhep.2014.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=25048953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlGnur3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=1166-1174&author=N.+V.+Naoumov&title=Cyclophilin+inhibition+as+potential+therapy+for+liver+diseases&doi=10.1016%2Fj.jhep.2014.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin inhibition as potential therapy for liver diseases</span></div><div class="casAuthors">Naoumov, Nikolai V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1166-1174</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The cyclophilins are a group of proteins with peptidyl-prolyl isomerase enzymic activity, localized in different cellular compartments and involved in a variety of functions related to cell metab. and energy homeostasis, having enhanced expression in inflammation or malignancy.  Cyclophilin A (CypA), the most abundantly expressed cyclophilin, is present mainly in the cytoplasm and is a host factor involved in the life cycle of multiple viruses.  The extracellular fractions of CypA and CypB are potent pro-inflammatory mediators.  CypD, located in mitochondria, is a key regulator of mitochondrial permeability transition pores, and is crit. for necrotic cell death.  Cyclosporines are the prototype cyclophilin inhibitors.  Cyclic peptides, which bind and inhibit cyclophilins without having immunosuppressive properties, have been generated by chem. modifications of cyclosporin A.  In addn., cyclophilin inhibitors that are structurally different from cyclosporines have been synthesized.  The involvement of cyclophilins in the pathogenesis of different liver diseases has been established using both in vitro and in vivo investigations, thus indicating that cyclophilin inhibition may be of therapeutic benefit.  This review summarizes the evidence for potential therapeutic applications of non-immunosuppressive cyclophilin inhibitors, alone or in combination with other agents, in virus-induced liver diseases like hepatitis C, B or Delta, liver inflammation and fibrosis, acetaminophen-induced liver toxicity and hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDuZeRwcwpWbVg90H21EOLACvtfcHk0lizlPl0xaecDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlGnur3P&md5=0016ff180631660ad9e395d086478913</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2014.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2014.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DNaoumov%26aufirst%3DN.%2BV.%26atitle%3DCyclophilin%2520inhibition%2520as%2520potential%2520therapy%2520for%2520liver%2520diseases%26jtitle%3DJ.%2520Hepatol.%26date%3D2014%26volume%3D61%26spage%3D1166%26epage%3D1174%26doi%3D10.1016%2Fj.jhep.2014.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elrod, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molkentin, J. D.</span></span> <span> </span><span class="NLM_article-title">Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore</span>. <i>Circ. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1111</span>â <span class="NLM_lpage">1122</span>, <span class="refDoi">Â DOI: 10.1253/circj.CJ-13-0321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1253%2Fcircj.CJ-13-0321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=23538482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFyktLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2013&pages=1111-1122&author=J.+W.+Elrodauthor=J.+D.+Molkentin&title=Physiologic+functions+of+cyclophilin+D+and+the+mitochondrial+permeability+transition+pore&doi=10.1253%2Fcircj.CJ-13-0321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore</span></div><div class="casAuthors">Elrod, John W.; Molkentin, Jeffery D.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1111-1122</span>CODEN:
                <span class="NLM_cas:coden">CJIOBY</span>;
        ISSN:<span class="NLM_cas:issn">1346-9843</span>.
    
            (<span class="NLM_cas:orgname">Japanese Circulation Society</span>)
        </div><div class="casAbstract">This review focuses on the role of cyclophilin D (CypD) as a prominent mediator of the mitochondrial permeability transition pore (MPTP) and subsequent effects on cardiovascular physiol. and pathol.  Although a great no. of reviews have been written on the MPTP and its effects on cell death, we focus on the biol. surrounding CypD itself and the non-cell death physiol. functions of the MPTP.  A greater understanding of the physiol. functions of the MPTP and its regulation by CypD will likely suggest novel therapeutic approaches for cardiovascular disease; both dependent and independent of programmed necrotic cell death mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOlnVzWQCgcrVg90H21EOLACvtfcHk0liXJSXwXvWIig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFyktLY%253D&md5=de3c68f408526c38d0569f79ca4587d1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1253%2Fcircj.CJ-13-0321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1253%252Fcircj.CJ-13-0321%26sid%3Dliteratum%253Aachs%26aulast%3DElrod%26aufirst%3DJ.%2BW.%26aulast%3DMolkentin%26aufirst%3DJ.%2BD.%26atitle%3DPhysiologic%2520functions%2520of%2520cyclophilin%2520D%2520and%2520the%2520mitochondrial%2520permeability%2520transition%2520pore%26jtitle%3DCirc.%2520J.%26date%3D2013%26volume%3D77%26spage%3D1111%26epage%3D1122%26doi%3D10.1253%2Fcircj.CJ-13-0321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P. A.</span></span> <span> </span><span class="NLM_article-title">The role of immunophilins in viral infection</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1850</i></span>,  <span class="NLM_fpage">2103</span>â <span class="NLM_lpage">2110</span>, <span class="refDoi">Â DOI: 10.1016/j.bbagen.2014.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.bbagen.2014.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=25445708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOgsLnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1850&publication_year=2015&pages=2103-2110&author=S.+Hopkinsauthor=P.+A.+Gallay&title=The+role+of+immunophilins+in+viral+infection&doi=10.1016%2Fj.bbagen.2014.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The role of immunophilins in viral infection</span></div><div class="casAuthors">Hopkins, Sam; Gallay, Philippe A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1850</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2103-2110</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tremendous progress has been made in the past 20 years in understanding the roles played by immunophilins, and in particular the cyclophilins, in supporting the replication cycles of human viruses.  A growing body of genetic and biochem. evidence and data from clin. trials confirm that cyclophilins are essential cofactors that contribute to establishing a permissive environment within the host cell that supports the replication of HIV-1 and HCV.  Cyclophilin A regulates HIV-1 replication kinetics and infectivity, modulates sensitivity to host restriction factors, and cooperates in the transit of the pre-integration complex into the nucleus of infected cells.  Cyclophilin A is an essential cofactor whose expression supports HCV-specific RNA replication in human hepatocytes.  Peptidyl-prolyl isomerase inhibitors have been used in clin. trials to validate cyclophilins as antiviral targets for the treatment of HIV-1 and Chronic Hepatitis C virus infection and as mol. probes to identify the roles played by immunophilins in supporting the replication cycles of human viruses.  This review summarizes emerging research that defines the functions of immunophilins in supporting the replication cycles of HIV-1, HCV, HBV, coronaviruses, and other viral pathogens and describes new information that suggests a role for immunophilins in regulating innate immune responses against chronic viral infection.  The dependence on cyclophilins by evolutionarily distinct viruses for accomplishing various steps in replication such as viral entry, initiation of genomic nucleic acid replication, viral genome uncoating, nuclear import and nuclear entry, emphasizes the potential of cyclophilin inhibitors as therapeutic agents.  This article is part of a Special Issue entitled Proline-directed Foldases: Cell Signaling Catalysts and Drug Targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJMknLj7Z4CrVg90H21EOLACvtfcHk0liXJSXwXvWIig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOgsLnF&md5=2dc25d75eba3c0f18a7289380894c17e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DGallay%26aufirst%3DP.%2BA.%26atitle%3DThe%2520role%2520of%2520immunophilins%2520in%2520viral%2520infection%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2015%26volume%3D1850%26spage%3D2103%26epage%3D2110%26doi%3D10.1016%2Fj.bbagen.2014.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flisiak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horban, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvarajah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiercinska-Drapalo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siwak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cielniak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higersberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kierkus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aeschlimann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosgurin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas-á¸¾etral, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabbe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalfaro, P.</span></span> <span> </span><span class="NLM_article-title">The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">817</span>â <span class="NLM_lpage">826</span>, <span class="refDoi">Â DOI: 10.1002/hep.22131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1002%2Fhep.22131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=18302285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVOiu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=817-826&author=R.+Flisiakauthor=A.+Horbanauthor=P.+Gallayauthor=M.+Bobardtauthor=S.+Selvarajahauthor=A.+Wiercinska-Drapaloauthor=E.+Siwakauthor=I.+Cielniakauthor=J.+Higersbergerauthor=J.+Kierkusauthor=C.+Aeschlimannauthor=P.+Grosgurinauthor=V.+Nicolas-%E1%B8%BEetralauthor=J.-M.+Dumontauthor=H.+Porchetauthor=R.+Crabbeauthor=P.+Scalfaro&title=The+cyclophilin+inhibitor+Debio-025+shows+potent+anti-hepatitis+C+effect+in+patients+coinfected+with+hepatitis+C+and+human+immunodeficiency+virus&doi=10.1002%2Fhep.22131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The cyclophilin inhibitor Debio-O25 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus</span></div><div class="casAuthors">Flisiak, Robert; Horban, Andrzej; Gallay, Philippe; Bobardt, Michael; Selvarajah, Suganya; Wiercinska-Drapalo, Alicja; Siwak, Ewa; Cielniak, Iwona; Higersberger, Jozef; Kierkus, Jarek; Aeschlimann, Christian; Grosgurin, Pierre; Nicolas-Metral, Valerie; Dumont, Jean-Maurice; Porchet, Herve; Crabbe, Raf; Scalfaro, Pietro</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">817-826</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Debio-025 is an oral cyclophilin (Cyp) inhibitor with potent anti-hepatitis C virus activity in vitro.  Its effect on viral load as well as its influence on intracellular Cyp levels was investigated in a randomized, double-blind, placebo-controlled study.  Mean hepatitis C viral load decreased significantly by 3.6 log10 after a 14-day oral treatment with 1200 mg twice daily (P < 0.0001) with an effect against the 3 genotypes (1, 3, and 4) represented in the study.  In addn., the absence of viral rebound during treatment indicates that Debio-025 has a high barrier for the selection of resistance.  In Debio-025-treated patients, cydophilin B (CypB) levels in peripheral blood mononuclear cells decreased from 67 Â± 6 (std. error) ng/mg protein (baseline) to 5 Â± 1 ng/mg protein at day 15 (P < 0.01).  Conclusion: Debio-025 induced a strong drop in CypB levels, coinciding with the decrease in hepatitis C viral load.  These are the first preliminary human data supporting the hypothesis that CypB may play an important role in hepatitis C virus replication and that Cyp inhibition is a valid target for the development of anti-hepatitis C drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxguJagRjm8bVg90H21EOLACvtfcHk0liXJSXwXvWIig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVOiu7o%253D&md5=8b864afa2a4d2b55fc90650d5ac4e30b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fhep.22131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22131%26sid%3Dliteratum%253Aachs%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DHorban%26aufirst%3DA.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DSelvarajah%26aufirst%3DS.%26aulast%3DWiercinska-Drapalo%26aufirst%3DA.%26aulast%3DSiwak%26aufirst%3DE.%26aulast%3DCielniak%26aufirst%3DI.%26aulast%3DHigersberger%26aufirst%3DJ.%26aulast%3DKierkus%26aufirst%3DJ.%26aulast%3DAeschlimann%26aufirst%3DC.%26aulast%3DGrosgurin%26aufirst%3DP.%26aulast%3DNicolas-%25E1%25B8%25BEetral%26aufirst%3DV.%26aulast%3DDumont%26aufirst%3DJ.-M.%26aulast%3DPorchet%26aufirst%3DH.%26aulast%3DCrabbe%26aufirst%3DR.%26aulast%3DScalfaro%26aufirst%3DP.%26atitle%3DThe%2520cyclophilin%2520inhibitor%2520Debio-025%2520shows%2520potent%2520anti-hepatitis%2520C%2520effect%2520in%2520patients%2520coinfected%2520with%2520hepatitis%2520C%2520and%2520human%2520immunodeficiency%2520virus%26jtitle%3DHepatology%26date%3D2008%26volume%3D47%26spage%3D817%26epage%3D826%26doi%3D10.1002%2Fhep.22131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMassimo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusnak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalezari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorneaux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalczyk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeill, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baugh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span> <span> </span><span class="NLM_article-title">The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">47</span>â <span class="NLM_lpage">54</span>, <span class="refDoi">Â DOI: 10.1016/j.jhep.2012.02.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.jhep.2012.02.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=22425702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC38XovV2nsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=47-54&author=S.+Hopkinsauthor=B.+DiMassimoauthor=P.+Rusnakauthor=D.+Heumanauthor=J.+Lalezariauthor=A.+Sluderauthor=B.+Scorneauxauthor=S.+Mosierauthor=P.+Kowalczykauthor=Y.+Ribeillauthor=J.+Baughauthor=P.+Gallay&title=The+cyclophilin+inhibitor+SCY-635+suppresses+viral+replication+and+induces+endogenous+interferons+in+patients+with+chronic+HCV+genotype+1+infection&doi=10.1016%2Fj.jhep.2012.02.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection</span></div><div class="casAuthors">Hopkins, Sam; DiMassimo, Betty; Rusnak, Pamela; Heuman, Douglas; Lalezari, Jacob; Sluder, Ann; Scorneaux, Bernard; Mosier, Sarah; Kowalczyk, Paul; Ribeill, Yves; Baugh, James; Gallay, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background & Aims: SCY-635 is a non-immunosuppressive analog of cyclosporin A that inhibits cyclophilins A and B and hepatitis C virus (HCV) replication in vitro.  In a phase 1b multi-dose escalation study, we evaluated the safety, plasma pharmacokinetics, and antiviral activity of 15 days of monotherapy with SCY-635 in adults with chronic genotype 1 HCV infection.  Methods: Twenty adults with chronic HCV genotype 1 were randomized to SCY-635 oral doses of 100, 200, or 300 mg three times daily for 15 days.  Results: No dose-limiting clin. or lab. toxicities were identified.  On day 15, the mean decline in plasma viremia was 2.24 Â± 1.74 log10 IU/mL with SCY-635 900 mg/d.  Individual antiviral responses correlated with host IL28B genotype.  Post hoc analyses indicated treatment with SCY-635 increased plasma protein concns. of interferon Î± (IFNÎ±), IFNs Î»1 and Î»3, and 2'5' oligoadenylate synthetase 1 (2'5'OAS-1), with the greatest increases in IL28B CC and CT subjects.  Changes in plasma concns. for all markers were coincident with changes in the plasma concn. of SCY-635.  Peaks of IFNs Î±, Î»1, and Î»3 and 2'5'OAS-1 were obsd. within 2 h after drug administration.  In replicon cells, SCY-635 enhanced secretion of type I and type III IFNs and increased the expression of IFN-stimulated genes (ISG).  Conclusions: These studies establish clin. proof of concept for SCY-635 as a novel antiviral agent and suggest that restoration of the host innate immune response to chronic hepatitis C infection may represent a major mechanism through which cyclophilin inhibitors exert clin. antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOeLKHF7TNQLVg90H21EOLACvtfcHk0lgeaSy28U5H-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovV2nsLc%253D&md5=43dcadacaaef7efd63d3d823f53ad514</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2012.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2012.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DDiMassimo%26aufirst%3DB.%26aulast%3DRusnak%26aufirst%3DP.%26aulast%3DHeuman%26aufirst%3DD.%26aulast%3DLalezari%26aufirst%3DJ.%26aulast%3DSluder%26aufirst%3DA.%26aulast%3DScorneaux%26aufirst%3DB.%26aulast%3DMosier%26aufirst%3DS.%26aulast%3DKowalczyk%26aufirst%3DP.%26aulast%3DRibeill%26aufirst%3DY.%26aulast%3DBaugh%26aufirst%3DJ.%26aulast%3DGallay%26aufirst%3DP.%26atitle%3DThe%2520cyclophilin%2520inhibitor%2520SCY-635%2520suppresses%2520viral%2520replication%2520and%2520induces%2520endogenous%2520interferons%2520in%2520patients%2520with%2520chronic%2520HCV%2520genotype%25201%2520infection%26jtitle%3DJ.%2520Hepatol.%26date%3D2012%26volume%3D57%26spage%3D47%26epage%3D54%26doi%3D10.1016%2Fj.jhep.2012.02.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keller, D. M.</span></span> <span> </span><span class="NLM_article-title">Pancreatitis Events Halt Development of Alisporivir for HCV</span>.  <i>Medscape</i>, Apr 19, <span class="NLM_year" style="font-weight: bold;">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+M.+Keller&title=Pancreatitis+Events+Halt+Development+of+Alisporivir+for+HCV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeller%26aufirst%3DD.%2BM.%26atitle%3DPancreatitis%2520Events%2520Halt%2520Development%2520of%2520Alisporivir%2520for%2520HCV%26jtitle%3DMedscape%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puyang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulin, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathy, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span> <span> </span><span class="NLM_article-title">Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1981</span>â <span class="NLM_lpage">1987</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01236-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1128%2FAAC.01236-09" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1981-1987&author=X.+Puyangauthor=D.+L.+Poulinauthor=J.+E.+Mathyauthor=L.+J.+Andersonauthor=S.+Maauthor=Z.+Fangauthor=S.+Zhuauthor=K.+Linauthor=R.+Fujimotoauthor=T.+Comptonauthor=B.+Wiedmann&title=Mechanism+of+resistance+of+hepatitis+C+virus+replicons+to+structurally+distinct+cyclophilin+inhibitors&doi=10.1128%2FAAC.01236-09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.01236-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01236-09%26sid%3Dliteratum%253Aachs%26aulast%3DPuyang%26aufirst%3DX.%26aulast%3DPoulin%26aufirst%3DD.%2BL.%26aulast%3DMathy%26aufirst%3DJ.%2BE.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DFujimoto%26aufirst%3DR.%26aulast%3DCompton%26aufirst%3DT.%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DMechanism%2520of%2520resistance%2520of%2520hepatitis%2520C%2520virus%2520replicons%2520to%2520structurally%2520distinct%2520cyclophilin%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D1981%26epage%3D1987%26doi%3D10.1128%2FAAC.01236-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robotham, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grise, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frausto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zayas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartenschlager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenstein, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nag, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkiewicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span> <span> </span><span class="NLM_article-title">A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e1001118</span>, <span class="refDoi">Â DOI: 10.1371/journal.ppat.1001118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1371%2Fjournal.ppat.1001118" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=e1001118&author=F.+Yangauthor=J.+M.+Robothamauthor=H.+Griseauthor=S.+Fraustoauthor=V.+Madanauthor=M.+Zayasauthor=R.+Bartenschlagerauthor=M.+Robinsonauthor=A.+E.+Greensteinauthor=A.+Nagauthor=T.+M.+Loganauthor=E.+Bienkiewiczauthor=H.+Tang&title=A+major+determinant+of+cyclophilin+dependence+and+cyclosporine+susceptibility+of+hepatitis+C+virus+identified+by+a+genetic+approach&doi=10.1371%2Fjournal.ppat.1001118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1001118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1001118%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DRobotham%26aufirst%3DJ.%2BM.%26aulast%3DGrise%26aufirst%3DH.%26aulast%3DFrausto%26aufirst%3DS.%26aulast%3DMadan%26aufirst%3DV.%26aulast%3DZayas%26aufirst%3DM.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DM.%26aulast%3DGreenstein%26aufirst%3DA.%2BE.%26aulast%3DNag%26aufirst%3DA.%26aulast%3DLogan%26aufirst%3DT.%2BM.%26aulast%3DBienkiewicz%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DH.%26atitle%3DA%2520major%2520determinant%2520of%2520cyclophilin%2520dependence%2520and%2520cyclosporine%2520susceptibility%2520of%2520hepatitis%2520C%2520virus%2520identified%2520by%2520a%2520genetic%2520approach%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26spage%3De1001118%26doi%3D10.1371%2Fjournal.ppat.1001118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanoulle, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieruszeski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdegem, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landrieu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartenschlager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippens, G.</span></span> <span> </span><span class="NLM_article-title">Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis/trans isomerase activity of cyclophilins A and B</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">13589</span>â <span class="NLM_lpage">13601</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M809244200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1074%2Fjbc.M809244200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=13589-13601&author=X.+Hanoulleauthor=A.+Badilloauthor=J.+M.+Wieruszeskiauthor=D.+Verdegemauthor=I.+Landrieuauthor=R.+Bartenschlagerauthor=F.+Peninauthor=G.+Lippens&title=Hepatitis+C+virus+NS5A+protein+is+a+substrate+for+the+peptidyl-prolyl+cis%2Ftrans+isomerase+activity+of+cyclophilins+A+and+B&doi=10.1074%2Fjbc.M809244200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M809244200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M809244200%26sid%3Dliteratum%253Aachs%26aulast%3DHanoulle%26aufirst%3DX.%26aulast%3DBadillo%26aufirst%3DA.%26aulast%3DWieruszeski%26aufirst%3DJ.%2BM.%26aulast%3DVerdegem%26aufirst%3DD.%26aulast%3DLandrieu%26aufirst%3DI.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DPenin%26aufirst%3DF.%26aulast%3DLippens%26aufirst%3DG.%26atitle%3DHepatitis%2520C%2520virus%2520NS5A%2520protein%2520is%2520a%2520substrate%2520for%2520the%2520peptidyl-prolyl%2520cis%252Ftrans%2520isomerase%2520activity%2520of%2520cyclophilins%2520A%2520and%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D13589%26epage%3D13601%26doi%3D10.1074%2Fjbc.M809244200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, I. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Striker, R.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e9815</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0009815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1371%2Fjournal.pone.0009815" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9815&author=F.+Fernandesauthor=I.+U.+Ansariauthor=R.+Striker&title=Cyclosporine+inhibits+a+direct+interaction+between+cyclophilins+and+hepatitis+C+NS5A&doi=10.1371%2Fjournal.pone.0009815"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009815%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DF.%26aulast%3DAnsari%26aufirst%3DI.%2BU.%26aulast%3DStriker%26aufirst%3DR.%26atitle%3DCyclosporine%2520inhibits%2520a%2520direct%2520interaction%2520between%2520cyclophilins%2520and%2520hepatitis%2520C%2520NS5A%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9815%26doi%3D10.1371%2Fjournal.pone.0009815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Rivera, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P. A.</span></span> <span> </span><span class="NLM_article-title">The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3888</span>â <span class="NLM_lpage">3897</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00693-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1128%2FAAC.00693-12" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3888-3897&author=S.+Hopkinsauthor=M.+Bobardtauthor=U.+Chatterjiauthor=J.+A.+Garcia-Riveraauthor=P.+Limauthor=P.+A.+Gallay&title=The+cyclophilin+inhibitor+SCY-635+disrupts+hepatitis+C+virus+NS5A-cyclophilin+A+complexes&doi=10.1128%2FAAC.00693-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.00693-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00693-12%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DGarcia-Rivera%26aufirst%3DJ.%2BA.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DGallay%26aufirst%3DP.%2BA.%26atitle%3DThe%2520cyclophilin%2520inhibitor%2520SCY-635%2520disrupts%2520hepatitis%2520C%2520virus%2520NS5A-cyclophilin%2520A%2520complexes%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3888%26epage%3D3897%26doi%3D10.1128%2FAAC.00693-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroto-Esoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizokami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakita, T.</span></span> <span> </span><span class="NLM_article-title">Cyclosporin A and its analogs inhibit Hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1726</span>â <span class="NLM_lpage">1737</span>, <span class="refDoi">Â DOI: 10.1002/hep.26982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1002%2Fhep.26982" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=1726-1737&issue=5&author=K.+Watashiauthor=A.+Sluderauthor=T.+Daitoauthor=S.+Matsunagaauthor=A.+Ryoauthor=S.+Nagamoriauthor=M.+Iwamotoauthor=S.+Nakajimaauthor=S.+Tsukudaauthor=K.+Borroto-Esodaauthor=M.+Sugiyamaauthor=Y.+Tanakaauthor=Y.+Kanaiauthor=H.+Kusuharaauthor=M.+Mizokamiauthor=T.+Wakita&title=Cyclosporin+A+and+its+analogs+inhibit+Hepatitis+B+virus+entry+into+cultured+hepatocytes+through+targeting+a+membrane+transporter%2C+sodium+taurocholate+cotransporting+polypeptide+%28NTCP%29&doi=10.1002%2Fhep.26982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fhep.26982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26982%26sid%3Dliteratum%253Aachs%26aulast%3DWatashi%26aufirst%3DK.%26aulast%3DSluder%26aufirst%3DA.%26aulast%3DDaito%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DRyo%26aufirst%3DA.%26aulast%3DNagamori%26aufirst%3DS.%26aulast%3DIwamoto%26aufirst%3DM.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DTsukuda%26aufirst%3DS.%26aulast%3DBorroto-Esoda%26aufirst%3DK.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DKusuhara%26aufirst%3DH.%26aulast%3DMizokami%26aufirst%3DM.%26aulast%3DWakita%26aufirst%3DT.%26atitle%3DCyclosporin%2520A%2520and%2520its%2520analogs%2520inhibit%2520Hepatitis%2520B%2520virus%2520entry%2520into%2520cultured%2520hepatocytes%2520through%2520targeting%2520a%2520membrane%2520transporter%252C%2520sodium%2520taurocholate%2520cotransporting%2520polypeptide%2520%2528NTCP%2529%26jtitle%3DHepatology%26date%3D2014%26volume%3D59%26issue%3D5%26spage%3D1726%26epage%3D1737%26doi%3D10.1002%2Fhep.26982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nkongolo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lempp, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esser-Nobis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehrle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, S.</span></span> <span> </span><span class="NLM_article-title">Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">723</span>â <span class="NLM_lpage">731</span>, <span class="refDoi">Â DOI: 10.1016/j.jhep.2013.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.jhep.2013.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=24295872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlagtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=723-731&issue=4&author=S.+Nkongoloauthor=Y.+Niauthor=F.+A.+Lemppauthor=C.+Kaufmanauthor=T.+Lindnerauthor=K.+Esser-Nobisauthor=V.+Lohmannauthor=W.+Mierauthor=S.+Mehrleauthor=S.+Urban&title=Cyclosporin+A+inhibits+hepatitis+B+and+hepatitis+D+virus+entry+by+cyclophilin-independent+interference+with+the+NTCP+receptor&doi=10.1016%2Fj.jhep.2013.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor</span></div><div class="casAuthors">Nkongolo, Shirin; Ni, Yi; Lempp, Florian A.; Kaufman, Christina; Lindner, Thomas; Esser-Nobis, Katharina; Lohmann, Volker; Mier, Walter; Mehrle, Stefan; Urban, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">723-731</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chronic hepatitis B and hepatitis D are global health problems caused by the human hepatitis B and hepatitis D virus.  The myristoylated preS1 domain of the large envelope protein mediates specific binding to hepatocytes by sodium taurocholate co-transporting polypeptide (NTCP).  NTCP is a bile salt transporter known to be inhibited by cyclosporin A.  This study aimed to characterize the effect of cyclosporin A on HBV/HDV infection.  HepaRG cells, primary human hepatocytes, and susceptible NTCP-expressing hepatoma cell lines were applied for infection expts.  The mode of action of cyclosporin A was studied by comparing the effect of different inhibitors, cyclophilin A/B/C-silenced cell lines as well as NTCP variants and mutants.  Bile salt transporter and HBV receptor functions were investigated by taurocholate uptake and quantification of HBVpreS binding.Cyclosporin A inhibited hepatitis B and D virus infections during and - less pronounced - prior to virus inoculation.  Binding of HBVpreS to NTCP was blocked by cyclosporin A concns. at 8 Î¼M.  An NTCP variant deficient in HBVpreS binding but competent for bile salt transport showed resistance to cyclosporin A.  Silencing of cyclophilins A/B/C did not abrogate transporter and receptor inhibition.  In contrast, tacrolimus, a cyclophilin-independent calcineurin inhibitor, was inactive.HBV and HDV entry via sodium taurocholate co-transporting polypeptide is inhibited by cyclosporin A.  The interaction between the drug and the viral receptor is direct and overlaps with a functional binding site of the preS1 domain, which mediates viral entry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTAVAhQe6_ErVg90H21EOLACvtfcHk0lidHG0E6vbQ2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlagtw%253D%253D&md5=d8c7e3698ac926cd5c06a9e7e2c4717b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2013.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2013.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DNkongolo%26aufirst%3DS.%26aulast%3DNi%26aufirst%3DY.%26aulast%3DLempp%26aufirst%3DF.%2BA.%26aulast%3DKaufman%26aufirst%3DC.%26aulast%3DLindner%26aufirst%3DT.%26aulast%3DEsser-Nobis%26aufirst%3DK.%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DMier%26aufirst%3DW.%26aulast%3DMehrle%26aufirst%3DS.%26aulast%3DUrban%26aufirst%3DS.%26atitle%3DCyclosporin%2520A%2520inhibits%2520hepatitis%2520B%2520and%2520hepatitis%2520D%2520virus%2520entry%2520by%2520cyclophilin-independent%2520interference%2520with%2520the%2520NTCP%2520receptor%26jtitle%3DJ.%2520Hepatol.%26date%3D2014%26volume%3D60%26issue%3D4%26spage%3D723%26epage%3D731%26doi%3D10.1016%2Fj.jhep.2013.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span> <span> </span><span class="NLM_article-title">From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7145</span>â <span class="NLM_lpage">7159</span>, <span class="refDoi">Â DOI: 10.1021/jm500223x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500223x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKgs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7145-7159&author=Z.+K.+Sweeneyauthor=J.+Fuauthor=B.+Wiedmann&title=From+chemical+tools+to+clinical+medicines%3A+nonimmunosuppressive+cyclophilin+inhibitors+derived+from+the+cyclosporin+and+sanglifehrin+scaffolds&doi=10.1021%2Fjm500223x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">From Chemical Tools to Clinical Medicines: Nonimmunosuppressive Cyclophilin Inhibitors Derived from the Cyclosporin and Sanglifehrin Scaffolds</span></div><div class="casAuthors">Sweeney, Zachary K.; Fu, Jiping; Wiedmann, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7145-7159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The cyclophilins are widely expressed enzymes that catalyze the interconversion of the cis and trans peptide bonds of prolines.  The immunosuppressive natural products cyclosporine A and sanglifehrin A inhibit the enzymic activity of the cyclophilins.  Chem. modification of both the cyclosporine and sanglifehrin scaffolds has produced many analogs that inhibit cyclophilins in vitro but have reduced immunosuppressive properties.  Three nonimmunosuppressive cyclophilin inhibitors (alisporivir, SCY-635, and NIM811) have demonstrated clin. efficacy for the treatment of hepatitis C infection.  Addnl. candidates are in various stages of preclin. development for the treatment of hepatitis C or myocardial reperfusion injury.  Recent publications suggest that cyclophilin inhibitors may have utility for the treatment of diverse viral infections, inflammatory indications, and cancer.  In this review, we document the structure-activity relationships of the nonimmunosuppressive cyclosporins and sanglifehrins in clin. and preclin. development.  Aspects of the pharmacokinetic behavior and chem. biol. of these drug candidates are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX8HG6odes7Vg90H21EOLACvtfcHk0libdKyYq5sBHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKgs74%253D&md5=c011a3ad8d4db9481fb5f99c1e917759</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm500223x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500223x%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DFrom%2520chemical%2520tools%2520to%2520clinical%2520medicines%253A%2520nonimmunosuppressive%2520cyclophilin%2520inhibitors%2520derived%2520from%2520the%2520cyclosporin%2520and%2520sanglifehrin%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7145%26epage%3D7159%26doi%3D10.1021%2Fjm500223x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RÃ¼ckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patiny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muamba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, R.</span></span> <span> </span><span class="NLM_article-title">Synthetic routes to NEtXaa<sup>4</sup>-cyclosporin A derivatives as potential anti-HIV I drugs</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">7193</span>â <span class="NLM_lpage">7196</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4039(00)01267-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2FS0040-4039%2800%2901267-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=7193-7196&author=F.+Hublerauthor=T.+R%C3%BCckleauthor=L.+Patinyauthor=T.+Muambaauthor=J.-F.+Guichouauthor=M.+Mutterauthor=R.+Wenger&title=Synthetic+routes+to+NEtXaa4-cyclosporin+A+derivatives+as+potential+anti-HIV+I+drugs&doi=10.1016%2FS0040-4039%2800%2901267-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2901267-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252901267-3%26sid%3Dliteratum%253Aachs%26aulast%3DHubler%26aufirst%3DF.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DPatiny%26aufirst%3DL.%26aulast%3DMuamba%26aufirst%3DT.%26aulast%3DGuichou%26aufirst%3DJ.-F.%26aulast%3DMutter%26aufirst%3DM.%26aulast%3DWenger%26aufirst%3DR.%26atitle%3DSynthetic%2520routes%2520to%2520NEtXaa4-cyclosporin%2520A%2520derivatives%2520as%2520potential%2520anti-HIV%2520I%2520drugs%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D7193%26epage%3D7196%26doi%3D10.1016%2FS0040-4039%2800%2901267-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scribner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorneaux, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of [D-lysine]<sup>8</sup>cyclosporin A analogs as potential anti-HCV agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6542</span>â <span class="NLM_lpage">6546</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2010.09.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.bmcl.2010.09.036" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6542-6546&author=A.+Scribnerauthor=D.+Houckauthor=Z.+Huangauthor=S.+Mosierauthor=M.+Peelauthor=B.+Scorneaux&title=Synthesis+and+biological+evaluation+of+%5BD-lysine%5D8cyclosporin+A+analogs+as+potential+anti-HCV+agents&doi=10.1016%2Fj.bmcl.2010.09.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.036%26sid%3Dliteratum%253Aachs%26aulast%3DScribner%26aufirst%3DA.%26aulast%3DHouck%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DMosier%26aufirst%3DS.%26aulast%3DPeel%26aufirst%3DM.%26aulast%3DScorneaux%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520%255BD-lysine%255D8cyclosporin%2520A%2520analogs%2520as%2520potential%2520anti-HCV%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6542%26epage%3D6546%26doi%3D10.1016%2Fj.bmcl.2010.09.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjandra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capparelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furegati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasprzyk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yifru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span> <span> </span><span class="NLM_article-title">Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8503</span>â <span class="NLM_lpage">8516</span>, <span class="refDoi">Â DOI: 10.1021/jm500862r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500862r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChsb3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8503-8516&author=J.+Fuauthor=M.+Tjandraauthor=C.+Beckerauthor=D.+Bednarczykauthor=M.+Capparelliauthor=R.+Ellingauthor=I.+Hannaauthor=R.+Fujimotoauthor=M.+Furegatiauthor=S.+Karurauthor=T.+Kasprzykauthor=M.+Knappauthor=K.+Leungauthor=X.+Liauthor=P.+Luauthor=W.+Mergoauthor=C.+Miaultauthor=S.+Ngauthor=D.+Parkerauthor=Y.+Pengauthor=S.+Roggoauthor=A.+Rivkinauthor=R.+L.+Simmonsauthor=M.+Wangauthor=B.+Wiedmannauthor=A.+H.+Weissauthor=L.+Xiaoauthor=L.+Xieauthor=A.+Yifruauthor=S.+Yangauthor=B.+Zhouauthor=Z.+K.+Sweeney&title=Potent+nonimmunosuppressive+cyclophilin+inhibitors+with+improved+pharmaceutical+properties+and+decreased+transporter+inhibition&doi=10.1021%2Fjm500862r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Nonimmunosuppressive Cyclophilin Inhibitors With Improved Pharmaceutical Properties and Decreased Transporter Inhibition</span></div><div class="casAuthors">Fu, Jiping; Tjandra, Meiliana; Becker, Christopher; Bednarczyk, Dallas; Capparelli, Michael; Elling, Robert; Hanna, Imad; Fujimoto, Roger; Furegati, Markus; Karur, Subramanian; Kasprzyk, Theresa; Knapp, Mark; Leung, Kwan; Li, Xiaolin; Lu, Peichao; Mergo, Wosenu; Miault, Charlotte; Ng, Simon; Parker, David; Peng, Yunshan; Roggo, Silvio; Rivkin, Alexey; Simmons, Robert L.; Wang, Michael; Wiedmann, Brigitte; Weiss, Andrew H.; Xiao, Linda; Xie, Lili; Xu, Wenjian; Yifru, Aregahegn; Yang, Shengtian; Zhou, Bo; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8503-8516</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonimmunosuppressive cyclophilin inhibitors have demonstrated efficacy for the treatment of hepatitis C infection (HCV).  However, alisporivir, cyclosporin A, and most other cyclosporins are potent inhibitors of OATP1B1, MRP2, MDR1, and other important drug transporters.  Redn. of the side chain hydrophobicity of the P4 residue preserves cyclophilin binding and antiviral potency while decreasing transporter inhibition.  Representative inhibitor 33 (NIM258) is a less potent transporter inhibitor relative to previously described cyclosporins, retains anti-HCV activity in cell culture, and has an acceptable pharmacokinetic profile in rats and dogs.  An X-ray structure of 33 bound to rat cyclophilin D is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJTTMugCPY6bVg90H21EOLACvtfcHk0libdKyYq5sBHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChsb3L&md5=80688933869bade9ce2684db9ca82cb6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm500862r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500862r%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DTjandra%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DBednarczyk%26aufirst%3DD.%26aulast%3DCapparelli%26aufirst%3DM.%26aulast%3DElling%26aufirst%3DR.%26aulast%3DHanna%26aufirst%3DI.%26aulast%3DFujimoto%26aufirst%3DR.%26aulast%3DFuregati%26aufirst%3DM.%26aulast%3DKarur%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DT.%26aulast%3DKnapp%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DMiault%26aufirst%3DC.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWiedmann%26aufirst%3DB.%26aulast%3DWeiss%26aufirst%3DA.%2BH.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DYifru%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DPotent%2520nonimmunosuppressive%2520cyclophilin%2520inhibitors%2520with%2520improved%2520pharmaceutical%2520properties%2520and%2520decreased%2520transporter%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8503%26epage%3D8516%26doi%3D10.1021%2Fjm500862r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedrani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin Cabrejas, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papageorgiou, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jutzi Eme, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rihs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span> <span> </span><span class="NLM_article-title">Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">3849</span>â <span class="NLM_lpage">3859</span>, <span class="refDoi">Â DOI: 10.1021/ja021327y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja021327y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=3849-3859&author=R.+Sedraniauthor=J.+Kallenauthor=L.+M.+Martin+Cabrejasauthor=C.+D.+Papageorgiouauthor=F.+Seniaauthor=S.+Rohrbachauthor=D.+Wagnerauthor=B.+Thaiauthor=A.+M.+Jutzi+Emeauthor=J.+Franceauthor=L.+Obererauthor=G.+Rihsauthor=G.+Zenkeauthor=J.+Wagner&title=Sanglifehrin-cyclophilin+interaction%3A+degradation+work%2C+synthetic+macrocyclic+analogues%2C+X-ray+crystal+structure%2C+and+binding+data&doi=10.1021%2Fja021327y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja021327y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja021327y%26sid%3Dliteratum%253Aachs%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMartin%2BCabrejas%26aufirst%3DL.%2BM.%26aulast%3DPapageorgiou%26aufirst%3DC.%2BD.%26aulast%3DSenia%26aufirst%3DF.%26aulast%3DRohrbach%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DD.%26aulast%3DThai%26aufirst%3DB.%26aulast%3DJutzi%2BEme%26aufirst%3DA.%2BM.%26aulast%3DFrance%26aufirst%3DJ.%26aulast%3DOberer%26aufirst%3DL.%26aulast%3DRihs%26aufirst%3DG.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DSanglifehrin-cyclophilin%2520interaction%253A%2520degradation%2520work%252C%2520synthetic%2520macrocyclic%2520analogues%252C%2520X-ray%2520crystal%2520structure%252C%2520and%2520binding%2520data%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D3849%26epage%3D3859%26doi%3D10.1021%2Fja021327y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Rivera, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendrew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyssen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nur-E-Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warneck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, M. A.</span></span> <span> </span><span class="NLM_article-title">Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">285</span>â <span class="NLM_lpage">292</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2014.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.chembiol.2014.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=25619934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVarsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=285-292&author=M.+J.+Hanssonauthor=S.+J.+Mossauthor=M.+Bobardtauthor=U.+Chatterjiauthor=N.+Coatesauthor=J.+A.+Garcia-Riveraauthor=E.+Elmerauthor=S.+Kendrewauthor=P.+Leyssenauthor=J.+Neytsauthor=M.+Nur-E-Alamauthor=T.+Warneckauthor=B.+Wilkinsonauthor=P.+Gallayauthor=M.+A.+Gregory&title=Bioengineering+and+semisynthesis+of+an+optimized+cyclophilin+inhibitor+for+treatment+of+chronic+viral+infection&doi=10.1016%2Fj.chembiol.2014.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection</span></div><div class="casAuthors">Hansson, Magnus Joakim; Moss, Steven James; Bobardt, Michael; Chatterji, Udayan; Coates, Nigel; Garcia-Rivera, Jose A.; Elmer, Eskil; Kendrew, Steve; Leyssen, Pieter; Neyts, Johan; Nur-E-Alam, Mohammad; Warneck, Tony; Wilkinson, Barrie; Gallay, Philippe; Gregory, Matthew Alan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">285-292</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Inhibition of host-encoded targets, such as the cyclophilins, provides an opportunity to generate potent high barrier to resistance antivirals for the treatment of a broad range of viral diseases.  However, many host-targeted agents are natural products, which can be difficult to optimize using synthetic chem. alone.  We describe the orthogonal combination of bioengineering and semisynthetic chem. to optimize the drug-like properties of sanglifehrin A, a known cyclophilin inhibitor of mixed nonribosomal peptide/polyketide origin, to generate the drug candidate NVP018 (formerly BC556).  NVP018 is a potent inhibitor of hepatitis B virus, hepatitis C virus (HCV), and HIV-1 replication, shows minimal inhibition of major drug transporters, and has a high barrier to generation of both HCV and HIV-1 resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCo6mutyu4O7Vg90H21EOLACvtfcHk0lgZjAZF37ZvAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVarsr0%253D&md5=04a944f9f00471426106940c3eaaf86f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DHansson%26aufirst%3DM.%2BJ.%26aulast%3DMoss%26aufirst%3DS.%2BJ.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DCoates%26aufirst%3DN.%26aulast%3DGarcia-Rivera%26aufirst%3DJ.%2BA.%26aulast%3DElmer%26aufirst%3DE.%26aulast%3DKendrew%26aufirst%3DS.%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DNur-E-Alam%26aufirst%3DM.%26aulast%3DWarneck%26aufirst%3DT.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DGregory%26aufirst%3DM.%2BA.%26atitle%3DBioengineering%2520and%2520semisynthesis%2520of%2520an%2520optimized%2520cyclophilin%2520inhibitor%2520for%2520treatment%2520of%2520chronic%2520viral%2520infection%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D285%26epage%3D292%26doi%3D10.1016%2Fj.chembiol.2014.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed-Belkacem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahnou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevers, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cala, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douguet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlotsky, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J.-F.</span></span> <span> </span><span class="NLM_article-title">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12777</span>â <span class="NLM_lpage">12788</span>, <span class="refDoi">Â DOI: 10.1038/ncomms12777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1038%2Fncomms12777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=27652979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12777-12788&author=A.+Ahmed-Belkacemauthor=L.+Colliandreauthor=N.+Ahnouauthor=Q.+Neversauthor=M.+Gelinauthor=Y.+Bessinauthor=R.+Brilletauthor=O.+Calaauthor=D.+Douguetauthor=W.+Bourguetauthor=I.+Krimmauthor=J.-M.+Pawlotskyauthor=J.-F.+Guichou&title=Fragment-based+discovery+of+a+new+family+of+non-peptidic+small-molecule+cyclophilin+inhibitors+with+potent+antiviral+activities&doi=10.1038%2Fncomms12777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span></div><div class="casAuthors">Ahmed-Belkacem, Abdelhakim; Colliandre, Lionel; Ahnou, Nazim; Nevers, Quentin; Gelin, Muriel; Bessin, Yannick; Brillet, Rozenn; Cala, Olivier; Douguet, Dominique; Bourguet, William; Krimm, Isabelle; Pawlotsky, Jean-Michel; Guichou, Jean- Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12777</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclophilins are peptidyl-prolyl cis/trans isomerases (PPIase) that catalyze the interconversion of the peptide bond at proline residues.  Several cyclophilins play a pivotal role in the life cycle of a no. of viruses.  The existing cyclophilin inhibitors, all derived from cyclosporine A or sanglifehrin A, have disadvantages, including their size, potential for side effects unrelated to cyclophilin inhibition and drug-drug interactions, unclear antiviral spectrum and manufg. issues.  Here we use a fragment-based drug discovery approach using nucleic magnetic resonance, X-ray crystallog. and structure-based compd. optimization to generate a new family of non-peptidic, small-mol. cyclophilin inhibitors with potent in vitro PPIase inhibitory activity and antiviral activity against hepatitis C virus, human immunodeficiency virus and coronaviruses.  This family of compds. has the potential for broad-spectrum, high-barrier-to-resistance treatment of viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyow1ByjcKUbVg90H21EOLACvtfcHk0lgZjAZF37ZvAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO&md5=f984a686b75eea86431cd048f82f11c5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fncomms12777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12777%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed-Belkacem%26aufirst%3DA.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DAhnou%26aufirst%3DN.%26aulast%3DNevers%26aufirst%3DQ.%26aulast%3DGelin%26aufirst%3DM.%26aulast%3DBessin%26aufirst%3DY.%26aulast%3DBrillet%26aufirst%3DR.%26aulast%3DCala%26aufirst%3DO.%26aulast%3DDouguet%26aufirst%3DD.%26aulast%3DBourguet%26aufirst%3DW.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DPawlotsky%26aufirst%3DJ.-M.%26aulast%3DGuichou%26aufirst%3DJ.-F.%26atitle%3DFragment-based%2520discovery%2520of%2520a%2520new%2520family%2520of%2520non-peptidic%2520small-molecule%2520cyclophilin%2520inhibitors%2520with%2520potent%2520antiviral%2520activities%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12777%26epage%3D12788%26doi%3D10.1038%2Fncomms12777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shore, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandalaneni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latawiec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javed, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criddle, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, R.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of cyclophilin D to protect mitochondrial function as a potential treatment of acute pancreatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2596</span>â <span class="NLM_lpage">2611</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01801</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01801" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2596-2611&author=E.+M.+Shoreauthor=M.+Awaisauthor=N.+M.+Kershawauthor=R.+R.+Gibsonauthor=S.+Pandalaneniauthor=D.+Latawiecauthor=L.+Wenauthor=M.+A.+Javedauthor=D.+N.+Criddleauthor=N.+Berryauthor=P.+M.+O%E2%80%99Neillauthor=L.-Y.+Lianauthor=R.+Sutton&title=Small+molecule+inhibitors+of+cyclophilin+D+to+protect+mitochondrial+function+as+a+potential+treatment+of+acute+pancreatitis&doi=10.1021%2Facs.jmedchem.5b01801"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01801%26sid%3Dliteratum%253Aachs%26aulast%3DShore%26aufirst%3DE.%2BM.%26aulast%3DAwais%26aufirst%3DM.%26aulast%3DKershaw%26aufirst%3DN.%2BM.%26aulast%3DGibson%26aufirst%3DR.%2BR.%26aulast%3DPandalaneni%26aufirst%3DS.%26aulast%3DLatawiec%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DJaved%26aufirst%3DM.%2BA.%26aulast%3DCriddle%26aufirst%3DD.%2BN.%26aulast%3DBerry%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DLian%26aufirst%3DL.-Y.%26aulast%3DSutton%26aufirst%3DR.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520cyclophilin%2520D%2520to%2520protect%2520mitochondrial%2520function%2520as%2520a%2520potential%2520treatment%2520of%2520acute%2520pancreatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2596%26epage%3D2611%26doi%3D10.1021%2Facs.jmedchem.5b01801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poullennec, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoisin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliri, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent inhibitors based on the structural simplification of sanglifehrin A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1000</span>â <span class="NLM_lpage">1017</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1000-1017&author=V.+A.+Steadmanauthor=S.+B.+Pettitauthor=K.+G.+Poullennecauthor=L.+Lazaridesauthor=A.+J.+Keatsauthor=D.+K.+Deanauthor=S.+J.+Stanwayauthor=C.+A.+Austinauthor=J.+A.+Sanvoisinauthor=G.+M.+Wattauthor=H.+G.+Fliriauthor=A.+C.+Liclicanauthor=D.+Jinauthor=M.+H.+Wongauthor=S.+A.+Leavittauthor=Y.-J.+Leeauthor=Y.+Tianauthor=C.+R.+Freyauthor=T.+C.+Applebyauthor=U.+Schmitzauthor=P.+Jansaauthor=R.+L.+Mackmanauthor=B.+E.+Schultz&title=Discovery+of+potent+inhibitors+based+on+the+structural+simplification+of+sanglifehrin+A&doi=10.1021%2Facs.jmedchem.6b01329"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01329%26sid%3Dliteratum%253Aachs%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26aulast%3DPettit%26aufirst%3DS.%2BB.%26aulast%3DPoullennec%26aufirst%3DK.%2BG.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DA.%2BJ.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DAustin%26aufirst%3DC.%2BA.%26aulast%3DSanvoisin%26aufirst%3DJ.%2BA.%26aulast%3DWatt%26aufirst%3DG.%2BM.%26aulast%3DFliri%26aufirst%3DH.%2BG.%26aulast%3DLiclican%26aufirst%3DA.%2BC.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLeavitt%26aufirst%3DS.%2BA.%26aulast%3DLee%26aufirst%3DY.-J.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DFrey%26aufirst%3DC.%2BR.%26aulast%3DAppleby%26aufirst%3DT.%2BC.%26aulast%3DSchmitz%26aufirst%3DU.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520based%2520on%2520the%2520structural%2520simplification%2520of%2520sanglifehrin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1000%26epage%3D1017%26doi%3D10.1021%2Facs.jmedchem.6b01329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span>; <span class="NLM_string-name">Puyang, X.</span>; <span class="NLM_string-name">Poulin, D.</span>; <span class="NLM_string-name">Mathy, J. E.</span>; <span class="NLM_string-name">Ma, S.</span>; <span class="NLM_string-name">Anderson, L. J.</span>; <span class="NLM_string-name">Fujimoto, R.</span>; <span class="NLM_string-name">Compton, T. G.</span>; <span class="NLM_string-name">Lin, K.</span></span> <span> </span><span class="NLM_article-title">Characterization of the mechanism of resistance to cyclophilin inhibitors in HCV replicon</span>;  <i>15th International Symposium on Hepatitis C Virus and Related Viruses</i>; San Antonio, TX, October 5â9, <span class="NLM_year">2008</span>, Poster #305.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Wiedmann&author=X.+Puyang&author=D.+Poulin&author=J.+E.+Mathy&author=S.+Ma&author=L.+J.+Anderson&author=R.+Fujimoto&author=T.+G.+Compton&author=K.+Lin&title=Characterization+of+the+mechanism+of+resistance+to+cyclophilin+inhibitors+in+HCV+replicon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520the%2520mechanism%2520of%2520resistance%2520to%2520cyclophilin%2520inhibitors%2520in%2520HCV%2520replicon%26jtitle%3D15th%2520International%2520Symposium%2520on%2520Hepatitis%2520C%2520Virus%2520and%2520Related%2520Viruses%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span>; <span class="NLM_string-name">Poullennec, K. G.</span>; <span class="NLM_string-name">Lazarides, L.</span>; <span class="NLM_string-name">Aciro, C.</span>; <span class="NLM_string-name">Dean, D. K.</span>; <span class="NLM_string-name">Keats, A. J.</span>; <span class="NLM_string-name">Siegel, D. S.</span>; <span class="NLM_string-name">Schrier, A. J.</span>; <span class="NLM_string-name">Mackman, R.</span>; <span class="NLM_string-name">Jansa, P.</span>; <span class="NLM_string-name">Watt, G.</span>; <span class="NLM_string-name">Highton, A. J.</span>; <span class="NLM_string-name">Chiva, J. Y.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of Flaviviridae Viruses</span>. International Patent <span class="NLM_patent">WO 2013185093A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=V.+A.+Steadman&author=K.+G.+Poullennec&author=L.+Lazarides&author=C.+Aciro&author=D.+K.+Dean&author=A.+J.+Keats&author=D.+S.+Siegel&author=A.+J.+Schrier&author=R.+Mackman&author=P.+Jansa&author=G.+Watt&author=A.+J.+Highton&author=J.+Y.+Chiva&title=Macrocyclic+Inhibitors+of+Flaviviridae+Viruses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520Flaviviridae%2520Viruses%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aciro, C.</span>; <span class="NLM_string-name">Steadman, V. A.</span>; <span class="NLM_string-name">Pettit, S. N.</span>; <span class="NLM_string-name">Poullennec, K. G.</span>; <span class="NLM_string-name">Lazarides, L.</span>; <span class="NLM_string-name">Dean, D. K.</span>; <span class="NLM_string-name">Dunbar, N. A.</span>; <span class="NLM_string-name">Highton, A. J.</span>; <span class="NLM_string-name">Keats, A. J.</span>; <span class="NLM_string-name">Siegel, D. S.</span>; <span class="NLM_string-name">Karki, K. K.</span>; <span class="NLM_string-name">Schrier, A. J.</span>; <span class="NLM_string-name">Jansa, P.</span>; <span class="NLM_string-name">Mackman, R.</span>; <span class="NLM_string-name">Chiva, J.
Y.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of Flaviviridae Viruses</span>. International Patent <span class="NLM_patent">WO 2013185103A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Aciro&author=V.+A.+Steadman&author=S.+N.+Pettit&author=K.+G.+Poullennec&author=L.+Lazarides&author=D.+K.+Dean&author=N.+A.+Dunbar&author=A.+J.+Highton&author=A.+J.+Keats&author=D.+S.+Siegel&author=K.+K.+Karki&author=A.+J.+Schrier&author=P.+Jansa&author=R.+Mackman&author=J.%0AY.+Chiva&title=Macrocyclic+Inhibitors+of+Flaviviridae+Viruses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAciro%26aufirst%3DC.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520Flaviviridae%2520Viruses%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aciro, C.</span>; <span class="NLM_string-name">Steadman, V. A.</span>; <span class="NLM_string-name">Pettit, S. N.</span>; <span class="NLM_string-name">Poullennec, K. G.</span>; <span class="NLM_string-name">Lazarides, L.</span>; <span class="NLM_string-name">Dean, D.
K.</span>; <span class="NLM_string-name">Dunbar, N.
A.</span>; <span class="NLM_string-name">Highton, A. J.</span>; <span class="NLM_string-name">Keats, A. J.</span>; <span class="NLM_string-name">Siegel, D. S.</span>; <span class="NLM_string-name">Karki, K. K.</span>; <span class="NLM_string-name">Schrier, A. J.</span>; <span class="NLM_string-name">Jansa, P.</span>; <span class="NLM_string-name">Mackman, R.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of Flaviviridae Viruses</span>. International Patent <span class="NLM_patent">WO 2013185090A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Aciro&author=V.+A.+Steadman&author=S.+N.+Pettit&author=K.+G.+Poullennec&author=L.+Lazarides&author=D.%0AK.+Dean&author=N.%0AA.+Dunbar&author=A.+J.+Highton&author=A.+J.+Keats&author=D.+S.+Siegel&author=K.+K.+Karki&author=A.+J.+Schrier&author=P.+Jansa&author=R.+Mackman&title=Macrocyclic+Inhibitors+of+Flaviviridae+Viruses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAciro%26aufirst%3DC.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520Flaviviridae%2520Viruses%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic drugs and synthetic methodologies towards macrocycles</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6230</span>â <span class="NLM_lpage">6268</span>, <span class="refDoi">Â DOI: 10.3390/molecules18066230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.3390%2Fmolecules18066230" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=6230-6268&author=X.+Yuauthor=D.+Sun&title=Macrocyclic+drugs+and+synthetic+methodologies+towards+macrocycles&doi=10.3390%2Fmolecules18066230"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18066230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18066230%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DMacrocyclic%2520drugs%2520and%2520synthetic%2520methodologies%2520towards%2520macrocycles%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D6230%26epage%3D6268%26doi%3D10.3390%2Fmolecules18066230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parenty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagne, J.-M.</span></span> <span> </span><span class="NLM_article-title">Update 1 of: Macrolactonizations in the total synthesis of natural products</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">PR1</span>â <span class="NLM_lpage">PR40</span>, <span class="refDoi">Â DOI: 10.1021/cr300129n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr300129n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=PR1-PR40&author=A.+Parentyauthor=X.+Moreauauthor=G.+Nielauthor=J.-M.+Campagne&title=Update+1+of%3A+Macrolactonizations+in+the+total+synthesis+of+natural+products&doi=10.1021%2Fcr300129n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcr300129n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300129n%26sid%3Dliteratum%253Aachs%26aulast%3DParenty%26aufirst%3DA.%26aulast%3DMoreau%26aufirst%3DX.%26aulast%3DNiel%26aufirst%3DG.%26aulast%3DCampagne%26aufirst%3DJ.-M.%26atitle%3DUpdate%25201%2520of%253A%2520Macrolactonizations%2520in%2520the%2520total%2520synthesis%2520of%2520natural%2520products%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3DPR1%26epage%3DPR40%26doi%3D10.1021%2Fcr300129n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshiumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, M.</span></span> <span> </span><span class="NLM_article-title">An effective use of benzoic anhydride and its deviatives for the synthesis of carboxylic esters and lactones: A powerful and convenient mixed anhydride method promoted by basic catalysts</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1822</span>â <span class="NLM_lpage">1830</span>, <span class="refDoi">Â DOI: 10.1021/jo030367x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo030367x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=1822-1830&author=I.+Shiinaauthor=M.+K.+Kubotaauthor=H.+Oshiumiauthor=M.+Hashizume&title=An+effective+use+of+benzoic+anhydride+and+its+deviatives+for+the+synthesis+of+carboxylic+esters+and+lactones%3A+A+powerful+and+convenient+mixed+anhydride+method+promoted+by+basic+catalysts&doi=10.1021%2Fjo030367x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo030367x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo030367x%26sid%3Dliteratum%253Aachs%26aulast%3DShiina%26aufirst%3DI.%26aulast%3DKubota%26aufirst%3DM.%2BK.%26aulast%3DOshiumi%26aufirst%3DH.%26aulast%3DHashizume%26aufirst%3DM.%26atitle%3DAn%2520effective%2520use%2520of%2520benzoic%2520anhydride%2520and%2520its%2520deviatives%2520for%2520the%2520synthesis%2520of%2520carboxylic%2520esters%2520and%2520lactones%253A%2520A%2520powerful%2520and%2520convenient%2520mixed%2520anhydride%2520method%2520promoted%2520by%2520basic%2520catalysts%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D1822%26epage%3D1830%26doi%3D10.1021%2Fjo030367x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robak, M.-A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbage, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and applications of <i>tert</i>-butanesulfinamide</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3600</span>â <span class="NLM_lpage">3740</span>, <span class="refDoi">Â DOI: 10.1021/cr900382t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=3600-3740&author=M.-A.+T.+Robakauthor=M.+A.+Herbageauthor=J.+A.+Ellman&title=Synthesis+and+applications+of+tert-butanesulfinamide&doi=10.1021%2Fcr900382t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Applications of tert-Butanesulfinamide</span></div><div class="casAuthors">Robak, MaryAnn T.; Herbage, Melissa A.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3600-3740</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past decade, an ever increasing collection of methods based upon the chiral amine reagent tert-butanesulfinamide (I) have become some of the most extensively used synthetic approaches for both the discovery and prodn. of drug candidates.  Either enantiomer of I is inexpensive to prep. on a large scale in enantiomerically pure form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLsVMjLa-pP7Vg90H21EOLACvtfcHk0ljvYUU9R3augg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D&md5=ad2c9e9a2b2044f47a00be408d0907d2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr900382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900382t%26sid%3Dliteratum%253Aachs%26aulast%3DRobak%26aufirst%3DM.-A.%2BT.%26aulast%3DHerbage%26aufirst%3DM.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520tert-butanesulfinamide%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D3600%26epage%3D3740%26doi%3D10.1021%2Fcr900382t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin Cabrejas, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span> <span> </span><span class="NLM_article-title">Macrolide analogues of the novel immunosuppressant sanglifehrin: new application of the ring-closing metathesis reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2443</span>â <span class="NLM_lpage">2446</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1521-3773(19990816)38:16<2443::AID-ANIE2443>3.0.CO;2-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1002%2F%28SICI%291521-3773%2819990816%2938%3A16%3C2443%3A%3AAID-ANIE2443%3E3.0.CO%3B2-B" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=2443-2446&author=L.+M.+Martin+Cabrejasauthor=S.+Rohrbachauthor=D.+Wagnerauthor=J.+Kallenauthor=G.+Zenkeauthor=J.+Wagner&title=Macrolide+analogues+of+the+novel+immunosuppressant+sanglifehrin%3A+new+application+of+the+ring-closing+metathesis+reaction&doi=10.1002%2F%28SICI%291521-3773%2819990816%2938%3A16%3C2443%3A%3AAID-ANIE2443%3E3.0.CO%3B2-B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990816%2938%3A16%3C2443%3A%3AAID-ANIE2443%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990816%252938%253A16%253C2443%253A%253AAID-ANIE2443%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%2BCabrejas%26aufirst%3DL.%2BM.%26aulast%3DRohrbach%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DD.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DMacrolide%2520analogues%2520of%2520the%2520novel%2520immunosuppressant%2520sanglifehrin%253A%2520new%2520application%2520of%2520the%2520ring-closing%2520metathesis%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D2443%26epage%3D2446%26doi%3D10.1002%2F%28SICI%291521-3773%2819990816%2938%3A16%3C2443%3A%3AAID-ANIE2443%3E3.0.CO%3B2-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shalaeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramov, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâConnell, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plummer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalamanchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. J.</span></span> <span> </span><span class="NLM_article-title">Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using delta logP as a tool</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4870</span>â <span class="NLM_lpage">4879</span>, <span class="refDoi">Â DOI: 10.1021/jm301850m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301850m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4870-4879&author=M.+Shalaevaauthor=G.+Caronauthor=Y.+A.+Abramovauthor=T.+N.+O%E2%80%99Connellauthor=M.+S.+Plummerauthor=G.+Yalamanchiauthor=K.+A.+Farleyauthor=G.+H.+Goetzauthor=L.+Philippeauthor=M.+J.+Shapiro&title=Integrating+intramolecular+hydrogen+bonding+%28IMHB%29+considerations+in+drug+discovery+using+delta+logP+as+a+tool&doi=10.1021%2Fjm301850m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301850m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301850m%26sid%3Dliteratum%253Aachs%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DT.%2BN.%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DYalamanchi%26aufirst%3DG.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26atitle%3DIntegrating%2520intramolecular%2520hydrogen%2520bonding%2520%2528IMHB%2529%2520considerations%2520in%2520drug%2520discovery%2520using%2520delta%2520logP%2520as%2520a%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4870%26epage%3D4879%26doi%3D10.1021%2Fjm301850m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Cell permeability beyond the rule of 5</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">42</span>â <span class="NLM_lpage">61</span>, <span class="refDoi">Â DOI: 10.1016/j.addr.2016.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.addr.2016.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=27067608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSgsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=42-61&author=P.+Matssonauthor=B.+C.+Doakauthor=B.+Overauthor=J.+Kihlberg&title=Cell+permeability+beyond+the+rule+of+5&doi=10.1016%2Fj.addr.2016.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cell permeability beyond the rule of 5</span></div><div class="casAuthors">Matsson, Paer; Doak, Bradley C.; Over, Bjoern; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-61</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Drug discovery for difficult targets that have large and flat binding sites is often better suited to compds. beyond the "rule of 5" (bRo5).  However, such compds. carry higher pharmacokinetic risks, such as low soly. and permeability, and increased efflux and metab.  Interestingly, recent drug approvals and studies suggest that cell permeable and orally bioavailable drugs can be discovered far into bRo5 space.  Tactics such as redn. or shielding of polarity by N-methylation, bulky side chains and intramol. hydrogen bonds may be used to increase cell permeability in this space, but often results in decreased soly.  Conformationally flexible compds. can, however, combine high permeability and soly., properties that are keys for cell permeability and intestinal absorption.  Recent developments in computational conformational anal. will aid design of such compds. and hence prediction of cell permeability.  Transporter mediated efflux occurs for most investigated drugs in bRo5 space, however it is commonly overcome by high local intestinal concns. on oral administration.  In contrast, there is little data to support significant impact of transporter-mediated intestinal absorption in bRo5 space.  Current knowledge of compd. properties that govern transporter effects of bRo5 drugs is limited and requires further fundamental and comprehensive studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3dS_FpMvvCbVg90H21EOLACvtfcHk0ljxzhvrcEfc6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSgsb0%253D&md5=1eacb5ab6e50159f3679e3d8a1f719c4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DCell%2520permeability%2520beyond%2520the%2520rule%2520of%25205%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D101%26spage%3D42%26epage%3D61%26doi%3D10.1016%2Fj.addr.2016.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span> <span> </span><span class="NLM_article-title">Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">14073</span>â <span class="NLM_lpage">14080</span>, <span class="refDoi">Â DOI: 10.1021/ja063076p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja063076p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14073-14080&author=T.+Rezaiauthor=J.+E.+Bockauthor=M.+V.+Zhouauthor=C.+Kalyanaramanauthor=R.+S.+Lokeyauthor=M.+P.+Jacobson&title=Conformational+flexibility%2C+internal+hydrogen+bonding%2C+and+passive+membrane+permeability%3A+successful+in+silico+prediction+of+the+relative+permeabilities+of+cyclic+peptides&doi=10.1021%2Fja063076p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span></div><div class="casAuthors">Rezai, Taha; Bock, Jonathan E.; Zhou, Mai V.; Kalyanaraman, Chakrapani; Lokey, R. Scott; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">14073-14080</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report an atomistic phys. model for the passive membrane permeability of cyclic peptides.  The computational modeling was performed in advance of the expts. and did not involve the use of "training data".  The model explicitly treats the conformational flexibility of the peptides by extensive conformational sampling in low (membrane) and high (water) dielec. environments.  The passive membrane permeabilities of 11 cyclic peptides were obtained exptl. using a parallel artificial membrane permeability assay (PAMPA) and showed a linear correlation with the computational results with R2 = 0.96.  In general, the results support the hypothesis, already well established in the literature, that the ability to form internal hydrogen bonds is crit. for passive membrane permeability and can be the distinguishing factor among closely related compds., such as those studied here.  However, we have found that the no. of internal hydrogen bonds that can form in the membrane and the solvent-exposed polar surface area correlate more poorly with PAMPA permeability than our model, which quant. ests. the solvation free energy losses upon moving from high-dielec. water to the low-dielec. interior of a membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofxfL018o86rVg90H21EOLACvtfcHk0ljxzhvrcEfc6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I&md5=78d4b4082e6a72b288d4b6dac933ca35</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja063076p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063076p%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DBock%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BV.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DConformational%2520flexibility%252C%2520internal%2520hydrogen%2520bonding%252C%2520and%2520passive%2520membrane%2520permeability%253A%2520successful%2520in%2520silico%2520prediction%2520of%2520the%2520relative%2520permeabilities%2520of%2520cyclic%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14073%26epage%3D14080%26doi%3D10.1021%2Fja063076p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viarengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beglov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span> <span> </span><span class="NLM_article-title">Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">712</span>â <span class="NLM_lpage">717</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2016.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.drudis.2016.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=26891978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVKrurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=712-717&issue=5&author=A.+Whittyauthor=M.+Zhongauthor=L.+Viarengoauthor=D.+Beglovauthor=D.+R.+Hallauthor=S.+Vajda&title=Quantifying+the+chameleonic+properties+of+macrocycles+and+other+high-molecular-weight+drugs&doi=10.1016%2Fj.drudis.2016.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs</span></div><div class="casAuthors">Whitty, Adrian; Zhong, Mengqi; Viarengo, Lauren; Beglov, Dmitri; Hall, David R.; Vajda, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">712-717</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Key to the pharmaceutical utility of certain macrocyclic drugs is a 'chameleonic' ability to change their conformation to expose polar groups in aq. soln., but bury them when traversing lipid membranes.  Based on anal. of the structures of 20 macrocyclic compds. that are approved oral drugs, we propose that good soly. requires a topol. polar surface area (TPSA, in Ã2) of â¥0.2 Ã mol. wt. (MW).  Meanwhile, good passive membrane permeability requires a mol. (i.e., 3D) PSA in nonpolar environments of â¤140 Ã2.  We show that one or other of these limits is almost invariably violated for compds. with MW > 600 Da, suggesting that some degree of chameleonic behavior is required for most high MW oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlN7rCqts5wLVg90H21EOLACvtfcHk0ljxzhvrcEfc6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVKrurs%253D&md5=024476298f7b72efa3f0a9303bed5900</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DViarengo%26aufirst%3DL.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DD.%2BR.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DQuantifying%2520the%2520chameleonic%2520properties%2520of%2520macrocycles%2520and%2520other%2520high-molecular-weight%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26issue%3D5%26spage%3D712%26epage%3D717%26doi%3D10.1016%2Fj.drudis.2016.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebastiano, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Impact of dynamically exposed polarity on permeability and solubility of chameleonic drugs beyond the rule of 5</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4189</span>â <span class="NLM_lpage">4202</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4189-4202&author=M.+R.+Sebastianoauthor=B.+C.+Doakauthor=M.+Backlundauthor=V.+Poongavanamauthor=B.+Overauthor=G.+Ermondiauthor=G.+Caronauthor=P.+Matssonauthor=J.+Kihlberg&title=Impact+of+dynamically+exposed+polarity+on+permeability+and+solubility+of+chameleonic+drugs+beyond+the+rule+of+5&doi=10.1021%2Facs.jmedchem.8b00347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00347%26sid%3Dliteratum%253Aachs%26aulast%3DSebastiano%26aufirst%3DM.%2BR.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DBacklund%26aufirst%3DM.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520dynamically%2520exposed%2520polarity%2520on%2520permeability%2520and%2520solubility%2520of%2520chameleonic%2520drugs%2520beyond%2520the%2520rule%2520of%25205%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4189%26epage%3D4202%26doi%3D10.1021%2Facs.jmedchem.8b00347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahar, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span> <span> </span><span class="NLM_article-title">Species differences of esterase expression and hydrolase activity in plasma</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3979</span>â <span class="NLM_lpage">3988</span>, <span class="refDoi">Â DOI: 10.1002/jps.23258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1002%2Fjps.23258" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=3979-3988&author=F.+G.+Baharauthor=K.+Ohuraauthor=T.+Ogiharaauthor=T.+Imai&title=Species+differences+of+esterase+expression+and+hydrolase+activity+in+plasma&doi=10.1002%2Fjps.23258"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fjps.23258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23258%26sid%3Dliteratum%253Aachs%26aulast%3DBahar%26aufirst%3DF.%2BG.%26aulast%3DOhura%26aufirst%3DK.%26aulast%3DOgihara%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DT.%26atitle%3DSpecies%2520differences%2520of%2520esterase%2520expression%2520and%2520hydrolase%2520activity%2520in%2520plasma%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D3979%26epage%3D3988%26doi%3D10.1002%2Fjps.23258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">The pregnane X receptor: From bench to bedside</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">895</span>â <span class="NLM_lpage">908</span>, <span class="refDoi">Â DOI: 10.1517/17425255.4.7.895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1517%2F17425255.4.7.895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=18624678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Chur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=895-908&author=X.+Maauthor=J.+R.+Idleauthor=F.+J.+Gonzalez&title=The+pregnane+X+receptor%3A+From+bench+to+bedside&doi=10.1517%2F17425255.4.7.895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The pregnane X receptor: from bench to bedside</span></div><div class="casAuthors">Ma, Xiaochao; Idle, Jeffrey R.; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">895-908</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The pregnane X receptor (PXR; NR1I2), a member of the nuclear receptor superfamily, regulates the expression of metabolic enzymes and transporters involved in the response of mammals to their chem. environment.  To summarize the functions and clin. implications of PXR.  In the current review, the clin. implications of PXR are discussed, and the use of genetically engineered PXR mouse models is highlighted.  Recent advances in mouse models, including Pxr-null and PXR-humanized mice, provide in vivo tools for evaluating the physiol. functions of PXR and its role in controlling xenobiotic metab. and transport.  By using the PXR knockout and humanized mouse models, PXR was found to influence drug-drug interactions, hepatic steatosis, and the homeostasis of vitamin D, bile acids, and steroid hormones.  PXR was also shown to influence inflammatory bowel diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPRNdc1axwrVg90H21EOLACvtfcHk0liZ0YM3diqRhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Chur0%253D&md5=d485d79dfef46f99ab106007ab32993a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1517%2F17425255.4.7.895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.4.7.895%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DIdle%26aufirst%3DJ.%2BR.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520pregnane%2520X%2520receptor%253A%2520From%2520bench%2520to%2520bedside%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2008%26volume%3D4%26spage%3D895%26epage%3D908%26doi%3D10.1517%2F17425255.4.7.895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bercot, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caille, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostick, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranganathan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faul, M. M.</span></span> <span> </span><span class="NLM_article-title">Diastereoselective palladium-catalyzed Î±-arylation of 4-substituted cyclohexyl esters</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5251</span>â <span class="NLM_lpage">5254</span>, <span class="refDoi">Â DOI: 10.1021/ol8021758</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol8021758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWqtLvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=5251-5254&author=E.+A.+Bercotauthor=S.+Cailleauthor=T.+M.+Bostickauthor=K.+Ranganathanauthor=R.+Jensenauthor=M.+M.+Faul&title=Diastereoselective+palladium-catalyzed+%CE%B1-arylation+of+4-substituted+cyclohexyl+esters&doi=10.1021%2Fol8021758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereoselective Palladium-Catalyzed Î±-Arylation of 4-Substituted Cyclohexyl Esters</span></div><div class="casAuthors">Bercot, Eric A.; Caille, Seb; Bostick, Tracy M.; Ranganathan, Krishnakumar; Jensen, Randy; Faul, Margaret M.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5251-5254</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diastereoselective palladium-catalyzed arylation of 4-substituted cyclohexyl esters has been developed.  The reaction proceeds at room temp. in the presence of [(t-Bu3P)PdBr]2 providing products in up to 37:1 dr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryE00lioSckLVg90H21EOLACvtfcHk0liZ0YM3diqRhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWqtLvN&md5=1b4a389a6dfd5815791d169da8cb81f7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fol8021758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol8021758%26sid%3Dliteratum%253Aachs%26aulast%3DBercot%26aufirst%3DE.%2BA.%26aulast%3DCaille%26aufirst%3DS.%26aulast%3DBostick%26aufirst%3DT.%2BM.%26aulast%3DRanganathan%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DR.%26aulast%3DFaul%26aufirst%3DM.%2BM.%26atitle%3DDiastereoselective%2520palladium-catalyzed%2520%25CE%25B1-arylation%2520of%25204-substituted%2520cyclohexyl%2520esters%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D5251%26epage%3D5254%26doi%3D10.1021%2Fol8021758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreyer, A.</span>; <span class="NLM_string-name">Doods, H.</span>; <span class="NLM_string-name">Gerlach, K.</span>; <span class="NLM_string-name">Gottschling, D.</span>; <span class="NLM_string-name">Heimann, A.</span>; <span class="NLM_string-name">Mueller, S. G.</span>; <span class="NLM_string-name">Rudolf, K.</span>; <span class="NLM_string-name">Schaenzle, G.</span></span> <span> </span><span class="NLM_article-title">New Compounds</span>. International Patent <span class="NLM_patent">WO 2010139717A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Dreyer&author=H.+Doods&author=K.+Gerlach&author=D.+Gottschling&author=A.+Heimann&author=S.+G.+Mueller&author=K.+Rudolf&author=G.+Schaenzle&title=New+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDreyer%26aufirst%3DA.%26atitle%3DNew%2520Compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 34 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong-Jin Wu, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9786-9874. <a href="https://doi.org/10.1021/acs.jmedchem.1c00790" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeminal%252BDiheteroatomic%252BMotifs%25253A%252BSome%252BApplications%252Bof%252BAcetals%25252C%252BKetals%25252C%252Band%252BTheir%252BSulfur%252Band%252BNitrogen%252BHomologues%252Bin%252BMedicinal%252BChemistry%252Band%252BDrug%252BDesign%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30042021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D9786%26epage%3D9874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sanja KoÅ¡trun, Andrea FajdetiÄ, Dijana PeÅ¡iÄ, Karmen BrajÅ¡a, Vlatka BencetiÄ MihaljeviÄ, Dubravko JeliÄ, Adriana PetriniÄ Grba, Ivaylo Elenkov, Renata RupÄiÄ, Samra KapiÄ, Ivana Ozimec Landek, Kristina ButkoviÄ, Ana GrgiÄeviÄ, Dinko Å½iher, Ana ÄikoÅ¡, Jasna Padovan, Gordon Saxty, Kevin Dack, Haakan Bladh, Tine Skak-Nielsen, Simon Feldbaek Nielsen, Maja Lambert, <span class="NLM_string-name hlFld-ContribAuthor">Martin Stahlhut</span>. </span><span class="cited-content_cbyCitation_article-title">Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8354-8383. <a href="https://doi.org/10.1021/acs.jmedchem.1c00327" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00327%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMacrolide%252BInspired%252BMacrocycles%252Bas%252BModulators%252Bof%252Bthe%252BIL-17A%25252FIL-17RA%252BInteraction%26aulast%3DKo%25C5%25A1trun%26aufirst%3DSanja%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D22022021%26date%3D08062021%26volume%3D64%26issue%3D12%26spage%3D8354%26epage%3D8383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael Bauder, Christian Meyners, Patrick L. Purder, Stephanie Merz, Wisely Oki Sugiarto, Andreas M. Voll, Tim Heymann, <span class="NLM_string-name hlFld-ContribAuthor">Felix Hausch</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3320-3349. <a href="https://doi.org/10.1021/acs.jmedchem.0c02195" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02195%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BHigh-Affinity%252BMacrocyclic%252BFKBP51%252BInhibitors%26aulast%3DBauder%26aufirst%3DMichael%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D19122020%26date%3D05032021%26volume%3D64%26issue%3D6%26spage%3D3320%26epage%3D3349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cedric L. Hugelshofer, Jianming Bao, Juana Du, Eric Ashley, Wensheng Yu, Tao Ji, Bin Hu, Dejun Liu, Ramu Rondla, Srinivas Karampuri, Vishal Sharma, Krishna Ethiraj, <span class="NLM_string-name hlFld-ContribAuthor">Yeon-Hee Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Scalable Preparation of 4,4-Disubstituted Six-Membered CyclicÂ Sulfones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 943-947. <a href="https://doi.org/10.1021/acs.orglett.0c04141" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c04141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c04141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c04141%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DScalable%252BPreparation%252Bof%252B4%25252C4-Disubstituted%252BSix-Membered%252BCyclic%2525C2%2525A0Sulfones%26aulast%3DHugelshofer%26aufirst%3DCedric%2BL.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D15122020%26date%3D08012021%26volume%3D23%26issue%3D3%26spage%3D943%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yoseph Atilaw, Vasanthanathan Poongavanam, Caroline Svensson Nilsson, Duy Nguyen, Anja Giese, Daniel Meibom, Mate Erdelyi, <span class="NLM_string-name hlFld-ContribAuthor">Jan Kihlberg</span>. </span><span class="cited-content_cbyCitation_article-title">Solution Conformations Shed Light on PROTAC Cell Permeability. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 107-114. <a href="https://doi.org/10.1021/acsmedchemlett.0c00556" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00556%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSolution%252BConformations%252BShed%252BLight%252Bon%252BPROTAC%252BCell%252BPermeability%26aulast%3DAtilaw%26aufirst%3DYoseph%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16102020%26date%3D18122020%26date%3D25122020%26volume%3D12%26issue%3D1%26spage%3D107%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13291-13315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00829" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Bfor%252BTapping%252Binto%252BThree-Dimensional%252BChemical%252BSpace%252Bthrough%252Ba%252BQuaternary%252BCarbon%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D31082020%26date%3D17082020%26volume%3D63%26issue%3D22%26spage%3D13291%26epage%3D13315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicolas J. Scheuplein, Nicole M. Bzdyl, Emily A. Kibble, Theresa Lohr, Ulrike Holzgrabe, <span class="NLM_string-name hlFld-ContribAuthor">Mitali Sarkar-Tyson</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein Folding: A Novel Approach for the Treatment of Pathogenic Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13355-13388. <a href="https://doi.org/10.1021/acs.jmedchem.0c00911" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00911%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BProtein%252BFolding%25253A%252BA%252BNovel%252BApproach%252Bfor%252Bthe%252BTreatment%252Bof%252BPathogenic%252BBacteria%26aulast%3DScheuplein%26aufirst%3DNicolas%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29052020%26date%3D28082020%26date%3D13082020%26volume%3D63%26issue%3D22%26spage%3D13355%26epage%3D13388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Janet L. Paulsen, Haoyu S. Yu, Dan Sindhikara, Lingle Wang, Todd Appleby, Armando G. VillaseÃ±or, Uli Schmitz, <span class="NLM_string-name hlFld-ContribAuthor">Devleena Shivakumar</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Free Energy Calculations for the Prioritization of Macrocycle Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (7)
                                     , 3489-3498. <a href="https://doi.org/10.1021/acs.jcim.0c00132" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00132%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEvaluation%252Bof%252BFree%252BEnergy%252BCalculations%252Bfor%252Bthe%252BPrioritization%252Bof%252BMacrocycle%252BSynthesis%26aulast%3DPaulsen%26aufirst%3DJanet%2BL.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05022020%26date%3D01072020%26date%3D15062020%26volume%3D60%26issue%3D7%26spage%3D3489%26epage%3D3498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kalindi D. Morgan, David E. Williams, Brian O. Patrick, Marion Remigy, Carmen A. Banuelos, Marianne D. Sadar, Katherine S. Ryan, <span class="NLM_string-name hlFld-ContribAuthor">Raymond J. Andersen</span>. </span><span class="cited-content_cbyCitation_article-title">Incarnatapeptins A and B, Nonribosomal Peptides Discovered Using Genome Mining and 1H/15N HSQC-TOCSY. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (11)
                                     , 4053-4057. <a href="https://doi.org/10.1021/acs.orglett.0c00818" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00818%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIncarnatapeptins%252BA%252Band%252BB%25252C%252BNonribosomal%252BPeptides%252BDiscovered%252BUsing%252BGenome%252BMining%252Band%252B1H%25252F15N%252BHSQC-TOCSY%26aulast%3DMorgan%26aufirst%3DKalindi%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03032020%26date%3D13042020%26volume%3D22%26issue%3D11%26spage%3D4053%26epage%3D4057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Julia Kopp, <span class="NLM_string-name hlFld-ContribAuthor">Reinhard BrÃ¼ckner</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Total Synthesis of the Dimeric Naphthoquinonopyrano-Î³-lactone (â)-Crisamicin A: Introducing the Dimerization Site by a Late-Stage Hartwig Borylation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (9)
                                     , 3607-3612. <a href="https://doi.org/10.1021/acs.orglett.0c01078" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01078%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DStereoselective%252BTotal%252BSynthesis%252Bof%252Bthe%252BDimeric%252BNaphthoquinonopyrano-%2525CE%2525B3-lactone%252B%252528%2525E2%252588%252592%252529-Crisamicin%252BA%25253A%252BIntroducing%252Bthe%252BDimerization%252BSite%252Bby%252Ba%252BLate-Stage%252BHartwig%252BBorylation%26aulast%3DKopp%26aufirst%3DJulia%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24032020%26date%3D16042020%26volume%3D22%26issue%3D9%26spage%3D3607%26epage%3D3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bradley
C. Doak, <span class="NLM_string-name hlFld-ContribAuthor">Jan Kihlberg</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclophilin Succumbs to a Macrocyclic Chameleon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9469-9472. <a href="https://doi.org/10.1021/acs.jmedchem.8b01555" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01555%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclophilin%252BSuccumbs%252Bto%252Ba%252BMacrocyclic%252BChameleon%26aulast%3DDoak%26aufirst%3DBradley%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05102018%26date%3D25102018%26volume%3D61%26issue%3D21%26spage%3D9469%26epage%3D9472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carla E.  Gallardo-Flores</span>, <span class="hlFld-ContribAuthor ">Che C.  Colpitts</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclophilins and Their Roles in Hepatitis C Virus and Flavivirus Infections: Perspectives for Novel Antiviral Approaches. </span><span class="cited-content_cbyCitation_journal-name">Pathogens</span><span> <strong>2021,</strong> <em>10 </em>
                                    (7)
                                     , 902. <a href="https://doi.org/10.3390/pathogens10070902" title="DOI URL">https://doi.org/10.3390/pathogens10070902</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pathogens10070902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpathogens10070902%26sid%3Dliteratum%253Aachs%26jtitle%3DPathogens%26atitle%3DCyclophilins%252Band%252BTheir%252BRoles%252Bin%252BHepatitis%252BC%252BVirus%252Band%252BFlavivirus%252BInfections%25253A%252BPerspectives%252Bfor%252BNovel%252BAntiviral%252BApproaches%26aulast%3DGallardo-Flores%26aufirst%3DCarla%2BE.%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D7%26spage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajarshi  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Muhammad  Awais</span>, <span class="hlFld-ContribAuthor ">Wenhao  Cai</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Peter  Szatmary</span>, <span class="hlFld-ContribAuthor ">Robert  Sutton</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Therapy for Acute Pancreatitis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 83-94. <a href="https://doi.org/10.1002/9781119570097.ch12" title="DOI URL">https://doi.org/10.1002/9781119570097.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119570097.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119570097.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacological%252BTherapy%252Bfor%252BAcute%252BPancreatitis%26aulast%3DMukherjee%26aufirst%3DRajarshi%26date%3D2021%26date%3D2021%26spage%3D83%26epage%3D94%26pub%3DWiley%26atitle%3DClinical%252BPancreatology%252Bfor%252BPractising%252BGastroenterologists%252Band%252BSurgeons%26aulast%3DDom%25C3%25ADnguez%25E2%2580%2590Mu%25C3%25B1oz%26aufirst%3DJ.%2BEnrique%26date%3D2021%26date%3D2021%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas M.  Voll</span>, <span class="hlFld-ContribAuthor ">Christian  Meyners</span>, <span class="hlFld-ContribAuthor ">Martha C.  Taubert</span>, <span class="hlFld-ContribAuthor ">Thomas  Bajaj</span>, <span class="hlFld-ContribAuthor ">Tim  Heymann</span>, <span class="hlFld-ContribAuthor ">Stephanie  Merz</span>, <span class="hlFld-ContribAuthor ">Anna  Charalampidou</span>, <span class="hlFld-ContribAuthor ">JÃ¼rgen  Kolos</span>, <span class="hlFld-ContribAuthor ">Patrick L.  Purder</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Geiger</span>, <span class="hlFld-ContribAuthor ">Pablo  Wessig</span>, <span class="hlFld-ContribAuthor ">Nils C.  Gassen</span>, <span class="hlFld-ContribAuthor ">Andreas  Bracher</span>, <span class="hlFld-ContribAuthor ">Felix  Hausch</span>. </span><span class="cited-content_cbyCitation_article-title">Makrozyklische FKBP51âLiganden enthÃ¼llen einen transienten Bindungsmodus mit erhÃ¶hter SelektivitÃ¤t. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (24)
                                     , 13366-13372. <a href="https://doi.org/10.1002/ange.202017352" title="DOI URL">https://doi.org/10.1002/ange.202017352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202017352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202017352%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DMakrozyklische%252BFKBP51%2525E2%252580%252590Liganden%252Benth%2525C3%2525BCllen%252Beinen%252Btransienten%252BBindungsmodus%252Bmit%252Berh%2525C3%2525B6hter%252BSelektivit%2525C3%2525A4t%26aulast%3DVoll%26aufirst%3DAndreas%2BM.%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D24%26spage%3D13366%26epage%3D13372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas M.  Voll</span>, <span class="hlFld-ContribAuthor ">Christian  Meyners</span>, <span class="hlFld-ContribAuthor ">Martha C.  Taubert</span>, <span class="hlFld-ContribAuthor ">Thomas  Bajaj</span>, <span class="hlFld-ContribAuthor ">Tim  Heymann</span>, <span class="hlFld-ContribAuthor ">Stephanie  Merz</span>, <span class="hlFld-ContribAuthor ">Anna  Charalampidou</span>, <span class="hlFld-ContribAuthor ">JÃ¼rgen  Kolos</span>, <span class="hlFld-ContribAuthor ">Patrick L.  Purder</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Geiger</span>, <span class="hlFld-ContribAuthor ">Pablo  Wessig</span>, <span class="hlFld-ContribAuthor ">Nils C.  Gassen</span>, <span class="hlFld-ContribAuthor ">Andreas  Bracher</span>, <span class="hlFld-ContribAuthor ">Felix  Hausch</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (24)
                                     , 13257-13263. <a href="https://doi.org/10.1002/anie.202017352" title="DOI URL">https://doi.org/10.1002/anie.202017352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202017352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202017352%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DMacrocyclic%252BFKBP51%252BLigands%252BDefine%252Ba%252BTransient%252BBinding%252BMode%252Bwith%252BEnhanced%252BSelectivity%26aulast%3DVoll%26aufirst%3DAndreas%2BM.%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D24%26spage%3D13257%26epage%3D13263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo L.G.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Adriano D.  Andricopulo</span>. </span><span class="cited-content_cbyCitation_article-title">StructureâBased Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-54. <a href="https://doi.org/10.1002/0471266949.bmc141.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc141.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc141.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc141.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DStructure%2525E2%252580%252590Based%252BDrug%252BDesign%26aulast%3DFerreira%26aufirst%3DLeonardo%2BL.G.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D54%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David A.  DeGoey</span>, <span class="hlFld-ContribAuthor ">Philip B.  Cox</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Beyond the Rule of Five. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-35. <a href="https://doi.org/10.1002/0471266949.bmc258" title="DOI URL">https://doi.org/10.1002/0471266949.bmc258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc258%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BDiscovery%252BBeyond%252Bthe%252BRule%252Bof%252BFive%26aulast%3DDeGoey%26aufirst%3DDavid%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D35%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>, <span class="hlFld-ContribAuthor ">Weijie  Gu</span>, <span class="hlFld-ContribAuthor ">Erik  Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">AntiâDNA Virus Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-41. <a href="https://doi.org/10.1002/0471266949.bmc237.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc237.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc237.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc237.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAnti%2525E2%252580%252590DNA%252BVirus%252BAgents%26aulast%3DHerdewijn%26aufirst%3DPiet%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D41%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhanusha  Yesudhas</span>, <span class="hlFld-ContribAuthor ">Ambuj  Srivastava</span>, <span class="hlFld-ContribAuthor ">M. Michael  Gromiha</span>. </span><span class="cited-content_cbyCitation_article-title">COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Infection</span><span> <strong>2021,</strong> <em>49 </em>
                                    (2)
                                     , 199-213. <a href="https://doi.org/10.1007/s15010-020-01516-2" title="DOI URL">https://doi.org/10.1007/s15010-020-01516-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s15010-020-01516-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs15010-020-01516-2%26sid%3Dliteratum%253Aachs%26jtitle%3DInfection%26atitle%3DCOVID-19%252Boutbreak%25253A%252Bhistory%25252C%252Bmechanism%25252C%252Btransmission%25252C%252Bstructural%252Bstudies%252Band%252Btherapeutics%26aulast%3DYesudhas%26aufirst%3DDhanusha%26date%3D2021%26date%3D2020%26volume%3D49%26issue%3D2%26spage%3D199%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren A.  Viarengo-Baker</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Brown</span>, <span class="hlFld-ContribAuthor ">Anna A.  Rzepiela</span>, <span class="hlFld-ContribAuthor ">Adrian  Whitty</span>. </span><span class="cited-content_cbyCitation_article-title">Defining and navigating macrocycle chemical space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (12)
                                     , 4309-4328. <a href="https://doi.org/10.1039/D0SC05788F" title="DOI URL">https://doi.org/10.1039/D0SC05788F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC05788F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC05788F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDefining%252Band%252Bnavigating%252Bmacrocycle%252Bchemical%252Bspace%26aulast%3DViarengo-Baker%26aufirst%3DLauren%2BA.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D12%26spage%3D4309%26epage%3D4328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khai Gene  Leong</span>, <span class="hlFld-ContribAuthor ">Elyce  Ozols</span>, <span class="hlFld-ContribAuthor ">John  Kanellis</span>, <span class="hlFld-ContribAuthor ">Shawn S.  Badal</span>, <span class="hlFld-ContribAuthor ">John T.  Liles</span>, <span class="hlFld-ContribAuthor ">David J.  Nikolic-Paterson</span>, <span class="hlFld-ContribAuthor ">Frank Y.  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (1)
                                     , 271. <a href="https://doi.org/10.3390/ijms22010271" title="DOI URL">https://doi.org/10.3390/ijms22010271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22010271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22010271%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCyclophilin%252BInhibition%252BProtects%252BAgainst%252BExperimental%252BAcute%252BKidney%252BInjury%252Band%252BRenal%252BInterstitial%252BFibrosis%26aulast%3DLeong%26aufirst%3DKhai%2BGene%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D1%26spage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pilar  Sanchez-Andrada</span>, <span class="hlFld-ContribAuthor ">Carmen  Lopez-Leonardo</span>, <span class="hlFld-ContribAuthor ">Mateo  Alajarin</span>. </span><span class="cited-content_cbyCitation_article-title">1,4-Dioxepanes, 1,4-Oxathiepanes, and 1,4-Dithiepanes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00088-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00088-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00088-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00088-3%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C4-Dioxepanes%25252C%252B1%25252C4-Oxathiepanes%25252C%252Band%252B1%25252C4-Dithiepanes%26aulast%3DSanchez-Andrada%26aufirst%3DPilar%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3Dvol.%25207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Di</span>, <span class="hlFld-ContribAuthor ">Per  Artursson</span>, <span class="hlFld-ContribAuthor ">Alex  Avdeef</span>, <span class="hlFld-ContribAuthor ">Leslie Z.  Benet</span>, <span class="hlFld-ContribAuthor ">J. Brian  Houston</span>, <span class="hlFld-ContribAuthor ">Manfred  Kansy</span>, <span class="hlFld-ContribAuthor ">Edward H.  Kerns</span>, <span class="hlFld-ContribAuthor ">Hans  LennernÃ¤s</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Smith</span>, <span class="hlFld-ContribAuthor ">Kiyohiko  Sugano</span>. </span><span class="cited-content_cbyCitation_article-title">The Critical Role of Passive Permeability in Designing Successful Drugs. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (20)
                                     , 1862-1874. <a href="https://doi.org/10.1002/cmdc.202000419" title="DOI URL">https://doi.org/10.1002/cmdc.202000419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000419%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BCritical%252BRole%252Bof%252BPassive%252BPermeability%252Bin%252BDesigning%252BSuccessful%252BDrugs%26aulast%3DDi%26aufirst%3DLi%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D20%26spage%3D1862%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chukuka  Achuenu</span>, <span class="hlFld-ContribAuthor ">SÃ©bastien  Carret</span>, <span class="hlFld-ContribAuthor ">JeanâFranÃ§ois  Poisson</span>, <span class="hlFld-ContribAuthor ">Florian  Berthiol</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Chiral Sulfinamides into Formation and Reduction of Sulfinylketimines to Obtain Valuable Î±âChiral Primary Amines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (37)
                                     , 5901-5916. <a href="https://doi.org/10.1002/ejoc.202000608" title="DOI URL">https://doi.org/10.1002/ejoc.202000608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000608%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DApplication%252Bof%252BChiral%252BSulfinamides%252Binto%252BFormation%252Band%252BReduction%252Bof%252BSulfinylketimines%252Bto%252BObtain%252BValuable%252B%2525CE%2525B1%2525E2%252580%252590Chiral%252BPrimary%252BAmines%26aulast%3DAchuenu%26aufirst%3DChukuka%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D37%26spage%3D5901%26epage%3D5916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics (
              ADME
              ). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 133-224. <a href="https://doi.org/10.1002/9781119607311.ch3" title="DOI URL">https://doi.org/10.1002/9781119607311.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacokinetics%252B%252528%252BADME%252B%252529%26date%3D2020%26date%3D2020%26spage%3D133%26epage%3D224%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Bioisosteres. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 225-304. <a href="https://doi.org/10.1002/9781119607311.ch4" title="DOI URL">https://doi.org/10.1002/9781119607311.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DBioisosteres%26date%3D2020%26date%3D2020%26spage%3D225%26epage%3D304%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Che C  Colpitts</span>, <span class="hlFld-ContribAuthor ">Sophie  Ridewood</span>, <span class="hlFld-ContribAuthor ">Bethany  Schneiderman</span>, <span class="hlFld-ContribAuthor ">Justin  Warne</span>, <span class="hlFld-ContribAuthor ">Keisuke  Tabata</span>, <span class="hlFld-ContribAuthor ">Caitlin F  Ng</span>, <span class="hlFld-ContribAuthor ">Ralf  Bartenschlager</span>, <span class="hlFld-ContribAuthor ">David L  Selwood</span>, <span class="hlFld-ContribAuthor ">Greg J  Towers</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C virus exploits cyclophilin A to evade PKR. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2020,</strong> <em>9 </em><a href="https://doi.org/10.7554/eLife.52237" title="DOI URL">https://doi.org/10.7554/eLife.52237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.52237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.52237%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DHepatitis%252BC%252Bvirus%252Bexploits%252Bcyclophilin%252BA%252Bto%252Bevade%252BPKR%26aulast%3DColpitts%26aufirst%3DChe%2BC%26date%3D2020%26date%3D2020%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma  Danelius</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Stefan  Peintner</span>, <span class="hlFld-ContribAuthor ">Lianne H. E.  Wieske</span>, <span class="hlFld-ContribAuthor ">MÃ¡tÃ©  ErdÃ©lyi</span>, <span class="hlFld-ContribAuthor ">Jan  Kihlberg</span>. </span><span class="cited-content_cbyCitation_article-title">Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs. </span><span class="cited-content_cbyCitation_journal-name">Chemistry â A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (23)
                                     , 5231-5244. <a href="https://doi.org/10.1002/chem.201905599" title="DOI URL">https://doi.org/10.1002/chem.201905599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201905599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201905599%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DSolution%252BConformations%252BExplain%252Bthe%252BChameleonic%252BBehaviour%252Bof%252BMacrocyclic%252BDrugs%26aulast%3DDanelius%26aufirst%3DEmma%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D23%26spage%3D5231%26epage%3D5244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Feng  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 275-286. <a href="https://doi.org/10.1080/13543776.2020.1729354" title="DOI URL">https://doi.org/10.1080/13543776.2020.1729354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1729354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1729354%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DLeucine-rich%252Brepeat%252Bkinase%252B2%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282014-present%252529%26aulast%3DDing%26aufirst%3DXiao%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daren R.  Ure</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Trepanier</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Mayo</span>, <span class="hlFld-ContribAuthor ">Robert T.  Foster</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2020,</strong> <em>29 </em>
                                    (2)
                                     , 163-178. <a href="https://doi.org/10.1080/13543784.2020.1703948" title="DOI URL">https://doi.org/10.1080/13543784.2020.1703948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2020.1703948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2020.1703948%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DCyclophilin%252Binhibition%252Bas%252Ba%252Bpotential%252Btreatment%252Bfor%252Bnonalcoholic%252Bsteatohepatitis%252B%252528NASH%252529%26aulast%3DUre%26aufirst%3DDaren%2BR.%26date%3D2020%26date%3D2019%26volume%3D29%26issue%3D2%26spage%3D163%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohit  Tyagi</span>, <span class="hlFld-ContribAuthor ">Fabio  Begnini</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Bradley C.  Doak</span>, <span class="hlFld-ContribAuthor ">Jan  Kihlberg</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Syntheses Beyond the Rule of 5. </span><span class="cited-content_cbyCitation_journal-name">Chemistry â A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (1)
                                     , 49-88. <a href="https://doi.org/10.1002/chem.201902716" title="DOI URL">https://doi.org/10.1002/chem.201902716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201902716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201902716%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DDrug%252BSyntheses%252BBeyond%252Bthe%252BRule%252Bof%252B5%26aulast%3DTyagi%26aufirst%3DMohit%26date%3D2020%26date%3D2019%26volume%3D26%26issue%3D1%26spage%3D49%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James W.  Herndon</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry of the carbon-transition metal double and triple bond: Annual survey covering the year 2018. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2019,</strong> <em>401 </em>, 213051. <a href="https://doi.org/10.1016/j.ccr.2019.213051" title="DOI URL">https://doi.org/10.1016/j.ccr.2019.213051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2019.213051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2019.213051%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DThe%252Bchemistry%252Bof%252Bthe%252Bcarbon-transition%252Bmetal%252Bdouble%252Band%252Btriple%252Bbond%25253A%252BAnnual%252Bsurvey%252Bcovering%252Bthe%252Byear%252B2018%26aulast%3DHerndon%26aufirst%3DJames%2BW.%26date%3D2019%26volume%3D401%26spage%3D213051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyusik  Kim</span>, <span class="hlFld-ContribAuthor ">Ann  Dauphin</span>, <span class="hlFld-ContribAuthor ">Sevnur  Komurlu</span>, <span class="hlFld-ContribAuthor ">Sean M.  McCauley</span>, <span class="hlFld-ContribAuthor ">Leonid  Yurkovetskiy</span>, <span class="hlFld-ContribAuthor ">Claudia  Carbone</span>, <span class="hlFld-ContribAuthor ">William E.  Diehl</span>, <span class="hlFld-ContribAuthor ">Caterina  Strambio-De-Castillia</span>, <span class="hlFld-ContribAuthor ">Edward M.  Campbell</span>, <span class="hlFld-ContribAuthor ">Jeremy  Luban</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclophilin A protects HIV-1 from restriction by human TRIM5Î±. </span><span class="cited-content_cbyCitation_journal-name">Nature Microbiology</span><span> <strong>2019,</strong> <em>4 </em>
                                    (12)
                                     , 2044-2051. <a href="https://doi.org/10.1038/s41564-019-0592-5" title="DOI URL">https://doi.org/10.1038/s41564-019-0592-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41564-019-0592-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41564-019-0592-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Microbiology%26atitle%3DCyclophilin%252BA%252Bprotects%252BHIV-1%252Bfrom%252Brestriction%252Bby%252Bhuman%252BTRIM5%2525CE%2525B1%26aulast%3DKim%26aufirst%3DKyusik%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D12%26spage%3D2044%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Lamaa</span>, <span class="hlFld-ContribAuthor ">Hsin-Ping  Lin</span>, <span class="hlFld-ContribAuthor ">Tourin  Bzeih</span>, <span class="hlFld-ContribAuthor ">Pascal  Retailleau</span>, <span class="hlFld-ContribAuthor ">Mouad  Alami</span>, <span class="hlFld-ContribAuthor ">Abdallah  Hamze</span>. </span><span class="cited-content_cbyCitation_article-title">TBAB-Catalyzed C
              sp
              3
              -N Bond Formation by Coupling Pyridotriazoles with Anilines: A New Route to (2-Pyridyl)alkylamines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (15)
                                     , 2602-2611. <a href="https://doi.org/10.1002/ejoc.201801803" title="DOI URL">https://doi.org/10.1002/ejoc.201801803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801803%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTBAB-Catalyzed%252BC%252Bsp%252B3%252B-N%252BBond%252BFormation%252Bby%252BCoupling%252BPyridotriazoles%252Bwith%252BAnilines%25253A%252BA%252BNew%252BRoute%252Bto%252B%2525282-Pyridyl%252529alkylamines%26aulast%3DLamaa%26aufirst%3DDiana%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D15%26spage%3D2602%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Simplified sanglifehrin macrocycles that bind to Cyp A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Overlay of sanglifehrin A (white) with lead <b>2</b> (yellow) illustrating that the piperazic acid-alanine/<i>m</i>-tyrosine-valine backbone atoms are positioned in a similar pose. The sanglifehrin A <i>m</i>-tyrosine group forms a hydrogen bond with histidine 126, and the diene is perpendicular to arginine 55, while the styrene in <b>2</b> invokes a Ï-stacking interaction with arginine 55 and the <i>m</i>-tyrosine is replaced with alanine. (B) Overlay of <b>2</b> (yellow) and the 21-membered ring macrocycle <b>8</b> (cyan) reflecting the differences upon changing the Ï-stacking group and the macrocycle ring size. In the smaller macrocycle <b>8</b>, the isoquinoline aryl ring is positioned over arginine 55 forming the Ï-stacking interaction, and the C13 to C16 carbon atoms in the spacer region are situated further away from the protein surface relative to C13 to C17 of <b>2</b>. A similar distance from arginine 55 is maintained for the Ï-stacking interactions of both <b>2</b> and <b>8</b>. (C) Overlay of isoquinoline <b>8</b> (cyan) and the corresponding quinoline <b>19</b> (purple) illustrating a close overlap of the macrocycle; the most significant difference is the orientation of the <i>trans</i> double bond. (D) Overlay of quinoline <b>19</b> (purple) and its C14 <i>gem</i>-dimethyl analogue <b>20</b> (orange) illustrating the positioning of the C13âC16 atoms closer to the protein surface and the C14 <i>pro-R</i> methyl group forming a lipophilic interaction with threonine 73. (E) Overlay of C1 lactone/C13 lactam <b>20</b> (orange), with C1 lactam/C13 lactone <b>34</b> (pink), illustrating that the respective switch of the C1 and C13 groups leads to a similar binding mode. (F) Overlay of C14 <i>spiro</i>-1,3-dioxane <b>3</b> (green) with C14 <i>gem</i>-dimethyl <b>34</b> (pink) illustrating a similar binding mode of the macrocycle and positioning of the C14 substituents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Macrocycles <b>4</b>-<b>9</b> via RCM<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSOTf, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C; (b) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, <b>14 (</b>93% over two steps), pent-4-enoic acid (62% over two steps), hex-5-enoic acid (82% over two steps), hept-6-enoic acid (75% over two steps); (c) Zn, NH<sub>4</sub>OAc, H<sub>2</sub>O, THF, 86â96%; (d) EDC, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, <b>17</b>, 42â89%; (e) Hoveyda-Grubbs II, PhMe, reflux, 3 mmol (2 mmol for <b>12d</b>), 23â63%; (f) EDC, HOBT, CH<sub>3</sub>CN, (<i>E</i>)-pent-3-enoic acid, 88% over two steps from <b>10</b>; (g) LiOH, THF, H<sub>2</sub>O, 95â97%; (h) 10% Pd/C, THF, EtOAc, H<sub>2</sub>, 48%; (i) TMSOTf, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, crotonaldehyde, 1 M TiCl<sub>4</sub> in CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C, 89%; (j) proton sponge, Me<sub>3</sub>OBF<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, quant.; (k) 2 M LiOH, THF, 60 Â°C, 59%; (l) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, tri-<i>n</i>-butyl(1-ethoxyvinyl)tin, PhMe, 50 Â°C, quant.; (m) 2 M HCl, 1,4-dioxane, 89%; (n) dichloro(<i>p</i>-cymene) ruthenium(II) dimer, (1<i>R</i>, 2<i>R</i>)-(â)-<i>N</i>-<i>p</i>-tosyl-1,2-diphenylethylenediamine, THF, H<sub>2</sub>O, HCO<sub>2</sub>Na, 40 Â°C, 92%; (o) tri-<i>n</i>-butyl(vinyl)tin, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1,4-dioxane, 150 Â°C, 50%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Precursors <b>24</b> and <b>27</b>â<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, Me(CO)N(OMe)Me, THF, â78 Â°C, 75%; (b) dichloro(<i>p</i>-cymene) ruthenium(II) dimer, H<sub>2</sub>O, (1<i>R</i>, 2<i>R</i>)-(â)-<i>N</i>-<i>p</i>-tosyl-1,2-diphenylethylenediamine, THF, HCO<sub>2</sub>Na, 40 Â°C, 69% (<b>23</b>), 98% (<b>26</b>); (c) Pd(OAc)<sub>2</sub>, P(<i>o</i>-PhMe)<sub>3</sub>, Et<sub>3</sub>N, CH<sub>3</sub>CN, 100â120 Â°C, but-3-enoic acid (81%); 2,2-dimethylbut-3-enoic acid (61%); (d) AcCl, NaI, CH<sub>3</sub>CN, 80 Â°C; (e) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, tri-<i>n</i>-butyl(1-ethoxyvinyl)tin, 1,4-dioxane, 100 Â°C, 66% over two steps from <b>25</b>; (f) Pd(P<sup><i>t</i></sup>Bu<sub>3</sub>)<sub>2</sub>, (C<sub>6</sub>H<sub>11</sub>)<sub>2</sub>NMe, CH<sub>3</sub>CN, but-3-enoic acid <i>tert</i>-butyl ester, reflux, 95%; (g) Ac<sub>2</sub>O, Et<sub>3</sub>N, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 99%; (h) PdCl<sub>2</sub>[PCy<sub>2</sub>(<i>p</i>-NMe<sub>2</sub>Ph)]<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, cyclopentylmethyl ether, H<sub>2</sub>O, 90 Â°C, <b>31</b>, 85%; (i) LiOH, THF, MeOH, H<sub>2</sub>O, quant.; (j) bis(cyclopentadienyl)zirconium chloride hydride, pinacolborane, CH<sub>2</sub>Cl<sub>2</sub>, 57%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>18</b>â<b>21</b> via C1 Macrolactonization or C13 Macrolactamization<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSOTf, CH<sub>2</sub>Cl<sub>2</sub>, <i>i</i>-Pr<sub>2</sub>NEt, 0 Â°C; (b) HATU, <i>i</i>-Pr<sub>2</sub>NEt, DMF, <b>24</b> (65% over two steps); <b>28</b> (62% over two steps); <b>29</b> (71% over two steps); (c) LiOH, THF, MeOH, H<sub>2</sub>O; (d) 2-methyl-6-nitrobenzoic anhydride, 4-DMAP, 1,2-dichloroethane, 50 Â°C, 3 mmol, 22% (two steps from <b>32a</b>); 51% (two steps from <b>32b</b>); 52% (two steps from <b>32c</b>); (e) Zn, NH<sub>4</sub>OAc, H<sub>2</sub>O, quant.; (f) EDC, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, <b>27</b>, 44% over two steps from <b>10</b>; (g) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, 0 Â°C-rt, 10 mmol, 10% over two steps from <b>33</b>.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>34</b> and <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (<i>R</i>)-(+)-2-methylpropanesulfinamide, Ti(OEt)<sub>4</sub>, THF, 60â65 Â°C, 86% (from <b>36</b>); 22% (from <b>40</b>); (b) dichloro(<i>p</i>-cymene) ruthenium(II) dimer, (1<i>S</i>,2<i>R</i>)-(â)-<i>cis</i>-1-amino-2-indanol, 4 Ã mol. sieves, 2-propanol, KO<sup><i>t</i></sup>Bu, 40 Â°C, 96% (<b>37</b>); 64% (<b>41</b>); (c) 4 M HCl, 1,4-dioxane, quant.; (d) Boc<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 79% over two steps; (e) PdCl<sub>2</sub>[PCy<sub>2</sub>(<i>p</i>-NMe<sub>2</sub>Ph)]<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, cyclopentylmethyl ether, H<sub>2</sub>O, 80 Â°C, <b>31</b>, 86% (from <b>41</b>); (f) 0.1 M NaOH, THF, 40 Â°C, 76% (over two steps from <b>38)</b>; (g) TMSOTf, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C; (h) EDC, HOBT, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, (<i>S</i>)-2-hydroxy-3-methylbutanoic acid, 0 Â°C, 73% over two steps; (i) LiOH, THF, H<sub>2</sub>O, quant.; (j) HATU, <i>i</i>-Pr<sub>2</sub>NEt, 4 Ã mol. sieves, CH<sub>3</sub>CN, <b>42</b>, 28% over two steps; (k) 2-methyl-6-nitrobenzoic anhydride, 4-DMAP, 1,2-dichloroethane, 4 Ã mol. sieves, 50 Â°C, 3 mmol, acid added over 5 h, 45%; (l) 2-methyl-6-nitrobenzoic anhydride, <i>i</i>-Pr<sub>2</sub>NEt, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, <b>39</b>, 97%; (m) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 2.5 mmol, 3% (over three steps from <b>46</b>).</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>47</b>â<b>50</b> via C1 Macrolactamization<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CH<sub>2</sub>Cl<sub>2</sub>, 4 M HCl, 1,4-dioxane; (b) Boc<sub>2</sub>O, Et<sub>3</sub>N, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 70% over two steps; (c) Pd(OAc)<sub>2</sub>, P(<i>o</i>-PhMe)<sub>3</sub>, Et<sub>3</sub>N, 1,4-dioxane, 100 Â°C, <b>58 (</b>65%), <b>59</b> (89%), <b>61</b> (59%); (d) K-selectride, THF, â60 Â°C, 81%; (e) LiOH, THF, MeOH, H<sub>2</sub>O, 50 Â°C; (f) TBSCl, imidazole, DMF, 35 Â°C; (g) K<sub>2</sub>CO<sub>3</sub>, THF, MeOH, 85% over three steps. (h) NaBH<sub>4</sub>, MeOH, 0 Â°C, 16%; (i) proton sponge, Me<sub>3</sub>OBF<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 49%; (j) LiOH, THF, MeOH, H<sub>2</sub>O, quant.; (k) LDA, [(<sup><i>t</i></sup>Bu<sub>3</sub>P)PdBr]<sub>2</sub>, PhMe, vinyl bromide, 0 Â°C, 45%; (l) 2-methyl-6-nitrobenzoic anhydride, <i>i</i>-Pr<sub>2</sub>NEt, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 39% (<b>62a</b>); 62% (<b>62b</b>); 85% (<b>62c</b> over two steps from <b>56c)</b>; (m) 1 M KOH, THF, MeOH, H<sub>2</sub>O, 50 Â°C; (n) K<sub>2</sub>CO<sub>3</sub>, THF, MeOH, H<sub>2</sub>O, 0â30 Â°C; (o) 4 M HCl, 1,4-dioxane; (p) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 1 mmol, 8% over three steps (<b>47</b>), 2% over three steps (<b>48</b>), 20% over three steps (<b>49</b>), 45% with cat. 4-DMAP over three steps (<b>50</b>); (q) LiOH, THF, H<sub>2</sub>O, quant.; (r) KOH, THF, H<sub>2</sub>O, rt.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>3</b> and <b>51</b>â<b>54</b> via C13 Macrolactonization<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CHO, THF, â78 Â°C, 87%; (b) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 60%; (c) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, then DBU, 70% over two steps; (d) LiOH, THF, MeOH, H<sub>2</sub>O, 95â100%; (e) 40% CH<sub>2</sub>O, Et<sub>3</sub>N, THF, 1,4-dioxane, 40 Â°C; (f) 40% CH<sub>2</sub>O, conc. HCl, 50 Â°C, 14% over two steps; (g) NaBH<sub>4</sub>, EtOH, 0 Â°C, 84%; (h) <i>p</i>-TsCl, pyridine, 0 Â°C, 76%; (i) DBU, 140 Â°C, 33%; (j) 2,2-dimethoxypropane, acetone, <i>p</i>-TsOH, 31% over two steps from <b>66</b>; (k) <i>n</i>-BuLi, <i>i</i>-Pr<sub>2</sub>NEt, THF, PhNTf<sub>2</sub>, â78 Â°C; (l) <i>n</i>-Bu<sub>3</sub>N, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, HCO<sub>2</sub>H, DMF, 60 Â°C, 50% over two steps; (m) LiOH, THF, MeOH, H<sub>2</sub>O, 90%; (n) CH<sub>3</sub>NO<sub>2</sub>, 2,8,9-triisopropyl-2,5,8,9-tetraaza-1-phosphabicyclo[3,3,3]undecane, MgSO<sub>4</sub>, 40 Â°C, 58%; (o) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C, 77%; (p) potassium vinyltrifluoroborate, 2,2â²-bis(diphenylphosphino)-1,1â²-binaphthalene, PhMe, H<sub>2</sub>O, bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate, reflux, 26%; (q) NaNO<sub>2</sub>, DMF, AcOH, 40 Â°C, 51%; (r) Zn, NH<sub>4</sub>OAc, THF, H<sub>2</sub>O; (s) HATU, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, 55% over two steps; (t) Pd(dba)<sub>2</sub>, P(<i>o</i>-PhMe)<sub>3</sub>, Et<sub>3</sub>N, 1,4-dioxane, 50â100 Â°C; (u) 2-methyl-6-nitrobenzoic anhydride, 4-DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 4 Ã mol. sieves, 2â5 mmol, acid added over 3â4 h, 7% over two steps (<b>51</b>), 20% over two steps (<b>52</b>), 30% over two steps (<b>3</b>), 8% over two steps (<b>53</b>); (v) 1 M HCl, MeOH, 75%.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/medium/jm-2018-00802m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Macrocycle 3 synthesis schematic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00802/20181101/images/large/jm-2018-00802m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00802&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Catalysis of protein folding by prolyl isomerase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">268</span>â <span class="NLM_lpage">270</span>, <span class="refDoi">Â DOI: 10.1038/329268a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1038%2F329268a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=268-270&author=K.+Langauthor=F.+X.+Schmidauthor=G.+Fischer&title=Catalysis+of+protein+folding+by+prolyl+isomerase&doi=10.1038%2F329268a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F329268a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F329268a0%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DK.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DCatalysis%2520of%2520protein%2520folding%2520by%2520prolyl%2520isomerase%26jtitle%3DNature%26date%3D1987%26volume%3D329%26spage%3D268%26epage%3D270%26doi%3D10.1038%2F329268a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann-Liebold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefhaber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">476</span>â <span class="NLM_lpage">478</span>, <span class="refDoi">Â DOI: 10.1038/337476a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1038%2F337476a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=2492638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADyaL1MXhs1yrtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1989&pages=476-478&author=G.+Fischerauthor=B.+Wittmann-Lieboldauthor=K.+Langauthor=T.+Kiefhaberauthor=F.+X.+Schmid&title=Cyclophilin+and+peptidyl-prolyl+cis-trans+isomerase+are+probably+identical+proteins&doi=10.1038%2F337476a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins</span></div><div class="casAuthors">Fischer, Gunter; Wittmann-Liebold, Brigitte; Lang, Kurt; Kiefhaber, Thomas; Schmid, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6206</span>),
    <span class="NLM_cas:pages">476-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The N-terminal sequence of peptidyl-prolyl cis-trans isomerase (PPIase), together with further chem. and enzymic properties are reported.  The results indicate that this enzyme is probably identical to cyclophilin, a recently discovered mammalian protein which binds tightly to cyclosporin A (CsA).  Cyclophilin is thought to be linked to the immunosuppressive action of CsA.  The 1st 38 amino acid residues of porcine PPIase and of bovine cyclophilin are identical and the 2 proteins both have a relative mol. mass of â¼17,000.  The catalysis of prolyl isomerization in oligopeptides and of protein folding by PPIase are strongly inhibited in the presence of low levels of CsA.  The activities of both PPIase and cyclophilin depend on a single SH group.  At present it is unknown whether the inhibition of prolyl isomerase activity is related to the immunosuppressive action of CsA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw-oWHYr-dkrVg90H21EOLACvtfcHk0ljLzE8JkQdCXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhs1yrtL4%253D&md5=91b3b3b13b28c21b61a63d7e65a95636</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F337476a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F337476a0%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DWittmann-Liebold%26aufirst%3DB.%26aulast%3DLang%26aufirst%3DK.%26aulast%3DKiefhaber%26aufirst%3DT.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26atitle%3DCyclophilin%2520and%2520peptidyl-prolyl%2520cis-trans%2520isomerase%2520are%2520probably%2520identical%2520proteins%26jtitle%3DNature%26date%3D1989%26volume%3D337%26spage%3D476%26epage%3D478%26doi%3D10.1038%2F337476a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handschumacher, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drugge, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speicher, D. W.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin: a specific cytosolic binding protein for cyclosporin A</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">544</span>â <span class="NLM_lpage">547</span>, <span class="refDoi">Â DOI: 10.1126/science.6238408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1126%2Fscience.6238408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=6238408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADyaL2MXktFOmtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=544-547&author=R.+E.+Handschumacherauthor=M.+W.+Hardingauthor=J.+Riceauthor=R.+J.+Druggeauthor=D.+W.+Speicher&title=Cyclophilin%3A+a+specific+cytosolic+binding+protein+for+cyclosporin+A&doi=10.1126%2Fscience.6238408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin:  a specific cytosolic binding protein for cyclosporin A</span></div><div class="casAuthors">Handschumacher, Robert E.; Harding, Matthew W.; Rice, Jeffrey; Drugge, Rhett J.; Speicher, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4674</span>),
    <span class="NLM_cas:pages">544-7</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Cyclophilin (I), a specific cytosolic binding protein responsible for the concn. of the immunosuppressant, cyclosporin A (II), by lymphoid cells, was purified to homogeneity from bovine thymocytes.  Cation-exchange HPLC resolved a major and minor I species that bound II with a dissocn. const. of â¼2 Ã 10-7 M and specific activities of 77 and 67 Î¼g/mg protein, resp.  Both I species had an apparent mol. wt. of 15,000, a pI of 9.6, and nearly identical amino acid compns.  A portion of the N-terminal amino acid sequence of the major species was detd.  The II-binding activity of I was SH group-dependent, unstable at 56Â° and at pH 4 or 9.5, and sensitive to trypsin but not to chymotrypsin degrdn.  I specifically bound a series of II analogs in proportion to their activity in a mixed lymphocyte reaction.  The isolation of I from the cytosol of thymocytes suggested that the immunosuppressive activity of II is mediated by an intracellular mechanism, rather than by a membrane-assocd. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX8f6D1eP5SLVg90H21EOLACvtfcHk0ljLzE8JkQdCXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktFOmtg%253D%253D&md5=a8c71d98008b8b2190bab4c091af4092</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.6238408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6238408%26sid%3Dliteratum%253Aachs%26aulast%3DHandschumacher%26aufirst%3DR.%2BE.%26aulast%3DHarding%26aufirst%3DM.%2BW.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DDrugge%26aufirst%3DR.%2BJ.%26aulast%3DSpeicher%26aufirst%3DD.%2BW.%26atitle%3DCyclophilin%253A%2520a%2520specific%2520cytosolic%2520binding%2520protein%2520for%2520cyclosporin%2520A%26jtitle%3DScience%26date%3D1984%26volume%3D226%26spage%3D544%26epage%3D547%26doi%3D10.1126%2Fscience.6238408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">807</span>â <span class="NLM_lpage">815</span>, <span class="refDoi">Â DOI: 10.1016/0092-8674(91)90124-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2F0092-8674%2891%2990124-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1715244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1991&pages=807-815&author=J.+Liuauthor=J.+D.+Farmerauthor=W.+S.+Laneauthor=J.+Friedmanauthor=I.+Weissmanauthor=S.+L.+Schreiber&title=Calcineurin+is+a+common+target+of+cyclophilin-cyclosporin+A+and+FKBP-FK506+complexes&doi=10.1016%2F0092-8674%2891%2990124-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</span></div><div class="casAuthors">Liu, Jun; Farmer, Jesse D., Jr.; Lane, Willam S.; Friedman, Jeff; Weissman, Irving; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Although the immediate receptors (immunophilins) of the immunosuppressants cyclosporin A (CsA) and FK506 are distinct, their similar mechanisms of inhibition of cell signaling suggest that their assocd. immunophilin complexes interact with a common target.  The authors report that the complexes cyclophilin-CsA and FKBP-FK506 (but not cyclophilin, FKBP, FKBP-rapamycin, or FKBP-506BD) competitively bind to and inhibit the Ca2+- and calmodulin-dependent phosphatase calcineurin, although the binding and inhibition of calcineurin do not require calmodulin.  These results suggest that calcineurin is involved in a common step assocd. with T cell receptor and IgE receptor signaling pathways and that cyclophilin and FKBP mediate the actions of CsA and FK506, resp., by forming drug-dependent complexes with and altering the activity of calcineurin-calmodulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfN8mg-hNhLVg90H21EOLACvtfcHk0limA0rvzV6FpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D&md5=00c4883ea86e6b2c554f8f72ed717ac9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2891%2990124-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252891%252990124-H%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFarmer%26aufirst%3DJ.%2BD.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DWeissman%26aufirst%3DI.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DCalcineurin%2520is%2520a%2520common%2520target%2520of%2520cyclophilin-cyclosporin%2520A%2520and%2520FKBP-FK506%2520complexes%26jtitle%3DCell%26date%3D1991%26volume%3D66%26spage%3D807%26epage%3D815%26doi%3D10.1016%2F0092-8674%2891%2990124-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatsch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerschmid, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaksche, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peichl, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1763</span>â <span class="NLM_lpage">1772</span>, <span class="refDoi">Â DOI: 10.1128/AAC.38.8.1763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1128%2FAAC.38.8.1763" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1994&pages=1763-1772&author=B.+Rosenwirthauthor=A.+Billichauthor=R.+Datemaauthor=P.+Donatschauthor=F.+Hammerschmidauthor=R.+Harrisonauthor=P.+Hiestandauthor=H.+Jakscheauthor=P.+Mayerauthor=P.+Peichl&title=Inhibition+of+human+immunodeficiency+virus+type+1+replication+by+SDZ+NIM+811%2C+a+nonimmunosuppressive+cyclosporine+analog&doi=10.1128%2FAAC.38.8.1763"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FAAC.38.8.1763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.38.8.1763%26sid%3Dliteratum%253Aachs%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DDatema%26aufirst%3DR.%26aulast%3DDonatsch%26aufirst%3DP.%26aulast%3DHammerschmid%26aufirst%3DF.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DJaksche%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DP.%26aulast%3DPeichl%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520by%2520SDZ%2520NIM%2520811%252C%2520a%2520nonimmunosuppressive%2520cyclosporine%2520analog%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1994%26volume%3D38%26spage%3D1763%26epage%3D1772%26doi%3D10.1128%2FAAC.38.8.1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loosli, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawen, A.</span></span> <span> </span><span class="NLM_article-title">[MeIle<sup>4</sup>]Cyclosporin, a novel natural cyclosporin with anti-HIV activity: structural elucidation, biosynthesis and biological properties</span>. <i>Antiviral Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">331</span>â <span class="NLM_lpage">339</span>, <span class="refDoi">Â DOI: 10.1177/095632029400500507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1177%2F095632029400500507" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=331-339&author=R.+Traberauthor=H.+Kobelauthor=H.-R.+Loosliauthor=H.+Sennauthor=B.+Rosenwirthauthor=A.+Lawen&title=%5BMeIle4%5DCyclosporin%2C+a+novel+natural+cyclosporin+with+anti-HIV+activity%3A+structural+elucidation%2C+biosynthesis+and+biological+properties&doi=10.1177%2F095632029400500507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1177%2F095632029400500507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F095632029400500507%26sid%3Dliteratum%253Aachs%26aulast%3DTraber%26aufirst%3DR.%26aulast%3DKobel%26aufirst%3DH.%26aulast%3DLoosli%26aufirst%3DH.-R.%26aulast%3DSenn%26aufirst%3DH.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DLawen%26aufirst%3DA.%26atitle%3D%255BMeIle4%255DCyclosporin%252C%2520a%2520novel%2520natural%2520cyclosporin%2520with%2520anti-HIV%2520activity%253A%2520structural%2520elucidation%252C%2520biosynthesis%2520and%2520biological%2520properties%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D1994%26volume%3D5%26spage%3D331%26epage%3D339%26doi%3D10.1177%2F095632029400500507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nigro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capogrossi, M. C.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin A: a key player for human disease</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e888</span>, <span class="refDoi">Â DOI: 10.1038/cddis.2013.410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1038%2Fcddis.2013.410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=24176846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCqsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e888&author=P.+Nigroauthor=G.+Pompilioauthor=M.+C.+Capogrossi&title=Cyclophilin+A%3A+a+key+player+for+human+disease&doi=10.1038%2Fcddis.2013.410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin A: a key player for human disease</span></div><div class="casAuthors">Nigro, P.; Pompilio, G.; Capogrossi, M. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">e888</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cyclophilin A (CyPA) is a ubiquitously distributed protein belonging to the immunophilin family.  CyPA has peptidyl prolyl cis-trans isomerase (PPIase) activity, which regulates protein folding and trafficking.  Although CyPA was initially believed to function primarily as an intracellular protein, recent studies have revealed that it can be secreted by cells in response to inflammatory stimuli.  Current research in animal models and humans has provided compelling evidences supporting the crit. function of CyPA in several human diseases.  This review discusses recently available data about CyPA in cardiovascular diseases, viral infections, neurodegeneration, cancer, rheumatoid arthritis, sepsis, asthma, periodontitis and aging.  It is believed that further elucidations of the role of CyPA will provide a better understanding of the mol. mechanisms underlying these diseases and will help develop novel pharmacol. therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2VfguTlVXYLVg90H21EOLACvtfcHk0lhFL1Y_c4MBQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCqsrbI&md5=8e09a9495fc807f0ca5832735cdd12d1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.410%26sid%3Dliteratum%253Aachs%26aulast%3DNigro%26aufirst%3DP.%26aulast%3DPompilio%26aufirst%3DG.%26aulast%3DCapogrossi%26aufirst%3DM.%2BC.%26atitle%3DCyclophilin%2520A%253A%2520a%2520key%2520player%2520for%2520human%2520disease%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De888%26doi%3D10.1038%2Fcddis.2013.410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naoumov, N. V.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin inhibition as potential therapy for liver diseases</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1166</span>â <span class="NLM_lpage">1174</span>, <span class="refDoi">Â DOI: 10.1016/j.jhep.2014.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.jhep.2014.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=25048953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlGnur3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=1166-1174&author=N.+V.+Naoumov&title=Cyclophilin+inhibition+as+potential+therapy+for+liver+diseases&doi=10.1016%2Fj.jhep.2014.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin inhibition as potential therapy for liver diseases</span></div><div class="casAuthors">Naoumov, Nikolai V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1166-1174</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The cyclophilins are a group of proteins with peptidyl-prolyl isomerase enzymic activity, localized in different cellular compartments and involved in a variety of functions related to cell metab. and energy homeostasis, having enhanced expression in inflammation or malignancy.  Cyclophilin A (CypA), the most abundantly expressed cyclophilin, is present mainly in the cytoplasm and is a host factor involved in the life cycle of multiple viruses.  The extracellular fractions of CypA and CypB are potent pro-inflammatory mediators.  CypD, located in mitochondria, is a key regulator of mitochondrial permeability transition pores, and is crit. for necrotic cell death.  Cyclosporines are the prototype cyclophilin inhibitors.  Cyclic peptides, which bind and inhibit cyclophilins without having immunosuppressive properties, have been generated by chem. modifications of cyclosporin A.  In addn., cyclophilin inhibitors that are structurally different from cyclosporines have been synthesized.  The involvement of cyclophilins in the pathogenesis of different liver diseases has been established using both in vitro and in vivo investigations, thus indicating that cyclophilin inhibition may be of therapeutic benefit.  This review summarizes the evidence for potential therapeutic applications of non-immunosuppressive cyclophilin inhibitors, alone or in combination with other agents, in virus-induced liver diseases like hepatitis C, B or Delta, liver inflammation and fibrosis, acetaminophen-induced liver toxicity and hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDuZeRwcwpWbVg90H21EOLACvtfcHk0lhFL1Y_c4MBQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlGnur3P&md5=0016ff180631660ad9e395d086478913</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2014.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2014.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DNaoumov%26aufirst%3DN.%2BV.%26atitle%3DCyclophilin%2520inhibition%2520as%2520potential%2520therapy%2520for%2520liver%2520diseases%26jtitle%3DJ.%2520Hepatol.%26date%3D2014%26volume%3D61%26spage%3D1166%26epage%3D1174%26doi%3D10.1016%2Fj.jhep.2014.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elrod, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molkentin, J. D.</span></span> <span> </span><span class="NLM_article-title">Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore</span>. <i>Circ. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1111</span>â <span class="NLM_lpage">1122</span>, <span class="refDoi">Â DOI: 10.1253/circj.CJ-13-0321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1253%2Fcircj.CJ-13-0321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=23538482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFyktLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2013&pages=1111-1122&author=J.+W.+Elrodauthor=J.+D.+Molkentin&title=Physiologic+functions+of+cyclophilin+D+and+the+mitochondrial+permeability+transition+pore&doi=10.1253%2Fcircj.CJ-13-0321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore</span></div><div class="casAuthors">Elrod, John W.; Molkentin, Jeffery D.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1111-1122</span>CODEN:
                <span class="NLM_cas:coden">CJIOBY</span>;
        ISSN:<span class="NLM_cas:issn">1346-9843</span>.
    
            (<span class="NLM_cas:orgname">Japanese Circulation Society</span>)
        </div><div class="casAbstract">This review focuses on the role of cyclophilin D (CypD) as a prominent mediator of the mitochondrial permeability transition pore (MPTP) and subsequent effects on cardiovascular physiol. and pathol.  Although a great no. of reviews have been written on the MPTP and its effects on cell death, we focus on the biol. surrounding CypD itself and the non-cell death physiol. functions of the MPTP.  A greater understanding of the physiol. functions of the MPTP and its regulation by CypD will likely suggest novel therapeutic approaches for cardiovascular disease; both dependent and independent of programmed necrotic cell death mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOlnVzWQCgcrVg90H21EOLACvtfcHk0lhFL1Y_c4MBQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFyktLY%253D&md5=de3c68f408526c38d0569f79ca4587d1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1253%2Fcircj.CJ-13-0321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1253%252Fcircj.CJ-13-0321%26sid%3Dliteratum%253Aachs%26aulast%3DElrod%26aufirst%3DJ.%2BW.%26aulast%3DMolkentin%26aufirst%3DJ.%2BD.%26atitle%3DPhysiologic%2520functions%2520of%2520cyclophilin%2520D%2520and%2520the%2520mitochondrial%2520permeability%2520transition%2520pore%26jtitle%3DCirc.%2520J.%26date%3D2013%26volume%3D77%26spage%3D1111%26epage%3D1122%26doi%3D10.1253%2Fcircj.CJ-13-0321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P. A.</span></span> <span> </span><span class="NLM_article-title">The role of immunophilins in viral infection</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1850</i></span>,  <span class="NLM_fpage">2103</span>â <span class="NLM_lpage">2110</span>, <span class="refDoi">Â DOI: 10.1016/j.bbagen.2014.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.bbagen.2014.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=25445708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOgsLnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1850&publication_year=2015&pages=2103-2110&author=S.+Hopkinsauthor=P.+A.+Gallay&title=The+role+of+immunophilins+in+viral+infection&doi=10.1016%2Fj.bbagen.2014.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The role of immunophilins in viral infection</span></div><div class="casAuthors">Hopkins, Sam; Gallay, Philippe A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1850</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2103-2110</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tremendous progress has been made in the past 20 years in understanding the roles played by immunophilins, and in particular the cyclophilins, in supporting the replication cycles of human viruses.  A growing body of genetic and biochem. evidence and data from clin. trials confirm that cyclophilins are essential cofactors that contribute to establishing a permissive environment within the host cell that supports the replication of HIV-1 and HCV.  Cyclophilin A regulates HIV-1 replication kinetics and infectivity, modulates sensitivity to host restriction factors, and cooperates in the transit of the pre-integration complex into the nucleus of infected cells.  Cyclophilin A is an essential cofactor whose expression supports HCV-specific RNA replication in human hepatocytes.  Peptidyl-prolyl isomerase inhibitors have been used in clin. trials to validate cyclophilins as antiviral targets for the treatment of HIV-1 and Chronic Hepatitis C virus infection and as mol. probes to identify the roles played by immunophilins in supporting the replication cycles of human viruses.  This review summarizes emerging research that defines the functions of immunophilins in supporting the replication cycles of HIV-1, HCV, HBV, coronaviruses, and other viral pathogens and describes new information that suggests a role for immunophilins in regulating innate immune responses against chronic viral infection.  The dependence on cyclophilins by evolutionarily distinct viruses for accomplishing various steps in replication such as viral entry, initiation of genomic nucleic acid replication, viral genome uncoating, nuclear import and nuclear entry, emphasizes the potential of cyclophilin inhibitors as therapeutic agents.  This article is part of a Special Issue entitled Proline-directed Foldases: Cell Signaling Catalysts and Drug Targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJMknLj7Z4CrVg90H21EOLACvtfcHk0lhFL1Y_c4MBQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOgsLnF&md5=2dc25d75eba3c0f18a7289380894c17e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DGallay%26aufirst%3DP.%2BA.%26atitle%3DThe%2520role%2520of%2520immunophilins%2520in%2520viral%2520infection%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2015%26volume%3D1850%26spage%3D2103%26epage%3D2110%26doi%3D10.1016%2Fj.bbagen.2014.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flisiak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horban, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvarajah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiercinska-Drapalo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siwak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cielniak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higersberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kierkus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aeschlimann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosgurin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas-á¸¾etral, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabbe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalfaro, P.</span></span> <span> </span><span class="NLM_article-title">The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">817</span>â <span class="NLM_lpage">826</span>, <span class="refDoi">Â DOI: 10.1002/hep.22131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1002%2Fhep.22131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=18302285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVOiu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=817-826&author=R.+Flisiakauthor=A.+Horbanauthor=P.+Gallayauthor=M.+Bobardtauthor=S.+Selvarajahauthor=A.+Wiercinska-Drapaloauthor=E.+Siwakauthor=I.+Cielniakauthor=J.+Higersbergerauthor=J.+Kierkusauthor=C.+Aeschlimannauthor=P.+Grosgurinauthor=V.+Nicolas-%E1%B8%BEetralauthor=J.-M.+Dumontauthor=H.+Porchetauthor=R.+Crabbeauthor=P.+Scalfaro&title=The+cyclophilin+inhibitor+Debio-025+shows+potent+anti-hepatitis+C+effect+in+patients+coinfected+with+hepatitis+C+and+human+immunodeficiency+virus&doi=10.1002%2Fhep.22131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The cyclophilin inhibitor Debio-O25 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus</span></div><div class="casAuthors">Flisiak, Robert; Horban, Andrzej; Gallay, Philippe; Bobardt, Michael; Selvarajah, Suganya; Wiercinska-Drapalo, Alicja; Siwak, Ewa; Cielniak, Iwona; Higersberger, Jozef; Kierkus, Jarek; Aeschlimann, Christian; Grosgurin, Pierre; Nicolas-Metral, Valerie; Dumont, Jean-Maurice; Porchet, Herve; Crabbe, Raf; Scalfaro, Pietro</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">817-826</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Debio-025 is an oral cyclophilin (Cyp) inhibitor with potent anti-hepatitis C virus activity in vitro.  Its effect on viral load as well as its influence on intracellular Cyp levels was investigated in a randomized, double-blind, placebo-controlled study.  Mean hepatitis C viral load decreased significantly by 3.6 log10 after a 14-day oral treatment with 1200 mg twice daily (P < 0.0001) with an effect against the 3 genotypes (1, 3, and 4) represented in the study.  In addn., the absence of viral rebound during treatment indicates that Debio-025 has a high barrier for the selection of resistance.  In Debio-025-treated patients, cydophilin B (CypB) levels in peripheral blood mononuclear cells decreased from 67 Â± 6 (std. error) ng/mg protein (baseline) to 5 Â± 1 ng/mg protein at day 15 (P < 0.01).  Conclusion: Debio-025 induced a strong drop in CypB levels, coinciding with the decrease in hepatitis C viral load.  These are the first preliminary human data supporting the hypothesis that CypB may play an important role in hepatitis C virus replication and that Cyp inhibition is a valid target for the development of anti-hepatitis C drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxguJagRjm8bVg90H21EOLACvtfcHk0lhPRxs5ZZrcJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVOiu7o%253D&md5=8b864afa2a4d2b55fc90650d5ac4e30b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fhep.22131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22131%26sid%3Dliteratum%253Aachs%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DHorban%26aufirst%3DA.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DSelvarajah%26aufirst%3DS.%26aulast%3DWiercinska-Drapalo%26aufirst%3DA.%26aulast%3DSiwak%26aufirst%3DE.%26aulast%3DCielniak%26aufirst%3DI.%26aulast%3DHigersberger%26aufirst%3DJ.%26aulast%3DKierkus%26aufirst%3DJ.%26aulast%3DAeschlimann%26aufirst%3DC.%26aulast%3DGrosgurin%26aufirst%3DP.%26aulast%3DNicolas-%25E1%25B8%25BEetral%26aufirst%3DV.%26aulast%3DDumont%26aufirst%3DJ.-M.%26aulast%3DPorchet%26aufirst%3DH.%26aulast%3DCrabbe%26aufirst%3DR.%26aulast%3DScalfaro%26aufirst%3DP.%26atitle%3DThe%2520cyclophilin%2520inhibitor%2520Debio-025%2520shows%2520potent%2520anti-hepatitis%2520C%2520effect%2520in%2520patients%2520coinfected%2520with%2520hepatitis%2520C%2520and%2520human%2520immunodeficiency%2520virus%26jtitle%3DHepatology%26date%3D2008%26volume%3D47%26spage%3D817%26epage%3D826%26doi%3D10.1002%2Fhep.22131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMassimo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusnak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalezari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorneaux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalczyk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeill, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baugh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span> <span> </span><span class="NLM_article-title">The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">47</span>â <span class="NLM_lpage">54</span>, <span class="refDoi">Â DOI: 10.1016/j.jhep.2012.02.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.jhep.2012.02.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=22425702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC38XovV2nsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=47-54&author=S.+Hopkinsauthor=B.+DiMassimoauthor=P.+Rusnakauthor=D.+Heumanauthor=J.+Lalezariauthor=A.+Sluderauthor=B.+Scorneauxauthor=S.+Mosierauthor=P.+Kowalczykauthor=Y.+Ribeillauthor=J.+Baughauthor=P.+Gallay&title=The+cyclophilin+inhibitor+SCY-635+suppresses+viral+replication+and+induces+endogenous+interferons+in+patients+with+chronic+HCV+genotype+1+infection&doi=10.1016%2Fj.jhep.2012.02.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection</span></div><div class="casAuthors">Hopkins, Sam; DiMassimo, Betty; Rusnak, Pamela; Heuman, Douglas; Lalezari, Jacob; Sluder, Ann; Scorneaux, Bernard; Mosier, Sarah; Kowalczyk, Paul; Ribeill, Yves; Baugh, James; Gallay, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background & Aims: SCY-635 is a non-immunosuppressive analog of cyclosporin A that inhibits cyclophilins A and B and hepatitis C virus (HCV) replication in vitro.  In a phase 1b multi-dose escalation study, we evaluated the safety, plasma pharmacokinetics, and antiviral activity of 15 days of monotherapy with SCY-635 in adults with chronic genotype 1 HCV infection.  Methods: Twenty adults with chronic HCV genotype 1 were randomized to SCY-635 oral doses of 100, 200, or 300 mg three times daily for 15 days.  Results: No dose-limiting clin. or lab. toxicities were identified.  On day 15, the mean decline in plasma viremia was 2.24 Â± 1.74 log10 IU/mL with SCY-635 900 mg/d.  Individual antiviral responses correlated with host IL28B genotype.  Post hoc analyses indicated treatment with SCY-635 increased plasma protein concns. of interferon Î± (IFNÎ±), IFNs Î»1 and Î»3, and 2'5' oligoadenylate synthetase 1 (2'5'OAS-1), with the greatest increases in IL28B CC and CT subjects.  Changes in plasma concns. for all markers were coincident with changes in the plasma concn. of SCY-635.  Peaks of IFNs Î±, Î»1, and Î»3 and 2'5'OAS-1 were obsd. within 2 h after drug administration.  In replicon cells, SCY-635 enhanced secretion of type I and type III IFNs and increased the expression of IFN-stimulated genes (ISG).  Conclusions: These studies establish clin. proof of concept for SCY-635 as a novel antiviral agent and suggest that restoration of the host innate immune response to chronic hepatitis C infection may represent a major mechanism through which cyclophilin inhibitors exert clin. antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOeLKHF7TNQLVg90H21EOLACvtfcHk0lhPRxs5ZZrcJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovV2nsLc%253D&md5=43dcadacaaef7efd63d3d823f53ad514</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2012.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2012.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DDiMassimo%26aufirst%3DB.%26aulast%3DRusnak%26aufirst%3DP.%26aulast%3DHeuman%26aufirst%3DD.%26aulast%3DLalezari%26aufirst%3DJ.%26aulast%3DSluder%26aufirst%3DA.%26aulast%3DScorneaux%26aufirst%3DB.%26aulast%3DMosier%26aufirst%3DS.%26aulast%3DKowalczyk%26aufirst%3DP.%26aulast%3DRibeill%26aufirst%3DY.%26aulast%3DBaugh%26aufirst%3DJ.%26aulast%3DGallay%26aufirst%3DP.%26atitle%3DThe%2520cyclophilin%2520inhibitor%2520SCY-635%2520suppresses%2520viral%2520replication%2520and%2520induces%2520endogenous%2520interferons%2520in%2520patients%2520with%2520chronic%2520HCV%2520genotype%25201%2520infection%26jtitle%3DJ.%2520Hepatol.%26date%3D2012%26volume%3D57%26spage%3D47%26epage%3D54%26doi%3D10.1016%2Fj.jhep.2012.02.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keller, D. M.</span></span> <span> </span><span class="NLM_article-title">Pancreatitis Events Halt Development of Alisporivir for HCV</span>.  <i>Medscape</i>, Apr 19, <span class="NLM_year" style="font-weight: bold;">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+M.+Keller&title=Pancreatitis+Events+Halt+Development+of+Alisporivir+for+HCV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeller%26aufirst%3DD.%2BM.%26atitle%3DPancreatitis%2520Events%2520Halt%2520Development%2520of%2520Alisporivir%2520for%2520HCV%26jtitle%3DMedscape%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puyang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulin, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathy, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span> <span> </span><span class="NLM_article-title">Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1981</span>â <span class="NLM_lpage">1987</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01236-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1128%2FAAC.01236-09" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1981-1987&author=X.+Puyangauthor=D.+L.+Poulinauthor=J.+E.+Mathyauthor=L.+J.+Andersonauthor=S.+Maauthor=Z.+Fangauthor=S.+Zhuauthor=K.+Linauthor=R.+Fujimotoauthor=T.+Comptonauthor=B.+Wiedmann&title=Mechanism+of+resistance+of+hepatitis+C+virus+replicons+to+structurally+distinct+cyclophilin+inhibitors&doi=10.1128%2FAAC.01236-09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.01236-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01236-09%26sid%3Dliteratum%253Aachs%26aulast%3DPuyang%26aufirst%3DX.%26aulast%3DPoulin%26aufirst%3DD.%2BL.%26aulast%3DMathy%26aufirst%3DJ.%2BE.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DFujimoto%26aufirst%3DR.%26aulast%3DCompton%26aufirst%3DT.%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DMechanism%2520of%2520resistance%2520of%2520hepatitis%2520C%2520virus%2520replicons%2520to%2520structurally%2520distinct%2520cyclophilin%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D1981%26epage%3D1987%26doi%3D10.1128%2FAAC.01236-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robotham, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grise, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frausto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zayas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartenschlager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenstein, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nag, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkiewicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span> <span> </span><span class="NLM_article-title">A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e1001118</span>, <span class="refDoi">Â DOI: 10.1371/journal.ppat.1001118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1371%2Fjournal.ppat.1001118" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=e1001118&author=F.+Yangauthor=J.+M.+Robothamauthor=H.+Griseauthor=S.+Fraustoauthor=V.+Madanauthor=M.+Zayasauthor=R.+Bartenschlagerauthor=M.+Robinsonauthor=A.+E.+Greensteinauthor=A.+Nagauthor=T.+M.+Loganauthor=E.+Bienkiewiczauthor=H.+Tang&title=A+major+determinant+of+cyclophilin+dependence+and+cyclosporine+susceptibility+of+hepatitis+C+virus+identified+by+a+genetic+approach&doi=10.1371%2Fjournal.ppat.1001118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1001118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1001118%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DRobotham%26aufirst%3DJ.%2BM.%26aulast%3DGrise%26aufirst%3DH.%26aulast%3DFrausto%26aufirst%3DS.%26aulast%3DMadan%26aufirst%3DV.%26aulast%3DZayas%26aufirst%3DM.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DM.%26aulast%3DGreenstein%26aufirst%3DA.%2BE.%26aulast%3DNag%26aufirst%3DA.%26aulast%3DLogan%26aufirst%3DT.%2BM.%26aulast%3DBienkiewicz%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DH.%26atitle%3DA%2520major%2520determinant%2520of%2520cyclophilin%2520dependence%2520and%2520cyclosporine%2520susceptibility%2520of%2520hepatitis%2520C%2520virus%2520identified%2520by%2520a%2520genetic%2520approach%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26spage%3De1001118%26doi%3D10.1371%2Fjournal.ppat.1001118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanoulle, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieruszeski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdegem, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landrieu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartenschlager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippens, G.</span></span> <span> </span><span class="NLM_article-title">Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis/trans isomerase activity of cyclophilins A and B</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">13589</span>â <span class="NLM_lpage">13601</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M809244200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1074%2Fjbc.M809244200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=13589-13601&author=X.+Hanoulleauthor=A.+Badilloauthor=J.+M.+Wieruszeskiauthor=D.+Verdegemauthor=I.+Landrieuauthor=R.+Bartenschlagerauthor=F.+Peninauthor=G.+Lippens&title=Hepatitis+C+virus+NS5A+protein+is+a+substrate+for+the+peptidyl-prolyl+cis%2Ftrans+isomerase+activity+of+cyclophilins+A+and+B&doi=10.1074%2Fjbc.M809244200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M809244200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M809244200%26sid%3Dliteratum%253Aachs%26aulast%3DHanoulle%26aufirst%3DX.%26aulast%3DBadillo%26aufirst%3DA.%26aulast%3DWieruszeski%26aufirst%3DJ.%2BM.%26aulast%3DVerdegem%26aufirst%3DD.%26aulast%3DLandrieu%26aufirst%3DI.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DPenin%26aufirst%3DF.%26aulast%3DLippens%26aufirst%3DG.%26atitle%3DHepatitis%2520C%2520virus%2520NS5A%2520protein%2520is%2520a%2520substrate%2520for%2520the%2520peptidyl-prolyl%2520cis%252Ftrans%2520isomerase%2520activity%2520of%2520cyclophilins%2520A%2520and%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D13589%26epage%3D13601%26doi%3D10.1074%2Fjbc.M809244200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, I. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Striker, R.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e9815</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0009815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1371%2Fjournal.pone.0009815" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9815&author=F.+Fernandesauthor=I.+U.+Ansariauthor=R.+Striker&title=Cyclosporine+inhibits+a+direct+interaction+between+cyclophilins+and+hepatitis+C+NS5A&doi=10.1371%2Fjournal.pone.0009815"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009815%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DF.%26aulast%3DAnsari%26aufirst%3DI.%2BU.%26aulast%3DStriker%26aufirst%3DR.%26atitle%3DCyclosporine%2520inhibits%2520a%2520direct%2520interaction%2520between%2520cyclophilins%2520and%2520hepatitis%2520C%2520NS5A%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9815%26doi%3D10.1371%2Fjournal.pone.0009815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Rivera, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P. A.</span></span> <span> </span><span class="NLM_article-title">The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3888</span>â <span class="NLM_lpage">3897</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00693-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1128%2FAAC.00693-12" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3888-3897&author=S.+Hopkinsauthor=M.+Bobardtauthor=U.+Chatterjiauthor=J.+A.+Garcia-Riveraauthor=P.+Limauthor=P.+A.+Gallay&title=The+cyclophilin+inhibitor+SCY-635+disrupts+hepatitis+C+virus+NS5A-cyclophilin+A+complexes&doi=10.1128%2FAAC.00693-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.00693-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00693-12%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DGarcia-Rivera%26aufirst%3DJ.%2BA.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DGallay%26aufirst%3DP.%2BA.%26atitle%3DThe%2520cyclophilin%2520inhibitor%2520SCY-635%2520disrupts%2520hepatitis%2520C%2520virus%2520NS5A-cyclophilin%2520A%2520complexes%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3888%26epage%3D3897%26doi%3D10.1128%2FAAC.00693-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroto-Esoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizokami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakita, T.</span></span> <span> </span><span class="NLM_article-title">Cyclosporin A and its analogs inhibit Hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1726</span>â <span class="NLM_lpage">1737</span>, <span class="refDoi">Â DOI: 10.1002/hep.26982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1002%2Fhep.26982" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=1726-1737&issue=5&author=K.+Watashiauthor=A.+Sluderauthor=T.+Daitoauthor=S.+Matsunagaauthor=A.+Ryoauthor=S.+Nagamoriauthor=M.+Iwamotoauthor=S.+Nakajimaauthor=S.+Tsukudaauthor=K.+Borroto-Esodaauthor=M.+Sugiyamaauthor=Y.+Tanakaauthor=Y.+Kanaiauthor=H.+Kusuharaauthor=M.+Mizokamiauthor=T.+Wakita&title=Cyclosporin+A+and+its+analogs+inhibit+Hepatitis+B+virus+entry+into+cultured+hepatocytes+through+targeting+a+membrane+transporter%2C+sodium+taurocholate+cotransporting+polypeptide+%28NTCP%29&doi=10.1002%2Fhep.26982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fhep.26982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26982%26sid%3Dliteratum%253Aachs%26aulast%3DWatashi%26aufirst%3DK.%26aulast%3DSluder%26aufirst%3DA.%26aulast%3DDaito%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DRyo%26aufirst%3DA.%26aulast%3DNagamori%26aufirst%3DS.%26aulast%3DIwamoto%26aufirst%3DM.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DTsukuda%26aufirst%3DS.%26aulast%3DBorroto-Esoda%26aufirst%3DK.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DKusuhara%26aufirst%3DH.%26aulast%3DMizokami%26aufirst%3DM.%26aulast%3DWakita%26aufirst%3DT.%26atitle%3DCyclosporin%2520A%2520and%2520its%2520analogs%2520inhibit%2520Hepatitis%2520B%2520virus%2520entry%2520into%2520cultured%2520hepatocytes%2520through%2520targeting%2520a%2520membrane%2520transporter%252C%2520sodium%2520taurocholate%2520cotransporting%2520polypeptide%2520%2528NTCP%2529%26jtitle%3DHepatology%26date%3D2014%26volume%3D59%26issue%3D5%26spage%3D1726%26epage%3D1737%26doi%3D10.1002%2Fhep.26982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nkongolo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lempp, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esser-Nobis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehrle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, S.</span></span> <span> </span><span class="NLM_article-title">Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">723</span>â <span class="NLM_lpage">731</span>, <span class="refDoi">Â DOI: 10.1016/j.jhep.2013.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.jhep.2013.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=24295872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlagtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=723-731&issue=4&author=S.+Nkongoloauthor=Y.+Niauthor=F.+A.+Lemppauthor=C.+Kaufmanauthor=T.+Lindnerauthor=K.+Esser-Nobisauthor=V.+Lohmannauthor=W.+Mierauthor=S.+Mehrleauthor=S.+Urban&title=Cyclosporin+A+inhibits+hepatitis+B+and+hepatitis+D+virus+entry+by+cyclophilin-independent+interference+with+the+NTCP+receptor&doi=10.1016%2Fj.jhep.2013.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor</span></div><div class="casAuthors">Nkongolo, Shirin; Ni, Yi; Lempp, Florian A.; Kaufman, Christina; Lindner, Thomas; Esser-Nobis, Katharina; Lohmann, Volker; Mier, Walter; Mehrle, Stefan; Urban, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">723-731</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chronic hepatitis B and hepatitis D are global health problems caused by the human hepatitis B and hepatitis D virus.  The myristoylated preS1 domain of the large envelope protein mediates specific binding to hepatocytes by sodium taurocholate co-transporting polypeptide (NTCP).  NTCP is a bile salt transporter known to be inhibited by cyclosporin A.  This study aimed to characterize the effect of cyclosporin A on HBV/HDV infection.  HepaRG cells, primary human hepatocytes, and susceptible NTCP-expressing hepatoma cell lines were applied for infection expts.  The mode of action of cyclosporin A was studied by comparing the effect of different inhibitors, cyclophilin A/B/C-silenced cell lines as well as NTCP variants and mutants.  Bile salt transporter and HBV receptor functions were investigated by taurocholate uptake and quantification of HBVpreS binding.Cyclosporin A inhibited hepatitis B and D virus infections during and - less pronounced - prior to virus inoculation.  Binding of HBVpreS to NTCP was blocked by cyclosporin A concns. at 8 Î¼M.  An NTCP variant deficient in HBVpreS binding but competent for bile salt transport showed resistance to cyclosporin A.  Silencing of cyclophilins A/B/C did not abrogate transporter and receptor inhibition.  In contrast, tacrolimus, a cyclophilin-independent calcineurin inhibitor, was inactive.HBV and HDV entry via sodium taurocholate co-transporting polypeptide is inhibited by cyclosporin A.  The interaction between the drug and the viral receptor is direct and overlaps with a functional binding site of the preS1 domain, which mediates viral entry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTAVAhQe6_ErVg90H21EOLACvtfcHk0ljRDcpBBoMNPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlagtw%253D%253D&md5=d8c7e3698ac926cd5c06a9e7e2c4717b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2013.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2013.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DNkongolo%26aufirst%3DS.%26aulast%3DNi%26aufirst%3DY.%26aulast%3DLempp%26aufirst%3DF.%2BA.%26aulast%3DKaufman%26aufirst%3DC.%26aulast%3DLindner%26aufirst%3DT.%26aulast%3DEsser-Nobis%26aufirst%3DK.%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DMier%26aufirst%3DW.%26aulast%3DMehrle%26aufirst%3DS.%26aulast%3DUrban%26aufirst%3DS.%26atitle%3DCyclosporin%2520A%2520inhibits%2520hepatitis%2520B%2520and%2520hepatitis%2520D%2520virus%2520entry%2520by%2520cyclophilin-independent%2520interference%2520with%2520the%2520NTCP%2520receptor%26jtitle%3DJ.%2520Hepatol.%26date%3D2014%26volume%3D60%26issue%3D4%26spage%3D723%26epage%3D731%26doi%3D10.1016%2Fj.jhep.2013.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span> <span> </span><span class="NLM_article-title">From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7145</span>â <span class="NLM_lpage">7159</span>, <span class="refDoi">Â DOI: 10.1021/jm500223x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500223x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKgs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7145-7159&author=Z.+K.+Sweeneyauthor=J.+Fuauthor=B.+Wiedmann&title=From+chemical+tools+to+clinical+medicines%3A+nonimmunosuppressive+cyclophilin+inhibitors+derived+from+the+cyclosporin+and+sanglifehrin+scaffolds&doi=10.1021%2Fjm500223x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">From Chemical Tools to Clinical Medicines: Nonimmunosuppressive Cyclophilin Inhibitors Derived from the Cyclosporin and Sanglifehrin Scaffolds</span></div><div class="casAuthors">Sweeney, Zachary K.; Fu, Jiping; Wiedmann, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7145-7159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The cyclophilins are widely expressed enzymes that catalyze the interconversion of the cis and trans peptide bonds of prolines.  The immunosuppressive natural products cyclosporine A and sanglifehrin A inhibit the enzymic activity of the cyclophilins.  Chem. modification of both the cyclosporine and sanglifehrin scaffolds has produced many analogs that inhibit cyclophilins in vitro but have reduced immunosuppressive properties.  Three nonimmunosuppressive cyclophilin inhibitors (alisporivir, SCY-635, and NIM811) have demonstrated clin. efficacy for the treatment of hepatitis C infection.  Addnl. candidates are in various stages of preclin. development for the treatment of hepatitis C or myocardial reperfusion injury.  Recent publications suggest that cyclophilin inhibitors may have utility for the treatment of diverse viral infections, inflammatory indications, and cancer.  In this review, we document the structure-activity relationships of the nonimmunosuppressive cyclosporins and sanglifehrins in clin. and preclin. development.  Aspects of the pharmacokinetic behavior and chem. biol. of these drug candidates are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX8HG6odes7Vg90H21EOLACvtfcHk0ljRDcpBBoMNPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKgs74%253D&md5=c011a3ad8d4db9481fb5f99c1e917759</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm500223x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500223x%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DFrom%2520chemical%2520tools%2520to%2520clinical%2520medicines%253A%2520nonimmunosuppressive%2520cyclophilin%2520inhibitors%2520derived%2520from%2520the%2520cyclosporin%2520and%2520sanglifehrin%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7145%26epage%3D7159%26doi%3D10.1021%2Fjm500223x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RÃ¼ckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patiny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muamba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, R.</span></span> <span> </span><span class="NLM_article-title">Synthetic routes to NEtXaa<sup>4</sup>-cyclosporin A derivatives as potential anti-HIV I drugs</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">7193</span>â <span class="NLM_lpage">7196</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4039(00)01267-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2FS0040-4039%2800%2901267-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=7193-7196&author=F.+Hublerauthor=T.+R%C3%BCckleauthor=L.+Patinyauthor=T.+Muambaauthor=J.-F.+Guichouauthor=M.+Mutterauthor=R.+Wenger&title=Synthetic+routes+to+NEtXaa4-cyclosporin+A+derivatives+as+potential+anti-HIV+I+drugs&doi=10.1016%2FS0040-4039%2800%2901267-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2901267-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252901267-3%26sid%3Dliteratum%253Aachs%26aulast%3DHubler%26aufirst%3DF.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DPatiny%26aufirst%3DL.%26aulast%3DMuamba%26aufirst%3DT.%26aulast%3DGuichou%26aufirst%3DJ.-F.%26aulast%3DMutter%26aufirst%3DM.%26aulast%3DWenger%26aufirst%3DR.%26atitle%3DSynthetic%2520routes%2520to%2520NEtXaa4-cyclosporin%2520A%2520derivatives%2520as%2520potential%2520anti-HIV%2520I%2520drugs%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D7193%26epage%3D7196%26doi%3D10.1016%2FS0040-4039%2800%2901267-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scribner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorneaux, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of [D-lysine]<sup>8</sup>cyclosporin A analogs as potential anti-HCV agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6542</span>â <span class="NLM_lpage">6546</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2010.09.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.bmcl.2010.09.036" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6542-6546&author=A.+Scribnerauthor=D.+Houckauthor=Z.+Huangauthor=S.+Mosierauthor=M.+Peelauthor=B.+Scorneaux&title=Synthesis+and+biological+evaluation+of+%5BD-lysine%5D8cyclosporin+A+analogs+as+potential+anti-HCV+agents&doi=10.1016%2Fj.bmcl.2010.09.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.036%26sid%3Dliteratum%253Aachs%26aulast%3DScribner%26aufirst%3DA.%26aulast%3DHouck%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DMosier%26aufirst%3DS.%26aulast%3DPeel%26aufirst%3DM.%26aulast%3DScorneaux%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520%255BD-lysine%255D8cyclosporin%2520A%2520analogs%2520as%2520potential%2520anti-HCV%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6542%26epage%3D6546%26doi%3D10.1016%2Fj.bmcl.2010.09.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjandra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capparelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furegati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasprzyk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yifru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span> <span> </span><span class="NLM_article-title">Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8503</span>â <span class="NLM_lpage">8516</span>, <span class="refDoi">Â DOI: 10.1021/jm500862r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500862r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChsb3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8503-8516&author=J.+Fuauthor=M.+Tjandraauthor=C.+Beckerauthor=D.+Bednarczykauthor=M.+Capparelliauthor=R.+Ellingauthor=I.+Hannaauthor=R.+Fujimotoauthor=M.+Furegatiauthor=S.+Karurauthor=T.+Kasprzykauthor=M.+Knappauthor=K.+Leungauthor=X.+Liauthor=P.+Luauthor=W.+Mergoauthor=C.+Miaultauthor=S.+Ngauthor=D.+Parkerauthor=Y.+Pengauthor=S.+Roggoauthor=A.+Rivkinauthor=R.+L.+Simmonsauthor=M.+Wangauthor=B.+Wiedmannauthor=A.+H.+Weissauthor=L.+Xiaoauthor=L.+Xieauthor=A.+Yifruauthor=S.+Yangauthor=B.+Zhouauthor=Z.+K.+Sweeney&title=Potent+nonimmunosuppressive+cyclophilin+inhibitors+with+improved+pharmaceutical+properties+and+decreased+transporter+inhibition&doi=10.1021%2Fjm500862r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Nonimmunosuppressive Cyclophilin Inhibitors With Improved Pharmaceutical Properties and Decreased Transporter Inhibition</span></div><div class="casAuthors">Fu, Jiping; Tjandra, Meiliana; Becker, Christopher; Bednarczyk, Dallas; Capparelli, Michael; Elling, Robert; Hanna, Imad; Fujimoto, Roger; Furegati, Markus; Karur, Subramanian; Kasprzyk, Theresa; Knapp, Mark; Leung, Kwan; Li, Xiaolin; Lu, Peichao; Mergo, Wosenu; Miault, Charlotte; Ng, Simon; Parker, David; Peng, Yunshan; Roggo, Silvio; Rivkin, Alexey; Simmons, Robert L.; Wang, Michael; Wiedmann, Brigitte; Weiss, Andrew H.; Xiao, Linda; Xie, Lili; Xu, Wenjian; Yifru, Aregahegn; Yang, Shengtian; Zhou, Bo; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8503-8516</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonimmunosuppressive cyclophilin inhibitors have demonstrated efficacy for the treatment of hepatitis C infection (HCV).  However, alisporivir, cyclosporin A, and most other cyclosporins are potent inhibitors of OATP1B1, MRP2, MDR1, and other important drug transporters.  Redn. of the side chain hydrophobicity of the P4 residue preserves cyclophilin binding and antiviral potency while decreasing transporter inhibition.  Representative inhibitor 33 (NIM258) is a less potent transporter inhibitor relative to previously described cyclosporins, retains anti-HCV activity in cell culture, and has an acceptable pharmacokinetic profile in rats and dogs.  An X-ray structure of 33 bound to rat cyclophilin D is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJTTMugCPY6bVg90H21EOLACvtfcHk0lj0WV_iuUsr4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChsb3L&md5=80688933869bade9ce2684db9ca82cb6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm500862r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500862r%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DTjandra%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DBednarczyk%26aufirst%3DD.%26aulast%3DCapparelli%26aufirst%3DM.%26aulast%3DElling%26aufirst%3DR.%26aulast%3DHanna%26aufirst%3DI.%26aulast%3DFujimoto%26aufirst%3DR.%26aulast%3DFuregati%26aufirst%3DM.%26aulast%3DKarur%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DT.%26aulast%3DKnapp%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DMiault%26aufirst%3DC.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWiedmann%26aufirst%3DB.%26aulast%3DWeiss%26aufirst%3DA.%2BH.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DYifru%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DPotent%2520nonimmunosuppressive%2520cyclophilin%2520inhibitors%2520with%2520improved%2520pharmaceutical%2520properties%2520and%2520decreased%2520transporter%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8503%26epage%3D8516%26doi%3D10.1021%2Fjm500862r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedrani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin Cabrejas, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papageorgiou, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jutzi Eme, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rihs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span> <span> </span><span class="NLM_article-title">Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">3849</span>â <span class="NLM_lpage">3859</span>, <span class="refDoi">Â DOI: 10.1021/ja021327y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja021327y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=3849-3859&author=R.+Sedraniauthor=J.+Kallenauthor=L.+M.+Martin+Cabrejasauthor=C.+D.+Papageorgiouauthor=F.+Seniaauthor=S.+Rohrbachauthor=D.+Wagnerauthor=B.+Thaiauthor=A.+M.+Jutzi+Emeauthor=J.+Franceauthor=L.+Obererauthor=G.+Rihsauthor=G.+Zenkeauthor=J.+Wagner&title=Sanglifehrin-cyclophilin+interaction%3A+degradation+work%2C+synthetic+macrocyclic+analogues%2C+X-ray+crystal+structure%2C+and+binding+data&doi=10.1021%2Fja021327y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja021327y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja021327y%26sid%3Dliteratum%253Aachs%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMartin%2BCabrejas%26aufirst%3DL.%2BM.%26aulast%3DPapageorgiou%26aufirst%3DC.%2BD.%26aulast%3DSenia%26aufirst%3DF.%26aulast%3DRohrbach%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DD.%26aulast%3DThai%26aufirst%3DB.%26aulast%3DJutzi%2BEme%26aufirst%3DA.%2BM.%26aulast%3DFrance%26aufirst%3DJ.%26aulast%3DOberer%26aufirst%3DL.%26aulast%3DRihs%26aufirst%3DG.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DSanglifehrin-cyclophilin%2520interaction%253A%2520degradation%2520work%252C%2520synthetic%2520macrocyclic%2520analogues%252C%2520X-ray%2520crystal%2520structure%252C%2520and%2520binding%2520data%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D3849%26epage%3D3859%26doi%3D10.1021%2Fja021327y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Rivera, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendrew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyssen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nur-E-Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warneck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, M. A.</span></span> <span> </span><span class="NLM_article-title">Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">285</span>â <span class="NLM_lpage">292</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2014.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.chembiol.2014.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=25619934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVarsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=285-292&author=M.+J.+Hanssonauthor=S.+J.+Mossauthor=M.+Bobardtauthor=U.+Chatterjiauthor=N.+Coatesauthor=J.+A.+Garcia-Riveraauthor=E.+Elmerauthor=S.+Kendrewauthor=P.+Leyssenauthor=J.+Neytsauthor=M.+Nur-E-Alamauthor=T.+Warneckauthor=B.+Wilkinsonauthor=P.+Gallayauthor=M.+A.+Gregory&title=Bioengineering+and+semisynthesis+of+an+optimized+cyclophilin+inhibitor+for+treatment+of+chronic+viral+infection&doi=10.1016%2Fj.chembiol.2014.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection</span></div><div class="casAuthors">Hansson, Magnus Joakim; Moss, Steven James; Bobardt, Michael; Chatterji, Udayan; Coates, Nigel; Garcia-Rivera, Jose A.; Elmer, Eskil; Kendrew, Steve; Leyssen, Pieter; Neyts, Johan; Nur-E-Alam, Mohammad; Warneck, Tony; Wilkinson, Barrie; Gallay, Philippe; Gregory, Matthew Alan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">285-292</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Inhibition of host-encoded targets, such as the cyclophilins, provides an opportunity to generate potent high barrier to resistance antivirals for the treatment of a broad range of viral diseases.  However, many host-targeted agents are natural products, which can be difficult to optimize using synthetic chem. alone.  We describe the orthogonal combination of bioengineering and semisynthetic chem. to optimize the drug-like properties of sanglifehrin A, a known cyclophilin inhibitor of mixed nonribosomal peptide/polyketide origin, to generate the drug candidate NVP018 (formerly BC556).  NVP018 is a potent inhibitor of hepatitis B virus, hepatitis C virus (HCV), and HIV-1 replication, shows minimal inhibition of major drug transporters, and has a high barrier to generation of both HCV and HIV-1 resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCo6mutyu4O7Vg90H21EOLACvtfcHk0lj0WV_iuUsr4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVarsr0%253D&md5=04a944f9f00471426106940c3eaaf86f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DHansson%26aufirst%3DM.%2BJ.%26aulast%3DMoss%26aufirst%3DS.%2BJ.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DCoates%26aufirst%3DN.%26aulast%3DGarcia-Rivera%26aufirst%3DJ.%2BA.%26aulast%3DElmer%26aufirst%3DE.%26aulast%3DKendrew%26aufirst%3DS.%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DNur-E-Alam%26aufirst%3DM.%26aulast%3DWarneck%26aufirst%3DT.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DGregory%26aufirst%3DM.%2BA.%26atitle%3DBioengineering%2520and%2520semisynthesis%2520of%2520an%2520optimized%2520cyclophilin%2520inhibitor%2520for%2520treatment%2520of%2520chronic%2520viral%2520infection%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D285%26epage%3D292%26doi%3D10.1016%2Fj.chembiol.2014.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed-Belkacem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahnou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevers, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cala, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douguet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlotsky, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J.-F.</span></span> <span> </span><span class="NLM_article-title">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12777</span>â <span class="NLM_lpage">12788</span>, <span class="refDoi">Â DOI: 10.1038/ncomms12777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1038%2Fncomms12777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=27652979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12777-12788&author=A.+Ahmed-Belkacemauthor=L.+Colliandreauthor=N.+Ahnouauthor=Q.+Neversauthor=M.+Gelinauthor=Y.+Bessinauthor=R.+Brilletauthor=O.+Calaauthor=D.+Douguetauthor=W.+Bourguetauthor=I.+Krimmauthor=J.-M.+Pawlotskyauthor=J.-F.+Guichou&title=Fragment-based+discovery+of+a+new+family+of+non-peptidic+small-molecule+cyclophilin+inhibitors+with+potent+antiviral+activities&doi=10.1038%2Fncomms12777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span></div><div class="casAuthors">Ahmed-Belkacem, Abdelhakim; Colliandre, Lionel; Ahnou, Nazim; Nevers, Quentin; Gelin, Muriel; Bessin, Yannick; Brillet, Rozenn; Cala, Olivier; Douguet, Dominique; Bourguet, William; Krimm, Isabelle; Pawlotsky, Jean-Michel; Guichou, Jean- Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12777</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclophilins are peptidyl-prolyl cis/trans isomerases (PPIase) that catalyze the interconversion of the peptide bond at proline residues.  Several cyclophilins play a pivotal role in the life cycle of a no. of viruses.  The existing cyclophilin inhibitors, all derived from cyclosporine A or sanglifehrin A, have disadvantages, including their size, potential for side effects unrelated to cyclophilin inhibition and drug-drug interactions, unclear antiviral spectrum and manufg. issues.  Here we use a fragment-based drug discovery approach using nucleic magnetic resonance, X-ray crystallog. and structure-based compd. optimization to generate a new family of non-peptidic, small-mol. cyclophilin inhibitors with potent in vitro PPIase inhibitory activity and antiviral activity against hepatitis C virus, human immunodeficiency virus and coronaviruses.  This family of compds. has the potential for broad-spectrum, high-barrier-to-resistance treatment of viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyow1ByjcKUbVg90H21EOLACvtfcHk0ljtxwdvv_HZfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO&md5=f984a686b75eea86431cd048f82f11c5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fncomms12777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12777%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed-Belkacem%26aufirst%3DA.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DAhnou%26aufirst%3DN.%26aulast%3DNevers%26aufirst%3DQ.%26aulast%3DGelin%26aufirst%3DM.%26aulast%3DBessin%26aufirst%3DY.%26aulast%3DBrillet%26aufirst%3DR.%26aulast%3DCala%26aufirst%3DO.%26aulast%3DDouguet%26aufirst%3DD.%26aulast%3DBourguet%26aufirst%3DW.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DPawlotsky%26aufirst%3DJ.-M.%26aulast%3DGuichou%26aufirst%3DJ.-F.%26atitle%3DFragment-based%2520discovery%2520of%2520a%2520new%2520family%2520of%2520non-peptidic%2520small-molecule%2520cyclophilin%2520inhibitors%2520with%2520potent%2520antiviral%2520activities%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12777%26epage%3D12788%26doi%3D10.1038%2Fncomms12777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shore, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandalaneni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latawiec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javed, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criddle, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, R.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of cyclophilin D to protect mitochondrial function as a potential treatment of acute pancreatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2596</span>â <span class="NLM_lpage">2611</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01801</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01801" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2596-2611&author=E.+M.+Shoreauthor=M.+Awaisauthor=N.+M.+Kershawauthor=R.+R.+Gibsonauthor=S.+Pandalaneniauthor=D.+Latawiecauthor=L.+Wenauthor=M.+A.+Javedauthor=D.+N.+Criddleauthor=N.+Berryauthor=P.+M.+O%E2%80%99Neillauthor=L.-Y.+Lianauthor=R.+Sutton&title=Small+molecule+inhibitors+of+cyclophilin+D+to+protect+mitochondrial+function+as+a+potential+treatment+of+acute+pancreatitis&doi=10.1021%2Facs.jmedchem.5b01801"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01801%26sid%3Dliteratum%253Aachs%26aulast%3DShore%26aufirst%3DE.%2BM.%26aulast%3DAwais%26aufirst%3DM.%26aulast%3DKershaw%26aufirst%3DN.%2BM.%26aulast%3DGibson%26aufirst%3DR.%2BR.%26aulast%3DPandalaneni%26aufirst%3DS.%26aulast%3DLatawiec%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DJaved%26aufirst%3DM.%2BA.%26aulast%3DCriddle%26aufirst%3DD.%2BN.%26aulast%3DBerry%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DLian%26aufirst%3DL.-Y.%26aulast%3DSutton%26aufirst%3DR.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520cyclophilin%2520D%2520to%2520protect%2520mitochondrial%2520function%2520as%2520a%2520potential%2520treatment%2520of%2520acute%2520pancreatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2596%26epage%3D2611%26doi%3D10.1021%2Facs.jmedchem.5b01801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poullennec, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoisin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliri, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent inhibitors based on the structural simplification of sanglifehrin A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1000</span>â <span class="NLM_lpage">1017</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1000-1017&author=V.+A.+Steadmanauthor=S.+B.+Pettitauthor=K.+G.+Poullennecauthor=L.+Lazaridesauthor=A.+J.+Keatsauthor=D.+K.+Deanauthor=S.+J.+Stanwayauthor=C.+A.+Austinauthor=J.+A.+Sanvoisinauthor=G.+M.+Wattauthor=H.+G.+Fliriauthor=A.+C.+Liclicanauthor=D.+Jinauthor=M.+H.+Wongauthor=S.+A.+Leavittauthor=Y.-J.+Leeauthor=Y.+Tianauthor=C.+R.+Freyauthor=T.+C.+Applebyauthor=U.+Schmitzauthor=P.+Jansaauthor=R.+L.+Mackmanauthor=B.+E.+Schultz&title=Discovery+of+potent+inhibitors+based+on+the+structural+simplification+of+sanglifehrin+A&doi=10.1021%2Facs.jmedchem.6b01329"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01329%26sid%3Dliteratum%253Aachs%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26aulast%3DPettit%26aufirst%3DS.%2BB.%26aulast%3DPoullennec%26aufirst%3DK.%2BG.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DA.%2BJ.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DAustin%26aufirst%3DC.%2BA.%26aulast%3DSanvoisin%26aufirst%3DJ.%2BA.%26aulast%3DWatt%26aufirst%3DG.%2BM.%26aulast%3DFliri%26aufirst%3DH.%2BG.%26aulast%3DLiclican%26aufirst%3DA.%2BC.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLeavitt%26aufirst%3DS.%2BA.%26aulast%3DLee%26aufirst%3DY.-J.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DFrey%26aufirst%3DC.%2BR.%26aulast%3DAppleby%26aufirst%3DT.%2BC.%26aulast%3DSchmitz%26aufirst%3DU.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520based%2520on%2520the%2520structural%2520simplification%2520of%2520sanglifehrin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1000%26epage%3D1017%26doi%3D10.1021%2Facs.jmedchem.6b01329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span>; <span class="NLM_string-name">Puyang, X.</span>; <span class="NLM_string-name">Poulin, D.</span>; <span class="NLM_string-name">Mathy, J. E.</span>; <span class="NLM_string-name">Ma, S.</span>; <span class="NLM_string-name">Anderson, L. J.</span>; <span class="NLM_string-name">Fujimoto, R.</span>; <span class="NLM_string-name">Compton, T. G.</span>; <span class="NLM_string-name">Lin, K.</span></span> <span> </span><span class="NLM_article-title">Characterization of the mechanism of resistance to cyclophilin inhibitors in HCV replicon</span>;  <i>15th International Symposium on Hepatitis C Virus and Related Viruses</i>; San Antonio, TX, October 5â9, <span class="NLM_year">2008</span>, Poster #305.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Wiedmann&author=X.+Puyang&author=D.+Poulin&author=J.+E.+Mathy&author=S.+Ma&author=L.+J.+Anderson&author=R.+Fujimoto&author=T.+G.+Compton&author=K.+Lin&title=Characterization+of+the+mechanism+of+resistance+to+cyclophilin+inhibitors+in+HCV+replicon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520the%2520mechanism%2520of%2520resistance%2520to%2520cyclophilin%2520inhibitors%2520in%2520HCV%2520replicon%26jtitle%3D15th%2520International%2520Symposium%2520on%2520Hepatitis%2520C%2520Virus%2520and%2520Related%2520Viruses%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span>; <span class="NLM_string-name">Poullennec, K. G.</span>; <span class="NLM_string-name">Lazarides, L.</span>; <span class="NLM_string-name">Aciro, C.</span>; <span class="NLM_string-name">Dean, D. K.</span>; <span class="NLM_string-name">Keats, A. J.</span>; <span class="NLM_string-name">Siegel, D. S.</span>; <span class="NLM_string-name">Schrier, A. J.</span>; <span class="NLM_string-name">Mackman, R.</span>; <span class="NLM_string-name">Jansa, P.</span>; <span class="NLM_string-name">Watt, G.</span>; <span class="NLM_string-name">Highton, A. J.</span>; <span class="NLM_string-name">Chiva, J. Y.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of Flaviviridae Viruses</span>. International Patent <span class="NLM_patent">WO 2013185093A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=V.+A.+Steadman&author=K.+G.+Poullennec&author=L.+Lazarides&author=C.+Aciro&author=D.+K.+Dean&author=A.+J.+Keats&author=D.+S.+Siegel&author=A.+J.+Schrier&author=R.+Mackman&author=P.+Jansa&author=G.+Watt&author=A.+J.+Highton&author=J.+Y.+Chiva&title=Macrocyclic+Inhibitors+of+Flaviviridae+Viruses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520Flaviviridae%2520Viruses%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aciro, C.</span>; <span class="NLM_string-name">Steadman, V. A.</span>; <span class="NLM_string-name">Pettit, S. N.</span>; <span class="NLM_string-name">Poullennec, K. G.</span>; <span class="NLM_string-name">Lazarides, L.</span>; <span class="NLM_string-name">Dean, D. K.</span>; <span class="NLM_string-name">Dunbar, N. A.</span>; <span class="NLM_string-name">Highton, A. J.</span>; <span class="NLM_string-name">Keats, A. J.</span>; <span class="NLM_string-name">Siegel, D. S.</span>; <span class="NLM_string-name">Karki, K. K.</span>; <span class="NLM_string-name">Schrier, A. J.</span>; <span class="NLM_string-name">Jansa, P.</span>; <span class="NLM_string-name">Mackman, R.</span>; <span class="NLM_string-name">Chiva, J.
Y.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of Flaviviridae Viruses</span>. International Patent <span class="NLM_patent">WO 2013185103A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Aciro&author=V.+A.+Steadman&author=S.+N.+Pettit&author=K.+G.+Poullennec&author=L.+Lazarides&author=D.+K.+Dean&author=N.+A.+Dunbar&author=A.+J.+Highton&author=A.+J.+Keats&author=D.+S.+Siegel&author=K.+K.+Karki&author=A.+J.+Schrier&author=P.+Jansa&author=R.+Mackman&author=J.%0AY.+Chiva&title=Macrocyclic+Inhibitors+of+Flaviviridae+Viruses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAciro%26aufirst%3DC.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520Flaviviridae%2520Viruses%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aciro, C.</span>; <span class="NLM_string-name">Steadman, V. A.</span>; <span class="NLM_string-name">Pettit, S. N.</span>; <span class="NLM_string-name">Poullennec, K. G.</span>; <span class="NLM_string-name">Lazarides, L.</span>; <span class="NLM_string-name">Dean, D.
K.</span>; <span class="NLM_string-name">Dunbar, N.
A.</span>; <span class="NLM_string-name">Highton, A. J.</span>; <span class="NLM_string-name">Keats, A. J.</span>; <span class="NLM_string-name">Siegel, D. S.</span>; <span class="NLM_string-name">Karki, K. K.</span>; <span class="NLM_string-name">Schrier, A. J.</span>; <span class="NLM_string-name">Jansa, P.</span>; <span class="NLM_string-name">Mackman, R.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of Flaviviridae Viruses</span>. International Patent <span class="NLM_patent">WO 2013185090A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Aciro&author=V.+A.+Steadman&author=S.+N.+Pettit&author=K.+G.+Poullennec&author=L.+Lazarides&author=D.%0AK.+Dean&author=N.%0AA.+Dunbar&author=A.+J.+Highton&author=A.+J.+Keats&author=D.+S.+Siegel&author=K.+K.+Karki&author=A.+J.+Schrier&author=P.+Jansa&author=R.+Mackman&title=Macrocyclic+Inhibitors+of+Flaviviridae+Viruses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAciro%26aufirst%3DC.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520Flaviviridae%2520Viruses%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic drugs and synthetic methodologies towards macrocycles</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6230</span>â <span class="NLM_lpage">6268</span>, <span class="refDoi">Â DOI: 10.3390/molecules18066230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.3390%2Fmolecules18066230" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=6230-6268&author=X.+Yuauthor=D.+Sun&title=Macrocyclic+drugs+and+synthetic+methodologies+towards+macrocycles&doi=10.3390%2Fmolecules18066230"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18066230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18066230%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DMacrocyclic%2520drugs%2520and%2520synthetic%2520methodologies%2520towards%2520macrocycles%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D6230%26epage%3D6268%26doi%3D10.3390%2Fmolecules18066230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parenty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagne, J.-M.</span></span> <span> </span><span class="NLM_article-title">Update 1 of: Macrolactonizations in the total synthesis of natural products</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">PR1</span>â <span class="NLM_lpage">PR40</span>, <span class="refDoi">Â DOI: 10.1021/cr300129n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr300129n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=PR1-PR40&author=A.+Parentyauthor=X.+Moreauauthor=G.+Nielauthor=J.-M.+Campagne&title=Update+1+of%3A+Macrolactonizations+in+the+total+synthesis+of+natural+products&doi=10.1021%2Fcr300129n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcr300129n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300129n%26sid%3Dliteratum%253Aachs%26aulast%3DParenty%26aufirst%3DA.%26aulast%3DMoreau%26aufirst%3DX.%26aulast%3DNiel%26aufirst%3DG.%26aulast%3DCampagne%26aufirst%3DJ.-M.%26atitle%3DUpdate%25201%2520of%253A%2520Macrolactonizations%2520in%2520the%2520total%2520synthesis%2520of%2520natural%2520products%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3DPR1%26epage%3DPR40%26doi%3D10.1021%2Fcr300129n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshiumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, M.</span></span> <span> </span><span class="NLM_article-title">An effective use of benzoic anhydride and its deviatives for the synthesis of carboxylic esters and lactones: A powerful and convenient mixed anhydride method promoted by basic catalysts</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1822</span>â <span class="NLM_lpage">1830</span>, <span class="refDoi">Â DOI: 10.1021/jo030367x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo030367x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=1822-1830&author=I.+Shiinaauthor=M.+K.+Kubotaauthor=H.+Oshiumiauthor=M.+Hashizume&title=An+effective+use+of+benzoic+anhydride+and+its+deviatives+for+the+synthesis+of+carboxylic+esters+and+lactones%3A+A+powerful+and+convenient+mixed+anhydride+method+promoted+by+basic+catalysts&doi=10.1021%2Fjo030367x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo030367x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo030367x%26sid%3Dliteratum%253Aachs%26aulast%3DShiina%26aufirst%3DI.%26aulast%3DKubota%26aufirst%3DM.%2BK.%26aulast%3DOshiumi%26aufirst%3DH.%26aulast%3DHashizume%26aufirst%3DM.%26atitle%3DAn%2520effective%2520use%2520of%2520benzoic%2520anhydride%2520and%2520its%2520deviatives%2520for%2520the%2520synthesis%2520of%2520carboxylic%2520esters%2520and%2520lactones%253A%2520A%2520powerful%2520and%2520convenient%2520mixed%2520anhydride%2520method%2520promoted%2520by%2520basic%2520catalysts%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D1822%26epage%3D1830%26doi%3D10.1021%2Fjo030367x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robak, M.-A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbage, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and applications of <i>tert</i>-butanesulfinamide</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3600</span>â <span class="NLM_lpage">3740</span>, <span class="refDoi">Â DOI: 10.1021/cr900382t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=3600-3740&author=M.-A.+T.+Robakauthor=M.+A.+Herbageauthor=J.+A.+Ellman&title=Synthesis+and+applications+of+tert-butanesulfinamide&doi=10.1021%2Fcr900382t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Applications of tert-Butanesulfinamide</span></div><div class="casAuthors">Robak, MaryAnn T.; Herbage, Melissa A.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3600-3740</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past decade, an ever increasing collection of methods based upon the chiral amine reagent tert-butanesulfinamide (I) have become some of the most extensively used synthetic approaches for both the discovery and prodn. of drug candidates.  Either enantiomer of I is inexpensive to prep. on a large scale in enantiomerically pure form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLsVMjLa-pP7Vg90H21EOLACvtfcHk0lj5Bj5ixSSOdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D&md5=ad2c9e9a2b2044f47a00be408d0907d2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr900382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900382t%26sid%3Dliteratum%253Aachs%26aulast%3DRobak%26aufirst%3DM.-A.%2BT.%26aulast%3DHerbage%26aufirst%3DM.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520tert-butanesulfinamide%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D3600%26epage%3D3740%26doi%3D10.1021%2Fcr900382t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin Cabrejas, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span> <span> </span><span class="NLM_article-title">Macrolide analogues of the novel immunosuppressant sanglifehrin: new application of the ring-closing metathesis reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2443</span>â <span class="NLM_lpage">2446</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1521-3773(19990816)38:16<2443::AID-ANIE2443>3.0.CO;2-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1002%2F%28SICI%291521-3773%2819990816%2938%3A16%3C2443%3A%3AAID-ANIE2443%3E3.0.CO%3B2-B" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=2443-2446&author=L.+M.+Martin+Cabrejasauthor=S.+Rohrbachauthor=D.+Wagnerauthor=J.+Kallenauthor=G.+Zenkeauthor=J.+Wagner&title=Macrolide+analogues+of+the+novel+immunosuppressant+sanglifehrin%3A+new+application+of+the+ring-closing+metathesis+reaction&doi=10.1002%2F%28SICI%291521-3773%2819990816%2938%3A16%3C2443%3A%3AAID-ANIE2443%3E3.0.CO%3B2-B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990816%2938%3A16%3C2443%3A%3AAID-ANIE2443%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990816%252938%253A16%253C2443%253A%253AAID-ANIE2443%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%2BCabrejas%26aufirst%3DL.%2BM.%26aulast%3DRohrbach%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DD.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DMacrolide%2520analogues%2520of%2520the%2520novel%2520immunosuppressant%2520sanglifehrin%253A%2520new%2520application%2520of%2520the%2520ring-closing%2520metathesis%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D2443%26epage%3D2446%26doi%3D10.1002%2F%28SICI%291521-3773%2819990816%2938%3A16%3C2443%3A%3AAID-ANIE2443%3E3.0.CO%3B2-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shalaeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramov, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâConnell, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plummer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalamanchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. J.</span></span> <span> </span><span class="NLM_article-title">Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using delta logP as a tool</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4870</span>â <span class="NLM_lpage">4879</span>, <span class="refDoi">Â DOI: 10.1021/jm301850m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301850m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4870-4879&author=M.+Shalaevaauthor=G.+Caronauthor=Y.+A.+Abramovauthor=T.+N.+O%E2%80%99Connellauthor=M.+S.+Plummerauthor=G.+Yalamanchiauthor=K.+A.+Farleyauthor=G.+H.+Goetzauthor=L.+Philippeauthor=M.+J.+Shapiro&title=Integrating+intramolecular+hydrogen+bonding+%28IMHB%29+considerations+in+drug+discovery+using+delta+logP+as+a+tool&doi=10.1021%2Fjm301850m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301850m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301850m%26sid%3Dliteratum%253Aachs%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DT.%2BN.%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DYalamanchi%26aufirst%3DG.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26atitle%3DIntegrating%2520intramolecular%2520hydrogen%2520bonding%2520%2528IMHB%2529%2520considerations%2520in%2520drug%2520discovery%2520using%2520delta%2520logP%2520as%2520a%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4870%26epage%3D4879%26doi%3D10.1021%2Fjm301850m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Cell permeability beyond the rule of 5</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">42</span>â <span class="NLM_lpage">61</span>, <span class="refDoi">Â DOI: 10.1016/j.addr.2016.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.addr.2016.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=27067608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSgsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=42-61&author=P.+Matssonauthor=B.+C.+Doakauthor=B.+Overauthor=J.+Kihlberg&title=Cell+permeability+beyond+the+rule+of+5&doi=10.1016%2Fj.addr.2016.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cell permeability beyond the rule of 5</span></div><div class="casAuthors">Matsson, Paer; Doak, Bradley C.; Over, Bjoern; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-61</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Drug discovery for difficult targets that have large and flat binding sites is often better suited to compds. beyond the "rule of 5" (bRo5).  However, such compds. carry higher pharmacokinetic risks, such as low soly. and permeability, and increased efflux and metab.  Interestingly, recent drug approvals and studies suggest that cell permeable and orally bioavailable drugs can be discovered far into bRo5 space.  Tactics such as redn. or shielding of polarity by N-methylation, bulky side chains and intramol. hydrogen bonds may be used to increase cell permeability in this space, but often results in decreased soly.  Conformationally flexible compds. can, however, combine high permeability and soly., properties that are keys for cell permeability and intestinal absorption.  Recent developments in computational conformational anal. will aid design of such compds. and hence prediction of cell permeability.  Transporter mediated efflux occurs for most investigated drugs in bRo5 space, however it is commonly overcome by high local intestinal concns. on oral administration.  In contrast, there is little data to support significant impact of transporter-mediated intestinal absorption in bRo5 space.  Current knowledge of compd. properties that govern transporter effects of bRo5 drugs is limited and requires further fundamental and comprehensive studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3dS_FpMvvCbVg90H21EOLACvtfcHk0ljEDIDLLEdx5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSgsb0%253D&md5=1eacb5ab6e50159f3679e3d8a1f719c4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DCell%2520permeability%2520beyond%2520the%2520rule%2520of%25205%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D101%26spage%3D42%26epage%3D61%26doi%3D10.1016%2Fj.addr.2016.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span> <span> </span><span class="NLM_article-title">Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">14073</span>â <span class="NLM_lpage">14080</span>, <span class="refDoi">Â DOI: 10.1021/ja063076p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja063076p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14073-14080&author=T.+Rezaiauthor=J.+E.+Bockauthor=M.+V.+Zhouauthor=C.+Kalyanaramanauthor=R.+S.+Lokeyauthor=M.+P.+Jacobson&title=Conformational+flexibility%2C+internal+hydrogen+bonding%2C+and+passive+membrane+permeability%3A+successful+in+silico+prediction+of+the+relative+permeabilities+of+cyclic+peptides&doi=10.1021%2Fja063076p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span></div><div class="casAuthors">Rezai, Taha; Bock, Jonathan E.; Zhou, Mai V.; Kalyanaraman, Chakrapani; Lokey, R. Scott; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">14073-14080</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report an atomistic phys. model for the passive membrane permeability of cyclic peptides.  The computational modeling was performed in advance of the expts. and did not involve the use of "training data".  The model explicitly treats the conformational flexibility of the peptides by extensive conformational sampling in low (membrane) and high (water) dielec. environments.  The passive membrane permeabilities of 11 cyclic peptides were obtained exptl. using a parallel artificial membrane permeability assay (PAMPA) and showed a linear correlation with the computational results with R2 = 0.96.  In general, the results support the hypothesis, already well established in the literature, that the ability to form internal hydrogen bonds is crit. for passive membrane permeability and can be the distinguishing factor among closely related compds., such as those studied here.  However, we have found that the no. of internal hydrogen bonds that can form in the membrane and the solvent-exposed polar surface area correlate more poorly with PAMPA permeability than our model, which quant. ests. the solvation free energy losses upon moving from high-dielec. water to the low-dielec. interior of a membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofxfL018o86rVg90H21EOLACvtfcHk0ljEDIDLLEdx5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I&md5=78d4b4082e6a72b288d4b6dac933ca35</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja063076p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063076p%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DBock%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BV.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DConformational%2520flexibility%252C%2520internal%2520hydrogen%2520bonding%252C%2520and%2520passive%2520membrane%2520permeability%253A%2520successful%2520in%2520silico%2520prediction%2520of%2520the%2520relative%2520permeabilities%2520of%2520cyclic%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14073%26epage%3D14080%26doi%3D10.1021%2Fja063076p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viarengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beglov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span> <span> </span><span class="NLM_article-title">Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">712</span>â <span class="NLM_lpage">717</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2016.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1016%2Fj.drudis.2016.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=26891978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVKrurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=712-717&issue=5&author=A.+Whittyauthor=M.+Zhongauthor=L.+Viarengoauthor=D.+Beglovauthor=D.+R.+Hallauthor=S.+Vajda&title=Quantifying+the+chameleonic+properties+of+macrocycles+and+other+high-molecular-weight+drugs&doi=10.1016%2Fj.drudis.2016.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs</span></div><div class="casAuthors">Whitty, Adrian; Zhong, Mengqi; Viarengo, Lauren; Beglov, Dmitri; Hall, David R.; Vajda, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">712-717</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Key to the pharmaceutical utility of certain macrocyclic drugs is a 'chameleonic' ability to change their conformation to expose polar groups in aq. soln., but bury them when traversing lipid membranes.  Based on anal. of the structures of 20 macrocyclic compds. that are approved oral drugs, we propose that good soly. requires a topol. polar surface area (TPSA, in Ã2) of â¥0.2 Ã mol. wt. (MW).  Meanwhile, good passive membrane permeability requires a mol. (i.e., 3D) PSA in nonpolar environments of â¤140 Ã2.  We show that one or other of these limits is almost invariably violated for compds. with MW > 600 Da, suggesting that some degree of chameleonic behavior is required for most high MW oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlN7rCqts5wLVg90H21EOLACvtfcHk0lhsNoTjYivTAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVKrurs%253D&md5=024476298f7b72efa3f0a9303bed5900</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DViarengo%26aufirst%3DL.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DD.%2BR.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DQuantifying%2520the%2520chameleonic%2520properties%2520of%2520macrocycles%2520and%2520other%2520high-molecular-weight%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26issue%3D5%26spage%3D712%26epage%3D717%26doi%3D10.1016%2Fj.drudis.2016.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebastiano, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Impact of dynamically exposed polarity on permeability and solubility of chameleonic drugs beyond the rule of 5</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4189</span>â <span class="NLM_lpage">4202</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4189-4202&author=M.+R.+Sebastianoauthor=B.+C.+Doakauthor=M.+Backlundauthor=V.+Poongavanamauthor=B.+Overauthor=G.+Ermondiauthor=G.+Caronauthor=P.+Matssonauthor=J.+Kihlberg&title=Impact+of+dynamically+exposed+polarity+on+permeability+and+solubility+of+chameleonic+drugs+beyond+the+rule+of+5&doi=10.1021%2Facs.jmedchem.8b00347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00347%26sid%3Dliteratum%253Aachs%26aulast%3DSebastiano%26aufirst%3DM.%2BR.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DBacklund%26aufirst%3DM.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520dynamically%2520exposed%2520polarity%2520on%2520permeability%2520and%2520solubility%2520of%2520chameleonic%2520drugs%2520beyond%2520the%2520rule%2520of%25205%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4189%26epage%3D4202%26doi%3D10.1021%2Facs.jmedchem.8b00347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahar, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span> <span> </span><span class="NLM_article-title">Species differences of esterase expression and hydrolase activity in plasma</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3979</span>â <span class="NLM_lpage">3988</span>, <span class="refDoi">Â DOI: 10.1002/jps.23258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1002%2Fjps.23258" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=3979-3988&author=F.+G.+Baharauthor=K.+Ohuraauthor=T.+Ogiharaauthor=T.+Imai&title=Species+differences+of+esterase+expression+and+hydrolase+activity+in+plasma&doi=10.1002%2Fjps.23258"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fjps.23258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23258%26sid%3Dliteratum%253Aachs%26aulast%3DBahar%26aufirst%3DF.%2BG.%26aulast%3DOhura%26aufirst%3DK.%26aulast%3DOgihara%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DT.%26atitle%3DSpecies%2520differences%2520of%2520esterase%2520expression%2520and%2520hydrolase%2520activity%2520in%2520plasma%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D3979%26epage%3D3988%26doi%3D10.1002%2Fjps.23258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">The pregnane X receptor: From bench to bedside</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">895</span>â <span class="NLM_lpage">908</span>, <span class="refDoi">Â DOI: 10.1517/17425255.4.7.895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=10.1517%2F17425255.4.7.895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=18624678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Chur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=895-908&author=X.+Maauthor=J.+R.+Idleauthor=F.+J.+Gonzalez&title=The+pregnane+X+receptor%3A+From+bench+to+bedside&doi=10.1517%2F17425255.4.7.895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The pregnane X receptor: from bench to bedside</span></div><div class="casAuthors">Ma, Xiaochao; Idle, Jeffrey R.; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">895-908</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The pregnane X receptor (PXR; NR1I2), a member of the nuclear receptor superfamily, regulates the expression of metabolic enzymes and transporters involved in the response of mammals to their chem. environment.  To summarize the functions and clin. implications of PXR.  In the current review, the clin. implications of PXR are discussed, and the use of genetically engineered PXR mouse models is highlighted.  Recent advances in mouse models, including Pxr-null and PXR-humanized mice, provide in vivo tools for evaluating the physiol. functions of PXR and its role in controlling xenobiotic metab. and transport.  By using the PXR knockout and humanized mouse models, PXR was found to influence drug-drug interactions, hepatic steatosis, and the homeostasis of vitamin D, bile acids, and steroid hormones.  PXR was also shown to influence inflammatory bowel diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPRNdc1axwrVg90H21EOLACvtfcHk0lhsNoTjYivTAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Chur0%253D&md5=d485d79dfef46f99ab106007ab32993a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1517%2F17425255.4.7.895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.4.7.895%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DIdle%26aufirst%3DJ.%2BR.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520pregnane%2520X%2520receptor%253A%2520From%2520bench%2520to%2520bedside%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2008%26volume%3D4%26spage%3D895%26epage%3D908%26doi%3D10.1517%2F17425255.4.7.895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bercot, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caille, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostick, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranganathan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faul, M. M.</span></span> <span> </span><span class="NLM_article-title">Diastereoselective palladium-catalyzed Î±-arylation of 4-substituted cyclohexyl esters</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5251</span>â <span class="NLM_lpage">5254</span>, <span class="refDoi">Â DOI: 10.1021/ol8021758</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol8021758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWqtLvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=5251-5254&author=E.+A.+Bercotauthor=S.+Cailleauthor=T.+M.+Bostickauthor=K.+Ranganathanauthor=R.+Jensenauthor=M.+M.+Faul&title=Diastereoselective+palladium-catalyzed+%CE%B1-arylation+of+4-substituted+cyclohexyl+esters&doi=10.1021%2Fol8021758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereoselective Palladium-Catalyzed Î±-Arylation of 4-Substituted Cyclohexyl Esters</span></div><div class="casAuthors">Bercot, Eric A.; Caille, Seb; Bostick, Tracy M.; Ranganathan, Krishnakumar; Jensen, Randy; Faul, Margaret M.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5251-5254</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diastereoselective palladium-catalyzed arylation of 4-substituted cyclohexyl esters has been developed.  The reaction proceeds at room temp. in the presence of [(t-Bu3P)PdBr]2 providing products in up to 37:1 dr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryE00lioSckLVg90H21EOLACvtfcHk0lg7K29uEs38og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWqtLvN&md5=1b4a389a6dfd5815791d169da8cb81f7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fol8021758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol8021758%26sid%3Dliteratum%253Aachs%26aulast%3DBercot%26aufirst%3DE.%2BA.%26aulast%3DCaille%26aufirst%3DS.%26aulast%3DBostick%26aufirst%3DT.%2BM.%26aulast%3DRanganathan%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DR.%26aulast%3DFaul%26aufirst%3DM.%2BM.%26atitle%3DDiastereoselective%2520palladium-catalyzed%2520%25CE%25B1-arylation%2520of%25204-substituted%2520cyclohexyl%2520esters%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D5251%26epage%3D5254%26doi%3D10.1021%2Fol8021758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreyer, A.</span>; <span class="NLM_string-name">Doods, H.</span>; <span class="NLM_string-name">Gerlach, K.</span>; <span class="NLM_string-name">Gottschling, D.</span>; <span class="NLM_string-name">Heimann, A.</span>; <span class="NLM_string-name">Mueller, S. G.</span>; <span class="NLM_string-name">Rudolf, K.</span>; <span class="NLM_string-name">Schaenzle, G.</span></span> <span> </span><span class="NLM_article-title">New Compounds</span>. International Patent <span class="NLM_patent">WO 2010139717A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Dreyer&author=H.+Doods&author=K.+Gerlach&author=D.+Gottschling&author=A.+Heimann&author=S.+G.+Mueller&author=K.+Rudolf&author=G.+Schaenzle&title=New+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDreyer%26aufirst%3DA.%26atitle%3DNew%2520Compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i90"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00802">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_13432"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00802">10.1021/acs.jmedchem.8b00802</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HCV replicon assay methods in huh-7 cells, MT4 viability and TR-FRET assay method for sanglifehrin A; organic compound liquid chromatography mass spectrometry methods; pharmacokinetic in vitro and in vivo methods; X-ray crystallography; <sup>1</sup>H NMR spectra for assayed compounds, carbon assignment for compound <b>3</b>, intramolecular hydrogen bond NMR data, and HPLC spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for <b>3</b>â<b>9</b>, <b>18</b>â<b>21</b>, <b>34</b>â<b>35</b>, <b>47</b>â<b>51</b>, and <b>53</b>â<b>54</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_001.pdf">jm8b00802_si_001.pdf (5.71 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00802/suppl_file/jm8b00802_si_002.csv">jm8b00802_si_002.csv (3.87 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Cocrystal structures of Cyp A and <b>3</b>, <b>8</b>, <b>19</b>, <b>20</b>, <b>34</b>. Authors will release the atomic coordinates upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-21%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00802%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00802" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997042fe2a1248","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
